(36651,97197,'tetraspanin-enriched microdomain','C','A pre-organized unit composed either of adhesion molecules (mainly integrins and members of the Ig superfamily), signaling receptors and/or enzyme-enriched plasma membrane domains that compartmentalizes cellular processes. Tetraspanin-enriched microdomains might be specially suited for the regulation of avidity of adhesion receptors and the compartmentalization of enzymatic activities.','2013-10-27','NSRP'),(36652,97198,'histone H3-K36 trimethylation','P','The modification of histone H3 by addition of three methyl groups to lysine at position 36 of the histone.','2013-10-27','NSRP'),(36653,97199,'cysteine-type endopeptidase activity involved in apoptotic signaling pathway','F','Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile, and contributing to the apoptotic signaling pathway.','2013-10-27','NSRP'),(36654,97200,'cysteine-type endopeptidase activity involved in execution phase of apoptosis','F','Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile, and contributing to the execution phase of apoptosis.','2013-10-27','NSRP'),(36655,97201,'negative regulation of transcription from RNA polymerase II promoter in response to stress','P','Any process that decreases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).','2013-10-27','NSRP'),(36656,97202,'activation of cysteine-type endopeptidase activity','P','Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase.','2013-10-27','NSRP'),(36657,97203,'phagocytic cup lip','C','The tip or margin of the progressing circular lamella that engulfs a particle during phagocytosis. When the two lips of the cup fuse it is converted into a phagosome.','2013-10-27','NSRP'),(36658,97204,'phagocytic cup base','C','The older part of the phagocytic cup where the actin cytoskeleton disassembles, allowing early incoming and outgoing vesicular trafficking.','2013-10-27','NSRP'),(36659,97205,'renal filtration','P','A renal system process in which fluid circulating through the body is filtered through a barrier system.','2013-10-27','NSRP'),(36660,97206,'nephrocyte filtration','P','The process by which hemolymph is filtered based on size and charge through a nephrocyte filtration barrier formed by the basement membrane and nephrocyte diaphragm.','2013-10-27','NSRP'),(36661,97207,'bud dormancy process','P','A dormancy process in which dormancy (sometimes called a dormant state) is induced, maintained or broken in a bud. Bud dormancy is a suspension of most physiological activity and growth that can be reactivated. It may be a response to environmental conditions such as seasonality or extreme heat, drought, or cold. The exit from bud dormancy is marked by the resumed growth of the bud.','2013-10-27','NSRP'),(36662,97208,'alveolar lamellar body','C','A specialized secretory organelle found in type II pneumocytes and involved in the synthesis, secretion, and reutilization of pulmonary surfactant.','2013-10-27','NSRP'),(36663,97209,'epidermal lamellar body','C','A specialized secretory organelle found in keratinocytes and involved in the formation of an impermeable, lipid-containing membrane that serves as a water barrier and is required for correct skin barrier function.','2013-10-27','NSRP'),(36664,97210,'response to gonadotropin-releasing hormone','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin-releasing hormone stimulus. Gonadotropin-releasing hormone (GnRH) is a peptide hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. GnRH is synthesized and released by the hypothalamus.','2013-10-27','NSRP'),(36665,97211,'cellular response to gonadotropin-releasing hormone','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin-releasing hormone stimulus. Gonadotropin-releasing hormone (GnRH) is a peptide hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. GnRH is synthesized and released by the hypothalamus.','2013-10-27','NSRP'),(36666,97212,'lysosomal membrane organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a lysosomal membrane. A lysosomal membrane is the lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.','2013-10-27','NSRP'),(36667,97213,'regulation of lysosomal membrane permeability','P','Any process that modulates the frequency, rate or extent of the passage or uptake of molecules by the lysosomal membrane.','2013-10-27','NSRP'),(36668,97214,'positive regulation of lysosomal membrane permeability','P','Any process that increases the frequency, rate or extent of the passage or uptake of molecules by the lysosomal membrane.','2013-10-27','NSRP'),(36669,97215,'negative regulation of lysosomal membrane permeability','P','Any process that decreases the frequency, rate or extent of the passage or uptake of molecules by the lysosomal membrane.','2013-10-27','NSRP'),(36670,97216,'guanosine tetraphosphate binding','F','Interacting selectively and non-covalently with guanosine tetraphosphate (5\'-ppGpp-3\'), a guanosine bisphosphate having diphosphate groups at both the 3\' and 5\'-positions.','2013-10-27','NSRP'),(36671,97217,'sieve area','C','A pit-like area in the cell wall of a sieve element; contains pores lined with callose and occupied by strands of protoplasmic material that interconnect the protoplasts of contiguous sieve elements.','2013-10-27','NSRP'),(36672,97218,'sieve plate','C','A part of the cell wall of a sieve tube member that bears one or more highly specialized sieve areas.','2013-10-27','NSRP'),(36673,97219,'compound sieve plate','C','A sieve plate that contains several specialized sieve areas in either a scalariform or reticulate arrangement.','2013-10-27','NSRP'),(36674,97220,'simple sieve plate','C','A sieve plate that contains a single specialized sieve area.','2013-10-27','NSRP'),(36675,97221,'MADS box-forkhead transcription factor complex','C','A protein complex that contains a MADS-box protein and two forkhead domain proteins, and binds to and regulates transcription from promoters of genes transcribed during the M/G1 transition of the cell cycle. In Schizosaccharomyces pombe, the complex contains the MADS-box protein Mbx1 and two forkhead proteins, Sep1 and Fkh2.','2013-10-27','NSRP'),(36676,97222,'mitochondrial mRNA polyadenylation','P','The enzymatic addition of a sequence of 40-60 adenylyl residues at the 3\' end of a eukaryotic mitochondrial mRNA primary transcript. Mitochondria contain both stabilizing and destabilizing poly(A) tails.','2013-10-27','NSRP'),(36677,97223,'sperm part','C','Any constituent part of a sperm, a mature male germ cell that develops from a spermatid.','2013-10-27','NSRP'),(36678,97224,'sperm connecting piece','C','The segment of the sperm flagellum that attaches to the implantation fossa of the nucleus in the sperm head; from the remnant of the centriole at this point, the axoneme extends throughout the length of the flagellum.','2013-10-27','NSRP'),(36679,97225,'sperm midpiece','C','The highly organized segment of the sperm flagellum which begins at the connecting piece and is characterized by the presence of 9 outer dense fibers (ODFs) that lie outside each of the 9 outer axonemal microtubule doublets and by a sheath of mitochondria that encloses the ODFs and the axoneme; the midpiece terminates about one-fourth of the way down the sperm flagellum at the annulus, which marks the beginning of the principal piece.','2013-10-27','NSRP'),(36680,97226,'sperm mitochondrial sheath','C','The tightly packed helical sheath of ATP-producing mitochondria restricted to the midpiece of the sperm flagellum.','2013-10-27','NSRP'),(36681,97227,'sperm annulus','C','The ring-like, filamentous structure located at the distal end of the midpiece of the sperm flagellum; the annulus is thought to form a diffusion barrier between the midpiece and the principal piece and serve as a stabilizing structure for tail rigidity.','2013-10-27','NSRP'),(36682,97228,'sperm principal piece','C','The segment of the sperm flagellum where the mitochondrial sheath ends, and the outer dense fibers (ODFs) associated with outer axonemal doublets 3 and 8 are replaced by the 2 longitudinal columns of the fibrous sheath (FS) which run the length of the principal piece and are stabilized by circumferential ribs. The principal piece makes up ~2/3 of the length of the sperm flagellum and is defined by the presence of the FS and of only 7 (rather than 9) ODFs which taper and then terminate near the distal end of the principal piece.','2013-10-27','NSRP'),(36683,97229,'sperm end piece','C','The short tip of the sperm flagellum, adjacent to the sperm principal piece and furthest from the sperm head, which contains only the axoneme surrounded by the plasma membrane.','2013-10-27','NSRP'),(36684,97230,'cell motility in response to potassium ion','P','Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another as a result of a potassium ion stimulus.','2013-10-27','NSRP'),(36685,97231,'cell motility in response to calcium ion','P','Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another as a result of a calcium ion stimulus.','2013-10-27','NSRP'),(36686,97232,'lamellar body membrane','C','The lipid bilayer surrounding a lamellar body. A lamellar body is a membrane-bounded organelle, specialized for the storage and secretion of various substances (surfactant phospholipids, glycoproteins and acid phosphates) which are arranged in the form of tightly packed, concentric, membrane sheets or lamellae. Has some similar properties to, but is distinct from, a lysosome.','2013-10-27','NSRP'),(36687,97233,'alveolar lamellar body membrane','C','The lipid bilayer surrounding an alveolar lamellar body, a specialized secretory organelle found in type II pneumocytes and involved in the synthesis, secretion, and reutilization of pulmonary surfactant.','2013-10-27','NSRP'),(36688,97234,'epidermal lamellar body membrane','C','The lipid bilayer surrounding an epidermal lamellar body, a specialized secretory organelle found in keratinocytes and involved in the formation of an impermeable, lipid-containing membrane that serves as a water barrier and is required for correct skin barrier function.','2013-10-27','NSRP'),(36689,97235,'positive regulation of fatty acid beta-oxidation by positive regulation of transcription from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of fatty acid beta-oxidation by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(36690,97236,'positive regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation','P','Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of deprivation of zinc ions.','2013-10-27','NSRP'),(36691,97237,'cellular response to toxic substance','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.','2013-10-27','NSRP'),(36692,97238,'cellular response to methylglyoxal','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylglyoxal stimulus. Methylglyoxal is a 2-oxoaldehyde derived from propanal.','2013-10-27','NSRP'),(36693,97239,'positive regulation of transcription from RNA polymerase II promoter in response to methylglyoxal','P','Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter in response to a methylglyoxal stimulus.','2013-10-27','NSRP'),(36694,97240,'attachment of chromatin to nuclear envelope','P','The process in which chromatin is anchored to the nuclear envelope.','2013-10-27','NSRP'),(36695,97241,'hematopoietic stem cell migration to bone marrow','P','The orderly movement of a hematopoietic stem cell into the bone marrow, and its subsequent positioning within defined functional compartments in that microenvironment. A hematopoietic stem cell is a cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system.','2013-10-27','NSRP'),(36696,97242,'beta-amyloid clearance','P','The process in which beta-amyloid is removed from the brain via receptors.','2013-10-27','NSRP'),(36697,97243,'flavonoid binding','F','Interacting selectively and non-covalently with a flavonoid, a compound containing two or more aromatic rings, each bearing at least one aromatic hydroxyl and connected with a carbon bridge.','2013-10-27','NSRP'),(36698,97244,'flavonol binding','F','Interacting selectively and non-covalently with a flavonol, a flavonoid that contains a 3-hydroxy-2-phenylchromen-4-one backbone.','2013-10-27','NSRP'),(36699,97245,'flavanol binding','F','Interacting selectively and non-covalently with a flavanol.','2013-10-27','NSRP'),(36700,97246,'catechin binding','F','Interacting selectively and non-covalently with a catechin, a polyphenolic antioxidant plant metabolite with a flavonoid or flavan-3-ol structure.','2013-10-27','NSRP'),(36701,97247,'epigallocatechin 3-gallate binding','F','Interacting selectively and non-covalently with epigallocatechin 3-gallate, a compound that is a gallic acid ester of a catechin.','2013-10-27','NSRP'),(36702,97248,'maintenance of protein location in cell cortex of cell tip','P','A process in which a protein or protein complex is maintained in a specific location in the cell cortex of a cell tip, and is prevented from moving elsewhere. The cell cortex of a cell tip is the region directly beneath the plasma membrane at either end of the longest axis of a cylindrical or elongated cell.','2013-10-27','NSRP'),(36703,97249,'mitochondrial respiratory chain supercomplex','C','A set of respiratory enzyme complexes of the mitochondrial inner membrane (including, for example, Complex II, Complex III, Complex IV, or F1-F0 ATPase) arranged to form a large supercomplex.','2013-10-27','NSRP'),(36704,97250,'mitochondrial respiratory chain supercomplex assembly','P','The aggregation, arrangement and bonding together of a set of respiratory enzyme complexes of the mitochondrial inner membrane (including, for example, Complex II, Complex III, Complex IV, or F1-F0 ATPase) to form a large supercomplex.','2013-10-27','NSRP'),(36705,97251,'leukotriene B4 biosynthetic process','P','The chemical reactions and pathways resulting in the formation of leukotriene B4, a leukotriene composed of (6Z,8E,10E,14Z)-eicosatetraenoic acid having (5S)- and (12R)-hydroxy substituents.','2013-10-27','NSRP'),(36706,97252,'oligodendrocyte apoptotic process','P','Any apoptotic process in an oligodendrocyte. Oligodendrocytes belong to a class of large neuroglial (macroglial) cells in the central nervous system, where they form the insulating myelin sheath of axons.','2013-10-27','NSRP'),(36707,97253,'beta-hydroxybutyrate transmembrane transporter activity','F','Catalysis of the transfer of beta-hydroxybutyrate from one side of the membrane to the other. Beta-hydroxybutyrate is the conjugate base of (R)-3-hydroxybutyric acid.','2013-10-27','NSRP'),(36708,97254,'renal tubular secretion','P','Secretion of substances from peritubular capillaries into the renal tubules to be incorporated subsequently into the urine. Substances that are secreted include organic anions, ammonia, potassium and drugs.','2013-10-27','NSRP'),(36709,97255,'R2TP complex','C','A highly conserved protein complex comprised of two ATP-dependent DNA helicases (Rvb1p and Rvb2p in yeast, Pontin52 and Reptin52 in humans), Pih1p in yeast or PIH1D1 in humans, and Tah1 in yeast or RPAP3 in humans. The complex associates with Hsp90 and is thought to have a role in assembly of large protein or protein/nucleic acid complexes. In this role it is involved in multiple processes such as box C/D snoRNP biogenesis, phosphatidylinositol-3 kinase-related protein kinase (PIKK) signaling, RNA polymerase II assembly, and others.','2013-10-27','NSRP'),(36710,97256,'phenyllactate dehydrogenase activity','F','Catalysis of the oxidation of phenyllactate to produce phenylpyruvate.','2013-10-27','NSRP'),(36711,97257,'leukotriene B4 12-hydroxy dehydrogenase activity','F','Catalysis of the reaction: leukotriene B4 + NADP(+) = 12-oxo-leukotriene B4 + NADPH + H(+).','2013-10-27','NSRP'),(36712,97258,'20-hydroxy-leukotriene B4 omega oxidase activity','F','Catalysis of the reaction: 20-hydroxy-leukotriene B4 + O2 + NADPH + H(+) = 20-aldehyde-leukotriene B4 + 2H2O + NADP(+).','2013-10-27','NSRP'),(36713,97259,'20-aldehyde-leukotriene B4 20-monooxygenase activity','F','Catalysis of the reaction: 20-aldehyde-leukotriene B4 + O2 + NADPH + H(+) = 20-carboxy-leukotriene B4 + H2O + NADP(+).','2013-10-27','NSRP'),(36714,97260,'eoxin A4 synthase activity','F','Catalysis of the reaction: leukotriene A4 = eoxin A4.','2013-10-27','NSRP'),(36715,97261,'eoxin C4 synthase activity','F','Catalysis of the reaction: eoxin A4 + glutathione = eoxin C4.','2013-10-27','NSRP'),(36716,97262,'eoxin D4 synthase activity','F','Catalysis of the reaction: eoxin C4 = eoxin D4 + 5-L-glutamyl amino acid.','2013-10-27','NSRP'),(36717,97263,'eoxin E4 synthase activity','F','Catalysis of the reaction: eoxin D4 + H20 = eoxin E4 + glycine.','2013-10-27','NSRP'),(36718,97264,'self proteolysis','P','The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their own peptide bonds.','2013-10-27','NSRP'),(36719,97265,'5(S)-hydroxyeicosatetraenoic acid dehydrogenase activity','F','Catalysis of the reaction: 5-HETE + NADP(+) = 5-oxo-ETE + NADPH + H(+).','2013-10-27','NSRP'),(36720,97266,'phenylacetyl-CoA 1,2-epoxidase activity','F','Catalysis of the reaction: phenylacetyl-CoA + H(+) + NADPH + O2 = 2-(1,2-epoxy-1,2-dihydrophenyl)acetyl-CoA + H2O + NADP(+).','2013-10-27','NSRP'),(36721,97267,'omega-hydroxylase P450 pathway','P','The chemical reactions and pathways by which arachidonic acid is converted to other compounds initially by omega-hydroxylation.','2013-10-27','NSRP'),(36722,97268,'cytoophidium','C','A subcellular filamentary structure where CTP synthase is compartmentalized in a range of organisms including bacteria, yeast, fruit fly, rat and human.','2013-10-27','NSRP'),(36723,97269,'all-trans-decaprenyl-diphosphate synthase activity','F','Catalysis of the reaction: 2-trans,6-trans-farnesyl diphosphate + 7 isopentenyl diphosphate = 7 diphosphate + all-trans-decaprenyl diphosphate.','2013-10-27','NSRP'),(36724,97270,'dishabituation','P','The temporary recovery of response to a stimulus when a novel stimulus is added.','2013-10-27','NSRP'),(36725,97271,'protein localization to bud neck','P','A process in which a protein is transported to, or maintained at, a location within a cellular bud neck.','2013-10-27','NSRP'),(36726,97272,'ammonia homeostasis','P','Any biological process involved in the maintenance of an internal steady state of ammonia.','2013-10-27','NSRP'),(36727,97273,'creatinine homeostasis','P','Any biological process involved in the maintenance of an internal steady state of creatinine.','2013-10-27','NSRP'),(36728,97274,'urea homeostasis','P','Any biological process involved in the maintenance of an internal steady state of urea.','2013-10-27','NSRP'),(36729,97275,'cellular ammonia homeostasis','P','Any biological process involved in the maintenance of an internal steady state of ammonia at the level of the cell.','2013-10-27','NSRP'),(36730,97276,'cellular creatinine homeostasis','P','Any biological process involved in the maintenance of an internal steady state of creatinine at the level of the cell.','2013-10-27','NSRP'),(36731,97277,'cellular urea homeostasis','P','Any biological process involved in the maintenance of an internal steady state of urea at the level of the cell.','2013-10-27','NSRP'),(36732,97278,'complement-dependent cytotoxicity','P','Lysis of a cell resulting from triggering of the complement cascade. An example can be seen with complement activation and subsequent lysis of a bacterial cell as a result of the binding of IgM to the cell surface followed by the binding of complement proteins to that antibody.','2013-10-27','NSRP'),(36733,97279,'histamine secretion mediated by IgE immunoglobulin','P','Histamine release triggered by the binding of an antigen to an IgE immunoglobulin bound to the cell surface. An example is mast cell histamine degranulation as a result of exposure of mast cell-bound IgE to alder tree pollen.','2013-10-27','NSRP'),(36734,97280,'histamine secretion mediated by immunoglobulin','P','Histamine release triggered by the binding of an antigen to an immunoglobulin bound to the cell surface.','2013-10-27','NSRP'),(36735,97281,'immune complex formation','P','The process that gives rise to an immune complex. Immune complexes are clusters of antibodies bound to antigen, to which complement may also be fixed, and which may precipitate or remain in solution. Examples are the clumping of cells such as bacteria or red blood cells in the presence of an antibody, precipitation of a toxin after an antibody binds to it, and clumping of viral particles as a result of antibody binding to the virus.','2013-10-27','NSRP'),(36736,97282,'immunoglobulin-mediated neutralization','P','The inhibition of an antigen\'s biological effects by antibody binding to it. An example is neutralization of diphtheria toxin by preventing its entry into human cells via the binding of antibody specific for diphtheria toxin.','2013-10-27','NSRP'),(36737,97283,'keratinocyte apoptotic process','P','Any apoptotic process in a keratinocyte. A keratinocyte is an epidermal cell which synthesizes keratin and undergoes a characteristic change as it moves upward from the basal layers of the epidermis to the cornified (horny) layer of the skin.','2013-10-27','NSRP'),(36738,97284,'hepatocyte apoptotic process','P','Any apoptotic process in a hepatocyte, the main structural component of the liver.','2013-10-27','NSRP'),(36739,97285,'cell-type specific apoptotic process','P','Any apoptotic process in a specific cell type.','2013-10-27','NSRP'),(36740,97286,'iron ion import','P','The directed movement of iron ions into a cell or organelle.','2013-10-27','NSRP'),(36741,97287,'7-cyano-7-deazaguanine metabolic process','P','The chemical reactions and pathways involving the Q nucleoside precursor 7-cyano-7-deazaguanine, also known as 2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile or preQo.','2013-10-27','NSRP'),(36742,97288,'7-cyano-7-deazaguanine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of the Q nucleoside precursor 7-cyano-7-deazaguanine, also known as 2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile or preQo.','2013-10-27','NSRP'),(36743,97289,'alpha-ribazole metabolic process','P','The chemical reactions and pathways involving alpha-ribazole, the benzimidazole nucleoside in adenosyl cobalamin (vitamin B12).','2013-10-27','NSRP'),(36744,97290,'alpha-ribazole biosynthetic process','P','The chemical reactions and pathways resulting in the formation of alpha-ribazole, the benzimidazole nucleoside in adenosyl cobalamin (vitamin B12).','2013-10-27','NSRP'),(36745,97291,'renal phosphate ion absorption','P','A renal system process in which phosphate ions are taken up from the collecting ducts and proximal and distal loops of the nephron.','2013-10-27','NSRP'),(36746,97292,'XMP metabolic process','P','The chemical reactions and pathways involving XMP, xanthosine monophosphate.','2013-10-27','NSRP'),(36747,97293,'XMP biosynthetic process','P','The chemical reactions and pathways resulting in the formation of XMP, xanthosine monophosphate.','2013-10-27','NSRP'),(36748,97294,'\'de novo\' XMP biosynthetic process','P','The chemical reactions and pathways resulting in the formation of XMP, xanthosine monophosphate, from simpler precursors.','2013-10-27','NSRP'),(36749,97295,'morphine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of morphine, 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol. Morphine is a highly potent opiate analgesic psychoactive drug obtained form the opium poppy, Papaver somniferum.','2013-10-27','NSRP'),(36750,97296,'activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway','P','Any process that initiates the activity of an inactive cysteine-type endopeptidase involved in the apoptotic signaling pathway.','2013-10-27','NSRP'),(36751,97297,'activation of cysteine-type endopeptidase activity involved in execution phase of apoptosis','P','Any process that initiates the activity of an inactive cysteine-type endopeptidase involved in the execution phase of apoptosis.','2013-10-27','NSRP'),(36752,97298,'regulation of nucleus size','P','Any process that modulates the size of the nucleus.','2013-10-27','NSRP'),(36753,97299,'cysteine-type endopeptidase activity involved in plant-type hypersensitive response','F','Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile, and contributing to plant-type hypersensitive response, the rapid, localized death of plant cells in response to invasion by a pathogen.','2013-10-27','NSRP'),(36754,97300,'programmed necrotic cell death','P','A necrotic cell death process that results from the activation of endogenous cellular processes, such as signaling involving death domain receptors and Toll-like receptors.','2013-10-27','NSRP'),(36755,97301,'regulation of potassium ion concentration by positive regulation of transcription from RNA polymerase II promoter','P','Any process that regulates the internal concentration of potassium ions at the level of a cell by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(36756,97302,'lipoprotein biosynthetic process via diacylglyceryl transfer','P','The chemical reactions and pathways by which diacylglyceryl transfer leads to formation of a water-soluble protein-lipid complex.','2013-10-27','NSRP'),(36757,97303,'lipoprotein biosynthetic process via N-acyl transfer','P','The chemical reactions and pathways by which N-acyl transfer leads to formation of a water-soluble protein-lipid complex.','2013-10-27','NSRP'),(36758,97304,'lipoprotein biosynthetic process via signal peptide cleavage','P','The chemical reactions and pathways by which signal peptide cleavage leads to formation of a water-soluble protein-lipid complex.','2013-10-27','NSRP'),(36759,97305,'response to alcohol','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alcohol stimulus.','2013-10-27','NSRP'),(36760,97306,'cellular response to alcohol','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alcohol stimulus.','2013-10-27','NSRP'),(36761,97307,'response to farnesol','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a farnesol stimulus.','2013-10-27','NSRP'),(36762,97308,'cellular response to farnesol','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a farnesol stimulus.','2013-10-27','NSRP'),(36763,97309,'cap1 mRNA methylation','P','Methylation of the ribose of the first nucleotide of a 5\'-capped mRNA.','2013-10-27','NSRP'),(36764,97310,'cap2 mRNA methylation','P','Methylation of the ribose of the first and second nucleotides of a 5\'-capped mRNA.','2013-10-27','NSRP'),(36765,97311,'biofilm matrix','C','A structure lying external to bacterial cells. A biofilm is an aggregate of surface-associated bacteria, and the biofilm matrix is the envelope of polymeric substances that surrounds the bacteria.','2013-10-27','NSRP'),(36766,97312,'biofilm matrix part','C','Any constituent part of the biofilm matrix, a structure lying external to bacterial cells. A biofilm is an aggregate of surface-associated bacteria, and the biofilm matrix is the envelope of polymeric substances that surrounds the bacteria.','2013-10-27','NSRP'),(36767,97313,'biofilm matrix surface','C','The external part of the biofilm matrix, a structure lying external to bacterial cells. A biofilm is an aggregate of surface-associated bacteria, and the biofilm matrix is the envelope of polymeric substances that surrounds the bacteria.','2013-10-27','NSRP'),(36768,97314,'apoptosome assembly','P','The aggregation, arrangement and bonding together of the apoptosome, a multisubunit protein complex involved in the signaling phase of the apoptotic process.','2013-10-27','NSRP'),(36769,97315,'response to N-acetyl-D-glucosamine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an N-acetyl-D-glucosamine stimulus.','2013-10-27','NSRP'),(36770,97316,'cellular response to N-acetyl-D-glucosamine','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an N-acetyl-D-glucosamine stimulus.','2013-10-27','NSRP'),(36771,97317,'invasive growth in response to biotic stimulus','P','The growth of colonies in filamentous chains of cells as a result of a biotic stimulus. An example of this is Candida albicans forming invasive filaments in agar medium in response to a serum stimulus.','2013-10-27','NSRP'),(36772,97318,'invasive growth in response to abiotic stimulus','P','The growth of colonies in filamentous chains of cells as a result of a abiotic stimulus. An example of this process is found in Candida albicans.','2013-10-27','NSRP'),(36773,97319,'carbohydrate import into cell','P','The directed movement of a carbohydrate into a cell.','2013-10-27','NSRP'),(36774,97320,'membrane tubulation','P','A modification in a plasma membrane resulting in formation of a tubular invagination.','2013-10-27','NSRP'),(36775,97321,'cell growth mode switching, filamentous to budding','P','The process in which a cell switches from growing as a filament (elongated cells attached end-to-end) to growing as a round budding cell. An example of this is observed in Candida albicans.','2013-10-27','NSRP'),(36776,97322,'7SK snRNA binding','F','Interacting selectively and non-covalently with a 7SK small nuclear RNA (7SK snRNA).','2013-10-27','NSRP'),(36777,97323,'B cell adhesion','P','The attachment of a B cell to another cell via adhesion molecules.','2013-10-27','NSRP'),(36778,97324,'melanocyte migration','P','The orderly movement of melanocytes from one site to another, often during the development of a multicellular organism. A melanocyte is a pigment cell derived from the neural crest. It contains melanin-filled pigment granules, which give a brown to black appearance.','2013-10-27','NSRP'),(36779,97325,'melanocyte proliferation','P','The multiplication or reproduction of melanocytes, resulting in the expansion of a cell population. A melanocyte is a pigment cell derived from the neural crest. It contains melanin-filled pigment granules, which give a brown to black appearance.','2013-10-27','NSRP'),(36780,97326,'melanocyte adhesion','P','The attachment of a melanocyte to another cell via adhesion molecules.','2013-10-27','NSRP'),(36781,97327,'response to antineoplastic agent','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antineoplastic agent stimulus. An antineoplastic agent is a substance that inhibits or prevents the proliferation of neoplasms.','2013-10-27','NSRP'),(36782,97328,'response to carboplatin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carboplatin stimulus.','2013-10-27','NSRP'),(36783,97329,'response to antimetabolite','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antimetabolite stimulus. An antimetabolite is a substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.','2013-10-27','NSRP'),(36784,97330,'response to 5-fluoro-2\'-deoxyuridine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 5-fluoro-2\'-deoxyuridine stimulus. 5-fluoro-2\'-deoxyuridine is a pyrimidine 2\'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; it is used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.','2013-10-27','NSRP'),(36785,97331,'response to cytarabine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytarabine stimulus.','2013-10-27','NSRP'),(36786,97332,'response to antipsychotic drug','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.','2013-10-27','NSRP'),(36787,97333,'response to olanzapine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an olanzapine stimulus.','2013-10-27','NSRP'),(36788,97334,'response to perphenazine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a perphenazine stimulus. Perphenazine is a phenothiazine derivative having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.','2013-10-27','NSRP'),(36789,97335,'response to quetiapine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a quetiapine stimulus.','2013-10-27','NSRP'),(36790,97336,'response to risperidone','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a risperidone stimulus.','2013-10-27','NSRP'),(36791,97337,'response to ziprasidone','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ziprasidone stimulus. Ziprasidone is a piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.','2013-10-27','NSRP'),(36792,97338,'response to clozapine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clozapine stimulus.','2013-10-27','NSRP'),(36793,97339,'glycolate transmembrane transport','P','A process in which glycolate is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. Glycolate is the anion of hydroxyethanoic acid (glycolic acid).','2013-10-27','NSRP'),(36794,97340,'inhibition of cysteine-type endopeptidase activity','P','Any process that prevents the activation of an inactive cysteine-type endopeptidase.','2013-10-27','NSRP'),(36795,97341,'zymogen inhibition','P','Any process that prevents the proteolytic processing of an inactive enzyme to an active form.','2013-10-27','NSRP'),(36796,97342,'ripoptosome','C','A protein complex formed by the association of a caspase, an adaptor protein and a RIP kinase and whose formation can induce either the extrinsic apoptotic signaling pathway or necroptosis.','2013-10-27','NSRP'),(36797,97343,'ripoptosome assembly','P','The aggregation, arrangement and bonding together of a set of components to form a ripoptosome, a protein complex whose formation can induce either the extrinsic apoptotic signaling pathway or necroptosis.','2013-10-27','NSRP'),(36798,97344,'Rix1 complex','C','A protein complex that comprises Rix1p, Ipi1p and Ipi3p, and is required for processing of ITS2 sequences from 35S pre-rRNA. The Rix1 complex has been identified in budding yeast and fission yeast, and members of this complex are conserved in higher eukaryotes.','2013-10-27','NSRP'),(36799,97345,'mitochondrial outer membrane permeabilization','P','The process by which the mitochondrial outer membrane becomes permeable to the passing of proteins and other molecules from the intermembrane space to the cytosol as part of the apoptotic signaling pathway.','2013-10-27','NSRP'),(36800,97346,'INO80-type complex','C','A chromatin remodeling protein complex initially purified from S. cerevisiae and containing more than 10 subunits, including the SWR1-related complexes. INO80 (inositol requiring 80)-type complexes have diverse functions, including promoting transcriptional activation and DNA repair.','2013-10-27','NSRP'),(36801,97347,'TAM protein secretion complex','C','A heterooligomeric protein complex that spans the bacterial periplasm and enables the secretion of adhesin proteins in Gram-negative bacteria. In Citrobacter rodentium, Salmonella enterica and Escherichia coli, the TAM complex consists of an Omp85-family protein, TamA, in the outer membrane and TamB in the inner membrane.','2013-10-27','NSRP'),(36802,97348,'host cell endocytic vesicle membrane','C','The lipid bilayer surrounding a host cell endocytic vesicle.','2013-10-27','NSRP'),(36803,97350,'neutrophil clearance','P','The selective elimination of senescent neutrophils from the body by autoregulatory mechanisms.','2013-10-27','NSRP'),(36804,97351,'toxin-antitoxin pair type II binding','F','Interacting selectively and non-covalently with a toxic protein, disabling its function. There may be more than one antitoxin to a toxic protein. Instances of this activity are known only in prokaryotes, where the toxic protein may be a ribonuclease, a DNA gyrase, or other.','2013-10-27','NSRP'),(36805,97352,'autophagic vacuole maturation','P','The process in which autophagic vacuoles (also called autophagosomes), double-membraned vacuoles containing cytoplasmic material, undergo a stepwise maturation. The process includes fusion with both endosomal and lysosomal vesicles providing an acidic environment and digestive function to the interior of the autophagic vacuole.','2013-10-27','NSRP'),(36806,97353,'centrolateral pattern formation','P','The regionalization process in which the areas along the centrolateral axis are established that will lead to differences in cell differentiation, or in which cells interpret a specific environment.','2013-10-27','NSRP'),(36807,97354,'prenylation','P','The covalent attachment of a prenyl group to a molecule; geranyl, farnesyl, or geranylgeranyl groups may be added.','2013-10-27','NSRP'),(36808,97355,'protein localization to heterochromatin','P','Any process in which a protein is transported to, or maintained at, a part of a chromosome that is organized into heterochromatin.','2013-10-27','NSRP'),(36809,97356,'perinucleolar compartment','C','The perinucleolar compartment (PNC) is a subnuclear structure associated with, but structurally distinct from, the nucleolus. The PNC contains large amounts of the heterogeneous nuclear ribonucleoprotein complex (hnRNP) called hnRNP 1 (PTB). Many RNA binding proteins as well as RNA polymerase III transcripts are highly enriched in this compartment. PTB and pol III transcripts are required for the integrity of the PNC.','2013-10-27','NSRP'),(36810,97357,'myo-inositol import into cell','P','The directed movement of myo-inositol into a cell.','2013-10-27','NSRP'),(36811,97358,'D-leucyl-tRNA(Leu) deacylase activity','F','Catalysis of the reaction: D-leucyl-tRNA(Leu) = D-leucine + tRNA(Leu). Hydrolysis of the removal of D-leucine from residues in charged tRNA(Leu).','2013-10-27','NSRP'),(36812,97359,'UDP-glucosylation','P','The covalent attachment of a UDP-glucose residue to a substrate molecule.','2013-10-27','NSRP'),(36813,97360,'chorionic trophoblast cell proliferation','P','The multiplication or reproduction of chorionic trophoblast cells, resulting in the expansion of their population.','2013-10-27','NSRP'),(36814,97361,'CIA complex','C','The cytosolic iron-sulfur protein assembly (CIA) complex mediates the incorporation of iron-sulfur clusters into apoproteins involved in DNA metabolism and genomic integrity.','2013-10-27','NSRP'),(36815,97362,'MCM8-MCM9 complex','C','A hexameric protein complex composed of MCM8 and MCM9 and involved in homologous recombination repair following DNA interstrand cross-links.','2013-10-27','NSRP'),(36816,97363,'protein O-GlcNAc transferase activity','F','Catalysis of the reaction: UDP-N-acetyl-D-glucosamine + [protein]-L-serine = UDP + [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine, or UDP-N-acetyl-D-glucosamine + [protein]-L-threonine = UDP + [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine.','2013-10-27','NSRP'),(36817,97364,'stretch-activated, cation-selective, calcium channel activity involved in regulation of action potential','F','Catalysis of the transmembrane transfer of a calcium ion by a channel that opens in response to a mechanical stress in the form of stretching, and contributing to the regulation of action potential.','2013-10-27','NSRP'),(36818,97365,'stretch-activated, cation-selective, calcium channel activity involved in regulation of cardiac muscle cell action potential','F','Catalysis of the transmembrane transfer of a calcium ion by a channel that opens in response to a mechanical stress in the form of stretching, and contributing to the regulation of action potential in a cardiac muscle cell.','2013-10-27','NSRP'),(36819,97366,'response to bronchodilator','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bronchodilator stimulus. A bronchodilator is a chemical that causes an increase in the expansion of a bronchus or bronchial tubes.','2013-10-27','NSRP'),(36820,97367,'carbohydrate derivative binding','F','Interacting selectively and non-covalently with a carbohydrate derivative.','2013-10-27','NSRP'),(36821,97368,'establishment of Sertoli cell barrier','P','Establishment of a structure near the basement membrane in adjacent Sertoli cells of the seminiferous epithelium for maintaining spermatogenesis. The structure consists of tight junctions, basal ectoplasmic specializations, and desmosome-like junctions.','2013-10-27','NSRP'),(36822,97369,'sodium ion import','P','The directed movement of sodium ions into a cell or organelle.','2013-10-27','NSRP'),(36823,97370,'protein O-GlcNAcylation via threonine','P','The glycosylation of a protein by addition of N-acetylglucosamine via the O3 atom of peptidyl-threonine, forming O3-N-acetylglucosamine-L-threonine.','2013-10-27','NSRP'),(36824,97371,'MDM2/MDM4 family protein binding','F','Interacting selectively and non-covalently with any isoform of the MDM2/MDM4 protein family, comprising negative regulators of p53.','2013-10-27','NSRP'),(36825,97372,'NAD-dependent histone deacetylase activity (H3-K18 specific)','F','Catalysis of the reaction: histone H3 N6-acetyl-L-lysine (position 18) + H2O = histone H3 L-lysine (position 18) + acetate. This reaction requires the presence of NAD, and represents the removal of an acetyl group from lysine at position 18 of the histone H3 protein.','2013-10-27','NSRP'),(36826,97373,'MCM core complex','C','A protein complex that contains Mcm4, Mcm6, and Mcm7 proteins, and possesses DNA helicase activity. In the heterohexameric MCM complex, the Mcm4/6/7 proteins form a stable core, and Mcm2, Mcm3, and Mcm5 are more peripherally associated.','2013-10-27','NSRP'),(36827,97374,'sensory neuron axon guidance','P','The process in which the migration of an axon growth cone of a sensory neuron is directed to a specific target site in response to a combination of attractive and repulsive cues. A sensory neuron is an afferent neuron conveying sensory impulses.','2013-10-27','NSRP'),(36828,97375,'spinal sensory neuron axon guidance','P','The process in which the migration of an axon growth cone of a spinal sensory neuron is directed to a specific target site in response to a combination of attractive and repulsive cues. A spinal sensory neuron is a sensory neuron that project to the spinal cord.','2013-10-27','NSRP'),(36829,97376,'interneuron axon guidance','P','The process in which the migration of an axon growth cone of an interneuron is directed to a specific target site in response to a combination of attractive and repulsive cues. An interneuron is any neuron which is not motor or sensory. Interneurons may also refer to neurons whose axons remain within a particular brain region, as contrasted with projection neurons which have axons projecting to other brain regions.','2013-10-27','NSRP'),(36830,97377,'spinal cord interneuron axon guidance','P','The process in which the migration of an axon growth cone of a spinal cord interneuron is directed to a specific target site in response to a combination of attractive and repulsive cues. A spinal cord interneuron is a CNS interneuron located in the spinal cord.','2013-10-27','NSRP'),(36831,97378,'dorsal spinal cord interneuron axon guidance','P','The process in which the migration of an axon growth cone of a dorsal spinal cord interneuron is directed to a specific target site in response to a combination of attractive and repulsive cues. A dorsal spinal cord interneuron is an interneuron located in the dorsal part of the spinal cord.','2013-10-27','NSRP'),(36832,97379,'dorsal spinal cord interneuron posterior axon guidance','P','The process in which the migration of an axon growth cone of a dorsal spinal cord interneuron is directed to a specific target site in the posterior direction along the anterior-posterior body axis in response to a combination of attractive and repulsive cues. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.','2013-10-27','NSRP'),(36833,97380,'dorsal spinal cord interneuron anterior axon guidance','P','The process in which the migration of an axon growth cone of a dorsal spinal cord interneuron is directed to a specific target site in the anterior direction along the anterior-posterior body axis in response to a combination of attractive and repulsive cues. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.','2013-10-27','NSRP'),(36834,97381,'photoreceptor disc membrane','C','Ovally-shaped membranous stack located inside the photoreceptor outer segment, and containing densely packed molecules of the photoreceptor protein rhodopsin that traverse the lipid bilayer. Disc membranes are apparently derived from the plasma membrane in the region of the cilium that connects the photoreceptor outer segment to the inner segment.','2013-10-27','NSRP'),(36835,97382,'deoxynucleoside-diphosphatase activity','F','Catalysis of the reaction: a deoxynucleoside diphosphate + H2O = a deoxynucleotide + phosphate.','2013-10-27','NSRP'),(36836,97383,'dIDP diphosphatase activity','F','Catalysis of the reaction: dIDP + H2O = dIMP + phosphate.','2013-10-27','NSRP'),(36837,97384,'cellular lipid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of lipids, as carried out by individual cells.','2013-10-27','NSRP'),(36838,97385,'necrotic cell death in response to starvation','P','A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents occurring as a result of a starvation stimulus (deprivation of nourishment).','2013-10-27','NSRP'),(36839,97386,'glial cell projection','C','A prolongation or process extending from a glial cell.','2013-10-27','NSRP'),(36840,97387,'capitate projection','C','Simple or compound process of epithelial glial cells with a spherical head that inserts into photoreceptor axons. Capitate projections have only been observed in Brachycera (flies).','2013-10-27','NSRP'),(36841,97388,'chemokine (C-C motif) ligand 19 production','P','The appearance of chemokine (C-C motif) ligand 19 (CCL19) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(36842,97389,'chemokine (C-C motif) ligand 21 production','P','The appearance of chemokine (C-C motif) ligand 21 (CCL21) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(36843,97390,'chemokine (C-X-C motif) ligand 12 production','P','The appearance of chemokine (C-X-C motif) ligand 12 (CXCL12) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(36844,97391,'chemokine (C-X-C motif) ligand 13 production','P','The appearance of chemokine (C-X-C motif) ligand 13 (CXCL13) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(36845,97392,'chemokine (C-X-C motif) ligand 16 production','P','The appearance of chemokine (C-X-C motif) ligand 16 (CXCL16) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(36846,97393,'telomeric RNA transcription','P','The synthesis of telomeric RNA from a DNA template. A telomere is a complex of DNA and proteins that seals the end of a chromosome.','2013-10-27','NSRP'),(36847,97394,'telomeric RNA transcription from RNA pol II promoter','P','The synthesis of telomeric RNA from a DNA template by RNA Polymerase II (Pol II), originating at a Pol II promoter.','2013-10-27','NSRP'),(36848,97395,'response to interleukin-32','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-32 stimulus.','2013-10-27','NSRP'),(36849,97396,'response to interleukin-17','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-17 stimulus.','2013-10-27','NSRP'),(36850,97397,'cellular response to interleukin-32','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-32 stimulus.','2013-10-27','NSRP'),(36851,97398,'cellular response to interleukin-17','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-17 stimulus.','2013-10-27','NSRP'),(36852,97399,'interleukin-32-mediated signaling pathway','P','A series of molecular signals initiated by the binding of interleukin-32 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.','2013-10-27','NSRP'),(36853,97400,'interleukin-17-mediated signaling pathway','P','A series of molecular signals initiated by the binding of interleukin-17 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.','2013-10-27','NSRP'),(36854,97401,'synaptic vesicle lumen acidification','P','Any process that reduces the pH of the synaptic vesicle lumen, measured by the concentration of the hydrogen ion.','2013-10-27','NSRP'),(36855,97402,'neuroblast migration','P','The orderly movement of a neuroblast from one site to another, often during the development of a multicellular organism or multicellular structure. A neuroblast is any cell that will divide and give rise to a neuron.','2013-10-27','NSRP'),(36856,97403,'cellular response to raffinose','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a raffinose stimulus.','2013-10-27','NSRP'),(36857,97404,'succinate import into cell','P','The directed movement of succinate into a cell.','2013-10-27','NSRP'),(36858,97405,'malate import into cell','P','The directed movement of malate into a cell.','2013-10-27','NSRP'),(36859,97406,'malonic acid import into cell','P','The directed movement of malonic acid into a cell.','2013-10-27','NSRP'),(36860,97407,'Bunina body','C','Small granular inclusions (about 1-3 microns in diameter) found in the anterior horn cells, and appearing either singly or in a group. Sometimes they are arranged in small beaded chains. Bunina bodies express cystatin C and consist of electron-dense amorphous material that contains tubules or vesicular structures. The amorphous material frequently includes a cytoplasmic island containing neurofilaments and other micro-organelles.','2013-10-27','NSRP'),(36861,97408,'fibrillary inclusion','C','Cellular inclusion consisting of circular areas filled with fine slender filaments about 10 nanometers in diameter, delimited by a wall of varying complexity (either a single continuous membrane or a tubular network consisting of a fine filamentous material giving the wall a honeycomb appearance). Fibrillary inclusions are found in the cytoplasm of giant cells of Dieters in the lateral vestibular nucleus of the rat; similar structures have been described in the ventral cochlear nucleus, spinal cord, and substantia nigra.','2013-10-27','NSRP'),(36862,97409,'glial cytoplasmic inclusion','C','Non-membrane-bound cytoplasmic inclusions composed of 10-40 nm granule-coated fibrils. These inclusions have an abnormal accumulation of alpha-synuclein protein and are found in association with multiple system atrophy.','2013-10-27','NSRP'),(36863,97410,'hippocampal interneuron differentiation','P','The process in which a relatively unspecialized cell acquires specialized features of a hippocampal interneuron.','2013-10-27','NSRP'),(36864,97411,'hypoxia-inducible factor-1alpha signaling pathway','P','A series of molecular signals mediated by hypoxia-inducible factor (HIF1) in response to lowered oxygen levels (hypoxia). Under hypoxic conditions, the oxygen-sensitive alpha-subunit of hypoxia-inducible factor (HIF)-1 dimerizes with a HIF1-beta subunit (also called ARNT or aryl-hydrocarbon-receptor nuclear translocator), translocates to the nucleus and activates transcription of genes whose products participate in responding to hypoxia.','2013-10-27','NSRP'),(36865,97412,'hyaline inclusion','C','A glass-like, pale intracellular inclusion.','2013-10-27','NSRP'),(36866,97413,'Lewy body','C','Cytoplasmic, spherical inclusion commonly found in damaged neurons, and composed of abnormally phosphorylated, neurofilament proteins aggregated with ubiquitin and alpha-synuclein.','2013-10-27','NSRP'),(36867,97414,'classical Lewy body','C','Cytoplasmic inclusion, 5 to 15 micrometers in diameter, with a dense core surrounded by a halo of 10 to 20 nm wide radially oriented alpha-synuclein fibrils.','2013-10-27','NSRP'),(36868,97415,'cortical Lewy body','C','Cytoplasmic inclusion similar to a classical Lewy body but lacking a halo of protein fibrils.','2013-10-27','NSRP'),(36869,97416,'Lewy body-like hyaline inclusion','C','Cytoplasmic inclusion found in neurons. It consists of filaments and granular materials, exhibits a dense core with a rough peripheral halo and lacks a limiting membrane. The filaments of these inclusions are composed of approximately 15-25 nm granule-coated fibrils in association with normal 10-nm neurofilaments.','2013-10-27','NSRP'),(36870,97417,'nematosome','C','Cytoplasmic, ball-like inclusion resembling a nucleolus and consisting of a convoluted network of electron-opaque strands embedded in a less dense matrix. It measures approximately 0.9 microns and lacks a limiting membrane. Its strands (diameter = 400-600 A) appear to be made of an entanglement of tightly packed filaments and particles approximately 25-50 A thick. Cytochemical studies suggest the presence of nonhistone proteins and some RNA. Usually only one such structure is present in a cell, and it appears to occur in most ganglion cells. Although they can be seen anywhere in the cell body, nematosomes are typically located in the perinuclear cytoplasm, where they are often associated with smooth-surfaced and coated vesicles.','2013-10-27','NSRP'),(36871,97418,'neurofibrillary tangle','C','Intracellular mass of paired, helically wound protein filaments (also called PHF) lying in the cytoplasm of neuronal cell bodies and neuritic cell processes. Neurofibrillary tangles contain an abnormally phosphorylated form of a microtubule-associated protein, tau. The shape of these inclusions may resemble a flame or a star.','2013-10-27','NSRP'),(36872,97419,'Pick body','C','Cellular inclusion composed of numerous tau fibrils arranged in a disorderly array. Tau protein is a major component, though Pick bodies also contain ubiquitin, alpha-synuclein, and apolipoprotein E.','2013-10-27','NSRP'),(36873,97420,'skein-like inclusion','C','Intracytoplasmic filamentous structure frequently encountered in preparations immunostained for ubiquitin.','2013-10-27','NSRP'),(36874,97421,'liver regeneration','P','The regrowth of lost or destroyed liver.','2013-10-27','NSRP'),(36875,97422,'tubular endosome','C','A network of fine tubules in the vicinity of the Golgi complex and around the centriole.','2013-10-27','NSRP'),(36876,97423,'mitochondrion-associated adherens complex','C','An organelle arrangement comprised of the following elements: a mitochondrion positioned near the presynaptic membrane; an electron-dense mitochondrial plaque adjacent to the outer mitochondrial membrane that faces the presynaptic membrane; filament-like elements appearing to link the mitochondrial plaque to a cell-cell junction region (sometimes termed punctum adherens); tubular or vesicular-appearing membrane (also called vesicular chain) interposed among the filaments. Mitochondrion-associated adherens complexes were initially described in the dorsal horn of the spinal cord. They are found in calyces and other large terminals of the auditory brainstem, and in a variety of mammalian species including humans.','2013-10-27','NSRP'),(36877,97424,'nucleolus-associated heterochromatin','C','Dense particles of heterochromatin, consisting of a loosely twisted strand about 600 Angstrom thick, found associated with the nucleolus.','2013-10-27','NSRP'),(36878,97425,'smooth endoplasmic reticulum part','C','Any constituent part of the smooth endoplasmic reticulum (also called smooth ER, or SER).','2013-10-27','NSRP'),(36879,97426,'glial filament','C','An intermediate filament composed of glial fibrillary acidic protein (GFAP) and found in astrocytes.','2013-10-27','NSRP'),(36880,97427,'microtubule bundle','C','An arrangement of closely apposed microtubules running parallel to each other.','2013-10-27','NSRP'),(36881,97428,'protein maturation by iron-sulfur cluster transfer','P','The transfer of an assembled iron-sulfur cluster from a scaffold protein to an acceptor protein that contributes to the attainment of the full functional capacity of a protein.','2013-10-27','NSRP'),(36882,97429,'amino acid ligation activity by nonribosomal peptide synthase','F','Catalysis of the ligation of an amino acid to another amino acid via a carbon-nitrogen bond, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate, carried out by a nonribosomal peptide synthase.','2013-10-27','NSRP'),(36883,97430,'copper ion import into ascospore-type prospore','P','The directed movement of copper ions into an ascospore-type prospore.','2013-10-27','NSRP'),(36884,97431,'mitotic spindle pole','C','Either of the ends of a mitotic spindle, a spindle that forms as part of mitosis, where spindle microtubules are organized; usually contains a microtubule organizing center and accessory molecules, spindle microtubules and astral microtubules.','2013-10-27','NSRP'),(36885,97432,'hippocampal pyramidal neuron differentiation','P','The process in which a relatively unspecialized cell acquires specialized features of a hippocampal pyramidal neuron, a pyramidal cell of the hippocampus.','2013-10-27','NSRP'),(36886,97433,'dense body','C','An electron dense body which may contain granules.','2013-10-27','NSRP'),(36887,97434,'succinate:hydrogen symporter activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: succinate(out) + H+(out) = succinate(in) + H+(in).','2013-10-27','NSRP'),(36888,97435,'fibril organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of fibrils, insoluble fibrous aggregates consisting of polysaccharides and/or proteins.','2013-10-27','NSRP'),(36889,97436,'entry into dormancy','P','The dormancy process that results in entry into dormancy. Dormancy (sometimes called a dormant state) is a suspension of most physiological activity and growth that can be reactivated.','2013-10-27','NSRP'),(36890,97437,'maintenance of dormancy','P','The dormancy process that results in an organism remaining in dormancy. Dormancy (sometimes called a dormant state) is a suspension of most physiological activity and growth that can be reactivated.','2013-10-27','NSRP'),(36891,97438,'exit from dormancy','P','The dormancy process that results in exit from dormancy. Dormancy (sometimes called a dormant state) is a suspension of most physiological activity and growth that can be reactivated.','2013-10-27','NSRP'),(36892,97439,'acquisition of desiccation tolerance','P','The process in which tolerance to severe drying is acquired, before entering into a dry, either dormant or quiescent state.','2013-10-27','NSRP'),(36893,97440,'apical dendrite','C','A dendrite that emerges near the apical pole of a neuron. In bipolar neurons, apical dendrites are located on the opposite side of the soma from the axon.','2013-10-27','NSRP'),(36894,97441,'basilar dendrite','C','A dendrite that emerges near the basal pole of a neuron. In bipolar neurons, basal dendrites are either on the same side of the soma as the axon, or project toward the axon.','2013-10-27','NSRP'),(36895,97442,'CA3 pyramidal cell dendrite','C','A dendrite of a hippocampal CA3 pyramidal cell.','2013-10-27','NSRP'),(36896,97443,'sorting endosome','C','A multivesicular body surrounded by and connected with multiple tubular compartments with associated vesicles.','2013-10-27','NSRP'),(36897,97444,'spine apparatus','C','A specialization of the endomembrane system found in some classes of neuron spines consisting of two or more closely apposed lamellae with interspersed dense material.','2013-10-27','NSRP'),(36898,97445,'presynaptic active zone dense projection','C','Electron dense projection extending from the cytomatrix into the cytoplasm on which synaptic vesicles are tethered.','2013-10-27','NSRP'),(36899,97446,'protein localization to eisosome filament','P','A process in which a protein is transported to, and/or maintained in, a specific location in a eisosome filament (also called linear eisosome), a filamentous cortical structure formed, in S. pombe, by the eisosome component Pil1.','2013-10-27','NSRP'),(36900,97447,'dendritic tree','C','The entire complement of dendrites for a neuron, consisting of each primary dendrite and all its branches.','2013-10-27','NSRP'),(36901,97448,'spine mat','C','A configuration of neuron spines found on ciliary ganglion neurons in the embryonic and adult brain consisting of patches of closely spaced spines lying flat against the soma.','2013-10-27','NSRP'),(36902,97449,'astrocyte projection','C','A prolongation or process extending from the soma of an astrocyte and wrapping around neurons.','2013-10-27','NSRP'),(36903,97450,'astrocyte end-foot','C','Terminal process of astrocyte abutting non-neuronal surfaces in the brain.','2013-10-27','NSRP'),(36904,97451,'glial limiting end-foot','C','Terminal process of astrocyte that extends to the surface of the central nervous system. Together, glial limiting end-feet form the glial limiting membrane or glia limitans.','2013-10-27','NSRP'),(36905,97452,'GAIT complex','C','A protein complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. The complex binds to stem loop-containing GAIT elements in the 3\'-UTR of diverse inflammatory mRNAs and suppresses their translation by blocking the recruitment of the 43S ribosomal complex to m7G cap-bound eIF4G. In humans it includes RPL13A, EPRS, SYNCRIP and GAPDH; mouse complexes lack SYNCRIP.','2013-10-27','NSRP'),(36906,97453,'mesaxon','C','Portion of the ensheathing process (either myelin or non-myelin) where the enveloping lips of the ensheathing cell come together so that their apposed plasma membranes run parallel to each other, separated by a cleft 12 nm wide.','2013-10-27','NSRP'),(36907,97454,'Schwann cell microvillus','C','Small finger-like extension of a Schwann cell that contacts the nodal membrane.','2013-10-27','NSRP'),(36908,97455,'spiny bracelet of Nageotte','C','Paranodal terminations of Schwann cells that do not directly contact the paranodal axon membrane. Usually found in thicker myelin.','2013-10-27','NSRP'),(36909,97456,'terminal loop','C','Portion of myelin-forming Schwann cell consisting of terminal cytoplasmic extensions adhered to the axon at the beginning and end of the myelin sheath.','2013-10-27','NSRP'),(36910,97457,'hippocampal mossy fiber','C','Axon of dentate gyrus granule cell projecting to hippocampal area CA3, characterized by expansions (mossy fiber expansions) giving the fibers a mossy appearance. These unmyelinated axons were first described by Ramon y Cajal.','2013-10-27','NSRP'),(36911,97458,'neuron part','C','Any constituent part of a neuron, the basic cellular unit of nervous tissue. A typical neuron consists of a cell body (often called the soma), an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.','2013-10-27','NSRP'),(36912,97459,'iron ion import into cell','P','The directed movement of iron ions across a membrane into a cell.','2013-10-27','NSRP'),(36913,97460,'ferrous iron import into cell','P','The directed movement of ferrous iron (Fe(II) or Fe2+) ions across a membrane into a cell.','2013-10-27','NSRP'),(36914,97461,'ferric iron import into cell','P','The directed movement of ferric iron (Fe(III) or Fe3+) ions across a membrane into a cell.','2013-10-27','NSRP'),(36915,97462,'Lewy neurite','C','Elongated neuronal process, often with side branches and more than one branching point, described in brains of patients with Parkinson\'s disease. Lewy neurites stain positively for ubiquitin in brainstem and forebrain regions affected in Parkinson\'s disease.','2013-10-27','NSRP'),(36916,97463,'gemmule','C','Spine-like process found on some neurons, e.g., periglomerular cells of olfactory cortex.','2013-10-27','NSRP'),(36917,97464,'thorny excrescence','C','Large complex spine protruding from a dendrite. Each excrescence is formed by a cluster of spine heads.','2013-10-27','NSRP'),(36918,97465,'somatic spine','C','Spine emanating from the cell soma of a neuron.','2013-10-27','NSRP'),(36919,97466,'misfolded or incompletely synthesized glycoprotein catabolic process','P','The chemical reactions and pathways resulting in the breakdown of misfolded or incompletely synthesized glycoproteins. A glycoprotein is a compound in which a carbohydrate component is covalently bound to a protein component.','2013-10-27','NSRP'),(36920,97467,'type III terminal bouton','C','Terminal inflated portion of the axon of a non-glutamatergic neuron, containing the specialized apparatus necessary to release neurotransmitters at a regulatory synapse. The axon terminus is considered to be the whole region of thickening and the terminal bouton is a specialized region of it. Type III terminal boutons are larger than type II ones.','2013-10-27','NSRP'),(36921,97468,'programmed cell death in response to reactive oxygen species','P','Cell death resulting from activation of endogenous cellular processes and occurring as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.','2013-10-27','NSRP'),(36922,97469,'cyclin-dependent protein tyrosine kinase activity','F','Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate. This reaction requires the binding of a regulatory cyclin subunit.','2013-10-27','NSRP'),(36923,97470,'ribbon synapse','C','Type of synapse characterized by an electron-dense ribbon, lamella (bar) or spherical body in the presynaptic process cytoplasm.','2013-10-27','NSRP'),(36924,97471,'mossy fiber rosette','C','A synapse of a mossy fiber onto the dendrite of a granule cell; each mossy fiber can have up to 50 rosettes.','2013-10-27','NSRP'),(36925,97472,'cyclin-dependent protein kinase activity','F','Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. This reaction requires the binding of a regulatory cyclin subunit and full activity requires stimulatory phosphorylation by a CDK-activating kinase (CAK).','2013-10-27','NSRP'),(36926,97473,'retinal rod cell apoptotic process','P','Any apoptotic process in a retinal rod cell, one of the two photoreceptor cell types of the vertebrate retina.','2013-10-27','NSRP'),(36927,97474,'retinal cone cell apoptotic process','P','Any apoptotic process in a retinal cone cell, one of the two photoreceptor cell types of the vertebrate retina.','2013-10-27','NSRP'),(36928,98001,'reversible bacteriophage attachment, binding of host cell surface receptor','P','Process by which a bacteriophage, using its tail fibers, spikes or a baseplate component, initially recognizes and binds to its specific receptor on the host cell surface. This process is reversible and allows the release of a bacteriophage without affecting infection.','2013-10-27','NSRP'),(36929,98002,'irreversible bacteriophage attachment, binding of host cell surface receptor','P','The processes by which a bacteriophage initially commits to infection by binding the host receptor irreversibly. Disruption of the phage:cell complex at this step results in the loss of infective phage virions since the process is characterized by conformational changes of bacteriophage head and tail proteins and injection of bacteriophage proteins into the infected cell.','2013-10-27','NSRP'),(36930,98003,'virus tail assembly','P','The aggregation, arrangement and bonding together of a set of components to form a virus tail.','2013-10-27','NSRP'),(36931,98004,'virus tail fiber assembly','P','The aggregation, arrangement and bonding together of a set of components to form a virus tail fiber.','2013-10-27','NSRP'),(36932,98005,'virus head-tail joining','P','Process by which virus heads and tails are attached to each other.','2013-10-27','NSRP'),(36933,98006,'viral DNA genome packaging, headful','P','The encapsulation of the viral genome within the capsid where DNA is packaged into the capsid until the capsid is full.','2013-10-27','NSRP'),(36934,98009,'virus terminase, large subunit','C','The part of the viral terminase complex that contains the translocase activity. The large subunit typically comprises a pentameric protein complex.','2013-10-27','NSRP'),(36935,98015,'virus tail','C','Part of the virion that may be used to recognize, attach and inject the viral genome and accessory proteins into the host cell.','2013-10-27','NSRP'),(36936,98017,'viral capsid, major subunit','C','The part of the viral capsid that comprises the most common capsomere type. For example, in a T=3 icosahedral capsid, which is composed of 12 pentameric and 20 hexameric capsomeres, the hexameric capsomeres are major subunits.','2013-10-27','NSRP'),(36937,98018,'viral capsid, minor subunit','C','The part of the viral capsid that comprises the less common capsomere type. For example, in a T=3 icosahedral capsid, which is composed of 12 pentameric and 20 hexameric capsomeres, the pentameric capsomeres are minor subunits.','2013-10-27','NSRP'),(36938,98019,'virus tail, major subunit','C','The part of the viral tail that comprises the most common subunit type.','2013-10-27','NSRP'),(36939,98020,'virus tail, minor subunit','C','The part of the viral tail that comprises the least common subunit type.','2013-10-27','NSRP'),(36940,98021,'viral capsid, decoration','C','Component of the virus capsid (head), located on the outer head surface. Involved in the stabilization of the head structure and usually non-essential.','2013-10-27','NSRP'),(36941,98022,'viral capsid, fiber','C','A type of capsid decoration composed of fiber structures.','2013-10-27','NSRP'),(36942,98023,'virus tail, tip','C','The basal end of the virus tail, which is used by the virus to attach to the host cell.','2013-10-27','NSRP'),(36943,98024,'virus tail, fiber','C','The fibrous region of the virus tail used to scan, recognize and attach to the host cell.','2013-10-27','NSRP'),(36944,98025,'virus tail, baseplate','C','Multiprotein component at the distal (head) end of the virus tail to which fibers of tailed viruses may be attached.','2013-10-27','NSRP'),(36945,98026,'virus tail, tube','C','The internal tube of the contractile tails of some viruses. The virus tail tube is the channel for DNA ejection into the host cytoplasm.','2013-10-27','NSRP'),(36946,98027,'virus tail, sheath','C','The external contractile envelope of the tail of some viruses. Its contraction ensures ejection of the virus DNA into the host cytoplasm.','2013-10-27','NSRP'),(36947,98028,'virus tail, shaft','C','The tube of the non-contractile tails of some viruses.','2013-10-27','NSRP'),(36948,98029,'icosahedral viral capsid, spike','C','A short structure attached to an icosahedral virion capsid, and used for attachment to the host cell.','2013-10-27','NSRP'),(36949,98030,'icosahedral viral capsid, neck','C','A region of constriction located below the head and above the tail sheath of viruses with contractile tails (Myoviridae).','2013-10-27','NSRP'),(36950,98031,'icosahedral viral capsid, collar','C','A small disk located at the base of some icosahedral virus capsids.','2013-10-27','NSRP'),(36951,98032,'icosahedral viral capsid, collar fiber','C','A fiber attached to the collar structure of some icosahedral viral capsids.','2013-10-27','NSRP'),(36952,98033,'icosahedral viral capsid, neck fiber','C','A fiber attached to the neck at the base of some icosahedral viral capsids.','2013-10-27','NSRP'),(36953,98035,'viral DNA genome packaging via site-specific sequence recognition','P','The encapsulation of the viral DNA genome within the capsid, which proceeds via cleavage of the viral DNA at specific sites by a viral terminase.','2013-10-27','NSRP'),(36954,98036,'viral DNA genome packaging, 3\' extended cos packaging','P','The encapsulation of the viral DNA genome within the capsid, which proceeds via cleavage of the viral DNA at specific sites to produce 3\' protruding ends.','2013-10-27','NSRP'),(36955,98037,'viral DNA genome packaging, 5\' extended cos packaging','P','The encapsulation of the viral DNA genome within the capsid, which proceeds via cleavage of the viral DNA at specific sites to produce 5\' protruding ends.','2013-10-27','NSRP'),(36956,98038,'non-replicative transposition, DNA-mediated','P','Process by which a transposable element is excised from the donor site and integrated at the target site without replication of the element. Also referred to as cut-and-paste transposition.','2013-10-27','NSRP'),(36957,98039,'replicative transposition, DNA-mediated','P','Process of transposition in which the existing element is replicated and one of the copies is excised and integrated at a new target site. Also referred to as copy-and-paste transposition.','2013-10-27','NSRP'),(36958,98045,'virus baseplate assembly','P','The aggregation, arrangement and bonding together of a set of components to form a virus baseplate.','2013-10-27','NSRP'),(36959,98046,'type V protein secretion system complex','C','A complex of proteins that permits the translocation of proteins across the outer membrane via a transmembrane pore, formed by a beta-barrel, into the extracellular milieu or directly into host cells; the secreted proteins contain all the information required for translocation of an effector molecule through the cell envelope. The type V secretion systems includes the autotransporters (type Va), the two-partner secretion system (type Vb) and the Oca family (type Vc).','2013-10-27','NSRP'),(36960,98061,'viral capsid, internal space','C','The region of a virus contained within the capsid shell, and usually containing the viral genome and accessory proteins.','2013-10-27','NSRP'),(36961,1900000,'regulation of anthocyanin catabolic process','P','Any process that modulates the frequency, rate or extent of anthocyanin catabolic process.','2013-10-27','NSRP'),(36962,1900001,'negative regulation of anthocyanin catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of anthocyanin catabolic process.','2013-10-27','NSRP'),(36963,1900002,'positive regulation of anthocyanin catabolic process','P','Any process that activates or increases the frequency, rate or extent of anthocyanin catabolic process.','2013-10-27','NSRP'),(36964,1900003,'regulation of serine-type endopeptidase activity','P','Any process that modulates the frequency, rate or extent of serine-type endopeptidase activity.','2013-10-27','NSRP'),(36965,1900004,'negative regulation of serine-type endopeptidase activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of serine-type endopeptidase activity.','2013-10-27','NSRP'),(36966,1900005,'positive regulation of serine-type endopeptidase activity','P','Any process that activates or increases the frequency, rate or extent of serine-type endopeptidase activity.','2013-10-27','NSRP'),(36967,1900006,'positive regulation of dendrite development','P','Any process that activates or increases the frequency, rate or extent of dendrite development.','2013-10-27','NSRP'),(36968,1900007,'regulation of extrachromosomal rDNA circle accumulation involved in replicative cell aging','P','Any process that modulates the frequency, rate or extent of extrachromosomal rDNA circle accumulation involved in replicative cell aging.','2013-10-27','NSRP'),(36969,1900008,'negative regulation of extrachromosomal rDNA circle accumulation involved in replicative cell aging','P','Any process that stops, prevents or reduces the frequency, rate or extent of extrachromosomal rDNA circle accumulation involved in replicative cell aging.','2013-10-27','NSRP'),(36970,1900009,'positive regulation of extrachromosomal rDNA circle accumulation involved in replicative cell aging','P','Any process that activates or increases the frequency, rate or extent of extrachromosomal rDNA circle accumulation involved in replicative cell aging.','2013-10-27','NSRP'),(36971,1900010,'regulation of corticotropin-releasing hormone receptor activity','P','Any process that modulates the frequency, rate or extent of corticotropin-releasing hormone receptor activity.','2013-10-27','NSRP'),(36972,1900011,'negative regulation of corticotropin-releasing hormone receptor activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of corticotropin-releasing hormone receptor activity.','2013-10-27','NSRP'),(36973,1900012,'positive regulation of corticotropin-releasing hormone receptor activity','P','Any process that activates or increases the frequency, rate or extent of corticotropin-releasing hormone receptor activity.','2013-10-27','NSRP'),(36974,1900013,'cellular response to potassium ion involved in chemotaxis to cAMP','P','OBSOLETE. The directed movement of a motile cell in response to the presence of 3\',5\'-cAMP that results in a change in state or activity (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a potassium ion stimulus.','2013-10-27','NSRP'),(36975,1900014,'cellular response to calcium ion involved in chemotaxis to cAMP','P','The directed movement of a motile cell in response to the presence of 3\',5\'-cAMP that results in a change in state or activity (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.','2013-10-27','NSRP'),(36976,1900015,'regulation of cytokine production involved in inflammatory response','P','Any process that modulates the frequency, rate or extent of cytokine production involved in inflammatory response.','2013-10-27','NSRP'),(36977,1900016,'negative regulation of cytokine production involved in inflammatory response','P','Any process that stops, prevents or reduces the frequency, rate or extent of cytokine production involved in inflammatory response.','2013-10-27','NSRP'),(36978,1900017,'positive regulation of cytokine production involved in inflammatory response','P','Any process that activates or increases the frequency, rate or extent of cytokine production involved in inflammatory response.','2013-10-27','NSRP'),(36979,1900018,'phosphorylation of RNA polymerase II C-terminal domain serine 5 residues involved in recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex','P','Any phosphorylation of RNA polymerase II C-terminal domain serine 5 residues that is involved in recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex.','2013-10-27','NSRP'),(36980,1900019,'regulation of protein kinase C activity','P','Any process that modulates the frequency, rate or extent of protein kinase C activity.','2013-10-27','NSRP'),(36981,1900020,'positive regulation of protein kinase C activity','P','Any process that activates or increases the frequency, rate or extent of protein kinase C activity.','2013-10-27','NSRP'),(36982,1900022,'regulation of D-erythro-sphingosine kinase activity','P','Any process that modulates the frequency, rate or extent of D-erythro-sphingosine kinase activity.','2013-10-27','NSRP'),(36983,1900023,'positive regulation of D-erythro-sphingosine kinase activity','P','Any process that activates or increases the frequency, rate or extent of D-erythro-sphingosine kinase activity.','2013-10-27','NSRP'),(36984,1900024,'regulation of substrate adhesion-dependent cell spreading','P','Any process that modulates the frequency, rate or extent of substrate adhesion-dependent cell spreading.','2013-10-27','NSRP'),(36985,1900025,'negative regulation of substrate adhesion-dependent cell spreading','P','Any process that stops, prevents or reduces the frequency, rate or extent of substrate adhesion-dependent cell spreading.','2013-10-27','NSRP'),(36986,1900026,'positive regulation of substrate adhesion-dependent cell spreading','P','Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading.','2013-10-27','NSRP'),(36987,1900027,'regulation of ruffle assembly','P','Any process that modulates the frequency, rate or extent of ruffle assembly.','2013-10-27','NSRP'),(36988,1900028,'negative regulation of ruffle assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of ruffle assembly.','2013-10-27','NSRP'),(36989,1900029,'positive regulation of ruffle assembly','P','Any process that activates or increases the frequency, rate or extent of ruffle assembly.','2013-10-27','NSRP'),(36990,1900030,'regulation of pectin biosynthetic process','P','Any process that modulates the frequency, rate or extent of pectin biosynthetic process.','2013-10-27','NSRP'),(36991,1900031,'regulation of transcription from RNA polymerase II promoter involved in calcium-mediated signaling','P','OBSOLETE. Any regulation of transcription from RNA polymerase II promoter that is involved in calcium-mediated signaling.','2013-10-27','NSRP'),(36992,1900032,'regulation of trichome patterning','P','Any process that modulates the frequency, rate or extent of trichome patterning.','2013-10-27','NSRP'),(36993,1900033,'negative regulation of trichome patterning','P','Any process that stops, prevents or reduces the frequency, rate or extent of trichome patterning.','2013-10-27','NSRP'),(36994,1900034,'regulation of cellular response to heat','P','Any process that modulates the frequency, rate or extent of cellular response to heat.','2013-10-27','NSRP'),(36995,1900035,'negative regulation of cellular response to heat','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to heat.','2013-10-27','NSRP'),(36996,1900036,'positive regulation of cellular response to heat','P','Any process that activates or increases the frequency, rate or extent of cellular response to heat.','2013-10-27','NSRP'),(36997,1900037,'regulation of cellular response to hypoxia','P','Any process that modulates the frequency, rate or extent of cellular response to hypoxia.','2013-10-27','NSRP'),(36998,1900038,'negative regulation of cellular response to hypoxia','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to hypoxia.','2013-10-27','NSRP'),(36999,1900039,'positive regulation of cellular response to hypoxia','P','Any process that activates or increases the frequency, rate or extent of cellular response to hypoxia.','2013-10-27','NSRP'),(37000,1900040,'regulation of interleukin-2 secretion','P','Any process that modulates the frequency, rate or extent of interleukin-2 secretion.','2013-10-27','NSRP'),(37001,1900041,'negative regulation of interleukin-2 secretion','P','Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-2 secretion.','2013-10-27','NSRP'),(37002,1900042,'positive regulation of interleukin-2 secretion','P','Any process that activates or increases the frequency, rate or extent of interleukin-2 secretion.','2013-10-27','NSRP'),(37003,1900043,'leptin-mediated signaling pathway involved in negative regulation of appetite','P','OBSOLETE. Any leptin-mediated signaling pathway that is involved in negative regulation of appetite.','2013-10-27','NSRP'),(37004,1900044,'regulation of protein K63-linked ubiquitination','P','Any process that modulates the frequency, rate or extent of protein K63-linked ubiquitination.','2013-10-27','NSRP'),(37005,1900045,'negative regulation of protein K63-linked ubiquitination','P','Any process that stops, prevents or reduces the frequency, rate or extent of protein K63-linked ubiquitination.','2013-10-27','NSRP'),(37006,1900046,'regulation of hemostasis','P','Any process that modulates the frequency, rate or extent of hemostasis.','2013-10-27','NSRP'),(37007,1900047,'negative regulation of hemostasis','P','Any process that stops, prevents or reduces the frequency, rate or extent of hemostasis.','2013-10-27','NSRP'),(37008,1900048,'positive regulation of hemostasis','P','Any process that activates or increases the frequency, rate or extent of hemostasis.','2013-10-27','NSRP'),(37009,1900049,'regulation of histone exchange','P','Any process that modulates the frequency, rate or extent of histone exchange.','2013-10-27','NSRP'),(37010,1900050,'negative regulation of histone exchange','P','Any process that stops, prevents or reduces the frequency, rate or extent of histone exchange.','2013-10-27','NSRP'),(37011,1900051,'positive regulation of histone exchange','P','Any process that activates or increases the frequency, rate or extent of histone exchange.','2013-10-27','NSRP'),(37012,1900052,'regulation of retinoic acid biosynthetic process','P','Any process that modulates the frequency, rate or extent of retinoic acid biosynthetic process.','2013-10-27','NSRP'),(37013,1900053,'negative regulation of retinoic acid biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of retinoic acid biosynthetic process.','2013-10-27','NSRP'),(37014,1900054,'positive regulation of retinoic acid biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of retinoic acid biosynthetic process.','2013-10-27','NSRP'),(37015,1900055,'regulation of leaf senescence','P','Any process that modulates the frequency, rate or extent of leaf senescence.','2013-10-27','NSRP'),(37016,1900056,'negative regulation of leaf senescence','P','Any process that stops, prevents or reduces the frequency, rate or extent of leaf senescence.','2013-10-27','NSRP'),(37017,1900057,'positive regulation of leaf senescence','P','Any process that activates or increases the frequency, rate or extent of leaf senescence.','2013-10-27','NSRP'),(37018,1900058,'regulation of sulfate assimilation','P','Any process that modulates the frequency, rate or extent of sulfate assimilation.','2013-10-27','NSRP'),(37019,1900059,'positive regulation of sulfate assimilation','P','Any process that activates or increases the frequency, rate or extent of sulfate assimilation.','2013-10-27','NSRP'),(37020,1900060,'negative regulation of ceramide biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of a ceramide biosynthetic process.','2013-10-27','NSRP'),(37021,1900061,'positive regulation of transcription from RNA polymerase II promoter involved in calcium-mediated signaling','P','OBSOLETE. Any positive regulation of transcription from RNA polymerase II promoter that is involved in calcium-mediated signaling.','2013-10-27','NSRP'),(37022,1900062,'regulation of replicative cell aging','P','Any process that modulates the frequency, rate or extent of replicative cell aging.','2013-10-27','NSRP'),(37023,1900063,'regulation of peroxisome organization','P','Any process that modulates the frequency, rate or extent of peroxisome organization.','2013-10-27','NSRP'),(37024,1900064,'positive regulation of peroxisome organization','P','Any process that activates or increases the frequency, rate or extent of peroxisome organization.','2013-10-27','NSRP'),(37025,1900065,'regulation of ethanol catabolic process','P','Any process that modulates the frequency, rate or extent of ethanol catabolic process.','2013-10-27','NSRP'),(37026,1900066,'positive regulation of ethanol catabolic process','P','Any process that activates or increases the frequency, rate or extent of ethanol catabolic process.','2013-10-27','NSRP'),(37027,1900067,'regulation of cellular response to alkalinity','P','Any process that modulates the frequency, rate or extent of cellular response to alkalinity.','2013-10-27','NSRP'),(37028,1900068,'negative regulation of cellular response to alkalinity','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to alkalinity.','2013-10-27','NSRP'),(37029,1900069,'regulation of cellular hyperosmotic salinity response','P','Any process that modulates the frequency, rate or extent of cellular hyperosmotic salinity response.','2013-10-27','NSRP'),(37030,1900070,'negative regulation of cellular hyperosmotic salinity response','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular hyperosmotic salinity response.','2013-10-27','NSRP'),(37031,1900071,'regulation of sulfite transport','P','Any process that modulates the frequency, rate or extent of sulfite transport.','2013-10-27','NSRP'),(37032,1900072,'positive regulation of sulfite transport','P','Any process that activates or increases the frequency, rate or extent of sulfite transport.','2013-10-27','NSRP'),(37033,1900073,'regulation of neuromuscular synaptic transmission','P','Any process that modulates the frequency, rate or extent of neuromuscular synaptic transmission.','2013-10-27','NSRP'),(37034,1900074,'negative regulation of neuromuscular synaptic transmission','P','Any process that stops, prevents or reduces the frequency, rate or extent of neuromuscular synaptic transmission.','2013-10-27','NSRP'),(37035,1900075,'positive regulation of neuromuscular synaptic transmission','P','Any process that activates or increases the frequency, rate or extent of neuromuscular synaptic transmission.','2013-10-27','NSRP'),(37036,1900076,'regulation of cellular response to insulin stimulus','P','Any process that modulates the frequency, rate or extent of cellular response to insulin stimulus.','2013-10-27','NSRP'),(37037,1900077,'negative regulation of cellular response to insulin stimulus','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to insulin stimulus.','2013-10-27','NSRP'),(37038,1900078,'positive regulation of cellular response to insulin stimulus','P','Any process that activates or increases the frequency, rate or extent of cellular response to insulin stimulus.','2013-10-27','NSRP'),(37039,1900079,'regulation of arginine biosynthetic process','P','Any process that modulates the frequency, rate or extent of arginine biosynthetic process.','2013-10-27','NSRP'),(37040,1900080,'positive regulation of arginine biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of arginine biosynthetic process.','2013-10-27','NSRP'),(37041,1900081,'regulation of arginine catabolic process','P','Any process that modulates the frequency, rate or extent of arginine catabolic process.','2013-10-27','NSRP'),(37042,1900082,'negative regulation of arginine catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of arginine catabolic process.','2013-10-27','NSRP'),(37043,1900083,'regulation of Sertoli cell proliferation','P','OBSOLETE. Any process that modulates the frequency, rate or extent of Sertoli cell proliferation.','2013-10-27','NSRP'),(37044,1900084,'regulation of peptidyl-tyrosine autophosphorylation','P','Any process that modulates the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.','2013-10-27','NSRP'),(37045,1900085,'negative regulation of peptidyl-tyrosine autophosphorylation','P','Any process that stops, prevents or reduces the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.','2013-10-27','NSRP'),(37046,1900086,'positive regulation of peptidyl-tyrosine autophosphorylation','P','Any process that activates or increases the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.','2013-10-27','NSRP'),(37047,1900087,'positive regulation of G1/S transition of mitotic cell cycle','P','Any cell cycle regulatory process that promotes the commitment of a cell from G1 to S phase of the mitotic cell cycle.','2013-10-27','NSRP'),(37048,1900088,'regulation of inositol biosynthetic process','P','Any process that modulates the frequency, rate or extent of inositol biosynthetic process.','2013-10-27','NSRP'),(37049,1900089,'negative regulation of inositol biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of inositol biosynthetic process.','2013-10-27','NSRP'),(37050,1900090,'positive regulation of inositol biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of inositol biosynthetic process.','2013-10-27','NSRP'),(37051,1900091,'regulation of raffinose biosynthetic process','P','Any process that modulates the frequency, rate or extent of raffinose biosynthetic process.','2013-10-27','NSRP'),(37052,1900092,'negative regulation of raffinose biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of raffinose biosynthetic process.','2013-10-27','NSRP'),(37053,1900093,'positive regulation of raffinose biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of raffinose biosynthetic process.','2013-10-27','NSRP'),(37054,1900094,'regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry','P','Any regulation of transcription from RNA polymerase II promoter that is involved in determination of left/right symmetry.','2013-10-27','NSRP'),(37055,1900095,'regulation of dosage compensation by inactivation of X chromosome','P','Any process that modulates the frequency, rate or extent of dosage compensation, by inactivation of X chromosome.','2013-10-27','NSRP'),(37056,1900096,'negative regulation of dosage compensation by inactivation of X chromosome','P','Any process that stops, prevents or reduces the frequency, rate or extent of dosage compensation, by inactivation of X chromosome.','2013-10-27','NSRP'),(37057,1900097,'positive regulation of dosage compensation by inactivation of X chromosome','P','Any process that activates or increases the frequency, rate or extent of dosage compensation, by inactivation of X chromosome.','2013-10-27','NSRP'),(37058,1900098,'regulation of plasma cell differentiation','P','Any process that modulates the frequency, rate or extent of plasma cell differentiation.','2013-10-27','NSRP'),(37059,1900099,'negative regulation of plasma cell differentiation','P','Any process that stops, prevents or reduces the frequency, rate or extent of plasma cell differentiation.','2013-10-27','NSRP'),(37060,1900100,'positive regulation of plasma cell differentiation','P','Any process that activates or increases the frequency, rate or extent of plasma cell differentiation.','2013-10-27','NSRP'),(37061,1900101,'regulation of endoplasmic reticulum unfolded protein response','P','Any process that modulates the frequency, rate or extent of endoplasmic reticulum unfolded protein response.','2013-10-27','NSRP'),(37062,1900102,'negative regulation of endoplasmic reticulum unfolded protein response','P','Any process that stops, prevents or reduces the frequency, rate or extent of endoplasmic reticulum unfolded protein response.','2013-10-27','NSRP'),(37063,1900103,'positive regulation of endoplasmic reticulum unfolded protein response','P','Any process that activates or increases the frequency, rate or extent of endoplasmic reticulum unfolded protein response.','2013-10-27','NSRP'),(37064,1900104,'regulation of hyaluranon cable assembly','P','Any process that modulates the frequency, rate or extent of hyaluranon cable assembly.','2013-10-27','NSRP'),(37065,1900105,'negative regulation of hyaluranon cable assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of hyaluranon cable assembly.','2013-10-27','NSRP'),(37066,1900106,'positive regulation of hyaluranon cable assembly','P','Any process that activates or increases the frequency, rate or extent of hyaluranon cable assembly.','2013-10-27','NSRP'),(37067,1900107,'regulation of nodal signaling pathway','P','Any process that modulates the frequency, rate or extent of nodal signaling pathway.','2013-10-27','NSRP'),(37068,1900108,'negative regulation of nodal signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of nodal signaling pathway.','2013-10-27','NSRP'),(37069,1900109,'regulation of histone H3-K9 dimethylation','P','Any process that modulates the frequency, rate or extent of histone H3-K9 dimethylation.','2013-10-27','NSRP'),(37070,1900110,'negative regulation of histone H3-K9 dimethylation','P','Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K9 dimethylation.','2013-10-27','NSRP'),(37071,1900111,'positive regulation of histone H3-K9 dimethylation','P','Any process that activates or increases the frequency, rate or extent of histone H3-K9 dimethylation.','2013-10-27','NSRP'),(37072,1900112,'regulation of histone H3-K9 trimethylation','P','Any process that modulates the frequency, rate or extent of histone H3-K9 trimethylation.','2013-10-27','NSRP'),(37073,1900113,'negative regulation of histone H3-K9 trimethylation','P','Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K9 trimethylation.','2013-10-27','NSRP'),(37074,1900114,'positive regulation of histone H3-K9 trimethylation','P','Any process that activates or increases the frequency, rate or extent of histone H3-K9 trimethylation.','2013-10-27','NSRP'),(37075,1900115,'extracellular regulation of signal transduction','P','Any regulation of signal transduction that takes place in the extracellular region.','2013-10-27','NSRP'),(37076,1900116,'extracellular negative regulation of signal transduction','P','Any negative regulation of signal transduction that takes place in extracellular region.','2013-10-27','NSRP'),(37077,1900117,'regulation of execution phase of apoptosis','P','Any process that modulates the frequency, rate or extent of execution phase of apoptosis.','2013-10-27','NSRP'),(37078,1900118,'negative regulation of execution phase of apoptosis','P','Any process that stops, prevents or reduces the frequency, rate or extent of execution phase of apoptosis.','2013-10-27','NSRP'),(37079,1900119,'positive regulation of execution phase of apoptosis','P','Any process that activates or increases the frequency, rate or extent of execution phase of apoptosis.','2013-10-27','NSRP'),(37080,1900120,'regulation of receptor binding','P','Any process that modulates the frequency, rate or extent of a protein or other molecule binding to a receptor.','2013-10-27','NSRP'),(37081,1900121,'negative regulation of receptor binding','P','Any process that stops, prevents or reduces the frequency, rate or extent of a protein or other molecule binding to a receptor.','2013-10-27','NSRP'),(37082,1900122,'positive regulation of receptor binding','P','Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor.','2013-10-27','NSRP'),(37083,1900123,'regulation of nodal receptor complex assembly','P','Any process that modulates the frequency, rate or extent of nodal receptor complex assembly.','2013-10-27','NSRP'),(37084,1900124,'negative regulation of nodal receptor complex assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of nodal receptor complex assembly.','2013-10-27','NSRP'),(37085,1900125,'regulation of hyaluronan biosynthetic process','P','Any process that modulates the frequency, rate or extent of hyaluronan biosynthetic process.','2013-10-27','NSRP'),(37086,1900126,'negative regulation of hyaluronan biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of hyaluronan biosynthetic process.','2013-10-27','NSRP'),(37087,1900127,'positive regulation of hyaluronan biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of hyaluronan biosynthetic process.','2013-10-27','NSRP'),(37088,1900128,'regulation of G-protein activated inward rectifier potassium channel activity','P','Any process that modulates the frequency, rate or extent of G-protein activated inward rectifier potassium channel activity.','2013-10-27','NSRP'),(37089,1900129,'positive regulation of G-protein activated inward rectifier potassium channel activity','P','Any process that activates or increases the frequency, rate or extent of G-protein activated inward rectifier potassium channel activity.','2013-10-27','NSRP'),(37090,1900130,'regulation of lipid binding','P','Any process that modulates the frequency, rate or extent of lipid binding.','2013-10-27','NSRP'),(37091,1900131,'negative regulation of lipid binding','P','Any process that stops, prevents or reduces the frequency, rate or extent of lipid binding.','2013-10-27','NSRP'),(37092,1900132,'positive regulation of lipid binding','P','Any process that activates or increases the frequency, rate or extent of lipid binding.','2013-10-27','NSRP'),(37093,1900133,'regulation of renin secretion into blood stream','P','Any process that modulates the frequency, rate or extent of renin secretion into blood stream.','2013-10-27','NSRP'),(37094,1900134,'negative regulation of renin secretion into blood stream','P','Any process that stops, prevents or reduces the frequency, rate or extent of renin secretion into blood stream.','2013-10-27','NSRP'),(37095,1900135,'positive regulation of renin secretion into blood stream','P','Any process that activates or increases the frequency, rate or extent of renin secretion into blood stream.','2013-10-27','NSRP'),(37096,1900136,'regulation of chemokine activity','P','Any process that modulates the frequency, rate or extent of chemokine activity.','2013-10-27','NSRP'),(37097,1900137,'negative regulation of chemokine activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of chemokine activity.','2013-10-27','NSRP'),(37098,1900138,'negative regulation of phospholipase A2 activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase A2 activity.','2013-10-27','NSRP'),(37099,1900139,'negative regulation of arachidonic acid secretion','P','Any process that stops, prevents or reduces the frequency, rate or extent of arachidonic acid secretion.','2013-10-27','NSRP'),(37100,1900140,'regulation of seedling development','P','Any process that modulates the frequency, rate or extent of seedling development.','2013-10-27','NSRP'),(37101,1900141,'regulation of oligodendrocyte apoptotic process','P','Any process that modulates the frequency, rate or extent of oligodendrocyte apoptotic process.','2013-10-27','NSRP'),(37102,1900142,'negative regulation of oligodendrocyte apoptotic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of oligodendrocyte apoptotic process.','2013-10-27','NSRP'),(37103,1900143,'positive regulation of oligodendrocyte apoptotic process','P','Any process that activates or increases the frequency, rate or extent of oligodendrocyte apoptotic process.','2013-10-27','NSRP'),(37104,1900144,'positive regulation of BMP secretion','P','Any process that activates or increases the frequency, rate or extent of BMP secretion.','2013-10-27','NSRP'),(37105,1900145,'regulation of nodal signaling pathway involved in determination of left/right asymmetry','P','Any process that modulates the frequency, rate or extent of a nodal signaling pathway, where the nodal signaling pathway is involved in determination of left/right asymmetry.','2013-10-27','NSRP'),(37106,1900146,'negative regulation of nodal signaling pathway involved in determination of left/right asymmetry','P','Any process that stops, prevents or reduces the frequency, rate or extent of a nodal signaling pathway, where the nodal signaling pathway is involved in determination of left/right asymmetry.','2013-10-27','NSRP'),(37107,1900147,'regulation of Schwann cell migration','P','Any process that modulates the frequency, rate or extent of Schwann cell migration.','2013-10-27','NSRP'),(37108,1900148,'negative regulation of Schwann cell migration','P','Any process that stops, prevents or reduces the frequency, rate or extent of Schwann cell migration.','2013-10-27','NSRP'),(37109,1900149,'positive regulation of Schwann cell migration','P','Any process that activates or increases the frequency, rate or extent of Schwann cell migration.','2013-10-27','NSRP'),(37110,1900150,'regulation of defense response to fungus','P','Any process that modulates the frequency, rate or extent of defense response to fungus.','2013-10-27','NSRP'),(37111,1900151,'regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay','P','Any process that modulates the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay.','2013-10-27','NSRP'),(37112,1900152,'negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay','P','Any process that stops, prevents or reduces the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay.','2013-10-27','NSRP'),(37113,1900153,'positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay','P','Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay.','2013-10-27','NSRP'),(37114,1900154,'regulation of bone trabecula formation','P','Any process that modulates the frequency, rate or extent of bone trabecula formation.','2013-10-27','NSRP'),(37115,1900155,'negative regulation of bone trabecula formation','P','Any process that stops, prevents or reduces the frequency, rate or extent of bone trabecula formation.','2013-10-27','NSRP'),(37116,1900156,'positive regulation of bone trabecula formation','P','Any process that activates or increases the frequency, rate or extent of bone trabecula formation.','2013-10-27','NSRP'),(37117,1900157,'regulation of bone mineralization involved in bone maturation','P','Any process that modulates the frequency, rate or extent of bone mineralization involved in bone maturation.','2013-10-27','NSRP'),(37118,1900158,'negative regulation of bone mineralization involved in bone maturation','P','Any process that stops, prevents or reduces the frequency, rate or extent of bone mineralization involved in bone maturation.','2013-10-27','NSRP'),(37119,1900159,'positive regulation of bone mineralization involved in bone maturation','P','Any process that activates or increases the frequency, rate or extent of bone mineralization involved in bone maturation.','2013-10-27','NSRP'),(37120,1900160,'plastid DNA packaging','P','Any process in which plastidial DNA and associated proteins are formed into a compact, orderly structure.','2013-10-27','NSRP'),(37121,1900161,'regulation of phospholipid scramblase activity','P','Any process that modulates the frequency, rate or extent of phospholipid scramblase activity.','2013-10-27','NSRP'),(37122,1900162,'negative regulation of phospholipid scramblase activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of phospholipid scramblase activity.','2013-10-27','NSRP'),(37123,1900163,'positive regulation of phospholipid scramblase activity','P','Any process that activates or increases the frequency, rate or extent of phospholipid scramblase activity.','2013-10-27','NSRP'),(37124,1900164,'nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry','P','A series of molecular signals initiated by the binding of a nodal protein to an activin receptor on the surface of a target cell, which contributes to the establishment of lateral mesoderm with respect to the left and right halves.','2013-10-27','NSRP'),(37125,1900165,'negative regulation of interleukin-6 secretion','P','Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-6 secretion.','2013-10-27','NSRP'),(37126,1900166,'regulation of glial cell line-derived neurotrophic factor secretion','P','Any process that modulates the frequency, rate or extent of glial cell line-derived neurotrophic factor secretion.','2013-10-27','NSRP'),(37127,1900167,'negative regulation of glial cell line-derived neurotrophic factor secretion','P','Any process that stops, prevents or reduces the frequency, rate or extent of glial cell line-derived neurotrophic factor secretion.','2013-10-27','NSRP'),(37128,1900168,'positive regulation of glial cell line-derived neurotrophic factor secretion','P','Any process that activates or increases the frequency, rate or extent of glial cell line-derived neurotrophic factor secretion.','2013-10-27','NSRP'),(37129,1900169,'regulation of glucocorticoid mediated signaling pathway','P','Any process that modulates the frequency, rate or extent of glucocorticoid mediated signaling pathway.','2013-10-27','NSRP'),(37130,1900170,'negative regulation of glucocorticoid mediated signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of glucocorticoid mediated signaling pathway.','2013-10-27','NSRP'),(37131,1900171,'positive regulation of glucocorticoid mediated signaling pathway','P','Any process that activates or increases the frequency, rate or extent of glucocorticoid mediated signaling pathway.','2013-10-27','NSRP'),(37132,1900172,'regulation of flagellum movement','P','Any process that modulates the frequency, rate or extent of flagellum movement.','2013-05-06','NSRP'),(37133,1900173,'negative regulation of flagellum movement','P','Any process that stops, prevents or reduces the frequency, rate or extent of flagellum movement.','2013-05-06','NSRP'),(37134,1900174,'positive regulation of flagellum movement','P','Any process that activates or increases the frequency, rate or extent of flagellum movement.','2013-05-06','NSRP'),(37135,1900175,'regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry','P','Any process that modulates the frequency, rate or extent of a nodal signaling pathway, where the nodal signaling pathway is involved in determination of left/right asymmetry in the lateral mesoderm.','2013-10-27','NSRP'),(37136,1900176,'negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry','P','Any process that stops, prevents or reduces the frequency, rate or extent of a nodal signaling pathway, where the nodal signaling pathway is involved in determination of left/right asymmetry in the lateral mesoderm.','2013-10-27','NSRP'),(37137,1900177,'regulation of aflatoxin biosynthetic process','P','Any process that modulates the frequency, rate or extent of aflatoxin biosynthetic process.','2013-10-27','NSRP'),(37138,1900178,'negative regulation of aflatoxin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of aflatoxin biosynthetic process.','2013-10-27','NSRP'),(37139,1900179,'positive regulation of aflatoxin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of aflatoxin biosynthetic process.','2013-10-27','NSRP'),(37140,1900180,'regulation of protein localization to nucleus','P','Any process that modulates the frequency, rate or extent of protein localization to nucleus.','2013-10-27','NSRP'),(37141,1900181,'negative regulation of protein localization to nucleus','P','Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to nucleus.','2013-10-27','NSRP'),(37142,1900182,'positive regulation of protein localization to nucleus','P','Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.','2013-10-27','NSRP'),(37143,1900183,'regulation of xanthone-containing compound biosynthetic process','P','Any process that modulates the frequency, rate or extent of xanthone-containing compound biosynthetic process.','2013-10-27','NSRP'),(37144,1900184,'negative regulation of xanthone-containing compound biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of xanthone-containing compound biosynthetic process.','2013-10-27','NSRP'),(37145,1900185,'positive regulation of xanthone-containing compound biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of xanthone-containing compound biosynthetic process.','2013-10-27','NSRP'),(37146,1900186,'negative regulation of clathrin-mediated endocytosis','P','Any process that stops, prevents or reduces the frequency, rate or extent of clathrin-mediated endocytosis.','2013-10-27','NSRP'),(37147,1900187,'regulation of cell adhesion involved in single-species biofilm formation','P','Any process that modulates the frequency, rate or extent of cell adhesion involved in single-species biofilm formation.','2013-10-27','NSRP'),(37148,1900188,'negative regulation of cell adhesion involved in single-species biofilm formation','P','Any process that stops, prevents or reduces the frequency, rate or extent of cell adhesion involved in single-species biofilm formation.','2013-10-27','NSRP'),(37149,1900189,'positive regulation of cell adhesion involved in single-species biofilm formation','P','Any process that activates or increases the frequency, rate or extent of cell adhesion involved in single-species biofilm formation.','2013-10-27','NSRP'),(37150,1900190,'regulation of single-species biofilm formation','P','Any process that modulates the frequency, rate or extent of single-species biofilm formation.','2013-10-27','NSRP'),(37151,1900191,'negative regulation of single-species biofilm formation','P','Any process that stops, prevents or reduces the frequency, rate or extent of single-species biofilm formation.','2013-10-27','NSRP'),(37152,1900192,'positive regulation of single-species biofilm formation','P','Any process that activates or increases the frequency, rate or extent of single-species biofilm formation.','2013-10-27','NSRP'),(37153,1900193,'regulation of oocyte maturation','P','Any process that modulates the frequency, rate or extent of oocyte maturation.','2013-10-27','NSRP'),(37154,1900194,'negative regulation of oocyte maturation','P','Any process that stops, prevents or reduces the frequency, rate or extent of oocyte maturation.','2013-10-27','NSRP'),(37155,1900195,'positive regulation of oocyte maturation','P','Any process that activates or increases the frequency, rate or extent of oocyte maturation.','2013-10-27','NSRP'),(37156,1900196,'regulation of penicillin biosynthetic process','P','Any process that modulates the frequency, rate or extent of penicillin biosynthetic process.','2013-10-27','NSRP'),(37157,1900197,'negative regulation of penicillin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of penicillin biosynthetic process.','2013-10-27','NSRP'),(37158,1900198,'positive regulation of penicillin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of penicillin biosynthetic process.','2013-10-27','NSRP'),(37159,1900199,'positive regulation of protein export from nucleus during meiotic anaphase II','P','Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the nucleus into the cytoplasm, during anaphase occurring as part of meiosis II.','2013-10-27','NSRP'),(37160,1900200,'mesenchymal cell apoptotic process involved in metanephros development','P','Any mesenchymal cell apoptotic process that is involved in metanephros development.','2013-10-27','NSRP'),(37161,1900201,'regulation of spread of virus in host, cell to cell','P','OBSOLETE. Any process that modulates the frequency, rate or extent of spread of virus in host, cell to cell.','2013-10-27','NSRP'),(37162,1900202,'negative regulation of spread of virus in host, cell to cell','P','OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of spread of virus in host, cell to cell.','2013-10-27','NSRP'),(37163,1900203,'positive regulation of spread of virus in host, cell to cell','P','OBSOLETE. Any process that activates or increases the frequency, rate or extent of spread of virus in host, cell to cell.','2013-10-27','NSRP'),(37164,1900204,'apoptotic process involved in metanephric collecting duct development','P','Any apoptotic process that is involved in metanephric collecting duct development.','2013-10-27','NSRP'),(37165,1900205,'apoptotic process involved in metanephric nephron tubule development','P','Any apoptotic process that is involved in metanephric nephron tubule development.','2013-10-27','NSRP'),(37166,1900206,'regulation of pronephric nephron tubule development','P','Any process that modulates the frequency, rate or extent of pronephric nephron tubule development.','2013-10-27','NSRP'),(37167,1900207,'negative regulation of pronephric nephron tubule development','P','Any process that stops, prevents or reduces the frequency, rate or extent of pronephric nephron tubule development.','2013-10-27','NSRP'),(37168,1900208,'regulation of cardiolipin metabolic process','P','Any process that modulates the frequency, rate or extent of cardiolipin metabolic process.','2013-10-27','NSRP'),(37169,1900209,'negative regulation of cardiolipin metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of cardiolipin metabolic process.','2013-10-27','NSRP'),(37170,1900210,'positive regulation of cardiolipin metabolic process','P','Any process that activates or increases the frequency, rate or extent of cardiolipin metabolic process.','2013-10-27','NSRP'),(37171,1900211,'regulation of mesenchymal cell apoptotic process involved in metanephros development','P','Any process that modulates the frequency, rate or extent of mesenchymal cell apoptotic process involved in metanephros development.','2013-10-27','NSRP'),(37172,1900212,'negative regulation of mesenchymal cell apoptotic process involved in metanephros development','P','Any process that stops, prevents or reduces the frequency, rate or extent of mesenchymal cell apoptotic process involved in metanephros development.','2013-10-27','NSRP'),(37173,1900213,'positive regulation of mesenchymal cell apoptotic process involved in metanephros development','P','Any process that activates or increases the frequency, rate or extent of mesenchymal cell apoptotic process involved in metanephros development.','2013-10-27','NSRP'),(37174,1900214,'regulation of apoptotic process involved in metanephric collecting duct development','P','Any process that modulates the frequency, rate or extent of apoptotic process involved in metanephric collecting duct development.','2013-10-27','NSRP'),(37175,1900215,'negative regulation of apoptotic process involved in metanephric collecting duct development','P','Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic process involved in metanephric collecting duct development.','2013-10-27','NSRP'),(37176,1900216,'positive regulation of apoptotic process involved in metanephric collecting duct development','P','Any process that activates or increases the frequency, rate or extent of apoptotic process involved in metanephric collecting duct development.','2013-10-27','NSRP'),(37177,1900217,'regulation of apoptotic process involved in metanephric nephron tubule development','P','Any process that modulates the frequency, rate or extent of apoptotic process involved in metanephric nephron tubule development.','2013-10-27','NSRP');
INSERT INTO `GO` VALUES (37178,1900218,'negative regulation of apoptotic process involved in metanephric nephron tubule development','P','Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic process involved in metanephric nephron tubule development.','2013-10-27','NSRP'),(37179,1900219,'positive regulation of apoptotic process involved in metanephric nephron tubule development','P','Any process that activates or increases the frequency, rate or extent of apoptotic process involved in metanephric nephron tubule development.','2013-10-27','NSRP'),(37180,1900220,'semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis','P','Any semaphorin-plexin signaling pathway that contributes to bone trabecula morphogenesis.','2013-10-27','NSRP'),(37181,1900221,'regulation of beta-amyloid clearance','P','Any process that modulates the frequency, rate or extent of beta-amyloid clearance.','2013-10-27','NSRP'),(37182,1900222,'negative regulation of beta-amyloid clearance','P','Any process that stops, prevents or reduces the frequency, rate or extent of beta-amyloid clearance.','2013-10-27','NSRP'),(37183,1900223,'positive regulation of beta-amyloid clearance','P','Any process that activates or increases the frequency, rate or extent of beta-amyloid clearance.','2013-10-27','NSRP'),(37184,1900224,'positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry','P','Any process that activates or increases the frequency, rate or extent of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry.','2013-10-27','NSRP'),(37185,1900225,'regulation of NLRP3 inflammasome complex assembly','P','Any process that modulates the frequency, rate or extent of NLRP3 inflammasome complex assembly.','2013-10-27','NSRP'),(37186,1900226,'negative regulation of NLRP3 inflammasome complex assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of NLRP3 inflammasome complex assembly.','2013-10-27','NSRP'),(37187,1900227,'positive regulation of NLRP3 inflammasome complex assembly','P','Any process that activates or increases the frequency, rate or extent of NLRP3 inflammasome complex assembly.','2013-10-27','NSRP'),(37188,1900228,'regulation of single-species biofilm formation in or on host organism','P','Any process that modulates the frequency, rate or extent of single-species biofilm formation in or on host organism.','2013-10-27','NSRP'),(37189,1900229,'negative regulation of single-species biofilm formation in or on host organism','P','Any process that stops, prevents or reduces the frequency, rate or extent of single-species biofilm formation in or on host organism.','2013-10-27','NSRP'),(37190,1900230,'positive regulation of single-species biofilm formation in or on host organism','P','Any process that activates or increases the frequency, rate or extent of single-species biofilm formation in or on host organism.','2013-10-27','NSRP'),(37191,1900231,'regulation of single-species biofilm formation on inanimate substrate','P','Any process that modulates the frequency, rate or extent of single-species biofilm formation on inanimate substrate.','2013-10-27','NSRP'),(37192,1900232,'negative regulation of single-species biofilm formation on inanimate substrate','P','Any process that stops, prevents or reduces the frequency, rate or extent of single-species biofilm formation on inanimate substrate.','2013-10-27','NSRP'),(37193,1900233,'positive regulation of single-species biofilm formation on inanimate substrate','P','Any process that activates or increases the frequency, rate or extent of single-species biofilm formation on inanimate substrate.','2013-10-27','NSRP'),(37194,1900234,'regulation of Kit signaling pathway','P','Any process that modulates the frequency, rate or extent of Kit signaling pathway.','2013-10-27','NSRP'),(37195,1900235,'negative regulation of Kit signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of Kit signaling pathway.','2013-10-27','NSRP'),(37196,1900236,'positive regulation of Kit signaling pathway','P','Any process that activates or increases the frequency, rate or extent of Kit signaling pathway.','2013-10-27','NSRP'),(37197,1900237,'positive regulation of induction of conjugation with cellular fusion','P','Any process that activates or increases the frequency, rate or extent of induction of conjugation with cellular fusion.','2013-10-27','NSRP'),(37198,1900238,'regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway','P','Any process that modulates the frequency, rate or extent of regulation of metanephric mesenchymal cell migration, by platelet-derived growth factor receptor-beta signaling pathway.','2013-10-27','NSRP'),(37199,1900239,'regulation of phenotypic switching','P','Any process that modulates the frequency, rate or extent of phenotypic switching.','2013-10-27','NSRP'),(37200,1900240,'negative regulation of phenotypic switching','P','Any process that stops, prevents or reduces the frequency, rate or extent of phenotypic switching.','2013-10-27','NSRP'),(37201,1900241,'positive regulation of phenotypic switching','P','Any process that activates or increases the frequency, rate or extent of phenotypic switching.','2013-10-27','NSRP'),(37202,1900242,'regulation of synaptic vesicle endocytosis','P','Any process that modulates the frequency, rate or extent of synaptic vesicle endocytosis.','2013-10-27','NSRP'),(37203,1900243,'negative regulation of synaptic vesicle endocytosis','P','Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle endocytosis.','2013-10-27','NSRP'),(37204,1900244,'positive regulation of synaptic vesicle endocytosis','P','Any process that activates or increases the frequency, rate or extent of synaptic vesicle endocytosis.','2013-10-27','NSRP'),(37205,1900245,'positive regulation of MDA-5 signaling pathway','P','Any process that activates or increases the frequency, rate or extent of MDA-5 signaling pathway.','2013-10-27','NSRP'),(37206,1900246,'positive regulation of RIG-I signaling pathway','P','Any process that activates or increases the frequency, rate or extent of RIG-I signaling pathway.','2013-10-27','NSRP'),(37207,1900247,'regulation of cytoplasmic translational elongation','P','Any process that modulates the frequency, rate or extent of cytoplasmic translational elongation.','2013-10-27','NSRP'),(37208,1900248,'negative regulation of cytoplasmic translational elongation','P','Any process that stops, prevents or reduces the frequency, rate or extent of cytoplasmic translational elongation.','2013-10-27','NSRP'),(37209,1900249,'positive regulation of cytoplasmic translational elongation','P','Any process that activates or increases the frequency, rate or extent of cytoplasmic translational elongation.','2013-10-27','NSRP'),(37210,1900256,'regulation of beta1-adrenergic receptor activity','P','Any process that modulates the frequency, rate or extent of beta1-adrenergic receptor activity.','2013-10-27','NSRP'),(37211,1900257,'negative regulation of beta1-adrenergic receptor activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of beta1-adrenergic receptor activity.','2013-10-27','NSRP'),(37212,1900258,'positive regulation of beta1-adrenergic receptor activity','P','Any process that activates or increases the frequency, rate or extent of beta1-adrenergic receptor activity.','2013-10-27','NSRP'),(37213,1900259,'regulation of RNA-directed RNA polymerase activity','P','Any process that modulates the frequency, rate or extent of RNA-directed RNA polymerase activity.','2013-10-27','NSRP'),(37214,1900260,'negative regulation of RNA-directed RNA polymerase activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of RNA-directed RNA polymerase activity.','2013-10-27','NSRP'),(37215,1900261,'positive regulation of RNA-directed RNA polymerase activity','P','Any process that activates or increases the frequency, rate or extent of RNA-directed RNA polymerase activity.','2013-10-27','NSRP'),(37216,1900262,'regulation of DNA-directed DNA polymerase activity','P','Any process that modulates the frequency, rate or extent of DNA-directed DNA polymerase activity.','2013-10-27','NSRP'),(37217,1900263,'negative regulation of DNA-directed DNA polymerase activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of DNA-directed DNA polymerase activity.','2013-10-27','NSRP'),(37218,1900264,'positive regulation of DNA-directed DNA polymerase activity','P','Any process that activates or increases the frequency, rate or extent of DNA-directed DNA polymerase activity.','2013-10-27','NSRP'),(37219,1900265,'regulation of substance P receptor binding','P','Any process that modulates the frequency, rate or extent of substance P receptor binding.','2013-10-27','NSRP'),(37220,1900266,'negative regulation of substance P receptor binding','P','Any process that stops, prevents or reduces the frequency, rate or extent of substance P receptor binding.','2013-10-27','NSRP'),(37221,1900267,'positive regulation of substance P receptor binding','P','Any process that activates or increases the frequency, rate or extent of substance P receptor binding.','2013-10-27','NSRP'),(37222,1900268,'regulation of reverse transcription','P','Any process that modulates the frequency, rate or extent of reverse transcription.','2013-10-27','NSRP'),(37223,1900269,'negative regulation of reverse transcription','P','Any process that stops, prevents or reduces the frequency, rate or extent of reverse transcription.','2013-10-27','NSRP'),(37224,1900270,'positive regulation of reverse transcription','P','Any process that activates or increases the frequency, rate or extent of reverse transcription.','2013-10-27','NSRP'),(37225,1900271,'regulation of long-term synaptic potentiation','P','Any process that modulates the frequency, rate or extent of long-term synaptic potentiation.','2013-10-27','NSRP'),(37226,1900272,'negative regulation of long-term synaptic potentiation','P','Any process that stops, prevents or reduces the frequency, rate or extent of long-term synaptic potentiation.','2013-10-27','NSRP'),(37227,1900273,'positive regulation of long-term synaptic potentiation','P','Any process that activates or increases the frequency, rate or extent of long-term synaptic potentiation.','2013-10-27','NSRP'),(37228,1900274,'regulation of phospholipase C activity','P','Any process that modulates the frequency, rate or extent of phospholipase C activity.','2013-10-27','NSRP'),(37229,1900275,'negative regulation of phospholipase C activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase C activity.','2013-10-27','NSRP'),(37230,1900276,'regulation of proteinase activated receptor activity','P','Any process that modulates the frequency, rate or extent of proteinase activated receptor activity.','2013-10-27','NSRP'),(37231,1900277,'negative regulation of proteinase activated receptor activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of proteinase activated receptor activity.','2013-10-27','NSRP'),(37232,1900278,'positive regulation of proteinase activated receptor activity','P','Any process that activates or increases the frequency, rate or extent of proteinase activated receptor activity.','2013-10-27','NSRP'),(37233,1900279,'regulation of CD4-positive, alpha-beta T cell costimulation','P','Any process that modulates the frequency, rate or extent of CD4-positive, alpha-beta T cell costimulation.','2013-10-27','NSRP'),(37234,1900280,'negative regulation of CD4-positive, alpha-beta T cell costimulation','P','Any process that stops, prevents or reduces the frequency, rate or extent of CD4-positive, alpha-beta T cell costimulation.','2013-10-27','NSRP'),(37235,1900281,'positive regulation of CD4-positive, alpha-beta T cell costimulation','P','Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell costimulation.','2013-10-27','NSRP'),(37236,1900282,'regulation of cellobiose catabolic process','P','Any process that modulates the frequency, rate or extent of cellobiose catabolic process.','2013-10-27','NSRP'),(37237,1900283,'negative regulation of cellobiose catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellobiose catabolic process.','2013-10-27','NSRP'),(37238,1900284,'positive regulation of cellobiose catabolic process','P','Any process that activates or increases the frequency, rate or extent of cellobiose catabolic process.','2013-10-27','NSRP'),(37239,1900285,'regulation of cellotriose transport','P','Any process that modulates the frequency, rate or extent of cellotriose transport.','2013-10-27','NSRP'),(37240,1900286,'negative regulation of cellotriose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellotriose transport.','2013-10-27','NSRP'),(37241,1900287,'positive regulation of cellotriose transport','P','Any process that activates or increases the frequency, rate or extent of cellotriose transport.','2013-10-27','NSRP'),(37242,1900288,'regulation of coenzyme F420-dependent bicyclic nitroimidazole catabolic process','P','Any process that modulates the frequency, rate or extent of coenzyme F420-dependent bicyclic nitroimidazole catabolic process.','2013-10-27','NSRP'),(37243,1900289,'negative regulation of coenzyme F420-dependent bicyclic nitroimidazole catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of coenzyme F420-dependent bicyclic nitroimidazole catabolic process.','2013-10-27','NSRP'),(37244,1900290,'positive regulation of coenzyme F420-dependent bicyclic nitroimidazole catabolic process','P','Any process that activates or increases the frequency, rate or extent of coenzyme F420-dependent bicyclic nitroimidazole catabolic process.','2013-10-27','NSRP'),(37245,1900291,'regulation of galactotriose transport','P','Any process that modulates the frequency, rate or extent of galactotriose transport.','2013-10-27','NSRP'),(37246,1900292,'negative regulation of galactotriose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of galactotriose transport.','2013-10-27','NSRP'),(37247,1900293,'positive regulation of galactotriose transport','P','Any process that activates or increases the frequency, rate or extent of galactotriose transport.','2013-10-27','NSRP'),(37248,1900294,'regulation of heptasaccharide transport','P','Any process that modulates the frequency, rate or extent of heptasaccharide transport.','2013-10-27','NSRP'),(37249,1900295,'negative regulation of heptasaccharide transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of heptasaccharide transport.','2013-10-27','NSRP'),(37250,1900296,'positive regulation of heptasaccharide transport','P','Any process that activates or increases the frequency, rate or extent of heptasaccharide transport.','2013-10-27','NSRP'),(37251,1900297,'regulation of hexasaccharide transport','P','Any process that modulates the frequency, rate or extent of hexasaccharide transport.','2013-10-27','NSRP'),(37252,1900298,'negative regulation of hexasaccharide transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of hexasaccharide transport.','2013-10-27','NSRP'),(37253,1900299,'positive regulation of hexasaccharide transport','P','Any process that activates or increases the frequency, rate or extent of hexasaccharide transport.','2013-10-27','NSRP'),(37254,1900300,'regulation of laminarabiose transport','P','Any process that modulates the frequency, rate or extent of laminarabiose transport.','2013-10-27','NSRP'),(37255,1900301,'negative regulation of laminarabiose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of laminarabiose transport.','2013-10-27','NSRP'),(37256,1900302,'positive regulation of laminarabiose transport','P','Any process that activates or increases the frequency, rate or extent of laminarabiose transport.','2013-10-27','NSRP'),(37257,1900303,'regulation of laminaritriose transport','P','Any process that modulates the frequency, rate or extent of laminaritriose transport.','2013-10-27','NSRP'),(37258,1900304,'negative regulation of laminaritriose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of laminaritriose transport.','2013-10-27','NSRP'),(37259,1900305,'positive regulation of laminaritriose transport','P','Any process that activates or increases the frequency, rate or extent of laminaritriose transport.','2013-10-27','NSRP'),(37260,1900306,'regulation of maltoheptaose transport','P','Any process that modulates the frequency, rate or extent of maltoheptaose transport.','2013-10-27','NSRP'),(37261,1900307,'negative regulation of maltoheptaose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of maltoheptaose transport.','2013-10-27','NSRP'),(37262,1900308,'positive regulation of maltoheptaose transport','P','Any process that activates or increases the frequency, rate or extent of maltoheptaose transport.','2013-10-27','NSRP'),(37263,1900309,'regulation of maltoheptaose metabolic process','P','Any process that modulates the frequency, rate or extent of maltoheptaose metabolic process.','2013-10-27','NSRP'),(37264,1900310,'negative regulation of maltoheptaose metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of maltoheptaose metabolic process.','2013-10-27','NSRP'),(37265,1900311,'positive regulation of maltoheptaose metabolic process','P','Any process that activates or increases the frequency, rate or extent of maltoheptaose metabolic process.','2013-10-27','NSRP'),(37266,1900312,'regulation of maltohexaose transport','P','Any process that modulates the frequency, rate or extent of maltohexaose transport.','2013-10-27','NSRP'),(37267,1900313,'negative regulation of maltohexaose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of maltohexaose transport.','2013-10-27','NSRP'),(37268,1900314,'positive regulation of maltohexaose transport','P','Any process that activates or increases the frequency, rate or extent of maltohexaose transport.','2013-10-27','NSRP'),(37269,1900315,'regulation of maltopentaose transport','P','Any process that modulates the frequency, rate or extent of maltopentaose transport.','2013-10-27','NSRP'),(37270,1900316,'negative regulation of maltopentaose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of maltopentaose transport.','2013-10-27','NSRP'),(37271,1900317,'positive regulation of maltopentaose transport','P','Any process that activates or increases the frequency, rate or extent of maltopentaose transport.','2013-10-27','NSRP'),(37272,1900318,'regulation of methane biosynthetic process from dimethylamine','P','Any process that modulates the frequency, rate or extent of methane biosynthetic process from dimethylamine.','2013-10-27','NSRP'),(37273,1900319,'negative regulation of methane biosynthetic process from dimethylamine','P','Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from dimethylamine.','2013-10-27','NSRP'),(37274,1900320,'positive regulation of methane biosynthetic process from dimethylamine','P','Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from dimethylamine.','2013-10-27','NSRP'),(37275,1900321,'regulation of maltotetraose transport','P','Any process that modulates the frequency, rate or extent of maltotetraose transport.','2013-10-27','NSRP'),(37276,1900322,'negative regulation of maltotetraose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of maltotetraose transport.','2013-10-27','NSRP'),(37277,1900323,'positive regulation of maltotetraose transport','P','Any process that activates or increases the frequency, rate or extent of maltotetraose transport.','2013-10-27','NSRP'),(37278,1900324,'regulation of maltotriulose transport','P','Any process that modulates the frequency, rate or extent of maltotriulose transport.','2013-10-27','NSRP'),(37279,1900325,'negative regulation of maltotriulose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of maltotriulose transport.','2013-10-27','NSRP'),(37280,1900326,'positive regulation of maltotriulose transport','P','Any process that activates or increases the frequency, rate or extent of maltotriulose transport.','2013-10-27','NSRP'),(37281,1900327,'regulation of mannotriose transport','P','Any process that modulates the frequency, rate or extent of mannotriose transport.','2013-10-27','NSRP'),(37282,1900328,'negative regulation of mannotriose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of mannotriose transport.','2013-10-27','NSRP'),(37283,1900329,'positive regulation of mannotriose transport','P','Any process that activates or increases the frequency, rate or extent of mannotriose transport.','2013-10-27','NSRP'),(37284,1900330,'regulation of methane biosynthetic process from trimethylamine','P','Any process that modulates the frequency, rate or extent of methane biosynthetic process from trimethylamine.','2013-10-27','NSRP'),(37285,1900331,'negative regulation of methane biosynthetic process from trimethylamine','P','Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from trimethylamine.','2013-10-27','NSRP'),(37286,1900332,'positive regulation of methane biosynthetic process from trimethylamine','P','Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from trimethylamine.','2013-10-27','NSRP'),(37287,1900333,'regulation of methane biosynthetic process from 3-(methylthio)propionic acid','P','Any process that modulates the frequency, rate or extent of methane biosynthetic process from 3-(methylthio)propionic acid.','2013-10-27','NSRP'),(37288,1900334,'negative regulation of methane biosynthetic process from 3-(methylthio)propionic acid','P','Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from 3-(methylthio)propionic acid.','2013-10-27','NSRP'),(37289,1900335,'positive regulation of methane biosynthetic process from 3-(methylthio)propionic acid','P','Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from 3-(methylthio)propionic acid.','2013-10-27','NSRP'),(37290,1900336,'regulation of methane biosynthetic process from carbon monoxide','P','Any process that modulates the frequency, rate or extent of methane biosynthetic process from carbon monoxide.','2013-10-27','NSRP'),(37291,1900337,'negative regulation of methane biosynthetic process from carbon monoxide','P','Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from carbon monoxide.','2013-10-27','NSRP'),(37292,1900338,'positive regulation of methane biosynthetic process from carbon monoxide','P','Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from carbon monoxide.','2013-10-27','NSRP'),(37293,1900339,'regulation of methane biosynthetic process from formic acid','P','Any process that modulates the frequency, rate or extent of methane biosynthetic process from formic acid.','2013-10-27','NSRP'),(37294,1900340,'negative regulation of methane biosynthetic process from formic acid','P','Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from formic acid.','2013-10-27','NSRP'),(37295,1900341,'positive regulation of methane biosynthetic process from formic acid','P','Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from formic acid.','2013-10-27','NSRP'),(37296,1900342,'regulation of methane biosynthetic process from dimethyl sulfide','P','Any process that modulates the frequency, rate or extent of methane biosynthetic process from dimethyl sulfide.','2013-10-27','NSRP'),(37297,1900343,'negative regulation of methane biosynthetic process from dimethyl sulfide','P','Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from dimethyl sulfide.','2013-10-27','NSRP'),(37298,1900344,'positive regulation of methane biosynthetic process from dimethyl sulfide','P','Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from dimethyl sulfide.','2013-10-27','NSRP'),(37299,1900345,'regulation of methane biosynthetic process from methanethiol','P','Any process that modulates the frequency, rate or extent of methane biosynthetic process from methanethiol.','2013-10-27','NSRP'),(37300,1900346,'negative regulation of methane biosynthetic process from methanethiol','P','Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from methanethiol.','2013-10-27','NSRP'),(37301,1900347,'positive regulation of methane biosynthetic process from methanethiol','P','Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from methanethiol.','2013-10-27','NSRP'),(37302,1900348,'regulation of methane biosynthetic process from methylamine','P','Any process that modulates the frequency, rate or extent of methane biosynthetic process from methylamine.','2013-10-27','NSRP'),(37303,1900349,'negative regulation of methane biosynthetic process from methylamine','P','Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from methylamine.','2013-10-27','NSRP'),(37304,1900350,'positive regulation of methane biosynthetic process from methylamine','P','Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from methylamine.','2013-10-27','NSRP'),(37305,1900351,'regulation of methanofuran biosynthetic process','P','Any process that modulates the frequency, rate or extent of methanofuran biosynthetic process.','2013-10-27','NSRP'),(37306,1900352,'negative regulation of methanofuran biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of methanofuran biosynthetic process.','2013-10-27','NSRP'),(37307,1900353,'positive regulation of methanofuran biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of methanofuran biosynthetic process.','2013-10-27','NSRP'),(37308,1900354,'regulation of methanofuran metabolic process','P','Any process that modulates the frequency, rate or extent of methanofuran metabolic process.','2013-10-27','NSRP'),(37309,1900355,'negative regulation of methanofuran metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of methanofuran metabolic process.','2013-10-27','NSRP'),(37310,1900356,'positive regulation of methanofuran metabolic process','P','Any process that activates or increases the frequency, rate or extent of methanofuran metabolic process.','2013-10-27','NSRP'),(37311,1900357,'regulation of nigerotriose transport','P','Any process that modulates the frequency, rate or extent of nigerotriose transport.','2013-10-27','NSRP'),(37312,1900358,'negative regulation of nigerotriose transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of nigerotriose transport.','2013-10-27','NSRP'),(37313,1900359,'positive regulation of nigerotriose transport','P','Any process that activates or increases the frequency, rate or extent of nigerotriose transport.','2013-10-27','NSRP'),(37314,1900360,'regulation of pentasaccharide transport','P','Any process that modulates the frequency, rate or extent of pentasaccharide transport.','2013-10-27','NSRP'),(37315,1900361,'negative regulation of pentasaccharide transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of pentasaccharide transport.','2013-10-27','NSRP'),(37316,1900362,'positive regulation of pentasaccharide transport','P','Any process that activates or increases the frequency, rate or extent of pentasaccharide transport.','2013-10-27','NSRP'),(37317,1900363,'regulation of mRNA polyadenylation','P','Any process that modulates the frequency, rate or extent of mRNA polyadenylation.','2013-10-27','NSRP'),(37318,1900364,'negative regulation of mRNA polyadenylation','P','Any process that stops, prevents or reduces the frequency, rate or extent of mRNA polyadenylation.','2013-10-27','NSRP'),(37319,1900365,'positive regulation of mRNA polyadenylation','P','Any process that activates or increases the frequency, rate or extent of mRNA polyadenylation.','2013-10-27','NSRP'),(37320,1900366,'negative regulation of defense response to insect','P','Any process that stops, prevents or reduces the frequency, rate or extent of defense response to insect.','2013-10-27','NSRP'),(37321,1900367,'positive regulation of defense response to insect','P','Any process that activates or increases the frequency, rate or extent of defense response to insect.','2013-10-27','NSRP'),(37322,1900368,'regulation of RNA interference','P','Any process that modulates the frequency, rate or extent of RNA interference.','2013-10-27','NSRP'),(37323,1900369,'negative regulation of RNA interference','P','Any process that stops, prevents or reduces the frequency, rate or extent of RNA interference.','2013-10-27','NSRP'),(37324,1900370,'positive regulation of RNA interference','P','Any process that activates or increases the frequency, rate or extent of RNA interference.','2013-10-27','NSRP'),(37325,1900371,'regulation of purine nucleotide biosynthetic process','P','Any process that modulates the frequency, rate or extent of purine nucleotide biosynthetic processes.','2013-10-27','NSRP'),(37326,1900372,'negative regulation of purine nucleotide biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of purine nucleotide biosynthetic processes.','2013-10-27','NSRP'),(37327,1900373,'positive regulation of purine nucleotide biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of purine nucleotide biosynthetic processes.','2013-10-27','NSRP'),(37328,1900374,'positive regulation of mating type switching by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in positive regulation of mating type switching.','2013-10-27','NSRP'),(37329,1900375,'positive regulation of inositol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter','P','A positive regulation of transcription from RNA polymerase II promoter that results in positive regulation of inositol biosynthetic process.','2013-10-27','NSRP'),(37330,1900376,'regulation of secondary metabolite biosynthetic process','P','Any process that modulates the frequency, rate or extent of secondary metabolite biosynthetic process.','2013-10-27','NSRP'),(37331,1900377,'negative regulation of secondary metabolite biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of secondary metabolite biosynthetic process.','2013-10-27','NSRP'),(37332,1900378,'positive regulation of secondary metabolite biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of secondary metabolite biosynthetic process.','2013-10-27','NSRP'),(37333,1900379,'regulation of asperthecin biosynthetic process','P','Any process that modulates the frequency, rate or extent of asperthecin biosynthetic process.','2013-10-27','NSRP'),(37334,1900380,'negative regulation of asperthecin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of asperthecin biosynthetic process.','2013-10-27','NSRP'),(37335,1900381,'positive regulation of asperthecin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of asperthecin biosynthetic process.','2013-10-27','NSRP'),(37336,1900382,'regulation of thiamine biosynthetic process by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of thiamine biosynthetic process.','2013-10-27','NSRP'),(37337,1900383,'regulation of synaptic plasticity by receptor localization to synapse','P','Any process that modulates synaptic plasticity, the ability of synapses to change as circumstances require, via receptor localization to the synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell. Processes may include receptor transport to, and/or maintenance at, the synapse.','2013-10-27','NSRP'),(37338,1900384,'regulation of flavonol biosynthetic process','P','Any process that modulates the frequency, rate or extent of flavonol biosynthetic process.','2013-10-27','NSRP'),(37339,1900385,'negative regulation of flavonol biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of flavonol biosynthetic process.','2013-10-27','NSRP'),(37340,1900386,'positive regulation of flavonol biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of flavonol biosynthetic process.','2013-10-27','NSRP'),(37341,1900387,'negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter','P','A negative regulation of transcription from RNA polymerase II promoter that results in negative regulation of cell-cell adhesion.','2013-10-27','NSRP'),(37342,1900388,'regulation of vesicle-mediated transport by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of vesicle-mediated transport.','2013-10-27','NSRP'),(37343,1900389,'regulation of glucose import by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of glucose import.','2013-10-27','NSRP'),(37344,1900390,'regulation of iron ion import','P','Any process that modulates the frequency, rate or extent of iron ion import.','2013-10-27','NSRP'),(37345,1900391,'regulation of cAMP-mediated signaling by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of cAMP-mediated signaling.','2013-10-27','NSRP'),(37346,1900392,'regulation of transport by negative regulation of transcription from RNA polymerase II promoter','P','A negative regulation of transcription from RNA polymerase II promoter that results in regulation of transport.','2013-10-27','NSRP'),(37347,1900393,'regulation of iron ion transport by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of iron ion transport.','2013-10-27','NSRP'),(37348,1900394,'regulation of kojic acid biosynthetic process','P','Any process that modulates the frequency, rate or extent of kojic acid biosynthetic process.','2013-10-27','NSRP'),(37349,1900395,'negative regulation of kojic acid biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of kojic acid biosynthetic process.','2013-10-27','NSRP'),(37350,1900396,'positive regulation of kojic acid biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of kojic acid biosynthetic process.','2013-10-27','NSRP'),(37351,1900397,'regulation of pyrimidine nucleotide biosynthetic process','P','Any process that modulates the frequency, rate or extent of pyrimidine nucleotide biosynthetic process.','2013-10-27','NSRP'),(37352,1900398,'negative regulation of pyrimidine nucleotide biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of pyrimidine nucleotide biosynthetic process.','2013-10-27','NSRP'),(37353,1900399,'positive regulation of pyrimidine nucleotide biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of pyrimidine nucleotide biosynthetic process.','2013-10-27','NSRP'),(37354,1900400,'regulation of iron ion import by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of iron ion import.','2013-10-27','NSRP'),(37355,1900401,'regulation of meiosis by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of meiosis.','2013-10-27','NSRP'),(37356,1900402,'regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of carbohydrate metabolic process.','2013-10-27','NSRP'),(37357,1900403,'negative regulation of cellular amino acid biosynthetic process by negative regulation of transcription from RNA polymerase II promoter','P','A negative regulation of transcription from RNA polymerase II promoter that results in negative regulation of cellular amino acid biosynthetic process.','2013-10-27','NSRP'),(37358,1900404,'positive regulation of DNA repair by positive regulation of transcription from RNA polymerase II promoter','P','A positive regulation of transcription from RNA polymerase II promoter that results in positive regulation of DNA repair.','2013-10-27','NSRP'),(37359,1900405,'regulation of cytokinetic cell separation by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of cytokinetic cell separation.','2013-10-27','NSRP'),(37360,1900406,'regulation of conjugation with cellular fusion by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of conjugation with cellular fusion.','2013-10-27','NSRP'),(37361,1900407,'regulation of cellular response to oxidative stress','P','Any process that modulates the frequency, rate or extent of cellular response to oxidative stress.','2013-10-27','NSRP'),(37362,1900408,'negative regulation of cellular response to oxidative stress','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to oxidative stress.','2013-10-27','NSRP'),(37363,1900409,'positive regulation of cellular response to oxidative stress','P','Any process that activates or increases the frequency, rate or extent of cellular response to oxidative stress.','2013-10-27','NSRP'),(37364,1900410,'regulation of histone modification by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of histone modification.','2013-10-27','NSRP'),(37365,1900411,'regulation of histone acetylation by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of histone acetylation.','2013-10-27','NSRP'),(37366,1900412,'regulation of histone methylation by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of histone methylation.','2013-10-27','NSRP'),(37367,1900413,'positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter','P','A positive regulation of transcription from RNA polymerase II promoter that results in positive regulation of phospholipid biosynthetic process.','2013-10-27','NSRP'),(37368,1900414,'regulation of cytokinesis by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of cytokinesis.','2013-10-27','NSRP'),(37369,1900415,'regulation of fungal-type cell wall biogenesis by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of fungal-type cell wall biogenesis.','2013-10-27','NSRP'),(37370,1900416,'regulation of 4,6-pyruvylated galactose residue biosynthetic process by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of 4,6-pyruvylated galactose residue biosynthetic process.','2013-10-27','NSRP'),(37371,1900417,'negative regulation of transmembrane transport by negative regulation of transcription from RNA polymerase II promoter','P','A negative regulation of transcription from RNA polymerase II promoter that results in negative regulation of transmembrane transport.','2013-10-27','NSRP'),(37372,1900418,'positive regulation of purine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter','P','A positive regulation of transcription from RNA polymerase II promoter that results in positive regulation of purine nucleotide biosynthetic process.','2013-10-27','NSRP'),(37373,1900419,'regulation of cellular alcohol catabolic process','P','Any process that modulates the frequency, rate or extent of cellular alcohol catabolic process.','2013-10-27','NSRP'),(37374,1900420,'negative regulation of cellular alcohol catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular alcohol catabolic process.','2013-10-27','NSRP'),(37375,1900421,'positive regulation of cellular alcohol catabolic process','P','Any process that activates or increases the frequency, rate or extent of cellular alcohol catabolic process.','2013-10-27','NSRP'),(37376,1900422,'positive regulation of cellular alcohol catabolic process by positive regulation of transcription from RNA polymerase II promoter','P','A positive regulation of transcription from RNA polymerase II promoter that results in positive regulation of cellular alcohol catabolic process.','2013-10-27','NSRP'),(37377,1900423,'positive regulation of mating type switching by positive regulation of transcription from RNA polymerase II promoter','P','A positive regulation of transcription from RNA polymerase II promoter that results in positive regulation of mating type switching.','2013-10-27','NSRP'),(37378,1900424,'regulation of defense response to bacterium','P','Any process that modulates the frequency, rate or extent of defense response to bacterium.','2013-10-27','NSRP'),(37379,1900425,'negative regulation of defense response to bacterium','P','Any process that stops, prevents or reduces the frequency, rate or extent of defense response to bacterium.','2013-10-27','NSRP'),(37380,1900426,'positive regulation of defense response to bacterium','P','Any process that activates or increases the frequency, rate or extent of defense response to bacterium.','2013-10-27','NSRP'),(37381,1900427,'regulation of cellular response to oxidative stress by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of cellular response to oxidative stress.','2013-10-27','NSRP'),(37382,1900428,'regulation of filamentous growth of a population of unicellular organisms','P','Any process that modulates the frequency, rate or extent of filamentous growth of a population of unicellular organisms.','2013-10-27','NSRP'),(37383,1900429,'negative regulation of filamentous growth of a population of unicellular organisms','P','Any process that stops, prevents or reduces the frequency, rate or extent of filamentous growth of a population of unicellular organisms.','2013-10-27','NSRP'),(37384,1900430,'positive regulation of filamentous growth of a population of unicellular organisms','P','Any process that activates or increases the frequency, rate or extent of filamentous growth of a population of unicellular organisms.','2013-10-27','NSRP'),(37385,1900431,'regulation of filamentous growth of a population of unicellular organisms in response to heat','P','Any process that modulates the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to heat.','2013-10-27','NSRP'),(37386,1900432,'negative regulation of filamentous growth of a population of unicellular organisms in response to heat','P','Any process that stops, prevents or reduces the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to heat.','2013-10-27','NSRP'),(37387,1900433,'positive regulation of filamentous growth of a population of unicellular organisms in response to heat','P','Any process that activates or increases the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to heat.','2013-10-27','NSRP'),(37388,1900434,'regulation of filamentous growth of a population of unicellular organisms in response to starvation','P','Any process that modulates the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to starvation.','2013-10-27','NSRP'),(37389,1900435,'negative regulation of filamentous growth of a population of unicellular organisms in response to starvation','P','Any process that stops, prevents or reduces the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to starvation.','2013-10-27','NSRP'),(37390,1900436,'positive regulation of filamentous growth of a population of unicellular organisms in response to starvation','P','Any process that activates or increases the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to starvation.','2013-10-27','NSRP'),(37391,1900437,'regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus','P','Any process that modulates the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to chemical stimulus.','2013-10-27','NSRP'),(37392,1900438,'negative regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus','P','Any process that stops, prevents or reduces the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to chemical stimulus.','2013-10-27','NSRP'),(37393,1900439,'positive regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus','P','Any process that activates or increases the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to chemical stimulus.','2013-10-27','NSRP'),(37394,1900440,'regulation of filamentous growth of a population of unicellular organisms in response to neutral pH','P','Any process that modulates the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to neutral pH.','2013-10-27','NSRP'),(37395,1900441,'negative regulation of filamentous growth of a population of unicellular organisms in response to neutral pH','P','Any process that stops, prevents or reduces the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to neutral pH.','2013-10-27','NSRP'),(37396,1900442,'positive regulation of filamentous growth of a population of unicellular organisms in response to neutral pH','P','Any process that activates or increases the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to neutral pH.','2013-10-27','NSRP'),(37397,1900443,'regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus','P','Any process that modulates the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to biotic stimulus.','2013-10-27','NSRP'),(37398,1900444,'negative regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus','P','Any process that stops, prevents or reduces the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to biotic stimulus.','2013-10-27','NSRP'),(37399,1900445,'positive regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus','P','Any process that activates or increases the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to biotic stimulus.','2013-10-27','NSRP'),(37400,1900446,'negative regulation of tRNA transcription from RNA polymerase III promoter','P','Any process that stops, prevents or reduces the frequency, rate or extent of tRNA transcription from RNA polymerase III promoter.','2013-10-27','NSRP'),(37401,1900447,'regulation of cell morphogenesis involved in phenotypic switching','P','Any process that modulates the frequency, rate or extent of cell morphogenesis contributing a phenotypic switch. Cell morphogenesis involved in differentiation is the change in form (cell shape and size) that occurs when relatively unspecialized cells, such as the opaque cells of C. albicans, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism\'s life history.','2013-10-27','NSRP'),(37402,1900448,'regulation of pyrimidine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter','P','Any process that modulates the frequency, rate or extent of pyrimidine nucleotide biosynthesis by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37403,1900449,'regulation of glutamate receptor signaling pathway','P','Any process that modulates the frequency, rate or extent of glutamate receptor signaling pathway.','2013-10-27','NSRP'),(37404,1900450,'negative regulation of glutamate receptor signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of glutamate receptor signaling pathway.','2013-10-27','NSRP'),(37405,1900451,'positive regulation of glutamate receptor signaling pathway','P','Any process that activates or increases the frequency, rate or extent of glutamate receptor signaling pathway.','2013-10-27','NSRP'),(37406,1900452,'regulation of long term synaptic depression','P','Any process that modulates the frequency, rate or extent of long term synaptic depression.','2013-10-27','NSRP'),(37407,1900453,'negative regulation of long term synaptic depression','P','Any process that stops, prevents or reduces the frequency, rate or extent of long term synaptic depression.','2013-10-27','NSRP'),(37408,1900454,'positive regulation of long term synaptic depression','P','Any process that activates or increases the frequency, rate or extent of long term synaptic depression.','2013-10-27','NSRP'),(37409,1900455,'regulation of flocculation via cell wall protein-carbohydrate interaction','P','Any process that modulates the frequency, rate or extent of flocculation via cell wall protein-carbohydrate interaction.','2013-10-27','NSRP'),(37410,1900456,'regulation of invasive growth in response to glucose limitation by regulation of transcription from RNA polymerase II promoter','P','OBSOLETE. Any process that modulates the frequency, rate or extent of invasive growth in response to glucose limitation by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37411,1900457,'regulation of brassinosteroid mediated signaling pathway','P','Any process that modulates the frequency, rate or extent of brassinosteroid mediated signaling pathway.','2013-10-27','NSRP'),(37412,1900458,'negative regulation of brassinosteroid mediated signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of brassinosteroid mediated signaling pathway.','2013-10-27','NSRP'),(37413,1900459,'positive regulation of brassinosteroid mediated signaling pathway','P','Any process that activates or increases the frequency, rate or extent of brassinosteroid mediated signaling pathway.','2013-10-27','NSRP'),(37414,1900460,'negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter','P','Any process that stops, prevents, or reduces the frequency, rate or extent of invasive growth in response to glucose limitation by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37415,1900461,'positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of pseudohyphal growth by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37416,1900462,'negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of pseudohyphal growth by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of pseudohyphal growth by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37417,1900463,'negative regulation of cellular response to alkalinity by negative regulation of transcription from RNA polymerase II promoter','P','Any process that stops, prevents, or reduces the frequency, rate or extent of cellular response to alkalinity by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37418,1900464,'negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter','P','Any process that stops, prevents, or reduces the frequency, rate or extent of cellular hyperosmotic salinity response by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37419,1900465,'negative regulation of arginine catabolic process by negative regulation of transcription from RNA polymerase II promoter','P','Any process that stops, prevents, or reduces the frequency, rate or extent of cellular arginine catabolic process by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37420,1900466,'positive regulation of arginine biosynthetic process by positive regulation of transcription from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of arginine biosynthetic process by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37421,1900467,'regulation of cellular potassium ion homeostasis','P','OBSOLETE. Any process that modulates the frequency, rate or extent of cellular potassium ion homeostasis.','2013-10-27','NSRP'),(37422,1900468,'regulation of phosphatidylserine biosynthetic process','P','Any process that modulates the frequency, rate or extent of phosphatidylserine biosynthetic process.','2013-10-27','NSRP'),(37423,1900469,'negative regulation of phosphatidylserine biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine biosynthetic process.','2013-10-27','NSRP'),(37424,1900470,'positive regulation of phosphatidylserine biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of phosphatidylserine biosynthetic process.','2013-10-27','NSRP'),(37425,1900471,'negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter','P','Any process that stops, prevents, or reduces the frequency, rate or extent of inositol biosynthetic process by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37426,1900472,'positive regulation of phosphatidylcholine biosynthetic process by positive regulation of transcription from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of phosphatidylcholine biosynthetic process by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37427,1900473,'negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter','P','Any process that stops, prevents, or reduces the frequency, rate or extent of phosphatidylcholine biosynthetic process by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37428,1900474,'negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter','P','Any process that stops, prevents, or reduces the frequency, rate or extent of mating type switching by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37429,1900475,'positive regulation of meiosis by negative regulation of transcription from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of meiosis by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37430,1900476,'positive regulation of meiosis by positive regulation of transcription from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of meiosis by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37431,1900477,'negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter','P','Any process that stops, prevents, or reduces the frequency, rate or extent of G1/S transition of mitotic cell cycle by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37432,1900478,'positive regulation of sulfate assimilation by positive regulation of transcription from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of sulfate assimilation by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37433,1900479,'positive regulation of flocculation via cell wall protein-carbohydrate interaction','P','Any process that activates or increases the frequency, rate or extent of flocculation via cell wall protein-carbohydrate interaction.','2013-10-27','NSRP'),(37434,1900480,'regulation of diacylglycerol biosynthetic process','P','Any process that modulates the frequency, rate or extent of diacylglycerol biosynthetic process.','2013-10-27','NSRP'),(37435,1900481,'negative regulation of diacylglycerol biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol biosynthetic process.','2013-10-27','NSRP'),(37436,1900482,'positive regulation of diacylglycerol biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of diacylglycerol biosynthetic process.','2013-10-27','NSRP'),(37437,1900483,'regulation of protein targeting to vacuolar membrane','P','Any process that modulates the frequency, rate or extent of protein targeting to vacuolar membrane.','2013-10-27','NSRP'),(37438,1900484,'negative regulation of protein targeting to vacuolar membrane','P','Any process that stops, prevents or reduces the frequency, rate or extent of protein targeting to vacuolar membrane.','2013-10-27','NSRP'),(37439,1900485,'positive regulation of protein targeting to vacuolar membrane','P','Any process that activates or increases the frequency, rate or extent of protein targeting to vacuolar membrane.','2013-10-27','NSRP'),(37440,1900486,'positive regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway','P','Any process that activates or increases the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.','2013-10-27','NSRP'),(37441,1900487,'regulation of [2Fe-2S] cluster assembly','P','Any process that modulates the frequency, rate or extent of [2Fe-2S] cluster assembly.','2013-10-27','NSRP'),(37442,1900488,'negative regulation of [2Fe-2S] cluster assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of [2Fe-2S] cluster assembly.','2013-10-27','NSRP'),(37443,1900489,'positive regulation of [2Fe-2S] cluster assembly','P','Any process that activates or increases the frequency, rate or extent of [2Fe-2S] cluster assembly.','2013-10-27','NSRP'),(37444,1900490,'positive regulation of hydroxymethylglutaryl-CoA reductase (NADPH) activity','P','Any process that activates or increases the frequency, rate or extent of hydroxymethylglutaryl-CoA reductase (NADPH) activity.','2013-10-27','NSRP'),(37445,1900491,'regulation of [4Fe-4S] cluster assembly','P','Any process that modulates the frequency, rate or extent of [4Fe-4S] cluster assembly.','2013-10-27','NSRP'),(37446,1900492,'negative regulation of [4Fe-4S] cluster assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of [4Fe-4S] cluster assembly.','2013-10-27','NSRP'),(37447,1900493,'positive regulation of [4Fe-4S] cluster assembly','P','Any process that activates or increases the frequency, rate or extent of [4Fe-4S] cluster assembly.','2013-10-27','NSRP'),(37448,1900494,'regulation of butyryl-CoA biosynthetic process from acetyl-CoA','P','Any process that modulates the frequency, rate or extent of butyryl-CoA biosynthetic process from acetyl-CoA.','2013-10-27','NSRP'),(37449,1900495,'negative regulation of butyryl-CoA biosynthetic process from acetyl-CoA','P','Any process that stops, prevents or reduces the frequency, rate or extent of butyryl-CoA biosynthetic process from acetyl-CoA.','2013-10-27','NSRP'),(37450,1900496,'positive regulation of butyryl-CoA biosynthetic process from acetyl-CoA','P','Any process that activates or increases the frequency, rate or extent of butyryl-CoA biosynthetic process from acetyl-CoA.','2013-10-27','NSRP'),(37451,1900497,'regulation of butyryl-CoA catabolic process to butanol','P','Any process that modulates the frequency, rate or extent of butyryl-CoA catabolic process to butanol.','2013-10-27','NSRP'),(37452,1900498,'negative regulation of butyryl-CoA catabolic process to butanol','P','Any process that stops, prevents or reduces the frequency, rate or extent of butyryl-CoA catabolic process to butanol.','2013-10-27','NSRP'),(37453,1900499,'positive regulation of butyryl-CoA catabolic process to butanol','P','Any process that activates or increases the frequency, rate or extent of butyryl-CoA catabolic process to butanol.','2013-10-27','NSRP'),(37454,1900500,'regulation of butyryl-CoA catabolic process to butyrate','P','Any process that modulates the frequency, rate or extent of butyryl-CoA catabolic process to butyrate.','2013-10-27','NSRP'),(37455,1900501,'negative regulation of butyryl-CoA catabolic process to butyrate','P','Any process that stops, prevents or reduces the frequency, rate or extent of butyryl-CoA catabolic process to butyrate.','2013-10-27','NSRP'),(37456,1900502,'positive regulation of butyryl-CoA catabolic process to butyrate','P','Any process that activates or increases the frequency, rate or extent of butyryl-CoA catabolic process to butyrate.','2013-10-27','NSRP'),(37457,1900503,'regulation of cellulosome assembly','P','Any process that modulates the frequency, rate or extent of cellulosome assembly.','2013-10-27','NSRP'),(37458,1900504,'negative regulation of cellulosome assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellulosome assembly.','2013-10-27','NSRP'),(37459,1900505,'positive regulation of cellulosome assembly','P','Any process that activates or increases the frequency, rate or extent of cellulosome assembly.','2013-10-27','NSRP'),(37460,1900506,'regulation of iron-sulfur-molybdenum cofactor assembly','P','Any process that modulates the frequency, rate or extent of iron-sulfur-molybdenum cofactor assembly.','2013-10-27','NSRP'),(37461,1900507,'negative regulation of iron-sulfur-molybdenum cofactor assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of iron-sulfur-molybdenum cofactor assembly.','2013-10-27','NSRP'),(37462,1900508,'positive regulation of iron-sulfur-molybdenum cofactor assembly','P','Any process that activates or increases the frequency, rate or extent of iron-sulfur-molybdenum cofactor assembly.','2013-10-27','NSRP'),(37463,1900509,'regulation of pentose catabolic process to ethanol','P','Any process that modulates the frequency, rate or extent of pentose catabolic process to ethanol.','2013-10-27','NSRP'),(37464,1900510,'negative regulation of pentose catabolic process to ethanol','P','Any process that stops, prevents or reduces the frequency, rate or extent of pentose catabolic process to ethanol.','2013-10-27','NSRP'),(37465,1900511,'positive regulation of pentose catabolic process to ethanol','P','Any process that activates or increases the frequency, rate or extent of pentose catabolic process to ethanol.','2013-10-27','NSRP'),(37466,1900512,'regulation of starch utilization system complex assembly','P','Any process that modulates the frequency, rate or extent of starch utilization system complex assembly.','2013-10-27','NSRP'),(37467,1900513,'negative regulation of starch utilization system complex assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of starch utilization system complex assembly.','2013-10-27','NSRP'),(37468,1900514,'positive regulation of starch utilization system complex assembly','P','Any process that activates or increases the frequency, rate or extent of starch utilization system complex assembly.','2013-10-27','NSRP'),(37469,1900515,'regulation of xylose catabolic process to ethanol','P','Any process that modulates the frequency, rate or extent of xylose catabolic process to ethanol.','2013-10-27','NSRP'),(37470,1900516,'negative regulation of xylose catabolic process to ethanol','P','Any process that stops, prevents or reduces the frequency, rate or extent of xylose catabolic process to ethanol.','2013-10-27','NSRP'),(37471,1900517,'positive regulation of xylose catabolic process to ethanol','P','Any process that activates or increases the frequency, rate or extent of xylose catabolic process to ethanol.','2013-10-27','NSRP'),(37472,1900518,'regulation of response to pullulan','P','Any process that modulates the frequency, rate or extent of response to pullulan.','2013-10-27','NSRP'),(37473,1900519,'negative regulation of response to pullulan','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to pullulan.','2013-10-27','NSRP'),(37474,1900520,'positive regulation of response to pullulan','P','Any process that activates or increases the frequency, rate or extent of response to pullulan.','2013-10-27','NSRP'),(37475,1900521,'regulation of response to amylopectin','P','Any process that modulates the frequency, rate or extent of response to amylopectin.','2013-10-27','NSRP'),(37476,1900522,'negative regulation of response to amylopectin','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to amylopectin.','2013-10-27','NSRP'),(37477,1900523,'positive regulation of response to amylopectin','P','Any process that activates or increases the frequency, rate or extent of response to amylopectin.','2013-10-27','NSRP'),(37478,1900524,'positive regulation of flocculation via cell wall protein-carbohydrate interaction by positive regulation of transcription from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of flocculation via cell wall protein-carbohydrate interaction process by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37479,1900525,'positive regulation of phosphatidylserine biosynthetic process by positive regulation of transcription from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of phosphatidylserine biosynthetic process by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37480,1900526,'negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter','P','Any process that stops, prevents, or reduces the frequency, rate or extent of phosphatidylserine biosynthetic process by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37481,1900527,'regulation of nucleus size involved in G1 to G0 transition','P','Any regulation of nucleus size that is involved in G1 to G0 transition.','2013-10-27','NSRP'),(37482,1900528,'regulation of cell shape involved in G1 to G0 transition','P','Any regulation of cell shape that is involved in G1 to G0 transition.','2013-10-27','NSRP'),(37483,1900529,'regulation of cell shape involved in cellular response to glucose starvation','P','OBSOLETE. Any regulation of cell shape that is involved in cellular response to glucose starvation.','2013-10-27','NSRP'),(37484,1900530,'regulation of cell shape involved in cellular response to salt stress','P','OBSOLETE. Any regulation of cell shape that is involved in cellular response to salt stress.','2013-10-27','NSRP'),(37485,1900531,'regulation of cell shape involved in cellular response to heat','P','OBSOLETE. Any regulation of cell shape that is involved in cellular response to heat.','2013-10-27','NSRP'),(37486,1900532,'negative regulation of cell proliferation involved in cellular hyperosmotic response','P','OBSOLETE. negative regulation of cell proliferation during cellular hyperosmotic response','2013-10-27','NSRP'),(37487,1900533,'palmitic acid metabolic process','P','The chemical reactions and pathways involving palmitic acid.','2013-10-27','NSRP'),(37488,1900534,'palmitic acid catabolic process','P','The chemical reactions and pathways resulting in the breakdown of palmitic acid.','2013-10-27','NSRP'),(37489,1900535,'palmitic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of palmitic acid.','2013-10-27','NSRP'),(37490,1900536,'regulation of glucose homeostasis','P','OBSOLETE. Any process that modulates the frequency, rate or extent of glucose homeostasis.','2013-10-27','NSRP'),(37491,1900537,'negative regulation of glucose homeostasis','P','OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of glucose homeostasis.','2013-10-27','NSRP'),(37492,1900538,'positive regulation of glucose homeostasis','P','OBSOLETE. Any process that activates or increases the frequency, rate or extent of glucose homeostasis.','2013-10-27','NSRP'),(37493,1900539,'fumonisin metabolic process','P','The chemical reactions and pathways involving fumonisin.','2013-10-27','NSRP'),(37494,1900540,'fumonisin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of fumonisin.','2013-10-27','NSRP'),(37495,1900541,'fumonisin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of fumonisin.','2013-10-27','NSRP'),(37496,1900542,'regulation of purine nucleotide metabolic process','P','Any process that modulates the frequency, rate or extent of purine nucleotide metabolic process.','2013-10-27','NSRP'),(37497,1900543,'negative regulation of purine nucleotide metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of purine nucleotide metabolic process.','2013-10-27','NSRP'),(37498,1900544,'positive regulation of purine nucleotide metabolic process','P','Any process that activates or increases the frequency, rate or extent of purine nucleotide metabolic process.','2013-10-27','NSRP'),(37499,1900545,'regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of phenotypic switching.','2013-10-27','NSRP'),(37500,1900546,'positive regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in positive regulation of phenotypic switching.','2013-10-27','NSRP'),(37501,1900547,'negative regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in negative regulation of phenotypic switching.','2013-10-27','NSRP'),(37502,1900548,'heme b catabolic process','P','The chemical reactions and pathways resulting in the breakdown of heme b, a Fe(II) porphyrin complex readily isolated from the hemoglobin of beef blood, but also found in other proteins including other hemoglobins, myoglobins, cytochromes P-450, catalases, peroxidases as well as b type cytochromes.','2013-10-27','NSRP'),(37503,1900549,'N\',N\'\',N\'\'\'-triacetylfusarinine C metabolic process','P','The chemical reactions and pathways involving N\',N\'\',N\'\'\'-triacetylfusarinine C.','2013-10-27','NSRP'),(37504,1900550,'N\',N\'\',N\'\'\'-triacetylfusarinine C catabolic process','P','The chemical reactions and pathways resulting in the breakdown of N\',N\'\',N\'\'\'-triacetylfusarinine C.','2013-10-27','NSRP'),(37505,1900551,'N\',N\'\',N\'\'\'-triacetylfusarinine C biosynthetic process','P','The chemical reactions and pathways resulting in the formation of N\',N\'\',N\'\'\'-triacetylfusarinine C.','2013-10-27','NSRP'),(37506,1900552,'asperfuranone metabolic process','P','The chemical reactions and pathways involving asperfuranone.','2013-10-27','NSRP'),(37507,1900553,'asperfuranone catabolic process','P','The chemical reactions and pathways resulting in the breakdown of asperfuranone.','2013-10-27','NSRP'),(37508,1900554,'asperfuranone biosynthetic process','P','The chemical reactions and pathways resulting in the formation of asperfuranone.','2013-10-27','NSRP'),(37509,1900555,'emericellamide metabolic process','P','The chemical reactions and pathways involving emericellamide.','2013-10-27','NSRP'),(37510,1900556,'emericellamide catabolic process','P','The chemical reactions and pathways resulting in the breakdown of emericellamide.','2013-10-27','NSRP'),(37511,1900557,'emericellamide biosynthetic process','P','The chemical reactions and pathways resulting in the formation of emericellamide.','2013-10-27','NSRP'),(37512,1900558,'austinol metabolic process','P','The chemical reactions and pathways involving austinol.','2013-10-27','NSRP'),(37513,1900559,'austinol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of austinol.','2013-10-27','NSRP'),(37514,1900560,'austinol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of austinol.','2013-10-27','NSRP'),(37515,1900561,'dehydroaustinol metabolic process','P','The chemical reactions and pathways involving dehydroaustinol.','2013-10-27','NSRP'),(37516,1900562,'dehydroaustinol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of dehydroaustinol.','2013-10-27','NSRP'),(37517,1900563,'dehydroaustinol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of dehydroaustinol.','2013-10-27','NSRP'),(37518,1900564,'chanoclavine-I metabolic process','P','The chemical reactions and pathways involving chanoclavine-I.','2013-10-27','NSRP'),(37519,1900565,'chanoclavine-I catabolic process','P','The chemical reactions and pathways resulting in the breakdown of chanoclavine-I.','2013-10-27','NSRP'),(37520,1900566,'chanoclavine-I biosynthetic process','P','The chemical reactions and pathways resulting in the formation of chanoclavine-I.','2013-10-27','NSRP'),(37521,1900567,'chanoclavine-I aldehyde metabolic process','P','The chemical reactions and pathways involving chanoclavine-I aldehyde.','2013-10-27','NSRP'),(37522,1900568,'chanoclavine-I aldehyde catabolic process','P','The chemical reactions and pathways resulting in the breakdown of chanoclavine-I aldehyde.','2013-10-27','NSRP'),(37523,1900569,'chanoclavine-I aldehyde biosynthetic process','P','The chemical reactions and pathways resulting in the formation of chanoclavine-I aldehyde.','2013-10-27','NSRP'),(37524,1900570,'diorcinol metabolic process','P','The chemical reactions and pathways involving diorcinol.','2013-10-27','NSRP'),(37525,1900571,'diorcinol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of diorcinol.','2013-10-27','NSRP'),(37526,1900572,'diorcinol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of diorcinol.','2013-10-27','NSRP'),(37527,1900573,'emodin metabolic process','P','The chemical reactions and pathways involving emodin.','2013-10-27','NSRP'),(37528,1900574,'emodin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of emodin.','2013-10-27','NSRP'),(37529,1900575,'emodin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of emodin.','2013-10-27','NSRP'),(37530,1900576,'gerfelin metabolic process','P','The chemical reactions and pathways involving gerfelin.','2013-10-27','NSRP'),(37531,1900577,'gerfelin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of gerfelin.','2013-10-27','NSRP'),(37532,1900578,'gerfelin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of gerfelin.','2013-10-27','NSRP'),(37533,1900579,'(17Z)-protosta-17(20),24-dien-3beta-ol metabolic process','P','The chemical reactions and pathways involving (17Z)-protosta-17(20),24-dien-3beta-ol.','2013-10-27','NSRP'),(37534,1900580,'(17Z)-protosta-17(20),24-dien-3beta-ol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of (17Z)-protosta-17(20),24-dien-3beta-ol.','2013-10-27','NSRP'),(37535,1900581,'(17Z)-protosta-17(20),24-dien-3beta-ol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (17Z)-protosta-17(20),24-dien-3beta-ol.','2013-10-27','NSRP'),(37536,1900582,'o-orsellinic acid metabolic process','P','The chemical reactions and pathways involving o-orsellinic acid.','2013-10-27','NSRP'),(37537,1900583,'o-orsellinic acid catabolic process','P','The chemical reactions and pathways resulting in the breakdown of o-orsellinic acid.','2013-10-27','NSRP'),(37538,1900584,'o-orsellinic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of o-orsellinic acid.','2013-10-27','NSRP'),(37539,1900585,'arugosin metabolic process','P','The chemical reactions and pathways involving arugosin.','2013-10-27','NSRP'),(37540,1900586,'arugosin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of arugosin.','2013-10-27','NSRP'),(37541,1900587,'arugosin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of arugosin.','2013-10-27','NSRP'),(37542,1900588,'violaceol I metabolic process','P','The chemical reactions and pathways involving violaceol I.','2013-10-27','NSRP'),(37543,1900589,'violaceol I catabolic process','P','The chemical reactions and pathways resulting in the breakdown of violaceol I.','2013-10-27','NSRP'),(37544,1900590,'violaceol I biosynthetic process','P','The chemical reactions and pathways resulting in the formation of violaceol I.','2013-10-27','NSRP'),(37545,1900591,'violaceol II metabolic process','P','The chemical reactions and pathways involving violaceol II.','2013-10-27','NSRP'),(37546,1900592,'violaceol II catabolic process','P','The chemical reactions and pathways resulting in the breakdown of violaceol II.','2013-10-27','NSRP'),(37547,1900593,'violaceol II biosynthetic process','P','The chemical reactions and pathways resulting in the formation of violaceol II.','2013-10-27','NSRP'),(37548,1900594,'(+)-kotanin metabolic process','P','The chemical reactions and pathways involving (+)-kotanin.','2013-10-27','NSRP'),(37549,1900595,'(+)-kotanin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of (+)-kotanin.','2013-10-27','NSRP'),(37550,1900596,'(+)-kotanin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (+)-kotanin.','2013-10-27','NSRP'),(37551,1900597,'demethylkotanin metabolic process','P','The chemical reactions and pathways involving demethylkotanin.','2013-10-27','NSRP'),(37552,1900598,'demethylkotanin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of demethylkotanin.','2013-10-27','NSRP'),(37553,1900599,'demethylkotanin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of demethylkotanin.','2013-10-27','NSRP'),(37554,1900600,'endocrocin metabolic process','P','The chemical reactions and pathways involving endocrocin.','2013-10-27','NSRP'),(37555,1900601,'endocrocin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of endocrocin.','2013-10-27','NSRP'),(37556,1900602,'endocrocin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of endocrocin.','2013-10-27','NSRP'),(37557,1900603,'tensidol A metabolic process','P','The chemical reactions and pathways involving tensidol A.','2013-10-27','NSRP'),(37558,1900604,'tensidol A catabolic process','P','The chemical reactions and pathways resulting in the breakdown of tensidol A.','2013-10-27','NSRP'),(37559,1900605,'tensidol A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of tensidol A.','2013-10-27','NSRP'),(37560,1900606,'tensidol B metabolic process','P','The chemical reactions and pathways involving tensidol B.','2013-10-27','NSRP'),(37561,1900607,'tensidol B catabolic process','P','The chemical reactions and pathways resulting in the breakdown of tensidol B.','2013-10-27','NSRP'),(37562,1900608,'tensidol B biosynthetic process','P','The chemical reactions and pathways resulting in the formation of tensidol B.','2013-10-27','NSRP'),(37563,1900609,'F-9775A metabolic process','P','The chemical reactions and pathways involving F-9775A.','2013-10-27','NSRP'),(37564,1900610,'F-9775A catabolic process','P','The chemical reactions and pathways resulting in the breakdown of F-9775A.','2013-10-27','NSRP'),(37565,1900611,'F-9775A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of F-9775A.','2013-10-27','NSRP'),(37566,1900612,'F-9775B metabolic process','P','The chemical reactions and pathways involving F-9775B.','2013-10-27','NSRP'),(37567,1900613,'F-9775B catabolic process','P','The chemical reactions and pathways resulting in the breakdown of F-9775B.','2013-10-27','NSRP'),(37568,1900614,'F-9775B biosynthetic process','P','The chemical reactions and pathways resulting in the formation of F-9775B.','2013-10-27','NSRP'),(37569,1900615,'emericellamide A metabolic process','P','The chemical reactions and pathways involving emericellamide A.','2013-10-27','NSRP'),(37570,1900616,'emericellamide A catabolic process','P','The chemical reactions and pathways resulting in the breakdown of emericellamide A.','2013-10-27','NSRP'),(37571,1900617,'emericellamide A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of emericellamide A.','2013-10-27','NSRP'),(37572,1900618,'regulation of shoot system morphogenesis','P','Any process that modulates the frequency, rate or extent of shoot morphogenesis.','2013-10-27','NSRP'),(37573,1900619,'acetate ester metabolic process','P','The chemical reactions and pathways involving an acetate ester, any carboxylic ester where the carboxylic acid component is acetic acid.','2013-10-27','NSRP'),(37574,1900620,'acetate ester biosynthetic process','P','The chemical reactions and pathways resulting in the formation of an acetate esteran acetate ester, any carboxylic ester where the carboxylic acid component is acetic acid.','2013-10-27','NSRP'),(37575,1900621,'regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling','P','Calcium-mediated signaling that results in regulation of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37576,1900622,'positive regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling','P','Calcium-mediated signaling that results in positive regulation of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(37577,1900623,'regulation of monocyte aggregation','P','Any process that modulates the frequency, rate or extent of monocyte aggregation.','2013-10-27','NSRP'),(37578,1900624,'negative regulation of monocyte aggregation','P','Any process that stops, prevents or reduces the frequency, rate or extent of monocyte aggregation.','2013-10-27','NSRP'),(37579,1900625,'positive regulation of monocyte aggregation','P','Any process that activates or increases the frequency, rate or extent of monocyte aggregation.','2013-10-27','NSRP'),(37580,1900626,'regulation of arugosin biosynthetic process','P','Any process that modulates the frequency, rate or extent of arugosin biosynthetic process.','2013-10-27','NSRP'),(37581,1900627,'negative regulation of arugosin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of arugosin biosynthetic process.','2013-10-27','NSRP'),(37582,1900628,'positive regulation of arugosin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of arugosin biosynthetic process.','2013-10-27','NSRP'),(37583,1900629,'methanophenazine metabolic process','P','The chemical reactions and pathways involving methanophenazine.','2013-10-27','NSRP'),(37584,1900630,'methanophenazine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of methanophenazine.','2013-10-27','NSRP'),(37585,1900631,'tridecane metabolic process','P','The chemical reactions and pathways involving tridecane.','2013-10-27','NSRP'),(37586,1900632,'tridecane biosynthetic process','P','The chemical reactions and pathways resulting in the formation of tridecane.','2013-10-27','NSRP'),(37587,1900633,'pentadecane metabolic process','P','The chemical reactions and pathways involving pentadecane.','2013-10-27','NSRP'),(37588,1900634,'pentadecane biosynthetic process','P','The chemical reactions and pathways resulting in the formation of pentadecane.','2013-10-27','NSRP'),(37589,1900635,'heptadecane metabolic process','P','The chemical reactions and pathways involving heptadecane.','2013-10-27','NSRP'),(37590,1900636,'heptadecane biosynthetic process','P','The chemical reactions and pathways resulting in the formation of heptadecane.','2013-10-27','NSRP'),(37591,1900637,'regulation of asperfuranone biosynthetic process','P','Any process that modulates the frequency, rate or extent of asperfuranone biosynthetic process.','2013-10-27','NSRP'),(37592,1900638,'negative regulation of asperfuranone biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of asperfuranone biosynthetic process.','2013-10-27','NSRP'),(37593,1900639,'positive regulation of asperfuranone biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of asperfuranone biosynthetic process.','2013-10-27','NSRP'),(37594,1900640,'regulation of austinol biosynthetic process','P','Any process that modulates the frequency, rate or extent of austinol biosynthetic process.','2013-10-27','NSRP'),(37595,1900641,'negative regulation of austinol biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of austinol biosynthetic process.','2013-10-27','NSRP'),(37596,1900642,'positive regulation of austinol biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of austinol biosynthetic process.','2013-10-27','NSRP'),(37597,1900643,'regulation of chanoclavine-I biosynthetic process','P','Any process that modulates the frequency, rate or extent of chanoclavine-I biosynthetic process.','2013-10-27','NSRP'),(37598,1900644,'negative regulation of chanoclavine-I biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of chanoclavine-I biosynthetic process.','2013-10-27','NSRP'),(37599,1900645,'positive regulation of chanoclavine-I biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of chanoclavine-I biosynthetic process.','2013-10-27','NSRP'),(37600,1900646,'regulation of chanoclavine-I aldehyde biosynthetic process','P','Any process that modulates the frequency, rate or extent of chanoclavine-I aldehyde biosynthetic process.','2013-10-27','NSRP'),(37601,1900647,'negative regulation of chanoclavine-I aldehyde biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of chanoclavine-I aldehyde biosynthetic process.','2013-10-27','NSRP'),(37602,1900648,'positive regulation of chanoclavine-I aldehyde biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of chanoclavine-I aldehyde biosynthetic process.','2013-10-27','NSRP'),(37603,1900649,'regulation of dehydroaustinol biosynthetic process','P','Any process that modulates the frequency, rate or extent of dehydroaustinol biosynthetic process.','2013-10-27','NSRP'),(37604,1900650,'negative regulation of dehydroaustinol biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of dehydroaustinol biosynthetic process.','2013-10-27','NSRP'),(37605,1900651,'positive regulation of dehydroaustinol biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of dehydroaustinol biosynthetic process.','2013-10-27','NSRP'),(37606,1900652,'regulation of demethylkotanin biosynthetic process','P','Any process that modulates the frequency, rate or extent of demethylkotanin biosynthetic process.','2013-10-27','NSRP'),(37607,1900653,'negative regulation of demethylkotanin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of demethylkotanin biosynthetic process.','2013-10-27','NSRP'),(37608,1900654,'positive regulation of demethylkotanin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of demethylkotanin biosynthetic process.','2013-10-27','NSRP'),(37609,1900655,'regulation of diorcinol biosynthetic process','P','Any process that modulates the frequency, rate or extent of diorcinol biosynthetic process.','2013-10-27','NSRP'),(37610,1900656,'negative regulation of diorcinol biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of diorcinol biosynthetic process.','2013-10-27','NSRP'),(37611,1900657,'positive regulation of diorcinol biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of diorcinol biosynthetic process.','2013-10-27','NSRP'),(37612,1900658,'regulation of emericellamide biosynthetic process','P','Any process that modulates the frequency, rate or extent of emericellamide biosynthetic process.','2013-10-27','NSRP'),(37613,1900659,'negative regulation of emericellamide biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of emericellamide biosynthetic process.','2013-10-27','NSRP'),(37614,1900660,'positive regulation of emericellamide biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of emericellamide biosynthetic process.','2013-10-27','NSRP'),(37615,1900661,'regulation of emericellamide A biosynthetic process','P','Any process that modulates the frequency, rate or extent of emericellamide A biosynthetic process.','2013-10-27','NSRP'),(37616,1900662,'negative regulation of emericellamide A biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of emericellamide A biosynthetic process.','2013-10-27','NSRP'),(37617,1900663,'positive regulation of emericellamide A biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of emericellamide A biosynthetic process.','2013-10-27','NSRP'),(37618,1900664,'regulation of emodin biosynthetic process','P','Any process that modulates the frequency, rate or extent of emodin biosynthetic process.','2013-10-27','NSRP'),(37619,1900665,'negative regulation of emodin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of emodin biosynthetic process.','2013-10-27','NSRP'),(37620,1900666,'positive regulation of emodin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of emodin biosynthetic process.','2013-10-27','NSRP'),(37621,1900667,'regulation of endocrocin biosynthetic process','P','Any process that modulates the frequency, rate or extent of endocrocin biosynthetic process.','2013-10-27','NSRP'),(37622,1900668,'negative regulation of endocrocin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of endocrocin biosynthetic process.','2013-10-27','NSRP'),(37623,1900669,'positive regulation of endocrocin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of endocrocin biosynthetic process.','2013-10-27','NSRP'),(37624,1900670,'regulation of F-9775A biosynthetic process','P','Any process that modulates the frequency, rate or extent of F-9775A biosynthetic process.','2013-10-27','NSRP'),(37625,1900671,'negative regulation of F-9775A biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of F-9775A biosynthetic process.','2013-10-27','NSRP'),(37626,1900672,'positive regulation of F-9775A biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of F-9775A biosynthetic process.','2013-10-27','NSRP'),(37627,1900673,'olefin metabolic process','P','The chemical reactions and pathways involving olefin.','2013-10-27','NSRP'),(37628,1900674,'olefin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of olefin.','2013-10-27','NSRP'),(37629,1900675,'regulation of F-9775B biosynthetic process','P','Any process that modulates the frequency, rate or extent of F-9775B biosynthetic process.','2013-10-27','NSRP'),(37630,1900676,'negative regulation of F-9775B biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of F-9775B biosynthetic process.','2013-10-27','NSRP'),(37631,1900677,'positive regulation of F-9775B biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of F-9775B biosynthetic process.','2013-10-27','NSRP'),(37632,1900678,'regulation of ferricrocin biosynthetic process','P','Any process that modulates the frequency, rate or extent of ferricrocin biosynthetic process.','2013-10-27','NSRP'),(37633,1900679,'negative regulation of ferricrocin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of ferricrocin biosynthetic process.','2013-10-27','NSRP'),(37634,1900680,'positive regulation of ferricrocin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of ferricrocin biosynthetic process.','2013-10-27','NSRP'),(37635,1900681,'octadecene metabolic process','P','The chemical reactions and pathways involving octadecene.','2013-10-27','NSRP'),(37636,1900682,'octadecene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of octadecene.','2013-10-27','NSRP'),(37637,1900683,'regulation of fumonisin biosynthetic process','P','Any process that modulates the frequency, rate or extent of fumonisin biosynthetic process.','2013-10-27','NSRP'),(37638,1900684,'negative regulation of fumonisin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of fumonisin biosynthetic process.','2013-10-27','NSRP'),(37639,1900685,'positive regulation of fumonisin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of fumonisin biosynthetic process.','2013-10-27','NSRP'),(37640,1900686,'regulation of gerfelin biosynthetic process','P','Any process that modulates the frequency, rate or extent of gerfelin biosynthetic process.','2013-10-27','NSRP'),(37641,1900687,'negative regulation of gerfelin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of gerfelin biosynthetic process.','2013-10-27','NSRP'),(37642,1900688,'positive regulation of gerfelin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of gerfelin biosynthetic process.','2013-10-27','NSRP'),(37643,1900689,'regulation of gliotoxin biosynthetic process','P','Any process that modulates the frequency, rate or extent of gliotoxin biosynthetic process.','2013-10-27','NSRP'),(37644,1900690,'negative regulation of gliotoxin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of gliotoxin biosynthetic process.','2013-10-27','NSRP'),(37645,1900691,'positive regulation of gliotoxin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of gliotoxin biosynthetic process.','2013-10-27','NSRP'),(37646,1900692,'regulation of (+)-kotanin biosynthetic process','P','Any process that modulates the frequency, rate or extent of (+)-kotanin biosynthetic process.','2013-10-27','NSRP'),(37647,1900693,'negative regulation of (+)-kotanin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of (+)-kotanin biosynthetic process.','2013-10-27','NSRP'),(37648,1900694,'positive regulation of (+)-kotanin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of (+)-kotanin biosynthetic process.','2013-10-27','NSRP'),(37649,1900695,'regulation of N\',N\'\',N\'\'\'-triacetylfusarinine C biosynthetic process','P','Any process that modulates the frequency, rate or extent of N\',N\'\',N\'\'\'-triacetylfusarinine C biosynthetic process.','2013-10-27','NSRP'),(37650,1900696,'negative regulation of N\',N\'\',N\'\'\'-triacetylfusarinine C biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of N\',N\'\',N\'\'\'-triacetylfusarinine C biosynthetic process.','2013-10-27','NSRP'),(37651,1900697,'positive regulation of N\',N\'\',N\'\'\'-triacetylfusarinine C biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of N\',N\'\',N\'\'\'-triacetylfusarinine C biosynthetic process.','2013-10-27','NSRP'),(37652,1900698,'regulation of o-orsellinic acid biosynthetic process','P','Any process that modulates the frequency, rate or extent of o-orsellinic acid biosynthetic process.','2013-10-27','NSRP'),(37653,1900699,'negative regulation of o-orsellinic acid biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of o-orsellinic acid biosynthetic process.','2013-10-27','NSRP'),(37654,1900700,'positive regulation of o-orsellinic acid biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of o-orsellinic acid biosynthetic process.','2013-10-27','NSRP'),(37655,1900701,'regulation of orcinol biosynthetic process','P','Any process that modulates the frequency, rate or extent of orcinol biosynthetic process.','2013-10-27','NSRP'),(37656,1900702,'negative regulation of orcinol biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of orcinol biosynthetic process.','2013-10-27','NSRP'),(37657,1900703,'positive regulation of orcinol biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of orcinol biosynthetic process.','2013-10-27','NSRP'),(37658,1900704,'regulation of siderophore biosynthetic process','P','Any process that modulates the frequency, rate or extent of siderophore biosynthetic process.','2013-10-27','NSRP'),(37659,1900705,'negative regulation of siderophore biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of siderophore biosynthetic process.','2013-10-27','NSRP'),(37660,1900706,'positive regulation of siderophore biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of siderophore biosynthetic process.','2013-10-27','NSRP'),(37661,1900707,'regulation of tensidol A biosynthetic process','P','Any process that modulates the frequency, rate or extent of tensidol A biosynthetic process.','2013-10-27','NSRP'),(37662,1900708,'negative regulation of tensidol A biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of tensidol A biosynthetic process.','2013-10-27','NSRP'),(37663,1900709,'positive regulation of tensidol A biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of tensidol A biosynthetic process.','2013-10-27','NSRP'),(37664,1900710,'regulation of tensidol B biosynthetic process','P','Any process that modulates the frequency, rate or extent of tensidol B biosynthetic process.','2013-10-27','NSRP'),(37665,1900711,'negative regulation of tensidol B biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of tensidol B biosynthetic process.','2013-10-27','NSRP'),(37666,1900712,'positive regulation of tensidol B biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of tensidol B biosynthetic process.','2013-10-27','NSRP'),(37667,1900713,'regulation of violaceol I biosynthetic process','P','Any process that modulates the frequency, rate or extent of violaceol I biosynthetic process.','2013-10-27','NSRP'),(37668,1900714,'negative regulation of violaceol I biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of violaceol I biosynthetic process.','2013-10-27','NSRP'),(37669,1900715,'positive regulation of violaceol I biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of violaceol I biosynthetic process.','2013-10-27','NSRP'),(37670,1900716,'regulation of violaceol II biosynthetic process','P','Any process that modulates the frequency, rate or extent of violaceol II biosynthetic process.','2013-10-27','NSRP'),(37671,1900717,'negative regulation of violaceol II biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of violaceol II biosynthetic process.','2013-10-27','NSRP'),(37672,1900718,'positive regulation of violaceol II biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of violaceol II biosynthetic process.','2013-10-27','NSRP'),(37673,1900719,'regulation of uterine smooth muscle relaxation','P','Any process that modulates the frequency, rate or extent of uterine smooth muscle relaxation.','2013-10-27','NSRP'),(37674,1900720,'negative regulation of uterine smooth muscle relaxation','P','Any process that stops, prevents or reduces the frequency, rate or extent of uterine smooth muscle relaxation.','2013-10-27','NSRP'),(37675,1900721,'positive regulation of uterine smooth muscle relaxation','P','Any process that activates or increases the frequency, rate or extent of uterine smooth muscle relaxation.','2013-10-27','NSRP'),(37676,1900722,'regulation of protein adenylylation','P','Any process that modulates the frequency, rate or extent of protein adenylylation.','2013-10-27','NSRP'),(37677,1900723,'negative regulation of protein adenylylation','P','Any process that stops, prevents or reduces the frequency, rate or extent of protein adenylylation.','2013-10-27','NSRP'),(37678,1900724,'positive regulation of protein adenylylation','P','Any process that activates or increases the frequency, rate or extent of protein adenylylation.','2013-10-27','NSRP'),(37679,1900725,'osmoregulated periplasmic glucan metabolic process','P','The chemical reactions and pathways involving osmoregulated periplasmic glucan.','2013-10-27','NSRP'),(37680,1900726,'osmoregulated periplasmic glucan catabolic process','P','The chemical reactions and pathways resulting in the breakdown of osmoregulated periplasmic glucan.','2013-10-27','NSRP'),(37681,1900727,'osmoregulated periplasmic glucan biosynthetic process','P','The chemical reactions and pathways resulting in the formation of osmoregulated periplasmic glucan.','2013-10-27','NSRP'),(37682,1900728,'cardiac neural crest cell delamination involved in outflow tract morphogenesis','P','Any cardiac neural crest cell delamination that is involved in outflow tract morphogenesis.','2013-10-27','NSRP'),(37683,1900729,'regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway','P','Any process that modulates the frequency, rate or extent of adenylate cyclase-inhibiting opioid receptor signaling pathway.','2013-10-27','NSRP'),(37684,1900730,'negative regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of adenylate cyclase-inhibiting opioid receptor signaling pathway.','2013-10-27','NSRP'),(37685,1900731,'positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway','P','Any process that activates or increases the frequency, rate or extent of adenylate cyclase-inhibiting opioid receptor signaling pathway.','2013-10-27','NSRP'),(37686,1900732,'regulation of polyketide biosynthetic process','P','Any process that modulates the frequency, rate or extent of polyketide biosynthetic process.','2013-10-27','NSRP'),(37687,1900733,'negative regulation of polyketide biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of polyketide biosynthetic process.','2013-10-27','NSRP'),(37688,1900734,'positive regulation of polyketide biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of polyketide biosynthetic process.','2013-10-27','NSRP'),(37689,1900735,'positive regulation of flocculation','P','Any process that activates or increases the frequency, rate or extent of flocculation.','2013-10-27','NSRP'),(37690,1900736,'regulation of phospholipase C-activating G-protein coupled receptor signaling pathway','P','Any process that modulates the frequency, rate or extent of phospholipase C-activating G-protein coupled receptor signaling pathway.','2013-10-27','NSRP'),(37691,1900737,'negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase C-activating G-protein coupled receptor signaling pathway.','2013-10-27','NSRP'),(37692,1900738,'positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway','P','Any process that activates or increases the frequency, rate or extent of phospholipase C-activating G-protein coupled receptor signaling pathway.','2013-10-27','NSRP'),(37693,1900739,'regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway','P','Any process that modulates the frequency, rate or extent of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway.','2013-10-27','NSRP'),(37694,1900740,'positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway','P','Any process that activates or increases the frequency, rate or extent of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway.','2013-10-27','NSRP'),(37695,1900741,'regulation of filamentous growth of a population of unicellular organisms in response to pH','P','Any process that modulates the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to pH.','2013-10-27','NSRP'),(37696,1900742,'negative regulation of filamentous growth of a population of unicellular organisms in response to pH','P','Any process that stops, prevents or reduces the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to pH.','2013-10-27','NSRP'),(37697,1900743,'positive regulation of filamentous growth of a population of unicellular organisms in response to pH','P','Any process that activates or increases the frequency, rate or extent of filamentous growth of a population of unicellular organisms in response to pH.','2013-10-27','NSRP'),(37698,1900744,'regulation of p38MAPK cascade','P','Any process that modulates the frequency, rate or extent of p38MAPK cascade.','2013-10-27','NSRP'),(37699,1900745,'positive regulation of p38MAPK cascade','P','Any process that activates or increases the frequency, rate or extent of p38MAPK cascade.','2013-10-27','NSRP'),(37700,1900746,'regulation of vascular endothelial growth factor signaling pathway','P','Any process that modulates the frequency, rate or extent of vascular endothelial growth factor signaling pathway.','2013-10-27','NSRP'),(37701,1900747,'negative regulation of vascular endothelial growth factor signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of vascular endothelial growth factor signaling pathway.','2013-10-27','NSRP'),(37702,1900748,'positive regulation of vascular endothelial growth factor signaling pathway','P','Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor signaling pathway.','2013-10-27','NSRP'),(37703,1900749,'(R)-carnitine transport','P','The directed movement of a (R)-carnitine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(37704,1900750,'oligopeptide binding','F','Interacting selectively and non-covalently with an oligopeptide.','2013-10-27','NSRP'),(37705,1900751,'4-(trimethylammonio)butanoate transport','P','The directed movement of a 4-(trimethylammonio)butanoate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(37706,1900752,'malonic acid transport','P','The directed movement of a malonic acid into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(37707,1900753,'doxorubicin transport','P','The directed movement of a doxorubicin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(37708,1900754,'4-hydroxyphenylacetate transport','P','The directed movement of a 4-hydroxyphenylacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(37709,1900756,'protein processing in phagocytic vesicle','P','Protein processing that takes place in the phagosome. Most protein processing in the phagosome represents protein degradation.','2013-10-27','NSRP'),(37710,1900757,'regulation of D-amino-acid oxidase activity','P','Any process that modulates the frequency, rate or extent of D-amino-acid oxidase activity.','2013-10-27','NSRP'),(37711,1900758,'negative regulation of D-amino-acid oxidase activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of D-amino-acid oxidase activity.','2013-10-27','NSRP'),(37712,1900759,'positive regulation of D-amino-acid oxidase activity','P','Any process that activates or increases the frequency, rate or extent of D-amino-acid oxidase activity.','2013-10-27','NSRP'),(37713,1900760,'negative regulation of sterigmatocystin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of sterigmatocystin biosynthetic process.','2013-10-27','NSRP'),(37714,1900761,'averantin metabolic process','P','The chemical reactions and pathways involving averantin.','2013-10-27','NSRP'),(37715,1900762,'averantin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of averantin.','2013-10-27','NSRP'),(37716,1900763,'averantin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of averantin.','2013-10-27','NSRP'),(37717,1900764,'emericellin metabolic process','P','The chemical reactions and pathways involving emericellin.','2013-10-27','NSRP'),(37718,1900765,'emericellin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of emericellin.','2013-10-27','NSRP'),(37719,1900766,'emericellin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of emericellin.','2013-10-27','NSRP'),(37720,1900767,'fonsecin metabolic process','P','The chemical reactions and pathways involving fonsecin.','2013-10-27','NSRP'),(37721,1900768,'fonsecin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of fonsecin.','2013-10-27','NSRP'),(37722,1900769,'fonsecin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of fonsecin.','2013-10-27','NSRP'),(37723,1900770,'fumitremorgin B metabolic process','P','The chemical reactions and pathways involving fumitremorgin B.','2013-10-27','NSRP'),(37724,1900771,'fumitremorgin B catabolic process','P','The chemical reactions and pathways resulting in the breakdown of fumitremorgin B.','2013-10-27','NSRP'),(37725,1900772,'fumitremorgin B biosynthetic process','P','The chemical reactions and pathways resulting in the formation of fumitremorgin B.','2013-10-27','NSRP'),(37726,1900773,'fumiquinazoline metabolic process','P','The chemical reactions and pathways involving fumiquinazoline.','2013-10-27','NSRP'),(37727,1900774,'fumiquinazoline catabolic process','P','The chemical reactions and pathways resulting in the breakdown of fumiquinazoline.','2013-10-27','NSRP'),(37728,1900775,'fumiquinazoline biosynthetic process','P','The chemical reactions and pathways resulting in the formation of fumiquinazoline.','2013-10-27','NSRP'),(37729,1900776,'fumiquinazoline A metabolic process','P','The chemical reactions and pathways involving fumiquinazoline A.','2013-10-27','NSRP'),(37730,1900777,'fumiquinazoline A catabolic process','P','The chemical reactions and pathways resulting in the breakdown of fumiquinazoline A.','2013-10-27','NSRP'),(37731,1900778,'fumiquinazoline A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of fumiquinazoline A.','2013-10-27','NSRP'),(37732,1900779,'fumiquinazoline C metabolic process','P','The chemical reactions and pathways involving fumiquinazoline C.','2013-10-27','NSRP'),(37733,1900780,'fumiquinazoline C catabolic process','P','The chemical reactions and pathways resulting in the breakdown of fumiquinazoline C.','2013-10-27','NSRP'),(37734,1900781,'fumiquinazoline C biosynthetic process','P','The chemical reactions and pathways resulting in the formation of fumiquinazoline C.','2013-10-27','NSRP'),(37735,1900782,'fumiquinazoline F metabolic process','P','The chemical reactions and pathways involving fumiquinazoline F.','2013-10-27','NSRP'),(37736,1900783,'fumiquinazoline F catabolic process','P','The chemical reactions and pathways resulting in the breakdown of fumiquinazoline F.','2013-10-27','NSRP'),(37737,1900784,'fumiquinazoline F biosynthetic process','P','The chemical reactions and pathways resulting in the formation of fumiquinazoline F.','2013-10-27','NSRP'),(37738,1900785,'naphtho-gamma-pyrone metabolic process','P','The chemical reactions and pathways involving naphtho-gamma-pyrone.','2013-10-27','NSRP'),(37739,1900786,'naphtho-gamma-pyrone catabolic process','P','The chemical reactions and pathways resulting in the breakdown of naphtho-gamma-pyrone.','2013-10-27','NSRP'),(37740,1900787,'naphtho-gamma-pyrone biosynthetic process','P','The chemical reactions and pathways resulting in the formation of naphtho-gamma-pyrone.','2013-10-27','NSRP'),(37741,1900788,'pseurotin A metabolic process','P','The chemical reactions and pathways involving pseurotin A.','2013-10-27','NSRP'),(37742,1900789,'pseurotin A catabolic process','P','The chemical reactions and pathways resulting in the breakdown of pseurotin A.','2013-10-27','NSRP'),(37743,1900790,'pseurotin A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of pseurotin A.','2013-10-27','NSRP'),(37744,1900791,'shamixanthone metabolic process','P','The chemical reactions and pathways involving shamixanthone.','2013-10-27','NSRP'),(37745,1900792,'shamixanthone catabolic process','P','The chemical reactions and pathways resulting in the breakdown of shamixanthone.','2013-10-27','NSRP'),(37746,1900793,'shamixanthone biosynthetic process','P','The chemical reactions and pathways resulting in the formation of shamixanthone.','2013-10-27','NSRP'),(37747,1900794,'terrequinone A metabolic process','P','The chemical reactions and pathways involving terrequinone A.','2013-10-27','NSRP'),(37748,1900795,'terrequinone A catabolic process','P','The chemical reactions and pathways resulting in the breakdown of terrequinone A.','2013-10-27','NSRP'),(37749,1900796,'terrequinone A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of terrequinone A.','2013-10-27','NSRP'),(37750,1900797,'cordyol C metabolic process','P','The chemical reactions and pathways involving cordyol C.','2013-10-27','NSRP'),(37751,1900798,'cordyol C catabolic process','P','The chemical reactions and pathways resulting in the breakdown of cordyol C.','2013-10-27','NSRP'),(37752,1900799,'cordyol C biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cordyol C.','2013-10-27','NSRP'),(37753,1900800,'cspyrone B1 metabolic process','P','The chemical reactions and pathways involving cspyrone B1.','2013-10-27','NSRP'),(37754,1900801,'cspyrone B1 catabolic process','P','The chemical reactions and pathways resulting in the breakdown of cspyrone B1.','2013-10-27','NSRP'),(37755,1900802,'cspyrone B1 biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cspyrone B1.','2013-10-27','NSRP'),(37756,1900803,'brevianamide F metabolic process','P','The chemical reactions and pathways involving brevianamide F.','2013-10-27','NSRP'),(37757,1900804,'brevianamide F catabolic process','P','The chemical reactions and pathways resulting in the breakdown of brevianamide F.','2013-10-27','NSRP'),(37758,1900805,'brevianamide F biosynthetic process','P','The chemical reactions and pathways resulting in the formation of brevianamide F.','2013-10-27','NSRP'),(37759,1900806,'ergot alkaloid catabolic process','P','The chemical reactions and pathways resulting in the breakdown of ergot alkaloid.','2013-10-27','NSRP'),(37760,1900807,'fumigaclavine C metabolic process','P','The chemical reactions and pathways involving fumigaclavine C.','2013-10-27','NSRP'),(37761,1900808,'fumigaclavine C catabolic process','P','The chemical reactions and pathways resulting in the breakdown of fumigaclavine C.','2013-10-27','NSRP'),(37762,1900809,'fumigaclavine C biosynthetic process','P','The chemical reactions and pathways resulting in the formation of fumigaclavine C.','2013-10-27','NSRP'),(37763,1900810,'helvolic acid metabolic process','P','The chemical reactions and pathways involving helvolic acid.','2013-10-27','NSRP'),(37764,1900811,'helvolic acid catabolic process','P','The chemical reactions and pathways resulting in the breakdown of helvolic acid.','2013-10-27','NSRP'),(37765,1900812,'helvolic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of helvolic acid.','2013-10-27','NSRP'),(37766,1900813,'monodictyphenone metabolic process','P','The chemical reactions and pathways involving monodictyphenone.','2013-10-27','NSRP'),(37767,1900814,'monodictyphenone catabolic process','P','The chemical reactions and pathways resulting in the breakdown of monodictyphenone.','2013-10-27','NSRP'),(37768,1900815,'monodictyphenone biosynthetic process','P','The chemical reactions and pathways resulting in the formation of monodictyphenone.','2013-10-27','NSRP'),(37769,1900816,'ochratoxin A metabolic process','P','The chemical reactions and pathways involving ochratoxin A.','2013-10-27','NSRP'),(37770,1900817,'ochratoxin A catabolic process','P','The chemical reactions and pathways resulting in the breakdown of ochratoxin A.','2013-10-27','NSRP'),(37771,1900818,'ochratoxin A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ochratoxin A.','2013-10-27','NSRP'),(37772,1900819,'orlandin metabolic process','P','The chemical reactions and pathways involving orlandin.','2013-10-27','NSRP'),(37773,1900820,'orlandin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of orlandin.','2013-10-27','NSRP'),(37774,1900821,'orlandin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of orlandin.','2013-10-27','NSRP'),(37775,1900822,'regulation of ergot alkaloid biosynthetic process','P','Any process that modulates the frequency, rate or extent of ergot alkaloid biosynthetic process.','2013-10-27','NSRP'),(37776,1900823,'negative regulation of ergot alkaloid biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of ergot alkaloid biosynthetic process.','2013-10-27','NSRP'),(37777,1900824,'positive regulation of ergot alkaloid biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of ergot alkaloid biosynthetic process.','2013-10-27','NSRP'),(37778,1900825,'regulation of membrane depolarization involved in regulation of cardiac muscle cell action potential','P','Any process that modulates the frequency, rate or extent of membrane depolarization involved in regulation of cardiac muscle cell action potential.','2013-10-27','NSRP'),(37779,1900826,'negative regulation of membrane depolarization involved in regulation of cardiac muscle cell action potential','P','Any process that stops, prevents or reduces the frequency, rate or extent of membrane depolarization involved in regulation of cardiac muscle cell action potential.','2013-10-27','NSRP'),(37780,1900827,'positive regulation of membrane depolarization involved in regulation of cardiac muscle cell action potential','P','Any process that activates or increases the frequency, rate or extent of membrane depolarization involved in regulation of cardiac muscle cell action potential.','2013-10-27','NSRP'),(37781,1900828,'D-tyrosine metabolic process','P','The chemical reactions and pathways involving D-tyrosine.','2013-10-27','NSRP'),(37782,1900829,'D-tyrosine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of D-tyrosine.','2013-10-27','NSRP'),(37783,1900830,'D-tyrosine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of D-tyrosine.','2013-10-27','NSRP'),(37784,1900831,'D-leucine metabolic process','P','The chemical reactions and pathways involving D-leucine.','2013-10-27','NSRP'),(37785,1900832,'D-leucine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of D-leucine.','2013-10-27','NSRP'),(37786,1900833,'D-leucine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of D-leucine.','2013-10-27','NSRP'),(37787,1900834,'regulation of emericellin biosynthetic process','P','Any process that modulates the frequency, rate or extent of emericellin biosynthetic process.','2013-10-27','NSRP'),(37788,1900835,'negative regulation of emericellin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of emericellin biosynthetic process.','2013-10-27','NSRP'),(37789,1900836,'positive regulation of emericellin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of emericellin biosynthetic process.','2013-10-27','NSRP'),(37790,1900837,'regulation of fumigaclavine C biosynthetic process','P','Any process that modulates the frequency, rate or extent of fumigaclavine C biosynthetic process.','2013-10-27','NSRP'),(37791,1900838,'negative regulation of fumigaclavine C biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of fumigaclavine C biosynthetic process.','2013-10-27','NSRP'),(37792,1900839,'positive regulation of fumigaclavine C biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of fumigaclavine C biosynthetic process.','2013-10-27','NSRP'),(37793,1900840,'regulation of helvolic acid biosynthetic process','P','Any process that modulates the frequency, rate or extent of helvolic acid biosynthetic process.','2013-10-27','NSRP'),(37794,1900841,'negative regulation of helvolic acid biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of helvolic acid biosynthetic process.','2013-10-27','NSRP'),(37795,1900842,'positive regulation of helvolic acid biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of helvolic acid biosynthetic process.','2013-10-27','NSRP'),(37796,1900843,'regulation of monodictyphenone biosynthetic process','P','Any process that modulates the frequency, rate or extent of monodictyphenone biosynthetic process.','2013-10-27','NSRP'),(37797,1900844,'negative regulation of monodictyphenone biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of monodictyphenone biosynthetic process.','2013-10-27','NSRP'),(37798,1900845,'positive regulation of monodictyphenone biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of monodictyphenone biosynthetic process.','2013-10-27','NSRP'),(37799,1900846,'regulation of naphtho-gamma-pyrone biosynthetic process','P','Any process that modulates the frequency, rate or extent of naphtho-gamma-pyrone biosynthetic process.','2013-10-27','NSRP'),(37800,1900847,'negative regulation of naphtho-gamma-pyrone biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of naphtho-gamma-pyrone biosynthetic process.','2013-10-27','NSRP'),(37801,1900848,'positive regulation of naphtho-gamma-pyrone biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of naphtho-gamma-pyrone biosynthetic process.','2013-10-27','NSRP'),(37802,1900849,'regulation of pseurotin A biosynthetic process','P','Any process that modulates the frequency, rate or extent of pseurotin A biosynthetic process.','2013-10-27','NSRP'),(37803,1900850,'negative regulation of pseurotin A biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of pseurotin A biosynthetic process.','2013-10-27','NSRP'),(37804,1900851,'positive regulation of pseurotin A biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of pseurotin A biosynthetic process.','2013-10-27','NSRP'),(37805,1900852,'regulation of terrequinone A biosynthetic process','P','Any process that modulates the frequency, rate or extent of terrequinone A biosynthetic process.','2013-10-27','NSRP'),(37806,1900853,'negative regulation of terrequinone A biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of terrequinone A biosynthetic process.','2013-10-27','NSRP'),(37807,1900854,'positive regulation of terrequinone A biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of terrequinone A biosynthetic process.','2013-10-27','NSRP'),(37808,1900855,'regulation of fumitremorgin B biosynthetic process','P','Any process that modulates the frequency, rate or extent of fumitremorgin B biosynthetic process.','2013-10-27','NSRP'),(37809,1900856,'negative regulation of fumitremorgin B biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of fumitremorgin B biosynthetic process.','2013-10-27','NSRP'),(37810,1900857,'positive regulation of fumitremorgin B biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of fumitremorgin B biosynthetic process.','2013-10-27','NSRP'),(37811,1900858,'regulation of brevianamide F biosynthetic process','P','Any process that modulates the frequency, rate or extent of brevianamide F biosynthetic process.','2013-10-27','NSRP'),(37812,1900859,'negative regulation of brevianamide F biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of brevianamide F biosynthetic process.','2013-10-27','NSRP'),(37813,1900860,'positive regulation of brevianamide F biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of brevianamide F biosynthetic process.','2013-10-27','NSRP'),(37814,1900861,'regulation of cordyol C biosynthetic process','P','Any process that modulates the frequency, rate or extent of cordyol C biosynthetic process.','2013-10-27','NSRP'),(37815,1900862,'negative regulation of cordyol C biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of cordyol C biosynthetic process.','2013-10-27','NSRP'),(37816,1900863,'positive regulation of cordyol C biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of cordyol C biosynthetic process.','2013-10-27','NSRP'),(37817,1900864,'mitochondrial RNA modification','P','Any RNA modification that takes place in mitochondrion.','2013-10-27','NSRP'),(37818,1900865,'chloroplast RNA modification','P','Any RNA modification that takes place in chloroplast.','2013-10-27','NSRP'),(37819,1900866,'glycolate transport','P','The directed movement of a glycolate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(37820,1900867,'sarcinapterin metabolic process','P','The chemical reactions and pathways involving sarcinapterin.','2013-10-27','NSRP'),(37821,1900868,'sarcinapterin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of sarcinapterin.','2013-10-27','NSRP'),(37822,1900869,'tatiopterin metabolic process','P','The chemical reactions and pathways involving tatiopterin.','2013-10-27','NSRP'),(37823,1900870,'tatiopterin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of tatiopterin.','2013-10-27','NSRP'),(37824,1900871,'chloroplast mRNA modification','P','The covalent alteration within the chloroplast of one or more nucleotides within an mRNA to produce an mRNA molecule with a sequence that differs from that coded genetically.','2013-10-27','NSRP'),(37825,1900872,'pentadec-1-ene metabolic process','P','The chemical reactions and pathways involving pentadec-1-ene.','2013-10-27','NSRP'),(37826,1900873,'pentadec-1-ene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of pentadec-1-ene.','2013-10-27','NSRP'),(37827,1900874,'heptadec-1-ene metabolic process','P','The chemical reactions and pathways involving heptadec-1-ene.','2013-10-27','NSRP'),(37828,1900875,'heptadec-1-ene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of heptadec-1-ene.','2013-10-27','NSRP'),(37829,1900876,'nonadec-1-ene metabolic process','P','The chemical reactions and pathways involving nonadec-1-ene.','2013-10-27','NSRP'),(37830,1900877,'nonadec-1-ene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of nonadec-1-ene.','2013-10-27','NSRP'),(37831,1900878,'(Z)-nonadeca-1,14-diene metabolic process','P','The chemical reactions and pathways involving (Z)-nonadeca-1,14-diene.','2013-10-27','NSRP'),(37832,1900879,'(Z)-nonadeca-1,14-diene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (Z)-nonadeca-1,14-diene.','2013-10-27','NSRP'),(37833,1900880,'18-methylnonadec-1-ene metabolic process','P','The chemical reactions and pathways involving 18-methylnonadec-1-ene.','2013-10-27','NSRP'),(37834,1900881,'18-methylnonadec-1-ene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 18-methylnonadec-1-ene.','2013-10-27','NSRP'),(37835,1900882,'17-methylnonadec-1-ene metabolic process','P','The chemical reactions and pathways involving 17-methylnonadec-1-ene.','2013-10-27','NSRP'),(37836,1900883,'17-methylnonadec-1-ene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 17-methylnonadec-1-ene.','2013-10-27','NSRP'),(37837,1900884,'regulation of tridecane biosynthetic process','P','Any process that modulates the frequency, rate or extent of tridecane biosynthetic process.','2013-10-27','NSRP'),(37838,1900885,'negative regulation of tridecane biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of tridecane biosynthetic process.','2013-10-27','NSRP'),(37839,1900886,'positive regulation of tridecane biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of tridecane biosynthetic process.','2013-10-27','NSRP'),(37840,1900887,'regulation of pentadecane biosynthetic process','P','Any process that modulates the frequency, rate or extent of pentadecane biosynthetic process.','2013-10-27','NSRP'),(37841,1900888,'negative regulation of pentadecane biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of pentadecane biosynthetic process.','2013-10-27','NSRP'),(37842,1900889,'positive regulation of pentadecane biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of pentadecane biosynthetic process.','2013-10-27','NSRP'),(37843,1900890,'regulation of pentadecane metabolic process','P','Any process that modulates the frequency, rate or extent of pentadecane metabolic process.','2013-10-27','NSRP'),(37844,1900891,'negative regulation of pentadecane metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of pentadecane metabolic process.','2013-10-27','NSRP'),(37845,1900892,'positive regulation of pentadecane metabolic process','P','Any process that activates or increases the frequency, rate or extent of pentadecane metabolic process.','2013-10-27','NSRP'),(37846,1900893,'regulation of tridecane metabolic process','P','Any process that modulates the frequency, rate or extent of tridecane metabolic process.','2013-10-27','NSRP'),(37847,1900894,'negative regulation of tridecane metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of tridecane metabolic process.','2013-10-27','NSRP'),(37848,1900895,'positive regulation of tridecane metabolic process','P','Any process that activates or increases the frequency, rate or extent of tridecane metabolic process.','2013-10-27','NSRP'),(37849,1900896,'regulation of heptadecane biosynthetic process','P','Any process that modulates the frequency, rate or extent of heptadecane biosynthetic process.','2013-10-27','NSRP'),(37850,1900897,'negative regulation of heptadecane biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of heptadecane biosynthetic process.','2013-10-27','NSRP'),(37851,1900898,'positive regulation of heptadecane biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of heptadecane biosynthetic process.','2013-10-27','NSRP'),(37852,1900899,'regulation of heptadecane metabolic process','P','Any process that modulates the frequency, rate or extent of heptadecane metabolic process.','2013-10-27','NSRP'),(37853,1900900,'negative regulation of heptadecane metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of heptadecane metabolic process.','2013-10-27','NSRP'),(37854,1900901,'positive regulation of heptadecane metabolic process','P','Any process that activates or increases the frequency, rate or extent of heptadecane metabolic process.','2013-10-27','NSRP'),(37855,1900902,'regulation of hexadecanal biosynthetic process','P','Any process that modulates the frequency, rate or extent of hexadecanal biosynthetic process.','2013-10-27','NSRP'),(37856,1900903,'negative regulation of hexadecanal biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of hexadecanal biosynthetic process.','2013-10-27','NSRP'),(37857,1900904,'positive regulation of hexadecanal biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of hexadecanal biosynthetic process.','2013-10-27','NSRP'),(37858,1900905,'regulation of hexadecanal metabolic process','P','Any process that modulates the frequency, rate or extent of hexadecanal metabolic process.','2013-10-27','NSRP'),(37859,1900906,'negative regulation of hexadecanal metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of hexadecanal metabolic process.','2013-10-27','NSRP'),(37860,1900907,'positive regulation of hexadecanal metabolic process','P','Any process that activates or increases the frequency, rate or extent of hexadecanal metabolic process.','2013-10-27','NSRP'),(37861,1900908,'regulation of olefin metabolic process','P','Any process that modulates the frequency, rate or extent of olefin metabolic process.','2013-10-27','NSRP'),(37862,1900909,'negative regulation of olefin metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of olefin metabolic process.','2013-10-27','NSRP'),(37863,1900910,'positive regulation of olefin metabolic process','P','Any process that activates or increases the frequency, rate or extent of olefin metabolic process.','2013-10-27','NSRP'),(37864,1900911,'regulation of olefin biosynthetic process','P','Any process that modulates the frequency, rate or extent of olefin biosynthetic process.','2013-10-27','NSRP'),(37865,1900912,'negative regulation of olefin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of olefin biosynthetic process.','2013-10-27','NSRP'),(37866,1900913,'positive regulation of olefin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of olefin biosynthetic process.','2013-10-27','NSRP'),(37867,1900914,'regulation of octadecene biosynthetic process','P','Any process that modulates the frequency, rate or extent of octadecene biosynthetic process.','2013-10-27','NSRP'),(37868,1900915,'negative regulation of octadecene biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of octadecene biosynthetic process.','2013-10-27','NSRP'),(37869,1900916,'positive regulation of octadecene biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of octadecene biosynthetic process.','2013-10-27','NSRP'),(37870,1900917,'regulation of octadecene metabolic process','P','Any process that modulates the frequency, rate or extent of octadecene metabolic process.','2013-10-27','NSRP'),(37871,1900918,'negative regulation of octadecene metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of octadecene metabolic process.','2013-10-27','NSRP'),(37872,1900919,'positive regulation of octadecene metabolic process','P','Any process that activates or increases the frequency, rate or extent of octadecene metabolic process.','2013-10-27','NSRP'),(37873,1900920,'regulation of L-glutamate import','P','Any process that modulates the frequency, rate or extent of L-glutamate import.','2013-10-27','NSRP'),(37874,1900921,'negative regulation of L-glutamate import','P','Any process that stops, prevents or reduces the frequency, rate or extent of L-glutamate import.','2013-10-27','NSRP'),(37875,1900922,'positive regulation of L-glutamate import','P','Any process that activates or increases the frequency, rate or extent of L-glutamate import.','2013-10-27','NSRP'),(37876,1900923,'regulation of glycine import','P','Any process that modulates the frequency, rate or extent of glycine import.','2013-10-27','NSRP'),(37877,1900924,'negative regulation of glycine import','P','Any process that stops, prevents or reduces the frequency, rate or extent of glycine import.','2013-10-27','NSRP'),(37878,1900925,'positive regulation of glycine import','P','Any process that activates or increases the frequency, rate or extent of glycine import.','2013-10-27','NSRP'),(37879,1900926,'regulation of L-threonine import','P','Any process that modulates the frequency, rate or extent of L-threonine import.','2013-10-27','NSRP'),(37880,1900927,'negative regulation of L-threonine import','P','Any process that stops, prevents or reduces the frequency, rate or extent of L-threonine import.','2013-10-27','NSRP'),(37881,1900928,'positive regulation of L-threonine import','P','Any process that activates or increases the frequency, rate or extent of L-threonine import.','2013-10-27','NSRP'),(37882,1900929,'regulation of L-tyrosine import','P','Any process that modulates the frequency, rate or extent of L-tyrosine import.','2013-10-27','NSRP'),(37883,1900930,'negative regulation of L-tyrosine import','P','Any process that stops, prevents or reduces the frequency, rate or extent of L-tyrosine import.','2013-10-27','NSRP'),(37884,1900931,'positive regulation of L-tyrosine import','P','Any process that activates or increases the frequency, rate or extent of L-tyrosine import.','2013-10-27','NSRP'),(37885,1900932,'regulation of nonadec-1-ene metabolic process','P','Any process that modulates the frequency, rate or extent of nonadec-1-ene metabolic process.','2013-10-27','NSRP'),(37886,1900933,'negative regulation of nonadec-1-ene metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of nonadec-1-ene metabolic process.','2013-10-27','NSRP'),(37887,1900934,'positive regulation of nonadec-1-ene metabolic process','P','Any process that activates or increases the frequency, rate or extent of nonadec-1-ene metabolic process.','2013-10-27','NSRP'),(37888,1900935,'regulation of nonadec-1-ene biosynthetic process','P','Any process that modulates the frequency, rate or extent of nonadec-1-ene biosynthetic process.','2013-10-27','NSRP'),(37889,1900936,'negative regulation of nonadec-1-ene biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of nonadec-1-ene biosynthetic process.','2013-10-27','NSRP'),(37890,1900937,'positive regulation of nonadec-1-ene biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of nonadec-1-ene biosynthetic process.','2013-10-27','NSRP'),(37891,1900938,'regulation of (Z)-nonadeca-1,14-diene metabolic process','P','Any process that modulates the frequency, rate or extent of (Z)-nonadeca-1,14-diene metabolic process.','2013-10-27','NSRP'),(37892,1900939,'negative regulation of (Z)-nonadeca-1,14-diene metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of (Z)-nonadeca-1,14-diene metabolic process.','2013-10-27','NSRP'),(37893,1900940,'positive regulation of (Z)-nonadeca-1,14-diene metabolic process','P','Any process that activates or increases the frequency, rate or extent of (Z)-nonadeca-1,14-diene metabolic process.','2013-10-27','NSRP'),(37894,1900941,'regulation of (Z)-nonadeca-1,14-diene biosynthetic process','P','Any process that modulates the frequency, rate or extent of (Z)-nonadeca-1,14-diene biosynthetic process.','2013-10-27','NSRP'),(37895,1900942,'negative regulation of (Z)-nonadeca-1,14-diene biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of (Z)-nonadeca-1,14-diene biosynthetic process.','2013-10-27','NSRP'),(37896,1900943,'positive regulation of (Z)-nonadeca-1,14-diene biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of (Z)-nonadeca-1,14-diene biosynthetic process.','2013-10-27','NSRP'),(37897,1900944,'regulation of isoprene metabolic process','P','Any process that modulates the frequency, rate or extent of isoprene metabolic process.','2013-10-27','NSRP'),(37898,1900945,'negative regulation of isoprene metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of isoprene metabolic process.','2013-10-27','NSRP'),(37899,1900946,'positive regulation of isoprene metabolic process','P','Any process that activates or increases the frequency, rate or extent of isoprene metabolic process.','2013-10-27','NSRP'),(37900,1900947,'regulation of isoprene biosynthetic process','P','Any process that modulates the frequency, rate or extent of isoprene biosynthetic process.','2013-10-27','NSRP'),(37901,1900948,'negative regulation of isoprene biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of isoprene biosynthetic process.','2013-10-27','NSRP'),(37902,1900949,'positive regulation of isoprene biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of isoprene biosynthetic process.','2013-10-27','NSRP'),(37903,1900950,'regulation of 18-methylnonadec-1-ene biosynthetic process','P','Any process that modulates the frequency, rate or extent of 18-methylnonadec-1-ene biosynthetic process.','2013-10-27','NSRP'),(37904,1900951,'negative regulation of 18-methylnonadec-1-ene biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of 18-methylnonadec-1-ene biosynthetic process.','2013-10-27','NSRP'),(37905,1900952,'positive regulation of 18-methylnonadec-1-ene biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of 18-methylnonadec-1-ene biosynthetic process.','2013-10-27','NSRP'),(37906,1900953,'regulation of 18-methylnonadec-1-ene metabolic process','P','Any process that modulates the frequency, rate or extent of 18-methylnonadec-1-ene metabolic process.','2013-10-27','NSRP'),(37907,1900954,'negative regulation of 18-methylnonadec-1-ene metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of 18-methylnonadec-1-ene metabolic process.','2013-10-27','NSRP'),(37908,1900955,'positive regulation of 18-methylnonadec-1-ene metabolic process','P','Any process that activates or increases the frequency, rate or extent of 18-methylnonadec-1-ene metabolic process.','2013-10-27','NSRP'),(37909,1900956,'regulation of 17-methylnonadec-1-ene biosynthetic process','P','Any process that modulates the frequency, rate or extent of 17-methylnonadec-1-ene biosynthetic process.','2013-10-27','NSRP'),(37910,1900957,'negative regulation of 17-methylnonadec-1-ene biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of 17-methylnonadec-1-ene biosynthetic process.','2013-10-27','NSRP'),(37911,1900958,'positive regulation of 17-methylnonadec-1-ene biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of 17-methylnonadec-1-ene biosynthetic process.','2013-10-27','NSRP'),(37912,1900959,'regulation of 17-methylnonadec-1-ene metabolic process','P','Any process that modulates the frequency, rate or extent of 17-methylnonadec-1-ene metabolic process.','2013-10-27','NSRP'),(37913,1900960,'negative regulation of 17-methylnonadec-1-ene metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of 17-methylnonadec-1-ene metabolic process.','2013-10-27','NSRP'),(37914,1900961,'positive regulation of 17-methylnonadec-1-ene metabolic process','P','Any process that activates or increases the frequency, rate or extent of 17-methylnonadec-1-ene metabolic process.','2013-10-27','NSRP'),(37915,1900962,'regulation of methanophenazine biosynthetic process','P','Any process that modulates the frequency, rate or extent of methanophenazine biosynthetic process.','2013-10-27','NSRP'),(37916,1900963,'negative regulation of methanophenazine biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of methanophenazine biosynthetic process.','2013-10-27','NSRP'),(37917,1900964,'positive regulation of methanophenazine biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of methanophenazine biosynthetic process.','2013-10-27','NSRP'),(37918,1900965,'regulation of methanophenazine metabolic process','P','Any process that modulates the frequency, rate or extent of methanophenazine metabolic process.','2013-10-27','NSRP'),(37919,1900966,'negative regulation of methanophenazine metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of methanophenazine metabolic process.','2013-10-27','NSRP'),(37920,1900967,'positive regulation of methanophenazine metabolic process','P','Any process that activates or increases the frequency, rate or extent of methanophenazine metabolic process.','2013-10-27','NSRP'),(37921,1900968,'regulation of sarcinapterin metabolic process','P','Any process that modulates the frequency, rate or extent of sarcinapterin metabolic process.','2013-10-27','NSRP'),(37922,1900969,'negative regulation of sarcinapterin metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of sarcinapterin metabolic process.','2013-10-27','NSRP'),(37923,1900970,'positive regulation of sarcinapterin metabolic process','P','Any process that activates or increases the frequency, rate or extent of sarcinapterin metabolic process.','2013-10-27','NSRP'),(37924,1900971,'regulation of sarcinapterin biosynthetic process','P','Any process that modulates the frequency, rate or extent of sarcinapterin biosynthetic process.','2013-10-27','NSRP'),(37925,1900972,'negative regulation of sarcinapterin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of sarcinapterin biosynthetic process.','2013-10-27','NSRP'),(37926,1900973,'positive regulation of sarcinapterin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of sarcinapterin biosynthetic process.','2013-10-27','NSRP'),(37927,1900974,'regulation of tatiopterin biosynthetic process','P','Any process that modulates the frequency, rate or extent of tatiopterin biosynthetic process.','2013-10-27','NSRP'),(37928,1900975,'negative regulation of tatiopterin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of tatiopterin biosynthetic process.','2013-10-27','NSRP'),(37929,1900976,'positive regulation of tatiopterin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of tatiopterin biosynthetic process.','2013-10-27','NSRP'),(37930,1900977,'regulation of tatiopterin metabolic process','P','Any process that modulates the frequency, rate or extent of tatiopterin metabolic process.','2013-10-27','NSRP'),(37931,1900978,'negative regulation of tatiopterin metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of tatiopterin metabolic process.','2013-10-27','NSRP'),(37932,1900979,'positive regulation of tatiopterin metabolic process','P','Any process that activates or increases the frequency, rate or extent of tatiopterin metabolic process.','2013-10-27','NSRP'),(37933,1900980,'regulation of phenazine biosynthetic process','P','Any process that modulates the frequency, rate or extent of phenazine biosynthetic process.','2013-10-27','NSRP'),(37934,1900981,'negative regulation of phenazine biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of phenazine biosynthetic process.','2013-10-27','NSRP'),(37935,1900982,'positive regulation of phenazine biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of phenazine biosynthetic process.','2013-10-27','NSRP'),(37936,1900983,'vindoline metabolic process','P','The chemical reactions and pathways involving vindoline.','2013-10-27','NSRP'),(37937,1900984,'vindoline catabolic process','P','The chemical reactions and pathways resulting in the breakdown of vindoline.','2013-10-27','NSRP'),(37938,1900985,'vindoline biosynthetic process','P','The chemical reactions and pathways resulting in the formation of vindoline.','2013-10-27','NSRP'),(37939,1900986,'ajmaline metabolic process','P','The chemical reactions and pathways involving ajmaline.','2013-10-27','NSRP'),(37940,1900987,'ajmaline catabolic process','P','The chemical reactions and pathways resulting in the breakdown of ajmaline.','2013-10-27','NSRP'),(37941,1900988,'ajmaline biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ajmaline.','2013-10-27','NSRP'),(37942,1900989,'scopolamine metabolic process','P','The chemical reactions and pathways involving scopolamine.','2013-10-27','NSRP'),(37943,1900990,'scopolamine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of scopolamine.','2013-10-27','NSRP'),(37944,1900991,'scopolamine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of scopolamine.','2013-10-27','NSRP'),(37945,1900992,'(-)-secologanin metabolic process','P','The chemical reactions and pathways involving (-)-secologanin.','2013-10-27','NSRP'),(37946,1900993,'(-)-secologanin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of (-)-secologanin.','2013-10-27','NSRP'),(37947,1900994,'(-)-secologanin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (-)-secologanin.','2013-10-27','NSRP'),(37948,1900995,'ubiquinone-6 binding','F','Interacting selectively and non-covalently with ubiquinone-6. Ubiquinone-6 is a ubiquinone compound having a (2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl substituent at position 2.','2013-10-27','NSRP'),(37949,1900996,'benzene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of benzene.','2013-10-27','NSRP'),(37950,1900997,'benzene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of benzene.','2013-10-27','NSRP'),(37951,1900998,'nitrobenzene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of nitrobenzene.','2013-10-27','NSRP'),(37952,1900999,'nitrobenzene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of nitrobenzene.','2013-10-27','NSRP'),(37953,1901000,'regulation of response to salt stress','P','Any process that modulates the frequency, rate or extent of response to salt stress.','2013-10-27','NSRP'),(37954,1901001,'negative regulation of response to salt stress','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to salt stress.','2013-10-27','NSRP'),(37955,1901002,'positive regulation of response to salt stress','P','Any process that activates or increases the frequency, rate or extent of response to salt stress.','2013-10-27','NSRP'),(37956,1901003,'negative regulation of fermentation','P','Any process that stops, prevents or reduces the frequency, rate or extent of fermentation.','2013-10-27','NSRP'),(37957,1901004,'ubiquinone-6 metabolic process','P','The chemical reactions and pathways involving ubiquinone-6. Ubiquinone-6 is a ubiquinone compound having a (2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl substituent at position 2.','2013-10-27','NSRP'),(37958,1901005,'ubiquinone-6 catabolic process','P','The chemical reactions and pathways resulting in the breakdown of ubiquinone-6.','2013-10-27','NSRP'),(37959,1901006,'ubiquinone-6 biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ubiquinone-6.','2013-10-27','NSRP'),(37960,1901007,'(S)-scoulerine metabolic process','P','The chemical reactions and pathways involving (S)-scoulerine.','2013-10-27','NSRP'),(37961,1901008,'(S)-scoulerine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of (S)-scoulerine.','2013-10-27','NSRP'),(37962,1901009,'(S)-scoulerine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (S)-scoulerine.','2013-10-27','NSRP'),(37963,1901010,'(S)-reticuline metabolic process','P','The chemical reactions and pathways involving (S)-reticuline.','2013-10-27','NSRP'),(37964,1901011,'(S)-reticuline catabolic process','P','The chemical reactions and pathways resulting in the breakdown of (S)-reticuline.','2013-10-27','NSRP'),(37965,1901012,'(S)-reticuline biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (S)-reticuline.','2013-10-27','NSRP'),(37966,1901013,'3alpha(S)-strictosidine metabolic process','P','The chemical reactions and pathways involving 3alpha(S)-strictosidine.','2013-10-27','NSRP'),(37967,1901014,'3alpha(S)-strictosidine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 3alpha(S)-strictosidine.','2013-10-27','NSRP'),(37968,1901015,'3alpha(S)-strictosidine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 3alpha(S)-strictosidine.','2013-10-27','NSRP'),(37969,1901016,'regulation of potassium ion transmembrane transporter activity','P','Any process that modulates the frequency, rate or extent of potassium ion transmembrane transporter activity.','2013-10-27','NSRP'),(37970,1901017,'negative regulation of potassium ion transmembrane transporter activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion transmembrane transporter activity.','2013-10-27','NSRP'),(37971,1901018,'positive regulation of potassium ion transmembrane transporter activity','P','Any process that activates or increases the frequency, rate or extent of potassium ion transmembrane transporter activity.','2013-10-27','NSRP'),(37972,1901019,'regulation of calcium ion transmembrane transporter activity','P','Any process that modulates the frequency, rate or extent of calcium ion transmembrane transporter activity.','2013-10-27','NSRP'),(37973,1901020,'negative regulation of calcium ion transmembrane transporter activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion transmembrane transporter activity.','2013-10-27','NSRP'),(37974,1901021,'positive regulation of calcium ion transmembrane transporter activity','P','Any process that activates or increases the frequency, rate or extent of calcium ion transmembrane transporter activity.','2013-10-27','NSRP'),(37975,1901022,'4-hydroxyphenylacetate metabolic process','P','The chemical reactions and pathways involving 4-hydroxyphenylacetate.','2013-10-27','NSRP'),(37976,1901023,'4-hydroxyphenylacetate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 4-hydroxyphenylacetate.','2013-10-27','NSRP'),(37977,1901024,'4-hydroxyphenylacetate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 4-hydroxyphenylacetate.','2013-10-27','NSRP'),(37978,1901025,'ripoptosome assembly involved in extrinsic apoptotic signaling pathway','P','The aggregation, arrangement and bonding together of ripoptosome components leading to apoptosis via the extrinsic apoptotic signaling pathway.','2013-10-27','NSRP'),(37979,1901026,'ripoptosome assembly involved in necroptosis','P','The aggregation, arrangement and bonding together of ripoptosome components leading to necroptosis.','2013-10-27','NSRP'),(37980,1901027,'dextrin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of dextrin.','2013-10-27','NSRP'),(37981,1901028,'regulation of mitochondrial outer membrane permeabilization','P','Any process that modulates the frequency, rate or extent of mitochondrial outer membrane permeabilization.','2013-10-27','NSRP'),(37982,1901029,'negative regulation of mitochondrial outer membrane permeabilization','P','Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial outer membrane permeabilization.','2013-10-27','NSRP'),(37983,1901030,'positive regulation of mitochondrial outer membrane permeabilization','P','Any process that activates or increases the frequency, rate or extent of mitochondrial outer membrane permeabilization.','2013-10-27','NSRP'),(37984,1901031,'regulation of response to reactive oxygen species','P','Any process that modulates the frequency, rate or extent of response to reactive oxygen species.','2013-10-27','NSRP'),(37985,1901032,'negative regulation of response to reactive oxygen species','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to reactive oxygen species.','2013-10-27','NSRP'),(37986,1901033,'positive regulation of response to reactive oxygen species','P','Any process that activates or increases the frequency, rate or extent of response to reactive oxygen species.','2013-10-27','NSRP'),(37987,1901034,'regulation of L-glutamine import','P','Any process that modulates the frequency, rate or extent of L-glutamine import.','2013-10-27','NSRP'),(37988,1901035,'negative regulation of L-glutamine import','P','Any process that stops, prevents or reduces the frequency, rate or extent of L-glutamine import.','2013-10-27','NSRP'),(37989,1901036,'positive regulation of L-glutamine import','P','Any process that activates or increases the frequency, rate or extent of L-glutamine import.','2013-10-27','NSRP'),(37990,1901037,'regulation of transcription from RNA polymerase II promoter during M/G1 transition of mitotic cell cycle','P','OBSOLETE. Any process that regulates transcription such that the target genes are transcribed during the M/G1 transition of the mitotic cell cycle.','2013-10-27','NSRP'),(37991,1901038,'cyanidin 3-O-glucoside metabolic process','P','The chemical reactions and pathways involving cyanidin 3-O-beta-D-glucoside.','2013-10-27','NSRP'),(37992,1901039,'regulation of peptide antigen transport','P','Any process that modulates the frequency, rate or extent of peptide antigen transport.','2013-10-27','NSRP'),(37993,1901040,'negative regulation of peptide antigen transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of peptide antigen transport.','2013-10-27','NSRP'),(37994,1901041,'positive regulation of peptide antigen transport','P','Any process that activates or increases the frequency, rate or extent of peptide antigen transport.','2013-10-27','NSRP'),(37995,1901042,'positive regulation of L-arginine import','P','Any process that activates or increases the frequency, rate or extent of L-arginine import.','2013-10-27','NSRP'),(37996,1901043,'protein polyubiquitination involved in cellular response to misfolded protein','P','OBSOLETE. Any protein polyubiquitination that is involved in cellular response to misfolded protein.','2013-10-27','NSRP'),(37997,1901044,'protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process','P','Any protein polyubiquitination that is involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process.','2013-10-27','NSRP'),(37998,1901045,'negative regulation of oviposition','P','Any process that stops, prevents or reduces the frequency, rate or extent of oviposition.','2013-10-27','NSRP'),(37999,1901046,'positive regulation of oviposition','P','Any process that activates or increases the frequency, rate or extent of oviposition.','2013-10-27','NSRP'),(38000,1901047,'insulin receptor signaling pathway involved in determination of adult lifespan','P','The series of molecular signals generated as a consequence of the insulin receptor binding to insulin that controls viability and duration in the adult phase of the life-cycle.','2013-10-27','NSRP'),(38001,1901048,'transforming growth factor beta receptor signaling pathway involved in regulation of multicellular organism growth','P','A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription, that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.','2013-10-27','NSRP'),(38002,1901049,'atropine metabolic process','P','The chemical reactions and pathways involving atropine.','2013-10-27','NSRP'),(38003,1901050,'atropine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of atropine.','2013-10-27','NSRP'),(38004,1901051,'atropine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of atropine.','2013-10-27','NSRP'),(38005,1901052,'sarcosine metabolic process','P','The chemical reactions and pathways involving sarcosine.','2013-10-27','NSRP'),(38006,1901053,'sarcosine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of sarcosine.','2013-10-27','NSRP'),(38007,1901054,'sarcosine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of sarcosine.','2013-10-27','NSRP'),(38008,1901055,'trimethylenediamine metabolic process','P','The chemical reactions and pathways involving trimethylenediamine.','2013-10-27','NSRP'),(38009,1901056,'trimethylenediamine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of trimethylenediamine.','2013-10-27','NSRP'),(38010,1901057,'trimethylenediamine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of trimethylenediamine.','2013-10-27','NSRP'),(38011,1901058,'p-hydroxyphenyl lignin metabolic process','P','The chemical reactions and pathways involving p-hydroxyphenyl lignin.','2013-10-27','NSRP'),(38012,1901059,'p-hydroxyphenyl lignin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of p-hydroxyphenyl lignin.','2013-10-27','NSRP'),(38013,1901060,'p-hydroxyphenyl lignin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of p-hydroxyphenyl lignin.','2013-10-27','NSRP'),(38014,1901061,'guaiacyl lignin metabolic process','P','The chemical reactions and pathways involving guaiacyl lignin.','2013-10-27','NSRP'),(38015,1901062,'guaiacyl lignin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of guaiacyl lignin.','2013-10-27','NSRP'),(38016,1901063,'guaiacyl lignin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of guaiacyl lignin.','2013-10-27','NSRP'),(38017,1901064,'syringal lignin metabolic process','P','The chemical reactions and pathways involving syringal lignin.','2013-10-27','NSRP'),(38018,1901065,'syringal lignin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of syringal lignin.','2013-10-27','NSRP'),(38019,1901066,'syringal lignin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of syringal lignin.','2013-10-27','NSRP'),(38020,1901067,'ferulate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of ferulate.','2013-10-27','NSRP'),(38021,1901068,'guanosine-containing compound metabolic process','P','The chemical reactions and pathways involving guanosine-containing compounds (guanosines).','2013-10-27','NSRP'),(38022,1901069,'guanosine-containing compound catabolic process','P','The chemical reactions and pathways resulting in the breakdown of guanosine-containing compounds (guanosines).','2013-10-27','NSRP'),(38023,1901070,'guanosine-containing compound biosynthetic process','P','The chemical reactions and pathways resulting in the formation of guanosine-containing compounds (guanosines).','2013-10-27','NSRP'),(38024,1901071,'glucosamine-containing compound metabolic process','P','The chemical reactions and pathways involving glucosamine-containing compounds (glucosamines).','2013-10-27','NSRP'),(38025,1901072,'glucosamine-containing compound catabolic process','P','The chemical reactions and pathways resulting in the breakdown of glucosamine-containing compounds (glucosamines).','2013-10-27','NSRP'),(38026,1901073,'glucosamine-containing compound biosynthetic process','P','The chemical reactions and pathways resulting in the formation of glucosamine-containing compounds (glucosamines).','2013-10-27','NSRP'),(38027,1901074,'regulation of engulfment of apoptotic cell','P','Any process that modulates the frequency, rate or extent of engulfment of apoptotic cell.','2013-10-27','NSRP'),(38028,1901075,'negative regulation of engulfment of apoptotic cell','P','Any process that stops, prevents or reduces the frequency, rate or extent of engulfment of apoptotic cell.','2013-10-27','NSRP'),(38029,1901076,'positive regulation of engulfment of apoptotic cell','P','Any process that activates or increases the frequency, rate or extent of engulfment of apoptotic cell.','2013-10-27','NSRP'),(38030,1901077,'regulation of relaxation of muscle','P','Any process that modulates the frequency, rate or extent of relaxation of muscle.','2013-10-27','NSRP'),(38031,1901078,'negative regulation of relaxation of muscle','P','Any process that stops, prevents or reduces the frequency, rate or extent of relaxation of muscle.','2013-10-27','NSRP'),(38032,1901079,'positive regulation of relaxation of muscle','P','Any process that activates or increases the frequency, rate or extent of relaxation of muscle.','2013-10-27','NSRP'),(38033,1901080,'regulation of relaxation of smooth muscle','P','Any process that modulates the frequency, rate or extent of relaxation of smooth muscle.','2013-10-27','NSRP'),(38034,1901081,'negative regulation of relaxation of smooth muscle','P','Any process that stops, prevents or reduces the frequency, rate or extent of relaxation of smooth muscle.','2013-10-27','NSRP'),(38035,1901082,'positive regulation of relaxation of smooth muscle','P','Any process that activates or increases the frequency, rate or extent of relaxation of smooth muscle.','2013-10-27','NSRP'),(38036,1901083,'pyrrolizidine alkaloid metabolic process','P','The chemical reactions and pathways involving pyrrolizidine alkaloid.','2013-10-27','NSRP'),(38037,1901084,'pyrrolizidine alkaloid catabolic process','P','The chemical reactions and pathways resulting in the breakdown of pyrrolizidine alkaloid.','2013-10-27','NSRP'),(38038,1901085,'pyrrolizidine alkaloid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of pyrrolizidine alkaloid.','2013-10-27','NSRP'),(38039,1901086,'benzylpenicillin metabolic process','P','The chemical reactions and pathways involving benzylpenicillin.','2013-10-27','NSRP'),(38040,1901087,'benzylpenicillin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of benzylpenicillin.','2013-10-27','NSRP'),(38041,1901088,'benzylpenicillin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of benzylpenicillin.','2013-10-27','NSRP'),(38042,1901089,'acetate ester metabolic process involved in fermentation','P','Any acetate ester metabolic process that is involved in fermentation.','2013-10-27','NSRP'),(38043,1901090,'regulation of protein tetramerization','P','Any process that modulates the frequency, rate or extent of protein tetramerization.','2013-10-27','NSRP'),(38044,1901091,'negative regulation of protein tetramerization','P','Any process that stops, prevents or reduces the frequency, rate or extent of protein tetramerization.','2013-10-27','NSRP'),(38045,1901092,'positive regulation of protein tetramerization','P','Any process that activates or increases the frequency, rate or extent of protein tetramerization.','2013-10-27','NSRP'),(38046,1901093,'regulation of protein homotetramerization','P','Any process that modulates the frequency, rate or extent of protein homotetramerization.','2013-10-27','NSRP'),(38047,1901094,'negative regulation of protein homotetramerization','P','Any process that stops, prevents or reduces the frequency, rate or extent of protein homotetramerization.','2013-10-27','NSRP'),(38048,1901095,'positive regulation of protein homotetramerization','P','Any process that activates or increases the frequency, rate or extent of protein homotetramerization.','2013-10-27','NSRP'),(38049,1901096,'regulation of autophagic vacuole maturation','P','Any process that modulates the frequency, rate or extent of autophagic vacuole maturation.','2013-10-27','NSRP'),(38050,1901097,'negative regulation of autophagic vacuole maturation','P','Any process that stops, prevents or reduces the frequency, rate or extent of autophagic vacuole maturation.','2013-10-27','NSRP'),(38051,1901098,'positive regulation of autophagic vacuole maturation','P','Any process that activates or increases the frequency, rate or extent of autophagic vacuole maturation.','2013-10-27','NSRP'),(38052,1901099,'negative regulation of signal transduction in absence of ligand','P','Any process that stops, prevents or reduces the frequency, rate or extent of signal transduction in absence of ligand.','2013-10-27','NSRP'),(38053,1901101,'gramicidin S metabolic process','P','The chemical reactions and pathways involving gramicidin S.','2013-10-27','NSRP'),(38054,1901102,'gramicidin S catabolic process','P','The chemical reactions and pathways resulting in the breakdown of gramicidin S.','2013-10-27','NSRP'),(38055,1901103,'gramicidin S biosynthetic process','P','The chemical reactions and pathways resulting in the formation of gramicidin S.','2013-10-27','NSRP'),(38056,1901104,'tetracenomycin C metabolic process','P','The chemical reactions and pathways involving tetracenomycin C.','2013-10-27','NSRP'),(38057,1901105,'tetracenomycin C catabolic process','P','The chemical reactions and pathways resulting in the breakdown of tetracenomycin C.','2013-10-27','NSRP'),(38058,1901106,'tetracenomycin C biosynthetic process','P','The chemical reactions and pathways resulting in the formation of tetracenomycin C.','2013-10-27','NSRP'),(38059,1901107,'granaticin metabolic process','P','The chemical reactions and pathways involving granaticin.','2013-10-27','NSRP'),(38060,1901108,'granaticin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of granaticin.','2013-10-27','NSRP'),(38061,1901109,'granaticin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of granaticin.','2013-10-27','NSRP'),(38062,1901110,'actinorhodin metabolic process','P','The chemical reactions and pathways involving actinorhodin.','2013-10-27','NSRP'),(38063,1901111,'actinorhodin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of actinorhodin.','2013-10-27','NSRP'),(38064,1901112,'actinorhodin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of actinorhodin.','2013-10-27','NSRP'),(38065,1901113,'erythromycin metabolic process','P','The chemical reactions and pathways involving erythromycin.','2013-10-27','NSRP'),(38066,1901114,'erythromycin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of erythromycin.','2013-10-27','NSRP'),(38067,1901115,'erythromycin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of erythromycin.','2013-10-27','NSRP'),(38068,1901116,'cephamycin C metabolic process','P','The chemical reactions and pathways involving cephamycin C.','2013-10-27','NSRP'),(38069,1901117,'cephamycin C catabolic process','P','The chemical reactions and pathways resulting in the breakdown of cephamycin C.','2013-10-27','NSRP'),(38070,1901118,'cephamycin C biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cephamycin C.','2013-10-27','NSRP'),(38071,1901119,'tobramycin metabolic process','P','The chemical reactions and pathways involving tobramycin.','2013-10-27','NSRP'),(38072,1901120,'tobramycin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of tobramycin.','2013-10-27','NSRP'),(38073,1901121,'tobramycin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of tobramycin.','2013-10-27','NSRP'),(38074,1901122,'bacitracin A metabolic process','P','The chemical reactions and pathways involving bacitracin A.','2013-10-27','NSRP'),(38075,1901123,'bacitracin A catabolic process','P','The chemical reactions and pathways resulting in the breakdown of bacitracin A.','2013-10-27','NSRP'),(38076,1901124,'bacitracin A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of bacitracin A.','2013-10-27','NSRP'),(38077,1901125,'candicidin metabolic process','P','The chemical reactions and pathways involving candicidin.','2013-10-27','NSRP'),(38078,1901126,'candicidin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of candicidin.','2013-10-27','NSRP'),(38079,1901127,'candicidin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of candicidin.','2013-10-27','NSRP'),(38080,1901128,'gentamycin metabolic process','P','The chemical reactions and pathways involving gentamycin.','2013-10-27','NSRP'),(38081,1901129,'gentamycin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of gentamycin.','2013-10-27','NSRP'),(38082,1901130,'gentamycin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of gentamycin.','2013-10-27','NSRP'),(38083,1901131,'kanamycin metabolic process','P','The chemical reactions and pathways involving kanamycin.','2013-10-27','NSRP'),(38084,1901132,'kanamycin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of kanamycin.','2013-10-27','NSRP'),(38085,1901133,'kanamycin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of kanamycin.','2013-10-27','NSRP'),(38086,1901134,'negative regulation of coflocculation via protein-carbohydrate interaction','P','Any process that stops, prevents or reduces the frequency, rate or extent of coflocculation via protein-carbohydrate interaction.','2013-10-27','NSRP'),(38087,1901135,'carbohydrate derivative metabolic process','P','The chemical reactions and pathways involving carbohydrate derivative.','2013-10-27','NSRP'),(38088,1901136,'carbohydrate derivative catabolic process','P','The chemical reactions and pathways resulting in the breakdown of carbohydrate derivative.','2013-10-27','NSRP'),(38089,1901137,'carbohydrate derivative biosynthetic process','P','The chemical reactions and pathways resulting in the formation of carbohydrate derivative.','2013-10-27','NSRP'),(38090,1901138,'regulation of barrier septum assembly involved in cell cycle cytokinesis','P','Any process that modulates the frequency, rate or extent of barrier septum assembly involved in cell cycle cytokinesis.','2013-04-22','NSRP'),(38091,1901139,'negative regulation of barrier septum assembly involved in cell cycle cytokinesis','P','Any process that stops, prevents or reduces the frequency, rate or extent of barrier septum assembly involved in cell cycle cytokinesis.','2013-04-22','NSRP'),(38092,1901140,'p-coumaryl alcohol transport','P','The directed movement of a p-coumaryl alcohol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38093,1901141,'regulation of lignin biosynthetic process','P','Any process that modulates the frequency, rate or extent of lignin biosynthetic process.','2013-10-27','NSRP'),(38094,1901142,'insulin metabolic process','P','The chemical reactions and pathways involving insulin.','2013-10-27','NSRP'),(38095,1901143,'insulin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of insulin.','2013-10-27','NSRP'),(38096,1901144,'insulin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of insulin.','2013-10-27','NSRP'),(38097,1901145,'mesenchymal cell apoptotic process involved in nephron morphogenesis','P','Any mesenchymal cell apoptotic process that is involved in nephron morphogenesis.','2013-10-27','NSRP'),(38098,1901146,'mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis','P','Any mesenchymal cell apoptotic process that is involved in mesonephric nephron morphogenesis.','2013-10-27','NSRP'),(38099,1901147,'mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis','P','Any mesenchymal cell apoptotic process that is involved in metanephric nephron morphogenesis.','2013-10-27','NSRP'),(38100,1901148,'gene expression involved in extracellular matrix organization','P','Any gene expression that is involved in extracellular matrix organization. Gene expression includes both transcription to produce an RNA transcript, and the translation of that mRNA into protein.','2013-10-27','NSRP'),(38101,1901149,'salicylic acid binding','F','Interacting selectively and non-covalently with salicylic acid.','2013-10-27','NSRP'),(38102,1901150,'vistamycin metabolic process','P','The chemical reactions and pathways involving vistamycin.','2013-10-27','NSRP'),(38103,1901151,'vistamycin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of vistamycin.','2013-10-27','NSRP'),(38104,1901152,'vistamycin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of vistamycin.','2013-10-27','NSRP'),(38105,1901153,'paromomycin metabolic process','P','The chemical reactions and pathways involving paromomycin.','2013-10-27','NSRP'),(38106,1901154,'paromomycin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of paromomycin.','2013-10-27','NSRP'),(38107,1901155,'paromomycin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of paromomycin.','2013-10-27','NSRP'),(38108,1901156,'neomycin metabolic process','P','The chemical reactions and pathways involving neomycin.','2013-10-27','NSRP'),(38109,1901157,'neomycin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of neomycin.','2013-10-27','NSRP'),(38110,1901158,'neomycin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of neomycin.','2013-10-27','NSRP'),(38111,1901159,'xylulose 5-phosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of xylulose 5-phosphate.','2013-10-27','NSRP'),(38112,1901160,'primary amino compound metabolic process','P','The chemical reactions and pathways involving primary amino compound.','2013-10-27','NSRP'),(38113,1901161,'primary amino compound catabolic process','P','The chemical reactions and pathways resulting in the breakdown of primary amino compound.','2013-10-27','NSRP'),(38114,1901162,'primary amino compound biosynthetic process','P','The chemical reactions and pathways resulting in the formation of primary amino compound.','2013-10-27','NSRP'),(38115,1901163,'regulation of trophoblast cell migration','P','Any process that modulates the frequency, rate or extent of trophoblast cell migration.','2013-10-27','NSRP'),(38116,1901164,'negative regulation of trophoblast cell migration','P','Any process that stops, prevents or reduces the frequency, rate or extent of trophoblast cell migration.','2013-10-27','NSRP'),(38117,1901165,'positive regulation of trophoblast cell migration','P','Any process that activates or increases the frequency, rate or extent of trophoblast cell migration.','2013-10-27','NSRP'),(38118,1901166,'neural crest cell migration involved in autonomic nervous system development','P','Any neural crest cell migration that is involved in autonomic nervous system development.','2013-10-27','NSRP'),(38119,1901167,'3-chlorocatechol metabolic process','P','The chemical reactions and pathways involving 3-chlorocatechol.','2013-10-27','NSRP'),(38120,1901168,'3-chlorocatechol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 3-chlorocatechol.','2013-10-27','NSRP'),(38121,1901169,'3-chlorocatechol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 3-chlorocatechol.','2013-10-27','NSRP'),(38122,1901170,'naphthalene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of naphthalene.','2013-10-27','NSRP'),(38123,1901171,'naphthalene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of naphthalene.','2013-10-27','NSRP'),(38124,1901172,'phytoene metabolic process','P','The chemical reactions and pathways involving phytoene.','2013-10-27','NSRP'),(38125,1901173,'phytoene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of phytoene.','2013-10-27','NSRP'),(38126,1901174,'phytoene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of phytoene.','2013-10-27','NSRP'),(38127,1901175,'lycopene metabolic process','P','The chemical reactions and pathways involving lycopene.','2013-10-27','NSRP'),(38128,1901176,'lycopene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of lycopene.','2013-10-27','NSRP'),(38129,1901177,'lycopene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of lycopene.','2013-10-27','NSRP'),(38130,1901178,'spheroidene metabolic process','P','The chemical reactions and pathways involving spheroidene.','2013-10-27','NSRP'),(38131,1901179,'spheroidene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of spheroidene.','2013-10-27','NSRP'),(38132,1901180,'spheroidene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of spheroidene.','2013-10-27','NSRP'),(38133,1901181,'negative regulation of cellular response to caffeine','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to caffeine.','2013-10-27','NSRP'),(38134,1901182,'regulation of camalexin biosynthetic process','P','Any process that modulates the frequency, rate or extent of camalexin biosynthetic process.','2013-10-27','NSRP'),(38135,1901183,'positive regulation of camalexin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of camalexin biosynthetic process.','2013-10-27','NSRP'),(38136,1901184,'regulation of ERBB signaling pathway','P','Any process that modulates the frequency, rate or extent of ERBB signaling pathway.','2013-10-27','NSRP'),(38137,1901185,'negative regulation of ERBB signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of ERBB signaling pathway.','2013-10-27','NSRP'),(38138,1901186,'positive regulation of ERBB signaling pathway','P','Any process that activates or increases the frequency, rate or extent of ERBB signaling pathway.','2013-10-27','NSRP'),(38139,1901187,'regulation of ephrin receptor signaling pathway','P','Any process that modulates the frequency, rate or extent of ephrin receptor signaling pathway.','2013-10-27','NSRP'),(38140,1901188,'negative regulation of ephrin receptor signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of ephrin receptor signaling pathway.','2013-10-27','NSRP'),(38141,1901189,'positive regulation of ephrin receptor signaling pathway','P','Any process that activates or increases the frequency, rate or extent of ephrin receptor signaling pathway.','2013-10-27','NSRP'),(38142,1901190,'regulation of formation of translation initiation ternary complex','P','Any process that modulates the frequency, rate or extent of formation of translation initiation ternary complex.','2013-10-27','NSRP'),(38143,1901191,'negative regulation of formation of translation initiation ternary complex','P','Any process that stops, prevents or reduces the frequency, rate or extent of formation of translation initiation ternary complex.','2013-10-27','NSRP'),(38144,1901192,'positive regulation of formation of translation initiation ternary complex','P','Any process that activates or increases the frequency, rate or extent of formation of translation initiation ternary complex.','2013-10-27','NSRP'),(38145,1901193,'regulation of formation of translation preinitiation complex','P','Any process that modulates the frequency, rate or extent of formation of translation preinitiation complex.','2013-10-27','NSRP'),(38146,1901194,'negative regulation of formation of translation preinitiation complex','P','Any process that stops, prevents or reduces the frequency, rate or extent of formation of translation preinitiation complex.','2013-10-27','NSRP'),(38147,1901195,'positive regulation of formation of translation preinitiation complex','P','Any process that activates or increases the frequency, rate or extent of formation of translation preinitiation complex.','2013-10-27','NSRP'),(38148,1901196,'positive regulation of calcium-mediated signaling involved in cellular response to salt stress','P','Any positive regulation of calcium-mediated signaling that is involved in cellular response to salt stress.','2013-10-27','NSRP'),(38149,1901197,'positive regulation of calcium-mediated signaling involved in cellular response to calcium ion','P','Any positive regulation of calcium-mediated signaling that is involved in cellular response to calcium ion.','2013-10-27','NSRP'),(38150,1901198,'positive regulation of calcium ion transport into cytosol involved in cellular response to calcium ion','P','Any positive regulation of calcium ion transport into cytosol that is involved in cellular response to calcium ion.','2013-10-27','NSRP'),(38151,1901199,'positive regulation of calcium ion transport into cytosol involved in cellular response to salt stress','P','Any positive regulation of calcium ion transport into cytosol that is involved in cellular response to salt stress.','2013-10-27','NSRP'),(38152,1901200,'negative regulation of calcium ion transport into cytosol involved in cellular response to salt stress','P','Any negative regulation of calcium ion transport into cytosol that is involved in cellular response to salt stress.','2013-10-27','NSRP'),(38153,1901201,'regulation of extracellular matrix assembly','P','Any process that modulates the frequency, rate or extent of extracellular matrix assembly.','2013-10-27','NSRP'),(38154,1901202,'negative regulation of extracellular matrix assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of extracellular matrix assembly.','2013-10-27','NSRP'),(38155,1901203,'positive regulation of extracellular matrix assembly','P','Any process that activates or increases the frequency, rate or extent of extracellular matrix assembly.','2013-10-27','NSRP'),(38156,1901204,'regulation of adrenergic receptor signaling pathway involved in heart process','P','Any process that modulates the frequency, rate or extent of a cardiac adrenergic receptor signaling pathway.','2013-10-27','NSRP'),(38157,1901205,'negative regulation of adrenergic receptor signaling pathway involved in heart process','P','Any process that stops, prevents or reduces the frequency, rate or extent of a cardiac adrenergic receptor signaling pathway.','2013-10-27','NSRP'),(38158,1901206,'positive regulation of adrenergic receptor signaling pathway involved in heart process','P','Any process that activates or increases the frequency, rate or extent of a cardiac adrenergic receptor signaling pathway.','2013-10-27','NSRP'),(38159,1901207,'regulation of heart looping','P','Any process that modulates the frequency, rate or extent of heart looping.','2013-10-27','NSRP'),(38160,1901208,'negative regulation of heart looping','P','Any process that stops, prevents or reduces the frequency, rate or extent of heart looping.','2013-10-27','NSRP'),(38161,1901209,'positive regulation of heart looping','P','Any process that activates or increases the frequency, rate or extent of heart looping.','2013-10-27','NSRP'),(38162,1901210,'regulation of cardiac chamber formation','P','Any process that modulates the frequency, rate or extent of cardiac chamber formation.','2013-10-27','NSRP'),(38163,1901211,'negative regulation of cardiac chamber formation','P','Any process that stops, prevents or reduces the frequency, rate or extent of cardiac chamber formation.','2013-10-27','NSRP'),(38164,1901212,'positive regulation of cardiac chamber formation','P','Any process that activates or increases the frequency, rate or extent of cardiac chamber formation.','2013-10-27','NSRP'),(38165,1901213,'regulation of transcription from RNA polymerase II promoter involved in heart development','P','Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter that contributes to the development of the heart over time.','2013-10-27','NSRP'),(38166,1901214,'regulation of neuron death','P','Any process that modulates the frequency, rate or extent of neuron death.','2013-10-27','NSRP'),(38167,1901215,'negative regulation of neuron death','P','Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.','2013-10-27','NSRP'),(38168,1901216,'positive regulation of neuron death','P','Any process that activates or increases the frequency, rate or extent of neuron death.','2013-10-27','NSRP'),(38169,1901217,'regulation of holin activity','P','Any process that modulates the frequency, rate or extent of holin activity.','2013-10-27','NSRP'),(38170,1901218,'negative regulation of holin activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of holin activity.','2013-10-27','NSRP'),(38171,1901219,'regulation of cardiac chamber morphogenesis','P','Any process that modulates the frequency, rate or extent of cardiac chamber morphogenesis.','2013-10-27','NSRP'),(38172,1901220,'negative regulation of cardiac chamber morphogenesis','P','Any process that stops, prevents or reduces the frequency, rate or extent of cardiac chamber morphogenesis.','2013-10-27','NSRP'),(38173,1901221,'positive regulation of cardiac chamber morphogenesis','P','Any process that activates or increases the frequency, rate or extent of cardiac chamber morphogenesis.','2013-10-27','NSRP'),(38174,1901222,'regulation of NIK/NF-kappaB cascade','P','Any process that modulates the frequency, rate or extent of a NIK/NF-kappaB cascade.','2013-10-27','NSRP'),(38175,1901223,'negative regulation of NIK/NF-kappaB cascade','P','Any process that stops, prevents or reduces the frequency, rate or extent of a NIK/NF-kappaB cascade.','2013-10-27','NSRP'),(38176,1901224,'positive regulation of NIK/NF-kappaB cascade','P','Any process that activates or increases the frequency, rate or extent of a NIK/NF-kappaB cascade.','2013-10-27','NSRP'),(38177,1901225,'negative regulation of transcription from RNA polymerase II promoter involved in heart development','P','OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of regulation of transcription from RNA polymerase II promoter involved in heart development.','2013-10-27','NSRP'),(38178,1901226,'positive regulation of transcription from RNA polymerase II promoter involved in heart development','P','OBSOLETE. Any process that activates or increases the frequency, rate or extent of regulation of transcription from RNA polymerase II promoter involved in heart development.','2013-10-27','NSRP'),(38179,1901227,'negative regulation of transcription from RNA polymerase II promoter involved in heart development','P','Any negative regulation of transcription from RNA polymerase II promoter that is involved in heart development.','2013-10-27','NSRP'),(38180,1901228,'positive regulation of transcription from RNA polymerase II promoter involved in heart development','P','Any positive regulation of transcription from RNA polymerase II promoter that is involved in heart development.','2013-10-27','NSRP'),(38181,1901229,'regulation of non-canonical Wnt receptor signaling pathway via JNK cascade','P','Any process that modulates the frequency, rate or extent of non-canonical Wnt receptor signaling pathway via JNK cascade.','2013-10-27','NSRP'),(38182,1901230,'negative regulation of non-canonical Wnt receptor signaling pathway via JNK cascade','P','Any process that stops, prevents or reduces the frequency, rate or extent of non-canonical Wnt receptor signaling pathway via JNK cascade.','2013-10-27','NSRP'),(38183,1901231,'positive regulation of non-canonical Wnt receptor signaling pathway via JNK cascade','P','Any process that activates or increases the frequency, rate or extent of non-canonical Wnt receptor signaling pathway via JNK cascade.','2013-10-27','NSRP'),(38184,1901232,'regulation of convergent extension involved in axis elongation','P','Any process that modulates the frequency, rate or extent of convergent extension involved in axis elongation.','2013-10-27','NSRP'),(38185,1901233,'negative regulation of convergent extension involved in axis elongation','P','Any process that stops, prevents or reduces the frequency, rate or extent of convergent extension involved in axis elongation.','2013-10-27','NSRP'),(38186,1901234,'positive regulation of convergent extension involved in axis elongation','P','Any process that activates or increases the frequency, rate or extent of convergent extension involved in axis elongation.','2013-10-27','NSRP'),(38187,1901235,'(R)-carnitine transmembrane transporter activity','F','Catalysis of the transfer of (R)-carnitine from one side of the membrane to the other.','2013-10-27','NSRP'),(38188,1901236,'4-(trimethylammonio)butanoate transmembrane transporter activity','F','Catalysis of the transfer of 4-(trimethylammonio)butanoate from one side of the membrane to the other.','2013-10-27','NSRP'),(38189,1901237,'tungstate transmembrane transporter activity','F','Catalysis of the transfer of tungstate from one side of the membrane to the other.','2013-10-27','NSRP'),(38190,1901238,'tungstate transmembrane-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + tungstate(in) = ADP + phosphate + tungstate(out).','2013-10-27','NSRP'),(38191,1901239,'malonate(1-) transmembrane transporter activity','F','Catalysis of the transfer of malonate(1-) from one side of the membrane to the other.','2013-10-27','NSRP'),(38192,1901241,'4-hydroxyphenylacetate transmembrane transporter activity','F','Catalysis of the transfer of 4-hydroxyphenylacetate from one side of the membrane to the other.','2013-10-27','NSRP'),(38193,1901242,'doxorubicin transmembrane-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + doxorubicin(in) = ADP + phosphate + doxorubicin(out).','2013-10-27','NSRP'),(38194,1901243,'methionine transmembrane-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + methionine(in) = ADP + phosphate + methionine(out).','2013-10-27','NSRP'),(38195,1901244,'positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus','P','Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter to protect the cell or organism in response to the presence of a fungus.','2013-10-27','NSRP'),(38196,1901245,'positive regulation of toll-like receptor 9 signaling pathway by B cell receptor internalization','P','The movement of a B cell receptor (BCR) from the plasma membrane to the inside of the cell, which results in positive regulation of toll-like receptor 9 (TLR9) signaling. For example, internalized BCR signals to recruit TLR9 from multiple small endosomes to large autophagosome-like compartments to enhance TLR9 signaling.','2013-10-27','NSRP'),(38197,1901246,'regulation of lung ciliated cell differentiation','P','Any process that modulates the frequency, rate or extent of lung ciliated cell differentiation.','2013-10-27','NSRP'),(38198,1901247,'negative regulation of lung ciliated cell differentiation','P','Any process that stops, prevents or reduces the frequency, rate or extent of lung ciliated cell differentiation.','2013-10-27','NSRP'),(38199,1901248,'positive regulation of lung ciliated cell differentiation','P','Any process that activates or increases the frequency, rate or extent of lung ciliated cell differentiation.','2013-10-27','NSRP'),(38200,1901249,'regulation of lung goblet cell differentiation','P','Any process that modulates the frequency, rate or extent of lung goblet cell differentiation.','2013-10-27','NSRP'),(38201,1901250,'negative regulation of lung goblet cell differentiation','P','Any process that stops, prevents or reduces the frequency, rate or extent of lung goblet cell differentiation.','2013-10-27','NSRP'),(38202,1901251,'positive regulation of lung goblet cell differentiation','P','Any process that activates or increases the frequency, rate or extent of lung goblet cell differentiation.','2013-10-27','NSRP'),(38203,1901252,'regulation of intracellular transport of viral material','P','Any process that modulates the frequency, rate or extent of egress of virus within host cell.','2013-10-27','NSRP'),(38204,1901253,'negative regulation of intracellular transport of viral material','P','Any process that stops, prevents or reduces the frequency, rate or extent of intracellular transport of viral material.','2013-10-27','NSRP'),(38205,1901254,'positive regulation of intracellular transport of viral material','P','Any process that activates or increases the frequency, rate or extent of intracellular transport of viral material.','2013-10-27','NSRP'),(38206,1901255,'nucleotide-excision repair involved in interstrand cross-link repair','P','Any nucleotide-excision repair that is involved in interstrand cross-link repair.','2013-10-27','NSRP'),(38207,1901256,'regulation of macrophage colony-stimulating factor production','P','Any process that modulates the frequency, rate or extent of macrophage colony-stimulating factor production.','2013-10-27','NSRP'),(38208,1901257,'negative regulation of macrophage colony-stimulating factor production','P','Any process that stops, prevents or reduces the frequency, rate or extent of macrophage colony-stimulating factor production.','2013-10-27','NSRP'),(38209,1901258,'positive regulation of macrophage colony-stimulating factor production','P','Any process that activates or increases the frequency, rate or extent of macrophage colony-stimulating factor production.','2013-10-27','NSRP'),(38210,1901259,'chloroplast rRNA processing','P','Any rRNA processing that takes place in chloroplast.','2013-10-27','NSRP'),(38211,1901260,'peptidyl-lysine hydroxylation involved in bacterial-type EF-P lysine modification','P','Any peptidyl-lysine hydroxylation that is involved in bacterial-type EF-P lysine modification.','2013-10-27','NSRP'),(38212,1901261,'regulation of sorocarp spore cell differentiation','P','Any process that modulates the frequency, rate or extent of sorocarp spore cell differentiation.','2013-10-27','NSRP'),(38213,1901262,'negative regulation of sorocarp spore cell differentiation','P','Any process that stops, prevents or reduces the frequency, rate or extent of sorocarp spore cell differentiation.','2013-10-27','NSRP'),(38214,1901263,'positive regulation of sorocarp spore cell differentiation','P','Any process that activates or increases the frequency, rate or extent of sorocarp spore cell differentiation.','2013-10-27','NSRP'),(38215,1901264,'carbohydrate derivative transport','P','The directed movement of a carbohydrate derivative into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38216,1901265,'nucleoside phosphate binding','F','Interacting selectively and non-covalently with nucleoside phosphate.','2013-10-27','NSRP'),(38217,1901266,'cephalosporin C metabolic process','P','The chemical reactions and pathways involving cephalosporin C.','2013-10-27','NSRP'),(38218,1901267,'cephalosporin C catabolic process','P','The chemical reactions and pathways resulting in the breakdown of cephalosporin C.','2013-10-27','NSRP'),(38219,1901268,'cephalosporin C biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cephalosporin C.','2013-10-27','NSRP'),(38220,1901269,'lipooligosaccharide metabolic process','P','The chemical reactions and pathways involving lipooligosaccharide.','2013-10-27','NSRP'),(38221,1901270,'lipooligosaccharide catabolic process','P','The chemical reactions and pathways resulting in the breakdown of lipooligosaccharide.','2013-10-27','NSRP'),(38222,1901271,'lipooligosaccharide biosynthetic process','P','The chemical reactions and pathways resulting in the formation of lipooligosaccharide.','2013-10-27','NSRP'),(38223,1901272,'2-dehydro-3-deoxy-D-gluconic acid metabolic process','P','The chemical reactions and pathways involving 2-dehydro-3-deoxy-D-gluconic acid.','2013-10-27','NSRP'),(38224,1901273,'2-dehydro-3-deoxy-D-gluconic acid catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 2-dehydro-3-deoxy-D-gluconic acid.','2013-10-27','NSRP'),(38225,1901274,'2-dehydro-3-deoxy-D-gluconic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 2-dehydro-3-deoxy-D-gluconic acid.','2013-10-27','NSRP'),(38226,1901275,'tartrate metabolic process','P','The chemical reactions and pathways involving tartrate.','2013-10-27','NSRP'),(38227,1901276,'tartrate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of tartrate.','2013-10-27','NSRP'),(38228,1901277,'tartrate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of tartrate.','2013-10-27','NSRP'),(38229,1901278,'D-ribose 5-phosphate metabolic process','P','The chemical reactions and pathways involving D-ribose 5-phosphate.','2013-10-27','NSRP'),(38230,1901279,'D-ribose 5-phosphate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of D-ribose 5-phosphate.','2013-10-27','NSRP'),(38231,1901280,'D-ribose 5-phosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of D-ribose 5-phosphate.','2013-10-27','NSRP'),(38232,1901281,'fructoselysine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of fructoselysine.','2013-10-27','NSRP'),(38233,1901282,'fructoselysine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of fructoselysine.','2013-10-27','NSRP'),(38234,1901283,'5,6,7,8-tetrahydromethanopterin metabolic process','P','The chemical reactions and pathways involving 5,6,7,8-tetrahydromethanopterin.','2013-10-27','NSRP'),(38235,1901284,'5,6,7,8-tetrahydromethanopterin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 5,6,7,8-tetrahydromethanopterin.','2013-10-27','NSRP'),(38236,1901285,'5,6,7,8-tetrahydromethanopterin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 5,6,7,8-tetrahydromethanopterin.','2013-10-27','NSRP'),(38237,1901286,'iron-sulfur-molybdenum cofactor metabolic process','P','The chemical reactions and pathways involving iron-sulfur-molybdenum cofactor.','2013-10-27','NSRP'),(38238,1901287,'iron-sulfur-molybdenum cofactor catabolic process','P','The chemical reactions and pathways resulting in the breakdown of iron-sulfur-molybdenum cofactor.','2013-10-27','NSRP'),(38239,1901288,'iron-sulfur-molybdenum cofactor biosynthetic process','P','The chemical reactions and pathways resulting in the formation of iron-sulfur-molybdenum cofactor.','2013-10-27','NSRP'),(38240,1901289,'succinyl-CoA catabolic process','P','The chemical reactions and pathways resulting in the breakdown of succinyl-CoA.','2013-10-27','NSRP'),(38241,1901290,'succinyl-CoA biosynthetic process','P','The chemical reactions and pathways resulting in the formation of succinyl-CoA.','2013-10-27','NSRP'),(38242,1901291,'negative regulation of double-strand break repair via single-strand annealing','P','Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair via single-strand annealing.','2013-10-27','NSRP'),(38243,1901292,'nucleoside phosphate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a nucleoside phosphate.','2013-10-27','NSRP'),(38244,1901293,'nucleoside phosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a nucleoside phosphate.','2013-10-27','NSRP'),(38245,1901294,'negative regulation of SREBP signaling pathway by negative regulation of DNA binding','P','Negative regulation of DNA binding that results in negative regulation of a SREBP signaling pathway.','2013-10-27','NSRP'),(38246,1901295,'regulation of canonical Wnt receptor signaling pathway involved in cardiac muscle cell fate commitment','P','Any process that modulates the frequency, rate or extent of canonical Wnt receptor signaling pathway involved in cardiac muscle cell fate commitment.','2013-10-27','NSRP'),(38247,1901296,'negative regulation of canonical Wnt receptor signaling pathway involved in cardiac muscle cell fate commitment','P','Any process that stops, prevents or reduces the frequency, rate or extent of canonical Wnt receptor signaling pathway involved in cardiac muscle cell fate commitment.','2013-10-27','NSRP'),(38248,1901297,'positive regulation of canonical Wnt receptor signaling pathway involved in cardiac muscle cell fate commitment','P','Any process that activates or increases the frequency, rate or extent of canonical Wnt receptor signaling pathway involved in cardiac muscle cell fate commitment.','2013-10-27','NSRP'),(38249,1901298,'regulation of hydrogen peroxide-mediated programmed cell death','P','Any process that modulates the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death.','2013-10-27','NSRP'),(38250,1901299,'negative regulation of hydrogen peroxide-mediated programmed cell death','P','Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death.','2013-10-27','NSRP'),(38251,1901300,'positive regulation of hydrogen peroxide-mediated programmed cell death','P','Any process that activates or increases the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death.','2013-10-27','NSRP'),(38252,1901301,'regulation of cargo loading into COPII-coated vesicle','P','Any process that modulates the frequency, rate or extent of cargo loading into COPII-coated vesicle.','2013-10-27','NSRP'),(38253,1901303,'negative regulation of cargo loading into COPII-coated vesicle','P','Any process that stops, prevents or reduces the frequency, rate or extent of cargo loading into a COPII-coated vesicle.','2013-10-27','NSRP'),(38254,1901304,'regulation of spermidine biosynthetic process','P','Any process that modulates the frequency, rate or extent of spermidine biosynthetic process.','2013-10-27','NSRP'),(38255,1901305,'negative regulation of spermidine biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of spermidine biosynthetic process.','2013-10-27','NSRP'),(38256,1901307,'positive regulation of spermidine biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of spermidine biosynthetic process.','2013-10-27','NSRP'),(38257,1901308,'regulation of sterol regulatory element binding protein cleavage','P','Any process that modulates the frequency, rate or extent of sterol regulatory element binding protein cleavage.','2013-10-27','NSRP'),(38258,1901309,'negative regulation of sterol regulatory element binding protein cleavage','P','Any process that stops, prevents or reduces the frequency, rate or extent of sterol regulatory element binding protein cleavage.','2013-10-27','NSRP'),(38259,1901310,'positive regulation of sterol regulatory element binding protein cleavage','P','Any process that activates or increases the frequency, rate or extent of sterol regulatory element binding protein cleavage.','2013-10-27','NSRP'),(38260,1901311,'regulation of gene expression involved in extracellular matrix organization','P','Any process that modulates the frequency, rate or extent of gene expression involved in extracellular matrix organization.','2013-10-27','NSRP'),(38261,1901312,'negative regulation of gene expression involved in extracellular matrix organization','P','Any process that stops, prevents or reduces the frequency, rate or extent of gene expression involved in extracellular matrix organization.','2013-10-27','NSRP'),(38262,1901313,'positive regulation of gene expression involved in extracellular matrix organization','P','Any process that activates or increases the frequency, rate or extent of gene expression involved in extracellular matrix organization.','2013-10-27','NSRP'),(38263,1901314,'regulation of histone H2A K63-linked ubiquitination','P','Any process that modulates the frequency, rate or extent of histone H2A K63-linked ubiquitination.','2013-10-27','NSRP'),(38264,1901315,'negative regulation of histone H2A K63-linked ubiquitination','P','Any process that stops, prevents or reduces the frequency, rate or extent of histone H2A K63-linked ubiquitination.','2013-10-27','NSRP'),(38265,1901316,'positive regulation of histone H2A K63-linked ubiquitination','P','Any process that activates or increases the frequency, rate or extent of histone H2A K63-linked ubiquitination.','2013-10-27','NSRP'),(38266,1901317,'regulation of sperm motility','P','Any process that modulates the frequency, rate or extent of sperm motility.','2013-10-27','NSRP'),(38267,1901318,'negative regulation of sperm motility','P','Any process that stops, prevents or reduces the frequency, rate or extent of sperm motility.','2013-10-27','NSRP'),(38268,1901319,'positive regulation of trehalose catabolic process','P','Any process that activates or increases the frequency, rate or extent of trehalose catabolic process.','2013-10-27','NSRP'),(38269,1901320,'negative regulation of heart induction','P','Any process that stops, prevents or reduces the frequency, rate or extent of heart induction.','2013-10-27','NSRP'),(38270,1901321,'positive regulation of heart induction','P','Any process that activates or increases the frequency, rate or extent of heart induction.','2013-10-27','NSRP'),(38271,1901322,'response to chloramphenicol','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chloramphenicol stimulus.','2013-10-27','NSRP'),(38272,1901323,'response to erythromycin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an erythromycin stimulus.','2013-10-27','NSRP'),(38273,1901324,'response to trichodermin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a trichodermin stimulus.','2013-10-27','NSRP'),(38274,1901325,'response to antimycin A','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antimycin A stimulus.','2013-10-27','NSRP'),(38275,1901326,'response to tetracycline','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tetracycline stimulus.','2013-10-27','NSRP'),(38276,1901327,'response to tacrolimus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tacrolimus stimulus.','2013-10-27','NSRP'),(38277,1901328,'response to cytochalasin B','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytochalasin B stimulus.','2013-10-27','NSRP'),(38278,1901329,'regulation of odontoblast differentiation','P','Any process that modulates the frequency, rate or extent of odontoblast differentiation.','2013-10-27','NSRP'),(38279,1901330,'negative regulation of odontoblast differentiation','P','Any process that stops, prevents or reduces the frequency, rate or extent of odontoblast differentiation.','2013-10-27','NSRP'),(38280,1901331,'positive regulation of odontoblast differentiation','P','Any process that activates or increases the frequency, rate or extent of odontoblast differentiation.','2013-10-27','NSRP'),(38281,1901332,'negative regulation of lateral root development','P','Any process that stops, prevents or reduces the frequency, rate or extent of lateral root development.','2013-10-27','NSRP'),(38282,1901333,'positive regulation of lateral root development','P','Any process that activates or increases the frequency, rate or extent of lateral root development.','2013-10-27','NSRP'),(38283,1901334,'lactone metabolic process','P','The chemical reactions and pathways involving lactone.','2013-10-27','NSRP'),(38284,1901335,'lactone catabolic process','P','The chemical reactions and pathways resulting in the breakdown of lactone.','2013-10-27','NSRP'),(38285,1901336,'lactone biosynthetic process','P','The chemical reactions and pathways resulting in the formation of lactone.','2013-10-27','NSRP'),(38286,1901337,'thioester transport','P','The directed movement of a thioester into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38287,1901338,'catecholamine binding','F','Interacting selectively and non-covalently with catecholamine.','2013-10-27','NSRP'),(38288,1901339,'regulation of store-operated calcium channel activity','P','Any process that modulates the frequency, rate or extent of store-operated calcium channel activity.','2013-10-27','NSRP'),(38289,1901340,'negative regulation of store-operated calcium channel activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of store-operated calcium channel activity.','2013-10-27','NSRP'),(38290,1901341,'positive regulation of store-operated calcium channel activity','P','Any process that activates or increases the frequency, rate or extent of store-operated calcium channel activity.','2013-10-27','NSRP'),(38291,1901342,'regulation of vasculature development','P','Any process that modulates the frequency, rate or extent of vasculature development.','2013-10-27','NSRP'),(38292,1901343,'negative regulation of vasculature development','P','Any process that stops, prevents or reduces the frequency, rate or extent of vasculature development.','2013-10-27','NSRP'),(38293,1901344,'response to leptomycin B','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptomycin B stimulus.','2013-10-27','NSRP'),(38294,1901345,'response to L-thialysine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-thialysine stimulus.','2013-10-27','NSRP'),(38295,1901346,'negative regulation of vasculature development involved in avascular cornea development in camera-type eye','P','Any negative regulation of vasculature development that is involved in developing an avascular cornea of a camera-type eye.','2013-10-27','NSRP'),(38296,1901347,'negative regulation of secondary cell wall biogenesis','P','Any process that stops, prevents or reduces the frequency, rate or extent of secondary cell wall biogenesis.','2013-10-27','NSRP'),(38297,1901348,'positive regulation of secondary cell wall biogenesis','P','Any process that activates or increases the frequency, rate or extent of secondary cell wall biogenesis.','2013-10-27','NSRP'),(38298,1901349,'glucosinolate transport','P','The directed movement of a glucosinolate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38299,1901350,'cell-cell signaling involved in cell-cell junction organization','P','Any cell-cell signaling that is involved in cell-cell junction organization.','2013-10-27','NSRP'),(38300,1901351,'regulation of phosphatidylglycerol biosynthetic process','P','Any process that modulates the frequency, rate or extent of phosphatidylglycerol biosynthetic process.','2013-10-27','NSRP'),(38301,1901352,'negative regulation of phosphatidylglycerol biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylglycerol biosynthetic process.','2013-10-27','NSRP'),(38302,1901353,'positive regulation of phosphatidylglycerol biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of phosphatidylglycerol biosynthetic process.','2013-10-27','NSRP'),(38303,1901354,'response to L-canavanine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-canavanine stimulus.','2013-10-27','NSRP'),(38304,1901355,'response to rapamycin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a rapamycin stimulus.','2013-10-27','NSRP'),(38305,1901356,'beta-D-galactofuranose metabolic process','P','The chemical reactions and pathways involving beta-D-galactofuranose.','2013-10-27','NSRP'),(38306,1901357,'beta-D-galactofuranose catabolic process','P','The chemical reactions and pathways resulting in the breakdown of beta-D-galactofuranose.','2013-10-27','NSRP'),(38307,1901358,'beta-D-galactofuranose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of beta-D-galactofuranose.','2013-10-27','NSRP'),(38308,1901359,'tungstate binding','F','Interacting selectively and non-covalently with tungstate.','2013-10-27','NSRP'),(38309,1901360,'organic cyclic compound metabolic process','P','The chemical reactions and pathways involving organic cyclic compound.','2013-10-27','NSRP'),(38310,1901361,'organic cyclic compound catabolic process','P','The chemical reactions and pathways resulting in the breakdown of organic cyclic compound.','2013-10-27','NSRP'),(38311,1901362,'organic cyclic compound biosynthetic process','P','The chemical reactions and pathways resulting in the formation of organic cyclic compound.','2013-10-27','NSRP'),(38312,1901363,'heterocyclic compound binding','F','Interacting selectively and non-covalently with heterocyclic compound.','2013-10-27','NSRP'),(38313,1901364,'funalenone metabolic process','P','The chemical reactions and pathways involving funalenone.','2013-10-27','NSRP'),(38314,1901365,'funalenone catabolic process','P','The chemical reactions and pathways resulting in the breakdown of funalenone.','2013-10-27','NSRP'),(38315,1901366,'funalenone biosynthetic process','P','The chemical reactions and pathways resulting in the formation of funalenone.','2013-10-27','NSRP'),(38316,1901367,'response to L-cysteine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-cysteine stimulus.','2013-10-27','NSRP'),(38317,1901368,'NAD transmembrane transporter activity','F','Catalysis of the transfer of NAD from one side of the membrane to the other.','2013-10-27','NSRP'),(38318,1901369,'cyclic 2,3-bisphospho-D-glycerate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cyclic 2,3-bisphospho-D-glyceric acid.','2013-10-27','NSRP'),(38319,1901370,'response to glutathione','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glutathione stimulus.','2013-10-27','NSRP'),(38320,1901371,'regulation of leaf morphogenesis','P','Any process that modulates the frequency, rate or extent of leaf morphogenesis.','2013-10-27','NSRP'),(38321,1901372,'trehalose biosynthetic process involved in ascospore formation','P','Any trehalose biosynthetic process that is involved in ascospore formation.','2013-10-27','NSRP'),(38322,1901373,'lipid hydroperoxide transport','P','The directed movement of a lipid hydroperoxide into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38323,1901374,'acetate ester transport','P','The directed movement of an acetate ester into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38324,1901375,'acetate ester transmembrane transporter activity','F','Catalysis of the transfer of an acetate ester from one side of the membrane to the other.','2013-10-27','NSRP'),(38325,1901376,'organic heteropentacyclic compound metabolic process','P','The chemical reactions and pathways involving organic heteropentacyclic compound.','2013-10-27','NSRP'),(38326,1901377,'organic heteropentacyclic compound catabolic process','P','The chemical reactions and pathways resulting in the breakdown of organic heteropentacyclic compound.','2013-10-27','NSRP'),(38327,1901378,'organic heteropentacyclic compound biosynthetic process','P','The chemical reactions and pathways resulting in the formation of organic heteropentacyclic compound.','2013-10-27','NSRP'),(38328,1901379,'regulation of potassium ion transmembrane transport','P','Any process that modulates the frequency, rate or extent of potassium ion transmembrane transport.','2013-10-27','NSRP'),(38329,1901380,'negative regulation of potassium ion transmembrane transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion transmembrane transport.','2013-10-27','NSRP'),(38330,1901381,'positive regulation of potassium ion transmembrane transport','P','Any process that activates or increases the frequency, rate or extent of potassium ion transmembrane transport.','2013-10-27','NSRP'),(38331,1901382,'regulation of chorionic trophoblast cell proliferation','P','Any process that modulates the frequency, rate or extent of chorionic trophoblast cell proliferation.','2013-10-27','NSRP'),(38332,1901383,'negative regulation of chorionic trophoblast cell proliferation','P','Any process that stops, prevents or reduces the frequency, rate or extent of chorionic trophoblast cell proliferation.','2013-10-27','NSRP'),(38333,1901384,'positive regulation of chorionic trophoblast cell proliferation','P','Any process that activates or increases the frequency, rate or extent of chorionic trophoblast cell proliferation.','2013-10-27','NSRP'),(38334,1901385,'regulation of voltage-gated calcium channel activity','P','Any process that modulates the frequency, rate or extent of voltage-gated calcium channel activity.','2013-10-27','NSRP'),(38335,1901386,'negative regulation of voltage-gated calcium channel activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of voltage-gated calcium channel activity.','2013-10-27','NSRP'),(38336,1901387,'positive regulation of voltage-gated calcium channel activity','P','Any process that activates or increases the frequency, rate or extent of voltage-gated calcium channel activity.','2013-10-27','NSRP'),(38337,1901388,'regulation of transforming growth factor beta activation','P','Any process that modulates the frequency, rate or extent of transforming growth factor beta activation.','2013-10-27','NSRP'),(38338,1901389,'negative regulation of transforming growth factor beta activation','P','Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor beta activation.','2013-10-27','NSRP'),(38339,1901390,'positive regulation of transforming growth factor beta activation','P','Any process that activates or increases the frequency, rate or extent of transforming growth factor beta activation.','2013-10-27','NSRP'),(38340,1901392,'regulation of transforming growth factor beta1 activation','P','Any process that modulates the frequency, rate or extent of transforming growth factor beta1 activation.','2013-10-27','NSRP'),(38341,1901393,'negative regulation of transforming growth factor beta1 activation','P','Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor beta1 activation.','2013-10-27','NSRP'),(38342,1901394,'positive regulation of transforming growth factor beta1 activation','P','Any process that activates or increases the frequency, rate or extent of transforming growth factor beta1 activation.','2013-10-27','NSRP'),(38343,1901395,'regulation of transforming growth factor beta2 activation','P','Any process that modulates the frequency, rate or extent of transforming growth factor beta2 activation.','2013-10-27','NSRP'),(38344,1901396,'negative regulation of transforming growth factor beta2 activation','P','Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor beta2 activation.','2013-10-27','NSRP'),(38345,1901397,'positive regulation of transforming growth factor beta2 activation','P','Any process that activates or increases the frequency, rate or extent of transforming growth factor beta2 activation.','2013-10-27','NSRP'),(38346,1901398,'regulation of transforming growth factor beta3 activation','P','Any process that modulates the frequency, rate or extent of transforming growth factor beta3 activation.','2013-10-27','NSRP'),(38347,1901399,'negative regulation of transforming growth factor beta3 activation','P','Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor beta3 activation.','2013-10-27','NSRP'),(38348,1901400,'positive regulation of transforming growth factor beta3 activation','P','Any process that activates or increases the frequency, rate or extent of transforming growth factor beta3 activation.','2013-10-27','NSRP'),(38349,1901401,'regulation of tetrapyrrole metabolic process','P','Any process that modulates the frequency, rate or extent of tetrapyrrole metabolic process.','2013-10-27','NSRP'),(38350,1901402,'negative regulation of tetrapyrrole metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of tetrapyrrole metabolic process.','2013-10-27','NSRP'),(38351,1901403,'positive regulation of tetrapyrrole metabolic process','P','Any process that activates or increases the frequency, rate or extent of tetrapyrrole metabolic process.','2013-10-27','NSRP'),(38352,1901404,'regulation of tetrapyrrole catabolic process','P','Any process that modulates the frequency, rate or extent of tetrapyrrole catabolic process.','2013-10-27','NSRP'),(38353,1901405,'negative regulation of tetrapyrrole catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of tetrapyrrole catabolic process.','2013-10-27','NSRP'),(38354,1901406,'positive regulation of tetrapyrrole catabolic process','P','Any process that activates or increases the frequency, rate or extent of tetrapyrrole catabolic process.','2013-10-27','NSRP'),(38355,1901407,'regulation of phosphorylation of RNA polymerase II C-terminal domain','P','Any process that modulates the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain.','2013-10-27','NSRP'),(38356,1901408,'negative regulation of phosphorylation of RNA polymerase II C-terminal domain','P','Any process that stops, prevents or reduces the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain.','2013-10-27','NSRP'),(38357,1901409,'positive regulation of phosphorylation of RNA polymerase II C-terminal domain','P','Any process that activates or increases the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain.','2013-10-27','NSRP'),(38358,1901410,'regulation of tetrapyrrole biosynthetic process from glutamate','P','Any process that modulates the frequency, rate or extent of tetrapyrrole biosynthetic process from glutamate.','2013-10-27','NSRP'),(38359,1901411,'negative regulation of tetrapyrrole biosynthetic process from glutamate','P','Any process that stops, prevents or reduces the frequency, rate or extent of tetrapyrrole biosynthetic process from glutamate.','2013-10-27','NSRP'),(38360,1901412,'positive regulation of tetrapyrrole biosynthetic process from glutamate','P','Any process that activates or increases the frequency, rate or extent of tetrapyrrole biosynthetic process from glutamate.','2013-10-27','NSRP'),(38361,1901413,'regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA','P','Any process that modulates the frequency, rate or extent of tetrapyrrole biosynthetic process from glycine and succinyl-CoA.','2013-10-27','NSRP'),(38362,1901414,'negative regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA','P','Any process that stops, prevents or reduces the frequency, rate or extent of tetrapyrrole biosynthetic process from glycine and succinyl-CoA.','2013-10-27','NSRP'),(38363,1901415,'positive regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA','P','Any process that activates or increases the frequency, rate or extent of tetrapyrrole biosynthetic process from glycine and succinyl-CoA.','2013-10-27','NSRP'),(38364,1901416,'regulation of response to ethanol','P','Any process that modulates the frequency, rate or extent of response to ethanol.','2013-10-27','NSRP'),(38365,1901417,'negative regulation of response to ethanol','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to ethanol.','2013-10-27','NSRP'),(38366,1901418,'positive regulation of response to ethanol','P','Any process that activates or increases the frequency, rate or extent of response to ethanol.','2013-10-27','NSRP'),(38367,1901419,'regulation of response to alcohol','P','Any process that modulates the frequency, rate or extent of response to alcohol.','2013-10-27','NSRP'),(38368,1901420,'negative regulation of response to alcohol','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to alcohol.','2013-10-27','NSRP'),(38369,1901421,'positive regulation of response to alcohol','P','Any process that activates or increases the frequency, rate or extent of response to alcohol.','2013-10-27','NSRP'),(38370,1901422,'response to butan-1-ol','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a butan-1-ol stimulus.','2013-10-27','NSRP'),(38371,1901423,'response to benzene','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a benzene stimulus.','2013-10-27','NSRP'),(38372,1901424,'response to toluene','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toluene stimulus.','2013-10-27','NSRP'),(38373,1901425,'response to formic acid','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a formic acid stimulus.','2013-10-27','NSRP'),(38374,1901426,'response to furfural','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a furfural stimulus.','2013-10-27','NSRP'),(38375,1901427,'response to propan-1-ol','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a propan-1-ol stimulus.','2013-10-27','NSRP'),(38376,1901428,'regulation of syringal lignin biosynthetic process','P','Any process that modulates the frequency, rate or extent of syringal lignin biosynthetic process.','2013-10-27','NSRP'),(38377,1901429,'negative regulation of syringal lignin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of syringal lignin biosynthetic process.','2013-10-27','NSRP'),(38378,1901430,'positive regulation of syringal lignin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of syringal lignin biosynthetic process.','2013-10-27','NSRP'),(38379,1901431,'regulation of response to cycloalkane','P','Any process that modulates the frequency, rate or extent of response to cycloalkane.','2013-10-27','NSRP'),(38380,1901432,'negative regulation of response to cycloalkane','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to cycloalkane.','2013-10-27','NSRP'),(38381,1901433,'positive regulation of response to cycloalkane','P','Any process that activates or increases the frequency, rate or extent of response to cycloalkane.','2013-10-27','NSRP'),(38382,1901434,'regulation of toluene catabolic process','P','Any process that modulates the frequency, rate or extent of toluene catabolic process.','2013-10-27','NSRP'),(38383,1901435,'negative regulation of toluene catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of toluene catabolic process.','2013-10-27','NSRP'),(38384,1901436,'positive regulation of toluene catabolic process','P','Any process that activates or increases the frequency, rate or extent of toluene catabolic process.','2013-10-27','NSRP'),(38385,1901437,'regulation of toluene metabolic process','P','Any process that modulates the frequency, rate or extent of toluene metabolic process.','2013-10-27','NSRP'),(38386,1901438,'negative regulation of toluene metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of toluene metabolic process.','2013-10-27','NSRP'),(38387,1901439,'positive regulation of toluene metabolic process','P','Any process that activates or increases the frequency, rate or extent of toluene metabolic process.','2013-10-27','NSRP'),(38388,1901440,'poly(hydroxyalkanoate) metabolic process','P','The chemical reactions and pathways involving poly(hydroxyalkanoate).','2013-10-27','NSRP'),(38389,1901441,'poly(hydroxyalkanoate) biosynthetic process','P','The chemical reactions and pathways resulting in the formation of poly(hydroxyalkanoate).','2013-10-27','NSRP'),(38390,1901442,'regulation of response to furfural','P','Any process that modulates the frequency, rate or extent of response to furfural.','2013-10-27','NSRP'),(38391,1901443,'negative regulation of response to furfural','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to furfural.','2013-10-27','NSRP'),(38392,1901444,'positive regulation of response to furfural','P','Any process that activates or increases the frequency, rate or extent of response to furfural.','2013-10-27','NSRP'),(38393,1901445,'regulation of response to propan-1-ol','P','Any process that modulates the frequency, rate or extent of response to propan-1-ol.','2013-10-27','NSRP'),(38394,1901446,'negative regulation of response to propan-1-ol','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to propan-1-ol.','2013-10-27','NSRP'),(38395,1901447,'positive regulation of response to propan-1-ol','P','Any process that activates or increases the frequency, rate or extent of response to propan-1-ol.','2013-10-27','NSRP'),(38396,1901448,'regulation of response to butan-1-ol','P','Any process that modulates the frequency, rate or extent of response to butan-1-ol.','2013-10-27','NSRP'),(38397,1901449,'negative regulation of response to butan-1-ol','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to butan-1-ol.','2013-10-27','NSRP'),(38398,1901450,'positive regulation of response to butan-1-ol','P','Any process that activates or increases the frequency, rate or extent of response to butan-1-ol.','2013-10-27','NSRP'),(38399,1901451,'regulation of response to benzene','P','Any process that modulates the frequency, rate or extent of response to benzene.','2013-10-27','NSRP'),(38400,1901452,'negative regulation of response to benzene','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to benzene.','2013-10-27','NSRP'),(38401,1901453,'positive regulation of response to benzene','P','Any process that activates or increases the frequency, rate or extent of response to benzene.','2013-10-27','NSRP'),(38402,1901454,'regulation of response to toluene','P','Any process that modulates the frequency, rate or extent of response to toluene.','2013-10-27','NSRP'),(38403,1901455,'negative regulation of response to toluene','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to toluene.','2013-10-27','NSRP'),(38404,1901456,'positive regulation of response to toluene','P','Any process that activates or increases the frequency, rate or extent of response to toluene.','2013-10-27','NSRP'),(38405,1901457,'regulation of response to acetate','P','Any process that modulates the frequency, rate or extent of response to acetate.','2013-10-27','NSRP'),(38406,1901458,'negative regulation of response to acetate','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to acetate.','2013-10-27','NSRP'),(38407,1901459,'positive regulation of response to acetate','P','Any process that activates or increases the frequency, rate or extent of response to acetate.','2013-10-27','NSRP'),(38408,1901460,'regulation of response to formic acid','P','Any process that modulates the frequency, rate or extent of response to formic acid.','2013-10-27','NSRP'),(38409,1901461,'negative regulation of response to formic acid','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to formic acid.','2013-10-27','NSRP'),(38410,1901462,'positive regulation of response to formic acid','P','Any process that activates or increases the frequency, rate or extent of response to formic acid.','2013-10-27','NSRP'),(38411,1901463,'regulation of tetrapyrrole biosynthetic process','P','Any process that modulates the frequency, rate or extent of tetrapyrrole biosynthetic process.','2013-10-27','NSRP'),(38412,1901464,'negative regulation of tetrapyrrole biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of tetrapyrrole biosynthetic process.','2013-10-27','NSRP'),(38413,1901465,'positive regulation of tetrapyrrole biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of tetrapyrrole biosynthetic process.','2013-10-27','NSRP'),(38414,1901466,'regulation of ferulate catabolic process','P','Any process that modulates the frequency, rate or extent of ferulate catabolic process.','2013-10-27','NSRP'),(38415,1901467,'negative regulation of ferulate catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of ferulate catabolic process.','2013-10-27','NSRP'),(38416,1901468,'positive regulation of ferulate catabolic process','P','Any process that activates or increases the frequency, rate or extent of ferulate catabolic process.','2013-10-27','NSRP'),(38417,1901469,'regulation of syringal lignin catabolic process','P','Any process that modulates the frequency, rate or extent of syringal lignin catabolic process.','2013-10-27','NSRP'),(38418,1901470,'negative regulation of syringal lignin catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of syringal lignin catabolic process.','2013-10-27','NSRP'),(38419,1901471,'positive regulation of syringal lignin catabolic process','P','Any process that activates or increases the frequency, rate or extent of syringal lignin catabolic process.','2013-10-27','NSRP'),(38420,1901472,'regulation of Golgi calcium ion export','P','Any process that modulates the frequency, rate or extent of Golgi calcium ion export.','2013-10-27','NSRP'),(38421,1901474,'azole transmembrane transporter activity','F','Catalysis of the transfer of azole from one side of the membrane to the other.','2013-10-27','NSRP'),(38422,1901475,'pyruvate transmembrane transport','P','The directed movement of pyruvate across a membrane.','2013-10-27','NSRP'),(38423,1901476,'carbohydrate transporter activity','F','Enables the directed movement of carbohydrate into, out of or within a cell, or between cells.','2013-10-27','NSRP'),(38424,1901477,'benomyl transmembrane transport','P','The directed movement of benomyl across a membrane.','2013-10-27','NSRP'),(38425,1901478,'aminotriazole transmembrane transporter activity','F','Catalysis of the transfer of amitrole from one side of the membrane to the other.','2013-10-27','NSRP'),(38426,1901479,'benomyl transmembrane transporter activity','F','Catalysis of the transfer of benomyl from one side of the membrane to the other.','2013-10-27','NSRP'),(38427,1901480,'oleate transporter activity','F','Enables the directed movement of oleate into, out of or within a cell, or between cells.','2013-10-27','NSRP'),(38428,1901481,'L-glutamate import involved in cellular response to nitrogen starvation','P','Any L-glutamate import that is involved in cellular response to nitrogen starvation.','2013-10-27','NSRP'),(38429,1901482,'L-lysine import involved in cellular response to nitrogen starvation','P','Any L-lysine import that is involved in cellular response to nitrogen starvation.','2013-10-27','NSRP'),(38430,1901483,'regulation of transcription factor catabolic process','P','Any process that modulates the frequency, rate or extent of transcription factor catabolic process.','2013-10-27','NSRP'),(38431,1901484,'negative regulation of transcription factor catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of transcription factor catabolic process.','2013-10-27','NSRP'),(38432,1901485,'positive regulation of transcription factor catabolic process','P','Any process that activates or increases the frequency, rate or extent of transcription factor catabolic process.','2013-10-27','NSRP'),(38433,1901486,'negative regulation of SREBP signaling pathway by positive regulation of transcription factor catabolic process','P','Positive regulation of transcription factor catabolism that results in negative regulation of the SREBP signaling pathway.','2013-10-27','NSRP'),(38434,1901487,'negative regulation of SREBP signaling pathway by positive regulation of transcription factor catabolic process in response to increased oxygen levels','P','Positive regulation of transcription factor catabolism in response to increased oxygen levels, which results in negative regulation of the SREBP signaling pathway.','2013-10-27','NSRP'),(38435,1901488,'positive regulation of SREBP signaling pathway by negative regulation of transcription factor catabolic process','P','Negative regulation of transcription factor catabolism that results in positive regulation of the SREBP signaling pathway.','2013-10-27','NSRP'),(38436,1901489,'positive regulation of SREBP signaling pathway by negative regulation of transcription factor catabolic process in response to decreased oxygen levels','P','Negative regulation of transcription factor catabolism in response to decreased oxygen levels, which results in positive regulation of the SREBP signaling pathway.','2013-10-27','NSRP'),(38437,1901490,'regulation of lymphangiogenesis','P','Any process that modulates the frequency, rate or extent of lymphangiogenesis.','2013-10-27','NSRP'),(38438,1901491,'negative regulation of lymphangiogenesis','P','Any process that stops, prevents or reduces the frequency, rate or extent of lymphangiogenesis.','2013-10-27','NSRP'),(38439,1901492,'positive regulation of lymphangiogenesis','P','Any process that activates or increases the frequency, rate or extent of lymphangiogenesis.','2013-10-27','NSRP'),(38440,1901493,'response to decalin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a decalin stimulus.','2013-10-27','NSRP'),(38441,1901494,'regulation of cysteine metabolic process','P','Any process that modulates the frequency, rate or extent of cysteine metabolic process.','2013-10-27','NSRP'),(38442,1901495,'negative regulation of cysteine metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of cysteine metabolic process.','2013-10-27','NSRP'),(38443,1901496,'positive regulation of cysteine metabolic process','P','Any process that activates or increases the frequency, rate or extent of cysteine metabolic process.','2013-10-27','NSRP'),(38444,1901497,'response to diphenyl ether','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a diphenyl ether stimulus.','2013-10-27','NSRP'),(38445,1901498,'response to tetralin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tetralin stimulus.','2013-10-27','NSRP'),(38446,1901499,'response to hexane','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hexane stimulus.','2013-10-27','NSRP'),(38447,1901500,'response to p-xylene','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a p-xylene stimulus.','2013-10-27','NSRP'),(38448,1901501,'response to xylene','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a xylene stimulus.','2013-10-27','NSRP'),(38449,1901502,'ether catabolic process','P','The chemical reactions and pathways resulting in the breakdown of ether.','2013-10-27','NSRP'),(38450,1901503,'ether biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ether.','2013-10-27','NSRP'),(38451,1901504,'triazole transport','P','The directed movement of a triazole into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38452,1901505,'carbohydrate derivative transporter activity','F','Enables the directed movement of carbohydrate derivative into, out of or within a cell, or between cells.','2013-10-27','NSRP'),(38453,1901506,'regulation of acylglycerol transport','P','Any process that modulates the frequency, rate or extent of acylglycerol transport.','2013-10-27','NSRP'),(38454,1901507,'negative regulation of acylglycerol transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of acylglycerol transport.','2013-10-27','NSRP'),(38455,1901508,'positive regulation of acylglycerol transport','P','Any process that activates or increases the frequency, rate or extent of acylglycerol transport.','2013-10-27','NSRP'),(38456,1901509,'regulation of endothelial tube morphogenesis','P','Any process that modulates the frequency, rate or extent of endothelial tube morphogenesis.','2013-10-27','NSRP'),(38457,1901510,'(-)-microperfuranone metabolic process','P','The chemical reactions and pathways involving (-)-microperfuranone.','2013-10-27','NSRP'),(38458,1901511,'(-)-microperfuranone catabolic process','P','The chemical reactions and pathways resulting in the breakdown of (-)-microperfuranone.','2013-10-27','NSRP'),(38459,1901512,'(-)-microperfuranone biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (-)-microperfuranone.','2013-10-27','NSRP'),(38460,1901513,'lipo-chitin oligosaccharide transmembrane transporter activity','F','Catalysis of the transfer of lipo-chitin oligosaccharide from one side of the membrane to the other.','2013-10-27','NSRP'),(38461,1901514,'lipo-chitin oligosaccharide transmembrane-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + lipo-chitin oligosaccharide(in) = ADP + phosphate + lipo-chitin oligosaccharide(out).','2013-10-27','NSRP'),(38462,1901515,'poly-beta-1,6-N-acetyl-D-glucosamine transmembrane transporter activity','F','Catalysis of the transfer of poly-beta-1,6-N-acetyl-D-glucosamine from one side of the membrane to the other.','2013-10-27','NSRP'),(38463,1901516,'aspyridone A metabolic process','P','The chemical reactions and pathways involving aspyridone A.','2013-10-27','NSRP'),(38464,1901517,'aspyridone A catabolic process','P','The chemical reactions and pathways resulting in the breakdown of aspyridone A.','2013-10-27','NSRP'),(38465,1901518,'aspyridone A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of aspyridone A.','2013-10-27','NSRP'),(38466,1901519,'aspyridone B metabolic process','P','The chemical reactions and pathways involving aspyridone B.','2013-10-27','NSRP'),(38467,1901520,'aspyridone B catabolic process','P','The chemical reactions and pathways resulting in the breakdown of aspyridone B.','2013-10-27','NSRP'),(38468,1901521,'aspyridone B biosynthetic process','P','The chemical reactions and pathways resulting in the formation of aspyridone B.','2013-10-27','NSRP'),(38469,1901522,'positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus','P','Any positive regulation of transcription from RNA polymerase II promoter that is involved in cellular response to chemical stimulus.','2013-10-27','NSRP'),(38470,1901523,'icosanoid catabolic process','P','The chemical reactions and pathways resulting in the breakdown of icosanoid.','2013-10-27','NSRP'),(38471,1901524,'regulation of macromitophagy','P','Any process that modulates the frequency, rate or extent of macromitophagy.','2013-10-27','NSRP'),(38472,1901525,'negative regulation of macromitophagy','P','Any process that stops, prevents or reduces the frequency, rate or extent of macromitophagy.','2013-10-27','NSRP'),(38473,1901526,'positive regulation of macromitophagy','P','Any process that activates or increases the frequency, rate or extent of macromitophagy.','2013-10-27','NSRP'),(38474,1901527,'abscisic acid mediated signaling pathway involved in stomatal movement','P','Any abscisic acid mediated signaling pathway that is involved in stomatal movement.','2013-10-27','NSRP'),(38475,1901528,'hydrogen peroxide mediated signaling pathway involved in stomatal movement','P','Any hydrogen peroxide mediated signaling pathway that is involved in stomatal movement.','2013-10-27','NSRP'),(38476,1901529,'positive regulation of anion channel activity','P','Any process that activates or increases the frequency, rate or extent of anion channel activity.','2013-10-27','NSRP'),(38477,1901530,'response to hypochlorite','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hypochlorite stimulus.','2013-10-27','NSRP'),(38478,1901531,'hypochlorite binding','F','Interacting selectively and non-covalently with hypochlorite.','2013-10-27','NSRP'),(38479,1901532,'regulation of hematopoietic progenitor cell differentiation','P','Any process that modulates the frequency, rate or extent of hematopoietic progenitor cell differentiation.','2013-10-27','NSRP'),(38480,1901533,'negative regulation of hematopoietic progenitor cell differentiation','P','Any process that stops, prevents or reduces the frequency, rate or extent of hematopoietic progenitor cell differentiation.','2013-10-27','NSRP'),(38481,1901534,'positive regulation of hematopoietic progenitor cell differentiation','P','Any process that activates or increases the frequency, rate or extent of hematopoietic progenitor cell differentiation.','2013-10-27','NSRP'),(38482,1901535,'regulation of DNA demethylation','P','Any process that modulates the frequency, rate or extent of DNA demethylation.','2013-10-27','NSRP'),(38483,1901536,'negative regulation of DNA demethylation','P','Any process that stops, prevents or reduces the frequency, rate or extent of DNA demethylation.','2013-10-27','NSRP'),(38484,1901537,'positive regulation of DNA demethylation','P','Any process that activates or increases the frequency, rate or extent of DNA demethylation.','2013-10-27','NSRP'),(38485,1901538,'changes to DNA methylation involved in embryo development','P','The addition or removal of methyl groups to DNA that contributes to the epigenetic regulation of embryonic gene expression.','2013-10-27','NSRP'),(38486,1901539,'ent-pimara-8(14),15-diene metabolic process','P','The chemical reactions and pathways involving ent-pimara-8(14),15-diene.','2013-10-27','NSRP'),(38487,1901540,'ent-pimara-8(14),15-diene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of ent-pimara-8(14),15-diene.','2013-10-27','NSRP'),(38488,1901541,'ent-pimara-8(14),15-diene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ent-pimara-8(14),15-diene.','2013-10-27','NSRP'),(38489,1901542,'regulation of ent-pimara-8(14),15-diene biosynthetic process','P','Any process that modulates the frequency, rate or extent of ent-pimara-8(14),15-diene biosynthetic process.','2013-10-27','NSRP'),(38490,1901543,'negative regulation of ent-pimara-8(14),15-diene biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of ent-pimara-8(14),15-diene biosynthetic process.','2013-10-27','NSRP'),(38491,1901544,'positive regulation of ent-pimara-8(14),15-diene biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of ent-pimara-8(14),15-diene biosynthetic process.','2013-10-27','NSRP'),(38492,1901545,'response to raffinose','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a raffinose stimulus.','2013-10-27','NSRP'),(38493,1901546,'regulation of synaptic vesicle lumen acidification','P','Any process that modulates the frequency, rate or extent of synaptic vesicle lumen acidification.','2013-10-27','NSRP'),(38494,1901547,'negative regulation of synaptic vesicle lumen acidification','P','Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle lumen acidification.','2013-10-27','NSRP'),(38495,1901548,'positive regulation of synaptic vesicle lumen acidification','P','Any process that activates or increases the frequency, rate or extent of synaptic vesicle lumen acidification.','2013-10-27','NSRP'),(38496,1901549,'malonic acid uptake transmembrane transporter activity','F','Catalysis of the transfer of malonic acid from the outside of a cell to the inside across a membrane.','2013-10-27','NSRP'),(38497,1901550,'regulation of endothelial cell development','P','Any process that modulates the frequency, rate or extent of endothelial cell development.','2013-10-27','NSRP'),(38498,1901551,'negative regulation of endothelial cell development','P','Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell development.','2013-10-27','NSRP'),(38499,1901552,'positive regulation of endothelial cell development','P','Any process that activates or increases the frequency, rate or extent of endothelial cell development.','2013-10-27','NSRP'),(38500,1901553,'malonic acid transmembrane transport','P','The directed movement of malonic acid across a membrane.','2013-10-27','NSRP'),(38501,1901554,'response to paracetamol','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a paracetamol stimulus.','2013-10-27','NSRP'),(38502,1901555,'response to paclitaxel','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a paclitaxel stimulus.','2013-10-27','NSRP'),(38503,1901556,'response to candesartan','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a candesartan stimulus.','2013-10-27','NSRP'),(38504,1901557,'response to fenofibrate','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fenofibrate stimulus.','2013-10-27','NSRP'),(38505,1901558,'response to metformin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metformin stimulus.','2013-10-27','NSRP'),(38506,1901559,'response to ribavirin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ribavirin stimulus.','2013-10-27','NSRP'),(38507,1901560,'response to purvalanol A','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a purvalanol A stimulus.','2013-10-27','NSRP'),(38508,1901561,'response to benomyl','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a benomyl stimulus.','2013-10-27','NSRP'),(38509,1901562,'response to paraquat','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a paraquat stimulus.','2013-10-27','NSRP'),(38510,1901563,'response to camptothecin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a camptothecin stimulus.','2013-10-27','NSRP'),(38511,1901564,'organonitrogen compound metabolic process','P','The chemical reactions and pathways involving organonitrogen compound.','2013-10-27','NSRP'),(38512,1901565,'organonitrogen compound catabolic process','P','The chemical reactions and pathways resulting in the breakdown of organonitrogen compound.','2013-10-27','NSRP'),(38513,1901566,'organonitrogen compound biosynthetic process','P','The chemical reactions and pathways resulting in the formation of organonitrogen compound.','2013-10-27','NSRP'),(38514,1901567,'fatty acid derivative binding','F','Interacting selectively and non-covalently with fatty acid derivative.','2013-10-27','NSRP'),(38515,1901568,'fatty acid derivative metabolic process','P','The chemical reactions and pathways involving fatty acid derivative.','2013-10-27','NSRP'),(38516,1901569,'fatty acid derivative catabolic process','P','The chemical reactions and pathways resulting in the breakdown of fatty acid derivative.','2013-10-27','NSRP'),(38517,1901570,'fatty acid derivative biosynthetic process','P','The chemical reactions and pathways resulting in the formation of fatty acid derivative.','2013-10-27','NSRP'),(38518,1901571,'fatty acid derivative transport','P','The directed movement of a fatty acid derivative into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38519,1901572,'chemical substance metabolic process','P','OBSOLETE. The chemical reactions and pathways involving chemical substance.','2013-10-27','NSRP'),(38520,1901573,'chemical substance catabolic process','P','OBSOLETE. The chemical reactions and pathways resulting in the breakdown of chemical substance.','2013-10-27','NSRP'),(38521,1901574,'chemical substance biosynthetic process','P','OBSOLETE. The chemical reactions and pathways resulting in the formation of chemical substance.','2013-10-27','NSRP'),(38522,1901575,'organic substance catabolic process','P','The chemical reactions and pathways resulting in the breakdown of an organic substance, any molecular entity containing carbon.','2013-10-27','NSRP'),(38523,1901576,'organic substance biosynthetic process','P','The chemical reactions and pathways resulting in the formation of an organic substance, any molecular entity containing carbon.','2013-10-27','NSRP'),(38524,1901577,'regulation of alkane biosynthetic process','P','Any process that modulates the frequency, rate or extent of alkane biosynthetic process.','2013-10-27','NSRP'),(38525,1901578,'negative regulation of alkane biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of alkane biosynthetic process.','2013-10-27','NSRP'),(38526,1901579,'positive regulation of alkane biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of alkane biosynthetic process.','2013-10-27','NSRP'),(38527,1901580,'regulation of telomeric RNA transcription from RNA pol II promoter','P','Any process that modulates the frequency, rate or extent of telomeric RNA transcription from RNA pol II promoter.','2013-10-27','NSRP'),(38528,1901581,'negative regulation of telomeric RNA transcription from RNA pol II promoter','P','Any process that stops, prevents or reduces the frequency, rate or extent of telomeric RNA transcription from RNA pol II promoter.','2013-10-27','NSRP'),(38529,1901582,'positive regulation of telomeric RNA transcription from RNA pol II promoter','P','Any process that activates or increases the frequency, rate or extent of telomeric RNA transcription from RNA pol II promoter.','2013-10-27','NSRP'),(38530,1901583,'tetrapeptide transmembrane transport','P','The directed movement of tetrapeptide across a membrane.','2013-10-27','NSRP'),(38531,1901584,'tetrapeptide transmembrane transporter activity','F','Catalysis of the transfer of tetrapeptide from one side of the membrane to the other.','2013-10-27','NSRP'),(38532,1901585,'regulation of acid-sensing ion channel activity','P','Any process that modulates the frequency, rate or extent of acid-sensing ion channel activity.','2013-10-27','NSRP'),(38533,1901586,'negative regulation of acid-sensing ion channel activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of acid-sensing ion channel activity.','2013-10-27','NSRP'),(38534,1901587,'positive regulation of acid-sensing ion channel activity','P','Any process that activates or increases the frequency, rate or extent of acid-sensing ion channel activity.','2013-10-27','NSRP'),(38535,1901588,'dendritic microtubule','C','Any microtubule in a dendrite, a neuron projection.','2013-10-27','NSRP'),(38536,1901589,'axon microtubule bundle','C','An arrangement of closely apposed microtubules running parallel to each other in the axon hillock and initial segment.','2013-10-27','NSRP'),(38537,1901591,'regulation of double-strand break repair via break-induced replication','P','Any process that modulates the frequency, rate or extent of double-strand break repair via break-induced replication.','2013-10-27','NSRP'),(38538,1901592,'negative regulation of double-strand break repair via break-induced replication','P','Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair via break-induced replication.','2013-10-27','NSRP'),(38539,1901593,'response to GW 7647','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a GW 7647 stimulus.','2013-10-27','NSRP'),(38540,1901594,'response to capsazepine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a capsazepine stimulus.','2013-10-27','NSRP'),(38541,1901595,'response to hesperadin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hesperadin stimulus.','2013-10-27','NSRP'),(38542,1901596,'response to reversine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reversine stimulus.','2013-10-27','NSRP'),(38543,1901597,'response to carbendazim','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbendazim stimulus.','2013-10-27','NSRP'),(38544,1901598,'(-)-pinoresinol metabolic process','P','The chemical reactions and pathways involving (-)-pinoresinol.','2013-10-27','NSRP'),(38545,1901599,'(-)-pinoresinol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (-)-pinoresinol.','2013-10-27','NSRP'),(38546,1901600,'strigolactone metabolic process','P','The chemical reactions and pathways involving strigolactone.','2013-10-27','NSRP'),(38547,1901601,'strigolactone biosynthetic process','P','The chemical reactions and pathways resulting in the formation of strigolactone.','2013-10-27','NSRP'),(38548,1901602,'dethiobiotin binding','F','Interacting selectively and non-covalently with dethiobiotin.','2013-10-27','NSRP'),(38549,1901603,'biotin transmembrane transporter activity','F','Catalysis of the transfer of biotin from one side of the membrane to the other.','2013-10-27','NSRP'),(38550,1901604,'dethiobiotin transmembrane transporter activity','F','Catalysis of the transfer of dethiobiotin from one side of the membrane to the other.','2013-10-27','NSRP'),(38551,1901605,'alpha-amino acid metabolic process','P','The chemical reactions and pathways involving an alpha-amino acid.','2013-10-27','NSRP'),(38552,1901606,'alpha-amino acid catabolic process','P','The chemical reactions and pathways resulting in the breakdown of an alpha-amino acid.','2013-10-27','NSRP'),(38553,1901607,'alpha-amino acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of an alpha-amino acid.','2013-10-27','NSRP'),(38554,1901608,'regulation of vesicle transport along microtubule','P','Any process that modulates the frequency, rate or extent of vesicle transport along microtubule.','2013-10-27','NSRP'),(38555,1901609,'negative regulation of vesicle transport along microtubule','P','Any process that stops, prevents or reduces the frequency, rate or extent of vesicle transport along microtubule.','2013-10-27','NSRP'),(38556,1901610,'positive regulation of vesicle transport along microtubule','P','Any process that activates or increases the frequency, rate or extent of vesicle transport along microtubule.','2013-10-27','NSRP'),(38557,1901611,'phosphatidylglycerol binding','F','Interacting selectively and non-covalently with phosphatidylglycerol.','2013-10-27','NSRP'),(38558,1901612,'cardiolipin binding','F','Interacting selectively and non-covalently with cardiolipin.','2013-10-27','NSRP'),(38559,1901613,'negative regulation of terminal button organization','P','Any process that stops, prevents or reduces the frequency, rate or extent of terminal button organization.','2013-10-27','NSRP'),(38560,1901614,'positive regulation of terminal button organization','P','Any process that activates or increases the frequency, rate or extent of terminal button organization.','2013-10-27','NSRP'),(38561,1901615,'organic hydroxy compound metabolic process','P','The chemical reactions and pathways involving organic hydroxy compound.','2013-10-27','NSRP'),(38562,1901616,'organic hydroxy compound catabolic process','P','The chemical reactions and pathways resulting in the breakdown of organic hydroxy compound.','2013-10-27','NSRP'),(38563,1901617,'organic hydroxy compound biosynthetic process','P','The chemical reactions and pathways resulting in the formation of organic hydroxy compound.','2013-10-27','NSRP'),(38564,1901618,'organic hydroxy compound transmembrane transporter activity','F','Catalysis of the transfer of organic hydroxy compound from one side of the membrane to the other.','2013-10-27','NSRP'),(38565,1901619,'tRNA methylation in response to nitrogen starvation','P','The posttranscriptional addition of methyl groups to specific residues in a tRNA molecule as a result of deprivation of nitrogen.','2013-10-27','NSRP'),(38566,1901620,'regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning','P','Any process that modulates the frequency, rate or extent of smoothened signaling pathway involved in dorsal/ventral neural tube patterning.','2013-10-27','NSRP'),(38567,1901621,'negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning','P','Any process that stops, prevents or reduces the frequency, rate or extent of smoothened signaling pathway involved in dorsal/ventral neural tube patterning.','2013-10-27','NSRP'),(38568,1901622,'positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning','P','Any process that activates or increases the frequency, rate or extent of smoothened signaling pathway involved in dorsal/ventral neural tube patterning.','2013-10-27','NSRP'),(38569,1901623,'regulation of lymphocyte chemotaxis','P','Any process that modulates the frequency, rate or extent of lymphocyte chemotaxis.','2013-10-27','NSRP'),(38570,1901624,'negative regulation of lymphocyte chemotaxis','P','Any process that stops, prevents or reduces the frequency, rate or extent of lymphocyte chemotaxis.','2013-10-27','NSRP'),(38571,1901625,'cellular response to ergosterol','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ergosterol stimulus.','2013-10-27','NSRP'),(38572,1901626,'regulation of postsynaptic membrane organization','P','Any process that modulates the frequency, rate or extent of postsynaptic membrane organization.','2013-10-27','NSRP'),(38573,1901627,'negative regulation of postsynaptic membrane organization','P','Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic membrane organization.','2013-10-27','NSRP'),(38574,1901628,'positive regulation of postsynaptic membrane organization','P','Any process that activates or increases the frequency, rate or extent of postsynaptic membrane organization.','2013-10-27','NSRP'),(38575,1901629,'regulation of presynaptic membrane organization','P','Any process that modulates the frequency, rate or extent of presynaptic membrane organization.','2013-10-27','NSRP'),(38576,1901630,'negative regulation of presynaptic membrane organization','P','Any process that stops, prevents or reduces the frequency, rate or extent of presynaptic membrane organization.','2013-10-27','NSRP'),(38577,1901631,'positive regulation of presynaptic membrane organization','P','Any process that activates or increases the frequency, rate or extent of presynaptic membrane organization.','2013-10-27','NSRP'),(38578,1901632,'regulation of synaptic vesicle membrane organization','P','Any process that modulates the frequency, rate or extent of synaptic vesicle membrane organization.','2013-10-27','NSRP'),(38579,1901633,'negative regulation of synaptic vesicle membrane organization','P','Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle membrane organization.','2013-10-27','NSRP'),(38580,1901634,'positive regulation of synaptic vesicle membrane organization','P','Any process that activates or increases the frequency, rate or extent of synaptic vesicle membrane organization.','2013-10-27','NSRP'),(38581,1901635,'regulation of maintenance of presynaptic active zone structure','P','OBSOLETE. Any process that modulates the frequency, rate or extent of maintenance of presynaptic active zone structure.','2013-10-27','NSRP'),(38582,1901636,'negative regulation of maintenance of presynaptic active zone structure','P','OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of presynaptic active zone structure.','2013-10-27','NSRP'),(38583,1901637,'positive regulation of maintenance of presynaptic active zone structure','P','OBSOLETE. Any process that activates or increases the frequency, rate or extent of maintenance of presynaptic active zone structure.','2013-10-27','NSRP'),(38584,1901638,'copper ion import into ascospore-type prospore','P','OBSOLETE. Any copper ion import that takes place in ascospore-type prospore.','2013-10-27','NSRP'),(38585,1901639,'XDP catabolic process','P','The chemical reactions and pathways resulting in the breakdown of XDP.','2013-10-27','NSRP'),(38586,1901640,'XTP binding','F','Interacting selectively and non-covalently with XTP.','2013-10-27','NSRP'),(38587,1901641,'ITP binding','F','Interacting selectively and non-covalently with ITP.','2013-10-27','NSRP'),(38588,1901642,'nucleoside transmembrane transport','P','The directed movement of nucleoside across a membrane.','2013-10-27','NSRP'),(38589,1901643,'regulation of tRNA methylation in response to nitrogen starvation','P','Any process that modulates the frequency, rate or extent of tRNA methylation in response to nitrogen starvation.','2013-10-27','NSRP'),(38590,1901644,'positive regulation of tRNA methylation in response to nitrogen starvation','P','Any process that activates or increases the frequency, rate or extent of tRNA methylation in response to nitrogen starvation.','2013-10-27','NSRP'),(38591,1901645,'regulation of synoviocyte proliferation','P','Any process that modulates the frequency, rate or extent of synoviocyte proliferation.','2013-10-27','NSRP'),(38592,1901646,'negative regulation of synoviocyte proliferation','P','Any process that stops, prevents or reduces the frequency, rate or extent of synoviocyte proliferation.','2013-10-27','NSRP'),(38593,1901647,'positive regulation of synoviocyte proliferation','P','Any process that activates or increases the frequency, rate or extent of synoviocyte proliferation.','2013-10-27','NSRP'),(38594,1901648,'regulation of actomyosin contractile ring localization','P','Any process that modulates the frequency, rate or extent of actomyosin contractile ring localization.','2013-10-27','NSRP'),(38595,1901649,'negative regulation of actomyosin contractile ring localization','P','Any process that stops, prevents or reduces the frequency, rate or extent of actomyosin contractile ring localization.','2013-10-27','NSRP'),(38596,1901650,'positive regulation of actomyosin contractile ring localization','P','Any process that activates or increases the frequency, rate or extent of actomyosin contractile ring localization.','2013-10-27','NSRP'),(38597,1901651,'regulation of mitotic chromosome decondensation','P','Any process that modulates the frequency, rate or extent of mitotic chromosome decondensation.','2013-10-27','NSRP'),(38598,1901652,'response to peptide','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide stimulus.','2013-10-27','NSRP'),(38599,1901653,'cellular response to peptide','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide stimulus.','2013-10-27','NSRP'),(38600,1901654,'response to ketone','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ketone stimulus.','2013-10-27','NSRP'),(38601,1901655,'cellular response to ketone','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ketone stimulus.','2013-10-27','NSRP'),(38602,1901656,'glycoside transport','P','The directed movement of a glycoside into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38603,1901657,'glycosyl compound metabolic process','P','The chemical reactions and pathways involving glycosyl compound.','2013-10-27','NSRP'),(38604,1901658,'glycosyl compound catabolic process','P','The chemical reactions and pathways resulting in the breakdown of glycosyl compound.','2013-10-27','NSRP'),(38605,1901659,'glycosyl compound biosynthetic process','P','The chemical reactions and pathways resulting in the formation of glycosyl compound.','2013-10-27','NSRP'),(38606,1901660,'calcium ion export','P','The directed movement of calcium ion out of a cell or organelle.','2013-10-27','NSRP'),(38607,1901661,'quinone metabolic process','P','The chemical reactions and pathways involving quinone.','2013-10-27','NSRP'),(38608,1901662,'quinone catabolic process','P','The chemical reactions and pathways resulting in the breakdown of quinone.','2013-10-27','NSRP'),(38609,1901663,'quinone biosynthetic process','P','The chemical reactions and pathways resulting in the formation of quinone.','2013-10-27','NSRP'),(38610,1901664,'regulation of NAD+ ADP-ribosyltransferase activity','P','Any process that modulates the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity.','2013-10-27','NSRP'),(38611,1901665,'negative regulation of NAD+ ADP-ribosyltransferase activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity.','2013-10-27','NSRP'),(38612,1901666,'positive regulation of NAD+ ADP-ribosyltransferase activity','P','Any process that activates or increases the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity.','2013-10-27','NSRP'),(38613,1901667,'negative regulation of satellite cell activation involved in skeletal muscle regeneration','P','Any process that stops, prevents or reduces the frequency, rate or extent of satellite cell activation involved in skeletal muscle regeneration.','2013-10-27','NSRP'),(38614,1901668,'regulation of superoxide dismutase activity','P','Any process that modulates the frequency, rate or extent of superoxide dismutase activity.','2013-10-27','NSRP'),(38615,1901670,'negative regulation of superoxide dismutase activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of superoxide dismutase activity.','2013-10-27','NSRP'),(38616,1901671,'positive regulation of superoxide dismutase activity','P','Any process that activates or increases the frequency, rate or extent of superoxide dismutase activity.','2013-10-27','NSRP'),(38617,1901672,'positive regulation of systemic acquired resistance','P','Any process that activates or increases the frequency, rate or extent of systemic acquired resistance.','2013-10-27','NSRP'),(38618,1901673,'regulation of spindle assembly involved in mitosis','P','Any process that modulates the frequency, rate or extent of spindle assembly involved in mitosis.','2013-10-27','NSRP'),(38619,1901674,'regulation of histone H3-K27 acetylation','P','Any process that modulates the frequency, rate or extent of histone H3-K27 acetylation.','2013-10-27','NSRP'),(38620,1901675,'negative regulation of histone H3-K27 acetylation','P','Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K27 acetylation.','2013-10-27','NSRP'),(38621,1901676,'positive regulation of histone H3-K27 acetylation','P','Any process that activates or increases the frequency, rate or extent of histone H3-K27 acetylation.','2013-10-27','NSRP'),(38622,1901677,'phosphate transmembrane transporter activity','F','Catalysis of the transfer of phosphate from one side of the membrane to the other.','2013-10-27','NSRP'),(38623,1901678,'iron coordination entity transport','P','The directed movement of an iron coordination entity into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38624,1901679,'nucleotide transmembrane transport','P','The directed movement of nucleotide across a membrane.','2013-10-27','NSRP'),(38625,1901680,'sulfur-containing amino acid secondary active transmembrane transporter activity','F','Catalysis of the transfer of sulfur-containing amino acid from one side of the membrane to the other, up its concentration gradient. The transporter binds the solute and undergoes a series of conformational changes. Transport works equally well in either direction and is driven by a chemiosmotic source of energy. Chemiosmotic sources of energy include uniport, symport or antiport.','2013-10-27','NSRP'),(38626,1901681,'sulfur compound binding','F','Interacting selectively and non-covalently with a sulfur compound.','2013-10-27','NSRP'),(38627,1901682,'sulfur compound transmembrane transporter activity','F','Catalysis of the transfer of a sulfur compound from one side of the membrane to the other.','2013-10-27','NSRP'),(38628,1901683,'arsenate ion transmembrane transporter activity','F','Catalysis of the transfer of an arsenate ion from one side of the membrane to the other.','2013-10-27','NSRP'),(38629,1901684,'arsenate ion transmembrane transport','P','The directed movement of arsenate ion across a membrane.','2013-10-27','NSRP'),(38630,1901685,'glutathione derivative metabolic process','P','The chemical reactions and pathways involving glutathione derivative.','2013-10-27','NSRP'),(38631,1901686,'glutathione derivative catabolic process','P','The chemical reactions and pathways resulting in the breakdown of glutathione derivative.','2013-10-27','NSRP'),(38632,1901687,'glutathione derivative biosynthetic process','P','The chemical reactions and pathways resulting in the formation of glutathione derivative.','2013-10-27','NSRP'),(38633,1901688,'pantothenate import','P','The directed movement of pantothenate into a cell or organelle.','2013-10-27','NSRP'),(38634,1901689,'biotin import','P','The directed movement of biotin into a cell or organelle.','2013-10-27','NSRP'),(38635,1901690,'dethiobiotin import','P','The directed movement of dethiobiotin into a cell or organelle.','2013-10-27','NSRP'),(38636,1901691,'proton binding','F','Interacting selectively and non-covalently with proton.','2013-10-27','NSRP'),(38637,1901692,'regulation of compound eye retinal cell apoptotic process','P','Any process that modulates the frequency, rate or extent of compound eye retinal cell apoptotic process.','2013-10-27','NSRP'),(38638,1901693,'negative regulation of compound eye retinal cell apoptotic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of compound eye retinal cell apoptotic process.','2013-10-27','NSRP'),(38639,1901694,'positive regulation of compound eye retinal cell apoptotic process','P','Any process that activates or increases the frequency, rate or extent of compound eye retinal cell apoptotic process.','2013-10-27','NSRP'),(38640,1901695,'tyramine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of tyramine.','2013-10-27','NSRP'),(38641,1901696,'cannabinoid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cannabinoid.','2013-10-27','NSRP'),(38642,1901697,'olivetolic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of olivetolic acid.','2013-10-27','NSRP'),(38643,1901698,'response to nitrogen compound','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrogen compound stimulus.','2013-10-27','NSRP'),(38644,1901699,'cellular response to nitrogen compound','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrogen compound stimulus.','2013-10-27','NSRP'),(38645,1901700,'response to oxygen-containing compound','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxygen-containing compound stimulus.','2013-10-27','NSRP'),(38646,1901701,'cellular response to oxygen-containing compound','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxygen-containing compound stimulus.','2013-10-27','NSRP'),(38647,1901702,'salt transmembrane transporter activity','F','Catalysis of the transfer of salt from one side of the membrane to the other.','2013-10-27','NSRP'),(38648,1901703,'protein localization involved in auxin polar transport','P','Any protein localization that is involved in auxin polar transport.','2013-10-27','NSRP'),(38649,1901704,'L-glutamine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of L-glutamine.','2013-10-27','NSRP'),(38650,1901705,'L-isoleucine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of L-isoleucine.','2013-10-27','NSRP'),(38651,1901706,'mesenchymal cell differentiation involved in bone development','P','The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of bone as it progresses from its formation to the mature state.','2013-10-27','NSRP'),(38652,1901707,'leptomycin B binding','F','Interacting selectively and non-covalently with leptomycin B.','2013-10-27','NSRP'),(38653,1901708,'(+)-3\'-hydroxylarreatricin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (+)-3\'-hydroxylarreatricin.','2013-10-27','NSRP'),(38654,1901709,'(+)-larreatricin metabolic process','P','The chemical reactions and pathways involving (+)-larreatricin.','2013-10-27','NSRP'),(38655,1901710,'regulation of homoserine biosynthetic process','P','Any process that modulates the frequency, rate or extent of homoserine biosynthetic process.','2013-10-27','NSRP'),(38656,1901711,'negative regulation of homoserine biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of homoserine biosynthetic process.','2013-10-27','NSRP'),(38657,1901712,'positive regulation of homoserine biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of homoserine biosynthetic process.','2013-10-27','NSRP'),(38658,1901713,'negative regulation of urea catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of urea catabolic process.','2013-10-27','NSRP'),(38659,1901714,'positive regulation of urea catabolic process','P','Any process that activates or increases the frequency, rate or extent of urea catabolic process.','2013-10-27','NSRP'),(38660,1901715,'regulation of gamma-aminobutyric acid catabolic process','P','Any process that modulates the frequency, rate or extent of gamma-aminobutyric acid catabolic process.','2013-10-27','NSRP'),(38661,1901716,'negative regulation of gamma-aminobutyric acid catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of gamma-aminobutyric acid catabolic process.','2013-10-27','NSRP'),(38662,1901717,'positive regulation of gamma-aminobutyric acid catabolic process','P','Any process that activates or increases the frequency, rate or extent of gamma-aminobutyric acid catabolic process.','2013-10-27','NSRP'),(38663,1901718,'regulation of dipeptide transmembrane transport by regulation of transcription from RNA polymerase II promoter','P','A regulation of transcription from RNA polymerase II promoter that results in regulation of dipeptide transmembrane transport.','2013-10-27','NSRP'),(38664,1901719,'regulation of NMS complex interaction involved in chromosome segregation','P','Any process that modulates the frequency, rate or extent of NMS complex interaction involved in chromosome segregation.','2013-10-27','NSRP'),(38665,1901720,'negative regulation of NMS complex interaction involved in chromosome segregation','P','Any process that stops, prevents or reduces the frequency, rate or extent of NMS complex interaction involved in chromosome segregation.','2013-10-27','NSRP'),(38666,1901721,'positive regulation of NMS complex interaction involved in chromosome segregation','P','Any process that activates or increases the frequency, rate or extent of NMS complex interaction involved in chromosome segregation.','2013-10-27','NSRP'),(38667,1901722,'regulation of cell proliferation involved in kidney development','P','Any process that modulates the frequency, rate or extent of cell proliferation involved in kidney development.','2013-10-27','NSRP'),(38668,1901723,'negative regulation of cell proliferation involved in kidney development','P','Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation involved in kidney development.','2013-10-27','NSRP'),(38669,1901724,'positive regulation of cell proliferation involved in kidney development','P','Any process that activates or increases the frequency, rate or extent of cell proliferation involved in kidney development.','2013-10-27','NSRP'),(38670,1901725,'regulation of histone deacetylase activity','P','Any process that modulates the frequency, rate or extent of histone deacetylase activity.','2013-10-27','NSRP'),(38671,1901726,'negative regulation of histone deacetylase activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of histone deacetylase activity.','2013-10-27','NSRP'),(38672,1901727,'positive regulation of histone deacetylase activity','P','Any process that activates or increases the frequency, rate or extent of histone deacetylase activity.','2013-10-27','NSRP'),(38673,1901728,'monensin A metabolic process','P','The chemical reactions and pathways involving monensin A.','2013-10-27','NSRP'),(38674,1901729,'monensin A catabolic process','P','The chemical reactions and pathways resulting in the breakdown of monensin A.','2013-10-27','NSRP'),(38675,1901730,'monensin A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of monensin A.','2013-10-27','NSRP'),(38676,1901731,'positive regulation of platelet aggregation','P','Any process that activates or increases the frequency, rate or extent of platelet aggregation. Platelet aggregation is the adhesion of one platelet to one or more other platelets via adhesion molecules.','2013-10-27','NSRP'),(38677,1901732,'quercetin metabolic process','P','The chemical reactions and pathways involving quercetin.','2013-10-27','NSRP'),(38678,1901733,'quercetin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of quercetin.','2013-10-27','NSRP'),(38679,1901734,'quercetin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of quercetin.','2013-10-27','NSRP'),(38680,1901735,'(R)-mevalonic acid metabolic process','P','The chemical reactions and pathways involving (R)-mevalonic acid.','2013-10-27','NSRP'),(38681,1901736,'(R)-mevalonic acid catabolic process','P','The chemical reactions and pathways resulting in the breakdown of (R)-mevalonic acid.','2013-10-27','NSRP'),(38682,1901737,'(R)-mevalonic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (R)-mevalonic acid.','2013-10-27','NSRP'),(38683,1901738,'regulation of vitamin A metabolic process','P','Any process that modulates the frequency, rate or extent of vitamin A metabolic process.','2013-10-27','NSRP'),(38684,1901739,'regulation of myoblast fusion','P','Any process that modulates the frequency, rate or extent of myoblast fusion.','2013-10-27','NSRP'),(38685,1901740,'negative regulation of myoblast fusion','P','Any process that stops, prevents or reduces the frequency, rate or extent of myoblast fusion.','2013-10-27','NSRP'),(38686,1901741,'positive regulation of myoblast fusion','P','Any process that activates or increases the frequency, rate or extent of myoblast fusion.','2013-10-27','NSRP'),(38687,1901742,'2-deoxystreptamine metabolic process','P','The chemical reactions and pathways involving 2-deoxystreptamine.','2013-10-27','NSRP'),(38688,1901743,'2-deoxystreptamine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 2-deoxystreptamine.','2013-10-27','NSRP'),(38689,1901744,'2-deoxystreptamine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 2-deoxystreptamine.','2013-10-27','NSRP'),(38690,1901745,'prephenate(2-) metabolic process','P','The chemical reactions and pathways involving prephenate(2-).','2013-10-27','NSRP'),(38691,1901746,'prephenate(2-) catabolic process','P','The chemical reactions and pathways resulting in the breakdown of prephenate(2-).','2013-10-27','NSRP'),(38692,1901747,'prephenate(2-) biosynthetic process','P','The chemical reactions and pathways resulting in the formation of prephenate(2-).','2013-10-27','NSRP'),(38693,1901748,'leukotriene D4 metabolic process','P','The chemical reactions and pathways involving leukotriene D4.','2013-10-27','NSRP'),(38694,1901749,'leukotriene D4 catabolic process','P','The chemical reactions and pathways resulting in the breakdown of leukotriene D4.','2013-10-27','NSRP'),(38695,1901750,'leukotriene D4 biosynthetic process','P','The chemical reactions and pathways resulting in the formation of leukotriene D4.','2013-10-27','NSRP'),(38696,1901751,'leukotriene A4 metabolic process','P','The chemical reactions and pathways involving leukotriene A4.','2013-10-27','NSRP'),(38697,1901752,'leukotriene A4 catabolic process','P','The chemical reactions and pathways resulting in the breakdown of leukotriene A4.','2013-10-27','NSRP'),(38698,1901753,'leukotriene A4 biosynthetic process','P','The chemical reactions and pathways resulting in the formation of leukotriene A4.','2013-10-27','NSRP'),(38699,1901754,'vitamin D3 catabolic process','P','The chemical reactions and pathways resulting in the breakdown of vitamin D3.','2013-10-27','NSRP'),(38700,1901755,'vitamin D3 biosynthetic process','P','The chemical reactions and pathways resulting in the formation of vitamin D3.','2013-10-27','NSRP'),(38701,1901756,'butirosin metabolic process','P','The chemical reactions and pathways involving butirosin.','2013-10-27','NSRP'),(38702,1901757,'butirosin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of butirosin.','2013-10-27','NSRP'),(38703,1901758,'butirosin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of butirosin.','2013-10-27','NSRP'),(38704,1901759,'beta-L-Ara4N-lipid A metabolic process','P','The chemical reactions and pathways involving beta-L-Ara4N-lipid A.','2013-10-27','NSRP'),(38705,1901760,'beta-L-Ara4N-lipid A biosynthetic process','P','The chemical reactions and pathways resulting in the formation of beta-L-Ara4N-lipid A which occurs as a result of modification of the lipid A moiety of lipopolysaccharide by the addition of the sugar 4-amino-4-deoxy-L-arabinose (L-Ara4N). This strategy is adopted by pathogenic Gram-negative bacteria to evade cationic antimicrobial peptides produced by the innate immune system.','2013-10-27','NSRP'),(38706,1901761,'oxytetracycline metabolic process','P','The chemical reactions and pathways involving oxytetracycline.','2013-10-27','NSRP'),(38707,1901762,'oxytetracycline catabolic process','P','The chemical reactions and pathways resulting in the breakdown of oxytetracycline.','2013-10-27','NSRP'),(38708,1901763,'oxytetracycline biosynthetic process','P','The chemical reactions and pathways resulting in the formation of oxytetracycline.','2013-10-27','NSRP'),(38709,1901764,'phosphinothricin metabolic process','P','The chemical reactions and pathways involving phosphinothricin.','2013-10-27','NSRP'),(38710,1901765,'phosphinothricin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of phosphinothricin.','2013-10-27','NSRP'),(38711,1901766,'phosphinothricin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of phosphinothricin.','2013-10-27','NSRP'),(38712,1901767,'carbapenem metabolic process','P','The chemical reactions and pathways involving carbapenem.','2013-10-27','NSRP'),(38713,1901768,'carbapenem catabolic process','P','The chemical reactions and pathways resulting in the breakdown of carbapenem.','2013-10-27','NSRP'),(38714,1901769,'carbapenem biosynthetic process','P','The chemical reactions and pathways resulting in the formation of carbapenem.','2013-10-27','NSRP'),(38715,1901770,'daunorubicin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of daunorubicin.','2013-10-27','NSRP'),(38716,1901771,'daunorubicin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of daunorubicin.','2013-10-27','NSRP'),(38717,1901772,'lincomycin metabolic process','P','The chemical reactions and pathways involving lincomycin.','2013-10-27','NSRP'),(38718,1901773,'lincomycin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of lincomycin.','2013-10-27','NSRP'),(38719,1901774,'lincomycin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of lincomycin.','2013-10-27','NSRP'),(38720,1901775,'mitomycin C metabolic process','P','The chemical reactions and pathways involving mitomycin C.','2013-10-27','NSRP'),(38721,1901776,'mitomycin C catabolic process','P','The chemical reactions and pathways resulting in the breakdown of mitomycin C.','2013-10-27','NSRP'),(38722,1901777,'mitomycin C biosynthetic process','P','The chemical reactions and pathways resulting in the formation of mitomycin C.','2013-10-27','NSRP'),(38723,1901778,'pentalenolactone metabolic process','P','The chemical reactions and pathways involving pentalenolactone.','2013-10-27','NSRP'),(38724,1901779,'pentalenolactone catabolic process','P','The chemical reactions and pathways resulting in the breakdown of pentalenolactone.','2013-10-27','NSRP'),(38725,1901780,'pentalenolactone biosynthetic process','P','The chemical reactions and pathways resulting in the formation of pentalenolactone.','2013-10-27','NSRP'),(38726,1901781,'p-cumate metabolic process','P','The chemical reactions and pathways involving p-cumate.','2013-10-27','NSRP'),(38727,1901782,'p-cumate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of p-cumate.','2013-10-27','NSRP'),(38728,1901783,'p-cumate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of p-cumate.','2013-10-27','NSRP'),(38729,1901784,'p-cresol metabolic process','P','The chemical reactions and pathways involving p-cresol.','2013-10-27','NSRP'),(38730,1901785,'p-cresol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of p-cresol.','2013-10-27','NSRP'),(38731,1901786,'p-cresol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of p-cresol.','2013-10-27','NSRP'),(38732,1901787,'benzoyl-CoA metabolic process','P','The chemical reactions and pathways involving benzoyl-CoA.','2013-10-27','NSRP'),(38733,1901788,'benzoyl-CoA catabolic process','P','The chemical reactions and pathways resulting in the breakdown of benzoyl-CoA.','2013-10-27','NSRP'),(38734,1901789,'benzoyl-CoA biosynthetic process','P','The chemical reactions and pathways resulting in the formation of benzoyl-CoA.','2013-10-27','NSRP'),(38735,1901790,'3-(2,3-dihydroxyphenyl)propanoate metabolic process','P','The chemical reactions and pathways involving 3-(2,3-dihydroxyphenyl)propanoate.','2013-10-27','NSRP'),(38736,1901791,'3-(2,3-dihydroxyphenyl)propanoate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 3-(2,3-dihydroxyphenyl)propanoate.','2013-10-27','NSRP'),(38737,1901792,'3-(2,3-dihydroxyphenyl)propanoate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 3-(2,3-dihydroxyphenyl)propanoate.','2013-10-27','NSRP'),(38738,1901793,'3-(3-hydroxyphenyl)propanoate metabolic process','P','The chemical reactions and pathways involving 3-(3-hydroxyphenyl)propanoate.','2013-10-27','NSRP'),(38739,1901794,'3-(3-hydroxyphenyl)propanoate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 3-(3-hydroxyphenyl)propanoate.','2013-10-27','NSRP'),(38740,1901795,'3-(3-hydroxyphenyl)propanoate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 3-(3-hydroxyphenyl)propanoate.','2013-10-27','NSRP'),(38741,1901796,'regulation of signal transduction by p53 class mediator','P','Any process that modulates the frequency, rate or extent of signal transduction by p53 class mediator.','2013-10-27','NSRP'),(38742,1901797,'negative regulation of signal transduction by p53 class mediator','P','Any process that stops, prevents or reduces the frequency, rate or extent of signal transduction by p53 class mediator.','2013-10-27','NSRP'),(38743,1901798,'positive regulation of signal transduction by p53 class mediator','P','Any process that activates or increases the frequency, rate or extent of signal transduction by p53 class mediator.','2013-10-27','NSRP'),(38744,1901799,'negative regulation of proteasomal protein catabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of proteasomal protein catabolic process.','2013-10-27','NSRP'),(38745,1901800,'positive regulation of proteasomal protein catabolic process','P','Any process that activates or increases the frequency, rate or extent of proteasomal protein catabolic process.','2013-10-27','NSRP'),(38746,1901801,'1,5-anhydro-D-fructose metabolic process','P','The chemical reactions and pathways involving 1,5-anhydro-D-fructose.','2013-10-27','NSRP'),(38747,1901802,'1,5-anhydro-D-fructose catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 1,5-anhydro-D-fructose.','2013-10-27','NSRP'),(38748,1901803,'1,5-anhydro-D-fructose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 1,5-anhydro-D-fructose.','2013-10-27','NSRP'),(38749,1901804,'beta-glucoside metabolic process','P','The chemical reactions and pathways involving beta-glucoside.','2013-10-27','NSRP'),(38750,1901805,'beta-glucoside catabolic process','P','The chemical reactions and pathways resulting in the breakdown of beta-glucoside.','2013-10-27','NSRP'),(38751,1901806,'beta-glucoside biosynthetic process','P','The chemical reactions and pathways resulting in the formation of beta-glucoside.','2013-10-27','NSRP'),(38752,1901807,'capsanthin metabolic process','P','The chemical reactions and pathways involving capsanthin.','2013-10-27','NSRP'),(38753,1901808,'capsanthin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of capsanthin.','2013-10-27','NSRP'),(38754,1901809,'capsanthin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of capsanthin.','2013-10-27','NSRP'),(38755,1901810,'beta-carotene metabolic process','P','The chemical reactions and pathways involving beta-carotene.','2013-10-27','NSRP'),(38756,1901811,'beta-carotene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of beta-carotene.','2013-10-27','NSRP'),(38757,1901812,'beta-carotene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of beta-carotene.','2013-10-27','NSRP'),(38758,1901813,'astaxanthin metabolic process','P','The chemical reactions and pathways involving astaxanthin.','2013-10-27','NSRP'),(38759,1901814,'astaxanthin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of astaxanthin.','2013-10-27','NSRP'),(38760,1901815,'astaxanthin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of astaxanthin.','2013-10-27','NSRP'),(38761,1901816,'beta-zeacarotene metabolic process','P','The chemical reactions and pathways involving beta-zeacarotene.','2013-10-27','NSRP'),(38762,1901817,'beta-zeacarotene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of beta-zeacarotene.','2013-10-27','NSRP'),(38763,1901818,'beta-zeacarotene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of beta-zeacarotene.','2013-10-27','NSRP'),(38764,1901819,'alpha-zeacarotene metabolic process','P','The chemical reactions and pathways involving alpha-zeacarotene.','2013-10-27','NSRP'),(38765,1901820,'alpha-zeacarotene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of alpha-zeacarotene.','2013-10-27','NSRP'),(38766,1901821,'alpha-zeacarotene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of alpha-zeacarotene.','2013-10-27','NSRP'),(38767,1901822,'delta-carotene metabolic process','P','The chemical reactions and pathways involving delta-carotene.','2013-10-27','NSRP'),(38768,1901823,'delta-carotene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of delta-carotene.','2013-10-27','NSRP'),(38769,1901824,'delta-carotene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of delta-carotene.','2013-10-27','NSRP'),(38770,1901825,'zeaxanthin metabolic process','P','The chemical reactions and pathways involving zeaxanthin.','2013-10-27','NSRP'),(38771,1901826,'zeaxanthin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of zeaxanthin.','2013-10-27','NSRP'),(38772,1901827,'zeaxanthin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of zeaxanthin.','2013-10-27','NSRP'),(38773,1901828,'zeaxanthin bis(beta-D-glucoside) metabolic process','P','The chemical reactions and pathways involving zeaxanthin bis(beta-D-glucoside).','2013-10-27','NSRP'),(38774,1901829,'zeaxanthin bis(beta-D-glucoside) catabolic process','P','The chemical reactions and pathways resulting in the breakdown of zeaxanthin bis(beta-D-glucoside).','2013-10-27','NSRP'),(38775,1901830,'zeaxanthin bis(beta-D-glucoside) biosynthetic process','P','The chemical reactions and pathways resulting in the formation of zeaxanthin bis(beta-D-glucoside).','2013-10-27','NSRP'),(38776,1901831,'all-trans-neoxanthin metabolic process','P','The chemical reactions and pathways involving all-trans-neoxanthin.','2013-10-27','NSRP'),(38777,1901832,'all-trans-neoxanthin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of all-trans-neoxanthin.','2013-10-27','NSRP'),(38778,1901833,'all-trans-neoxanthin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of all-trans-neoxanthin.','2013-10-27','NSRP'),(38779,1901834,'regulation of deadenylation-independent decapping of nuclear-transcribed mRNA','P','Any process that modulates the frequency, rate or extent of deadenylation-independent decapping of nuclear-transcribed mRNA.','2013-10-27','NSRP'),(38780,1901835,'positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA','P','Any process that activates or increases the frequency, rate or extent of deadenylation-independent decapping of nuclear-transcribed mRNA.','2013-10-27','NSRP'),(38781,1901836,'regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter','P','Any process that modulates the frequency, rate or extent of transcription of nuclear large rRNA transcript from RNA polymerase I promoter.','2013-10-27','NSRP'),(38782,1901837,'negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter','P','Any process that stops, prevents or reduces the frequency, rate or extent of transcription of nuclear large rRNA transcript from RNA polymerase I promoter.','2013-10-27','NSRP'),(38783,1901838,'positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter','P','Any process that activates or increases the frequency, rate or extent of transcription of nuclear large rRNA transcript from RNA polymerase I promoter.','2013-10-27','NSRP'),(38784,1901839,'regulation of RNA polymerase I regulatory region sequence-specific DNA binding','P','Any process that modulates the frequency, rate or extent of RNA polymerase I regulatory region sequence-specific DNA binding.','2013-10-27','NSRP'),(38785,1901840,'negative regulation of RNA polymerase I regulatory region sequence-specific DNA binding','P','Any process that stops, prevents or reduces the frequency, rate or extent of RNA polymerase I regulatory region sequence-specific DNA binding.','2013-10-27','NSRP'),(38786,1901841,'regulation of high voltage-gated calcium channel activity','P','Any process that modulates the frequency, rate or extent of high voltage-gated calcium channel activity.','2013-10-27','NSRP'),(38787,1901842,'negative regulation of high voltage-gated calcium channel activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of high voltage-gated calcium channel activity.','2013-10-27','NSRP'),(38788,1901843,'positive regulation of high voltage-gated calcium channel activity','P','Any process that activates or increases the frequency, rate or extent of high voltage-gated calcium channel activity.','2013-10-27','NSRP'),(38789,1901844,'regulation of cell communication by electrical coupling involved in cardiac conduction','P','Any process that modulates the frequency, rate or extent of cell communication by electrical coupling involved in cardiac conduction.','2013-10-27','NSRP'),(38790,1901845,'negative regulation of cell communication by electrical coupling involved in cardiac conduction','P','Any process that stops, prevents or reduces the frequency, rate or extent of cell communication by electrical coupling involved in cardiac conduction.','2013-10-27','NSRP'),(38791,1901846,'positive regulation of cell communication by electrical coupling involved in cardiac conduction','P','Any process that activates or increases the frequency, rate or extent of cell communication by electrical coupling involved in cardiac conduction.','2013-10-27','NSRP'),(38792,1901847,'nicotinate metabolic process','P','The chemical reactions and pathways involving nicotinate.','2013-10-27','NSRP'),(38793,1901848,'nicotinate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of nicotinate.','2013-10-27','NSRP'),(38794,1901849,'nicotinate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of nicotinate.','2013-10-27','NSRP'),(38795,1901850,'7,8-didemethyl-8-hydroxy-5-deazariboflavin metabolic process','P','The chemical reactions and pathways involving 7,8-didemethyl-8-hydroxy-5-deazariboflavin.','2013-10-27','NSRP'),(38796,1901851,'7,8-didemethyl-8-hydroxy-5-deazariboflavin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 7,8-didemethyl-8-hydroxy-5-deazariboflavin.','2013-10-27','NSRP'),(38797,1901852,'7,8-didemethyl-8-hydroxy-5-deazariboflavin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 7,8-didemethyl-8-hydroxy-5-deazariboflavin.','2013-10-27','NSRP'),(38798,1901853,'5,6,7,8-tetrahydrosarcinapterin metabolic process','P','The chemical reactions and pathways involving 5,6,7,8-tetrahydrosarcinapterin.','2013-10-27','NSRP'),(38799,1901854,'5,6,7,8-tetrahydrosarcinapterin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 5,6,7,8-tetrahydrosarcinapterin.','2013-10-27','NSRP'),(38800,1901855,'5,6,7,8-tetrahydrosarcinapterin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 5,6,7,8-tetrahydrosarcinapterin.','2013-10-27','NSRP'),(38801,1901856,'negative regulation of cellular respiration','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular respiration.','2013-10-27','NSRP'),(38802,1901857,'positive regulation of cellular respiration','P','Any process that activates or increases the frequency, rate or extent of cellular respiration.','2013-10-27','NSRP'),(38803,1901858,'regulation of mitochondrial DNA metabolic process','P','Any process that modulates the frequency, rate or extent of mitochondrial DNA metabolic process.','2013-10-27','NSRP'),(38804,1901859,'negative regulation of mitochondrial DNA metabolic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial DNA metabolic process.','2013-10-27','NSRP'),(38805,1901860,'positive regulation of mitochondrial DNA metabolic process','P','Any process that activates or increases the frequency, rate or extent of mitochondrial DNA metabolic process.','2013-10-27','NSRP'),(38806,1901861,'regulation of muscle tissue development','P','Any process that modulates the frequency, rate or extent of muscle tissue development.','2013-10-27','NSRP'),(38807,1901862,'negative regulation of muscle tissue development','P','Any process that stops, prevents or reduces the frequency, rate or extent of muscle tissue development.','2013-10-27','NSRP'),(38808,1901863,'positive regulation of muscle tissue development','P','Any process that activates or increases the frequency, rate or extent of muscle tissue development.','2013-10-27','NSRP'),(38809,1901864,'capsorubin metabolic process','P','The chemical reactions and pathways involving capsorubin.','2013-10-27','NSRP'),(38810,1901865,'capsorubin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of capsorubin.','2013-10-27','NSRP'),(38811,1901866,'capsorubin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of capsorubin.','2013-10-27','NSRP'),(38812,1901867,'ecgonine methyl ester metabolic process','P','The chemical reactions and pathways involving ecgonine methyl ester.','2013-10-27','NSRP'),(38813,1901868,'ecgonine methyl ester catabolic process','P','The chemical reactions and pathways resulting in the breakdown of ecgonine methyl ester.','2013-10-27','NSRP'),(38814,1901869,'ecgonine methyl ester biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ecgonine methyl ester.','2013-10-27','NSRP'),(38815,1901870,'ecgonone methyl ester metabolic process','P','The chemical reactions and pathways involving ecgonone methyl ester.','2013-10-27','NSRP'),(38816,1901871,'ecgonone methyl ester catabolic process','P','The chemical reactions and pathways resulting in the breakdown of ecgonone methyl ester.','2013-10-27','NSRP'),(38817,1901872,'ecgonone methyl ester biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ecgonone methyl ester.','2013-10-27','NSRP'),(38818,1901873,'regulation of post-translational protein modification','P','Any process that modulates the frequency, rate or extent of post-translational protein modification.','2013-10-27','NSRP'),(38819,1901874,'negative regulation of post-translational protein modification','P','Any process that stops, prevents or reduces the frequency, rate or extent of post-translational protein modification.','2013-10-27','NSRP'),(38820,1901875,'positive regulation of post-translational protein modification','P','Any process that activates or increases the frequency, rate or extent of post-translational protein modification.','2013-10-27','NSRP'),(38821,1901876,'regulation of calcium ion binding','P','Any process that modulates the frequency, rate or extent of calcium ion binding.','2013-10-27','NSRP'),(38822,1901877,'negative regulation of calcium ion binding','P','Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion binding.','2013-10-27','NSRP'),(38823,1901878,'positive regulation of calcium ion binding','P','Any process that activates or increases the frequency, rate or extent of calcium ion binding.','2013-10-27','NSRP'),(38824,1901879,'regulation of protein depolymerization','P','Any process that modulates the frequency, rate or extent of protein depolymerization.','2013-10-27','NSRP'),(38825,1901880,'negative regulation of protein depolymerization','P','Any process that stops, prevents or reduces the frequency, rate or extent of protein depolymerization.','2013-10-27','NSRP'),(38826,1901881,'positive regulation of protein depolymerization','P','Any process that activates or increases the frequency, rate or extent of protein depolymerization.','2013-10-27','NSRP'),(38827,1901882,'4-hydroxycoumarin metabolic process','P','The chemical reactions and pathways involving 4-hydroxycoumarin.','2013-10-27','NSRP'),(38828,1901883,'4-hydroxycoumarin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 4-hydroxycoumarin.','2013-10-27','NSRP'),(38829,1901884,'4-hydroxycoumarin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 4-hydroxycoumarin.','2013-10-27','NSRP'),(38830,1901885,'2-hydroxybenzoyl-CoA metabolic process','P','The chemical reactions and pathways involving 2-hydroxybenzoyl-CoA.','2013-10-27','NSRP'),(38831,1901886,'2-hydroxybenzoyl-CoA catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 2-hydroxybenzoyl-CoA.','2013-10-27','NSRP'),(38832,1901887,'2-hydroxybenzoyl-CoA biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 2-hydroxybenzoyl-CoA.','2013-10-27','NSRP'),(38833,1901888,'regulation of cell junction assembly','P','Any process that modulates the frequency, rate or extent of cell junction assembly.','2013-10-27','NSRP'),(38834,1901889,'negative regulation of cell junction assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of cell junction assembly.','2013-10-27','NSRP'),(38835,1901890,'positive regulation of cell junction assembly','P','Any process that activates or increases the frequency, rate or extent of cell junction assembly.','2013-10-27','NSRP'),(38836,1901891,'regulation of cell septum assembly','P','Any process that modulates the frequency, rate or extent of cell septum assembly.','2013-10-27','NSRP'),(38837,1901892,'negative regulation of cell septum assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of cell septum assembly.','2013-10-27','NSRP'),(38838,1901893,'positive regulation of cell septum assembly','P','Any process that activates or increases the frequency, rate or extent of cell septum assembly.','2013-10-27','NSRP'),(38839,1901894,'regulation of calcium-transporting ATPase activity','P','Any process that modulates the frequency, rate or extent of calcium-transporting ATPase activity.','2013-10-27','NSRP'),(38840,1901895,'negative regulation of calcium-transporting ATPase activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of calcium-transporting ATPase activity.','2013-10-27','NSRP'),(38841,1901896,'positive regulation of calcium-transporting ATPase activity','P','Any process that activates or increases the frequency, rate or extent of calcium-transporting ATPase activity.','2013-10-27','NSRP'),(38842,1901897,'regulation of relaxation of cardiac muscle','P','Any process that modulates the frequency, rate or extent of relaxation of cardiac muscle.','2013-10-27','NSRP'),(38843,1901898,'negative regulation of relaxation of cardiac muscle','P','Any process that stops, prevents or reduces the frequency, rate or extent of relaxation of cardiac muscle.','2013-10-27','NSRP'),(38844,1901899,'positive regulation of relaxation of cardiac muscle','P','Any process that activates or increases the frequency, rate or extent of relaxation of cardiac muscle.','2013-10-27','NSRP'),(38845,1901900,'regulation of protein localization to cell division site','P','Any process that modulates the frequency, rate or extent of protein localization to cell division site.','2013-10-27','NSRP'),(38846,1901901,'regulation of protein localization to cell division site involved in cytokinesis','P','Any regulation of protein localization to cell division site that is involved in cytokinesis.','2013-10-27','NSRP'),(38847,1901902,'tyrocidine metabolic process','P','The chemical reactions and pathways involving tyrocidine.','2013-10-27','NSRP'),(38848,1901903,'tyrocidine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of tyrocidine.','2013-10-27','NSRP'),(38849,1901904,'tyrocidine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of tyrocidine.','2013-10-27','NSRP'),(38850,1901905,'response to tamsulosin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tamsulosin stimulus.','2013-10-27','NSRP'),(38851,1901906,'diadenosine pentaphosphate metabolic process','P','The chemical reactions and pathways involving diadenosine pentaphosphate.','2013-10-27','NSRP'),(38852,1901907,'diadenosine pentaphosphate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of diadenosine pentaphosphate.','2013-10-27','NSRP'),(38853,1901908,'diadenosine hexaphosphate metabolic process','P','The chemical reactions and pathways involving diadenosine hexaphosphate.','2013-10-27','NSRP'),(38854,1901909,'diadenosine hexaphosphate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of diadenosine hexaphosphate.','2013-10-27','NSRP'),(38855,1901910,'adenosine 5\'-(hexahydrogen pentaphosphate) metabolic process','P','The chemical reactions and pathways involving adenosine 5\'-(hexahydrogen pentaphosphate).','2013-10-27','NSRP'),(38856,1901911,'adenosine 5\'-(hexahydrogen pentaphosphate) catabolic process','P','The chemical reactions and pathways resulting in the breakdown of adenosine 5\'-(hexahydrogen pentaphosphate).','2013-10-27','NSRP'),(38857,1901912,'positive regulation of barrier septum assembly involved in cell cycle cytokinesis','P','Any process that activates or increases the frequency, rate or extent of barrier septum assembly involved in cell cycle cytokinesis.','2013-04-22','NSRP'),(38858,1901913,'regulation of capsule organization','P','Any process that modulates the frequency, rate or extent of capsule organization.','2013-10-27','NSRP'),(38859,1901914,'negative regulation of capsule organization','P','Any process that stops, prevents or reduces the frequency, rate or extent of capsule organization.','2013-10-27','NSRP'),(38860,1901915,'positive regulation of capsule organization','P','Any process that activates or increases the frequency, rate or extent of capsule organization.','2013-10-27','NSRP'),(38861,1901916,'protein kinase activity involved in regulation of protein localization to cell division site involved in cytokinesis','F','Any protein kinase activity that is involved in regulation of protein localization to cell division site involved in cytokinesis.','2013-10-27','NSRP'),(38862,1901917,'regulation of exoribonuclease activity','P','Any process that modulates the frequency, rate or extent of exoribonuclease activity.','2013-10-27','NSRP'),(38863,1901918,'negative regulation of exoribonuclease activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of exoribonuclease activity.','2013-10-27','NSRP'),(38864,1901919,'positive regulation of exoribonuclease activity','P','Any process that activates or increases the frequency, rate or extent of exoribonuclease activity.','2013-10-27','NSRP'),(38865,1901920,'peptidyl-tyrosine dephosphorylation involved in activation of protein kinase activity','P','Any peptidyl-tyrosine dephosphorylation that is involved in activation of protein kinase activity.','2013-10-27','NSRP'),(38866,1901921,'phosphorylation of RNA polymerase II C-terminal domain involved in recruitment of 3\'-end processing factors to RNA polymerase II holoenzyme complex','P','Any phosphorylation of RNA polymerase II C-terminal domain that is involved in recruitment of 3\'-end processing factors to RNA polymerase II holoenzyme complex.','2013-10-27','NSRP'),(38867,1901922,'regulation of sclerotium development','P','Any process that modulates the frequency, rate or extent of sclerotium development.','2013-10-27','NSRP'),(38868,1901923,'negative regulation of sclerotium development','P','Any process that stops, prevents or reduces the frequency, rate or extent of sclerotium development.','2013-10-27','NSRP'),(38869,1901924,'positive regulation of sclerotium development','P','Any process that activates or increases the frequency, rate or extent of sclerotium development.','2013-10-27','NSRP'),(38870,1901925,'negative regulation of protein import into nucleus during spindle assembly checkpoint','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of proteins from the cytoplasm into the nucleus, and that occurs as part of the mitotic cell cycle spindle assembly checkpoint. In S. cerevisiae, this process involves inhibition of the karyopherin/importin Kap121p (also known as Pse1p), which acts as the specific nuclear import receptor for several proteins, including Glc7p. Glc7p functions in opposition to key spindle assembly checkpoint protein Aurora kinase (Ipl1p).','2013-10-27','NSRP'),(38871,1901926,'cadinene metabolic process','P','The chemical reactions and pathways involving cadinene.','2013-10-27','NSRP'),(38872,1901927,'cadinene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of cadinene.','2013-10-27','NSRP'),(38873,1901928,'cadinene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cadinene.','2013-10-27','NSRP'),(38874,1901929,'alpha-copaene metabolic process','P','The chemical reactions and pathways involving alpha-copaene.','2013-10-27','NSRP'),(38875,1901930,'alpha-copaene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of alpha-copaene.','2013-10-27','NSRP'),(38876,1901931,'alpha-copaene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of alpha-copaene.','2013-10-27','NSRP'),(38877,1901932,'bicyclogermacrene metabolic process','P','The chemical reactions and pathways involving bicyclogermacrene.','2013-10-27','NSRP'),(38878,1901933,'bicyclogermacrene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of bicyclogermacrene.','2013-10-27','NSRP'),(38879,1901934,'bicyclogermacrene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of bicyclogermacrene.','2013-10-27','NSRP'),(38880,1901935,'beta-caryophyllene metabolic process','P','The chemical reactions and pathways involving beta-caryophyllene.','2013-10-27','NSRP'),(38881,1901936,'beta-caryophyllene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of beta-caryophyllene.','2013-10-27','NSRP'),(38882,1901937,'beta-caryophyllene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of beta-caryophyllene.','2013-10-27','NSRP'),(38883,1901938,'(-)-exo-alpha-bergamotene metabolic process','P','The chemical reactions and pathways involving (-)-exo-alpha-bergamotene.','2013-10-27','NSRP'),(38884,1901939,'(-)-exo-alpha-bergamotene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of (-)-exo-alpha-bergamotene.','2013-10-27','NSRP'),(38885,1901940,'(-)-exo-alpha-bergamotene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (-)-exo-alpha-bergamotene.','2013-10-27','NSRP'),(38886,1901941,'(+)-epi-alpha-bisabolol metabolic process','P','The chemical reactions and pathways involving (+)-epi-alpha-bisabolol.','2013-10-27','NSRP'),(38887,1901942,'(+)-epi-alpha-bisabolol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of (+)-epi-alpha-bisabolol.','2013-10-27','NSRP'),(38888,1901943,'(+)-epi-alpha-bisabolol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (+)-epi-alpha-bisabolol.','2013-10-27','NSRP'),(38889,1901944,'miltiradiene metabolic process','P','The chemical reactions and pathways involving miltiradiene.','2013-10-27','NSRP'),(38890,1901945,'miltiradiene catabolic process','P','The chemical reactions and pathways resulting in the breakdown of miltiradiene.','2013-10-27','NSRP'),(38891,1901946,'miltiradiene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of miltiradiene.','2013-10-27','NSRP'),(38892,1901947,'5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate metabolic process','P','The chemical reactions and pathways involving 5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate.','2013-10-27','NSRP'),(38893,1901948,'5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate.','2013-10-27','NSRP'),(38894,1901949,'5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of 5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate.','2013-10-27','NSRP'),(38895,1901950,'dense core granule transport','P','The directed movement of dense core granule into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38896,1901951,'regulation of anterograde dense core granule transport','P','Any process that modulates the frequency, rate or extent of anterograde dense core granule transport.','2013-10-27','NSRP'),(38897,1901952,'negative regulation of anterograde dense core granule transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of anterograde dense core granule transport.','2013-10-27','NSRP'),(38898,1901953,'positive regulation of anterograde dense core granule transport','P','Any process that activates or increases the frequency, rate or extent of anterograde dense core granule transport.','2013-10-27','NSRP'),(38899,1901954,'regulation of retrograde dense core granule transport','P','Any process that modulates the frequency, rate or extent of retrograde dense core granule transport.','2013-10-27','NSRP'),(38900,1901955,'negative regulation of retrograde dense core granule transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of retrograde dense core granule transport.','2013-10-27','NSRP'),(38901,1901956,'positive regulation of retrograde dense core granule transport','P','Any process that activates or increases the frequency, rate or extent of retrograde dense core granule transport.','2013-10-27','NSRP'),(38902,1901957,'regulation of cutin biosynthetic process','P','Any process that modulates the frequency, rate or extent of cutin biosynthetic process.','2013-10-27','NSRP'),(38903,1901958,'negative regulation of cutin biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of cutin biosynthetic process.','2013-10-27','NSRP'),(38904,1901959,'positive regulation of cutin biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of cutin biosynthetic process.','2013-10-27','NSRP'),(38905,1901960,'isobutanol metabolic process','P','The chemical reactions and pathways involving isobutanol.','2013-10-27','NSRP'),(38906,1901961,'isobutanol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of isobutanol.','2013-10-27','NSRP'),(38907,1901962,'S-adenosyl-L-methionine transmembrane transport','P','The directed movement of S-adenosyl-L-methionine across a membrane.','2013-10-27','NSRP'),(38908,1901963,'regulation of cell proliferation involved in outflow tract morphogenesis','P','Any process that modulates the frequency, rate or extent of cell proliferation involved in outflow tract morphogenesis.','2013-10-27','NSRP'),(38909,1901964,'positive regulation of cell proliferation involved in outflow tract morphogenesis','P','Any process that activates or increases the frequency, rate or extent of cell proliferation involved in outflow tract morphogenesis.','2013-10-27','NSRP'),(38910,1901965,'endoplasmic reticulum to chloroplast transport','P','The directed movement of substances from endoplasmic reticulum to chloroplast.','2013-10-27','NSRP'),(38911,1901966,'regulation of cellular response to iron ion starvation','P','Any process that modulates the frequency, rate or extent of cellular response to iron ion starvation.','2013-10-27','NSRP'),(38912,1901967,'negative regulation of cellular response to iron ion starvation','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to iron ion starvation.','2013-10-27','NSRP'),(38913,1901968,'regulation of polynucleotide 3\'-phosphatase activity','P','Any process that modulates the frequency, rate or extent of polynucleotide 3\'-phosphatase activity.','2013-10-27','NSRP'),(38914,1901969,'positive regulation of polynucleotide 3\'-phosphatase activity','P','Any process that activates or increases the frequency, rate or extent of polynucleotide 3\'-phosphatase activity.','2013-10-27','NSRP'),(38915,1901970,'positive regulation of mitotic sister chromatid separation','P','Any process that activates or increases the frequency, rate or extent of mitotic sister chromatid separation.','2013-10-27','NSRP'),(38916,1901971,'regulation of DNA-5-methylcytosine glycosylase activity','P','Any process that modulates the frequency, rate or extent of DNA-5-methylcytosine glycosylase activity.','2013-10-27','NSRP'),(38917,1901972,'positive regulation of DNA-5-methylcytosine glycosylase activity','P','Any process that activates or increases the frequency, rate or extent of DNA-5-methylcytosine glycosylase activity.','2013-10-27','NSRP'),(38918,1901973,'proline binding','F','Interacting selectively and non-covalently with proline.','2013-10-27','NSRP'),(38919,1901974,'glycerate transmembrane transporter activity','F','Catalysis of the transfer of glycerate from one side of the membrane to the other.','2013-10-27','NSRP'),(38920,1901975,'glycerate transmembrane transport','P','The directed movement of glycerate across a membrane.','2013-10-27','NSRP'),(38921,1901976,'regulation of cell cycle checkpoint','P','Any process that modulates the frequency, rate or extent of cell cycle checkpoint.','2013-10-27','NSRP'),(38922,1901977,'negative regulation of cell cycle checkpoint','P','Any process that stops, prevents or reduces the frequency, rate or extent of cell cycle checkpoint.','2013-10-27','NSRP'),(38923,1901978,'positive regulation of cell cycle checkpoint','P','Any process that activates or increases the frequency, rate or extent of cell cycle checkpoint.','2013-10-27','NSRP'),(38924,1901979,'regulation of inward rectifier potassium channel activity','P','Any process that modulates the frequency, rate or extent of inward rectifier potassium channel activity.','2013-10-27','NSRP'),(38925,1901980,'positive regulation of inward rectifier potassium channel activity','P','Any process that activates or increases the frequency, rate or extent of inward rectifier potassium channel activity.','2013-10-27','NSRP'),(38926,1901981,'phosphatidylinositol phosphate binding','F','Interacting selectively and non-covalently with phosphatidylinositol phosphate.','2013-10-27','NSRP'),(38927,1901982,'maltose binding','F','Interacting selectively and non-covalently with maltose.','2013-10-27','NSRP'),(38928,1901983,'regulation of protein acetylation','P','Any process that modulates the frequency, rate or extent of protein acetylation.','2013-10-27','NSRP'),(38929,1901984,'negative regulation of protein acetylation','P','Any process that stops, prevents or reduces the frequency, rate or extent of protein acetylation.','2013-10-27','NSRP'),(38930,1901985,'positive regulation of protein acetylation','P','Any process that activates or increases the frequency, rate or extent of protein acetylation.','2013-10-27','NSRP'),(38931,1901986,'response to ketamine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ketamine stimulus.','2013-10-27','NSRP'),(38932,1901987,'regulation of cell cycle phase transition','P','Any process that modulates the frequency, rate or extent of cell cycle phase transition.','2013-10-27','NSRP'),(38933,1901988,'negative regulation of cell cycle phase transition','P','Any process that stops, prevents or reduces the frequency, rate or extent of cell cycle phase transition.','2013-10-27','NSRP'),(38934,1901989,'positive regulation of cell cycle phase transition','P','Any process that activates or increases the frequency, rate or extent of cell cycle phase transition.','2013-10-27','NSRP'),(38935,1901990,'regulation of mitotic cell cycle phase transition','P','Any process that modulates the frequency, rate or extent of mitotic cell cycle phase transition.','2013-10-27','NSRP'),(38936,1901991,'negative regulation of mitotic cell cycle phase transition','P','Any process that stops, prevents or reduces the frequency, rate or extent of mitotic cell cycle phase transition.','2013-10-27','NSRP'),(38937,1901992,'positive regulation of mitotic cell cycle phase transition','P','Any process that activates or increases the frequency, rate or extent of mitotic cell cycle phase transition.','2013-10-27','NSRP'),(38938,1901993,'regulation of meiotic cell cycle phase transition','P','Any process that modulates the frequency, rate or extent of meiotic cell cycle phase transition.','2013-10-27','NSRP'),(38939,1901994,'negative regulation of meiotic cell cycle phase transition','P','Any process that stops, prevents or reduces the frequency, rate or extent of meiotic cell cycle phase transition.','2013-10-27','NSRP'),(38940,1901995,'positive regulation of meiotic cell cycle phase transition','P','Any process that activates or increases the frequency, rate or extent of meiotic cell cycle phase transition.','2013-10-27','NSRP'),(38941,1901996,'regulation of indoleacetic acid biosynthetic process via tryptophan','P','Any process that modulates the frequency, rate or extent of indoleacetic acid biosynthetic process via tryptophan.','2013-10-27','NSRP'),(38942,1901997,'negative regulation of indoleacetic acid biosynthetic process via tryptophan','P','Any process that stops, prevents or reduces the frequency, rate or extent of indoleacetic acid biosynthetic process via tryptophan.','2013-10-27','NSRP'),(38943,1901998,'toxin transport','P','The directed movement of a toxin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(38944,1901999,'homogentisate metabolic process','P','The chemical reactions and pathways involving homogentisate.','2013-10-27','NSRP'),(38945,1902000,'homogentisate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of homogentisate.','2013-10-27','NSRP'),(38946,1902001,'fatty acid transmembrane transport','P','The directed movement of fatty acid across a membrane.','2013-10-27','NSRP'),(38947,1902002,'protein phosphorylation involved in cellular protein catabolic process','P','Any protein phosphorylation that is involved in cellular protein catabolic process.','2013-10-27','NSRP'),(38948,1902003,'regulation of beta-amyloid formation','P','Any process that modulates the frequency, rate or extent of beta-amyloid formation.','2013-10-27','NSRP'),(38949,1902004,'positive regulation of beta-amyloid formation','P','Any process that activates or increases the frequency, rate or extent of beta-amyloid formation.','2013-10-27','NSRP'),(38950,1902005,'regulation of proline biosynthetic process','P','Any process that modulates the frequency, rate or extent of proline biosynthetic process.','2013-10-27','NSRP'),(38951,1902006,'negative regulation of proline biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of proline biosynthetic process.','2013-10-27','NSRP'),(38952,1902007,'regulation of toxin transport','P','Any process that modulates the frequency, rate or extent of toxin transport.','2013-10-27','NSRP'),(38953,1902008,'negative regulation of toxin transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of toxin transport.','2013-10-27','NSRP'),(38954,1902009,'positive regulation of toxin transport','P','Any process that activates or increases the frequency, rate or extent of toxin transport.','2013-10-27','NSRP'),(38955,1902010,'negative regulation of translation involved in response to endoplasmic reticulum stress','P','Any negative regulation of translation that is involved in response to endoplasmic reticulum stress.','2013-10-27','NSRP'),(38956,1902011,'poly(ribitol phosphate) teichoic acid metabolic process','P','The chemical reactions and pathways involving poly(ribitol phosphate) teichoic acid.','2013-10-27','NSRP'),(38957,1902012,'poly(ribitol phosphate) teichoic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of poly(ribitol phosphate) teichoic acid.','2013-10-27','NSRP'),(38958,1902013,'poly(glycerol phosphate) teichoic acid metabolic process','P','The chemical reactions and pathways involving poly(glycerol phosphate) teichoic acid.','2013-10-27','NSRP'),(38959,1902014,'poly(glycerol phosphate) teichoic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of poly(glycerol phosphate) teichoic acid.','2013-10-27','NSRP'),(38960,1902015,'poly(glucopyranosyl N-acetylgalactosamine 1-phosphate) teichoic acid metabolic process','P','The chemical reactions and pathways involving poly(glucopyranosyl N-acetylgalactosamine 1-phosphate) teichoic acid.','2013-10-27','NSRP'),(38961,1902016,'poly(glucopyranosyl N-acetylgalactosamine 1-phosphate) teichoic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of poly(glucopyranosyl N-acetylgalactosamine 1-phosphate) teichoic acid.','2013-10-27','NSRP'),(38962,1990000,'amyloid fibril formation','P','The generation of amyloid fibrils, insoluble fibrous protein aggregates exhibiting beta sheet structure, from proteins. An example of this is seen when human RIP1 and RIP3 kinases form a heterodimeric functional amyloid signaling complex (PMID:22817896).','2013-10-27','NSRP'),(38963,1990001,'inhibition of cysteine-type endopeptidase activity involved in apoptotic process','P','Any process that prevents the activation of an inactive cysteine-type endopeptidase involved in an apoptotic process.','2013-10-27','NSRP'),(38964,1990002,'methylglyoxal reductase (NADPH-dependent, acetol producing)','F','Catalysis of the reaction: H+ + methylglyoxal + NADPH <=> hydroxyacetone + NADP+.','2013-10-27','NSRP'),(38965,1990003,'IDP phosphatase activity','F','Catalysis of the reaction: IDP + H2O = IMP + phosphate.','2013-10-27','NSRP'),(38966,1990004,'XDP phosphatase activity','F','Catalysis of the reaction: XDP + H2O = XMP + phosphate.','2013-10-27','NSRP'),(38967,1990005,'granular vesicle','C','A cytoplasmic membrane-bounded vesicle of varying size, but usually larger than 45 nm, with an electron dense granular core, found in noradrenergic and peptidergic cells.','2013-10-27','NSRP'),(38968,1990006,'amorphous vesicle','C','A cytoplasmic membrane-bounded vesicle first described in dendrites, categorized by smooth membranes, electron-lucent interiors and irregular shapes. Sometimes occurs in clumps. Amorphous vesicles have been found to contain material taken up from the extracellular space, therefore suggesting that they may be part of the endosomal pathway.','2013-10-27','NSRP'),(38969,1990007,'membrane stack','C','A configuration of endoplasmic reticulum (ER) found in Purkinje cells in the cerebellum and in axons in the lateral vestibular nucleus, consisting of parallel and interconnecting tubules whose outer surfaces are covered by particles or ringlike structures.','2013-10-27','NSRP'),(38970,1990008,'neurosecretory vesicle','C','A large cytoplasmic membrane-bounded vesicle with an electron dense granular core, up to 150-200 nm in diameter, found in neurosecretory cells in the hypothalamus.','2013-10-27','NSRP'),(38971,1990009,'retinal cell apoptotic process','P','Any apoptotic process in a retinal cell.','2013-10-27','NSRP'),(38972,1990010,'compound eye retinal cell apoptotic process','P','Any apoptotic process in a compound eye retinal cell.','2013-10-27','NSRP'),(38973,1990011,'laminated body','C','Inclusion body characterized by regularly spaced sheets of tubules arranged in a whorl pattern resembling a fingerprint. Laminated bodies have been observed in neurons of the lateral geniculate nucleus.','2013-10-27','NSRP'),(38974,1990012,'complex laminated body','C','A cytoplasmic inclusion body found in some lateral geniculate neurons and composed of sheets of tubules (25 nm in diameter) separated by dense material (about 75 nm wide), which together with the tubules whorl give a structure resembling a fingerprint.','2013-10-27','NSRP'),(38975,1990013,'presynaptic grid','C','A hexagonal array of electron dense particles attached to the cytoplasmic face of the presynaptic membrane.','2013-10-27','NSRP'),(38976,1990014,'orthogonal array','C','Square array of closely spaced intramembrane particles, 4-6 nm in size, that form supramolecular aggregates found in the plasma membrane of astrocytes, skeletal muscle and epithelial cells. They have been shown to contain aquaporins (water channels).','2013-10-27','NSRP'),(38977,1990015,'ensheathing process','C','A cell projection (often from glial cells such as Schwann cells) that surrounds an unmyelinated axon or cell soma.','2013-10-27','NSRP'),(38978,1990016,'neck portion of tanycyte','C','Elongated portion of a tanycyte that sticks into the periventricular layer of neuropil where it appears to contact a blood vessel; characterized by numerous cytoplasmic extensions. A tanycyte is a specialized elongated ventricular ependymal cell that has processes that extend to the outer, or pial, surface of the CNS.','2013-10-27','NSRP'),(38979,1990017,'somatic portion of tanycyte','C','Portion of a tanycyte that lies within the ependyma and contains the nucleus. A tanycyte is a specialized elongated ventricular ependymal cell that has processes that extend to the outer, or pial, surface of the CNS.','2013-10-27','NSRP'),(38980,1990018,'tail portion of tanycyte','C','Elongated process of a tanycyte, devoid of cytoplasmic extensions, that courses through the hypothalamic nuclei to form small endfoot processes that terminate either on blood vessels or at the pial surface of the brain. A tanycyte is a specialized elongated ventricular ependymal cell.','2013-10-27','NSRP'),(38981,1990019,'protein storage vacuole organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a protein storage vacuole, a storage vacuole that contains a lytic vacuole.','2013-10-27','NSRP'),(38982,1990020,'recurrent axon collateral','C','Axon collateral that ramifies in the area of the soma of the cell of origin.','2013-10-27','NSRP'),(38983,1990021,'Schaffer axon collateral','C','Part of axon of a CA3 pyramidal neuron that projects to hippocampal area CA1.','2013-10-27','NSRP'),(38984,1990022,'RNA polymerase III complex localization to nucleus','P','The directed movement of an RNA polymerase III complex from the cytoplasm to the nucleus.','2013-10-27','NSRP'),(38985,1990023,'mitotic spindle midzone','C','The area in the center of the mitotic spindle where the spindle microtubules from opposite poles overlap.','2013-10-27','NSRP'),(38986,1990024,'C bouton','C','Synaptic bouton found in spinal cord on the soma and proximal dendrites of motor neurons.','2013-10-27','NSRP'),(38987,1990025,'F bouton','C','Synaptic bouton found in the ventral horn of the spinal cord. F boutons range in diameter from 0.5 to 7 um and contain flattened or pleomorphic synaptic vesicles.','2013-10-27','NSRP'),(38988,1990026,'hippocampal mossy fiber expansion','C','Synaptic expansion of hippocampal mossy fiber axon that makes contact with the thorny excrescences of hippocampal CA3 pyramidal cell dendrites.','2013-10-27','NSRP'),(38989,1990027,'S bouton','C','Synaptic bouton found in the ventral horn of the spinal cord. S boutons range in diameter from 0.5 to 8 um and contain spherical synaptic vesicles.','2013-10-27','NSRP'),(38990,1990028,'intermediate voltage-gated calcium channel activity','F','Catalysis of the transmembrane transfer of a calcium ion by an intermediate voltage-gated channel. An intermediate voltage-gated channel is a channel whose open state is dependent on intermediate voltage across the membrane in which it is embedded.','2013-10-27','NSRP'),(38991,1990029,'vasomotion','P','The rhythmical contraction and relaxation of arterioles, observed as slow and fast waves, with frequencies of 1-2 and 10-20 cpm.','2013-10-27','NSRP'),(38992,1990030,'pericellular basket','C','Ramification of basket cell axon surrounding cell bodies, forming the characteristic pericellular baskets from which the cell class derives its name.','2013-10-27','NSRP'),(38993,1990031,'pinceau fiber','C','Dense plexus formed by the descending collaterals of cerebellar basket cells that wrap around a Purkinje cell axonal initial segment.','2013-10-27','NSRP'),(38994,1990032,'parallel fiber','C','A parallel fiber results from the bifurcation of a cerebellar granule cell axon in the molecular layer into two diametrically opposed branches, that are oriented parallel to the long axis of the folium.','2013-10-27','NSRP'),(38995,1990033,'dendritic branch point','C','The part of a dendrite where the cell projection branches, giving rise to a dendritic branch.','2013-10-27','NSRP'),(38996,1990034,'calcium ion export from cell','P','The directed movement of calcium ions out of a cell.','2013-10-27','NSRP'),(38997,1990035,'calcium ion import into cell','P','The directed movement of calcium ions into a cell.','2013-10-27','NSRP'),(38998,1990036,'calcium ion import into sarcoplasmic reticulum','P','The directed movement of calcium ions into a sarcoplasmic reticulum.','2013-10-27','NSRP'),(38999,1990037,'Lewy body core','C','The center portion of a Lewy body. In Parkinson\'s disease, it contains a matted meshwork of filaments.','2013-10-27','NSRP'),(39000,1990038,'Lewy body corona','C','The periphery of a Lewy body. In Parkinson\'s disease, it contains spherical accumulations of filaments arranged in a loose, radiating array.','2013-10-27','NSRP'),(39001,1990039,'hypolemmal cisterna','C','Specialized part of the smooth endoplasmic reticulum that closely underlies the plasma membrane, usually within 60 nm or closer.','2013-10-27','NSRP'),(39002,1990040,'sub-surface cisterna','C','Specialization of the hypolemmal cisterna consisting of either single profiles or closely apposed stacks of endoplasmic reticulum in which the lumen is obliterated, lying 10-20 nm beneath the plasma membrane.','2013-10-27','NSRP'),(39003,1990042,'glycerol dehydrogenase [NAD(P)+] activity','F','Catalysis of an oxidation-reduction (redox) reaction in which glycerol is converted into glycerone and NAD+ or NADP is reduced.','2013-10-27','NSRP'),(39004,1990043,'5\' deoxyribonuclease (pyrimidine dimer) activity','F','Catalysis of the endonucleolytic cleavage immediately 5\' to pyrimidine dimers to products with 5\'-phosphate.','2013-10-27','NSRP'),(39005,1990044,'protein localization to lipid particle','P','A process in which a protein is transported to, or maintained in, a location on or within a lipid particle.','2013-10-27','NSRP'),(39006,1990045,'sclerotium development','P','The process whose specific outcome is the progression of the sclerotium over time, from its formation to the mature structure. A sclerotium is a mycelial resting body, resistant to adverse environmental conditions.','2013-10-27','NSRP'),(39007,1990046,'stress-induced mitochondrial fusion','P','Merging of two or more mitochondria within a cell to form a single compartment, as a result of a disturbance in cellular homeostasis.','2013-10-27','NSRP'),(39008,1990047,'spindle matrix','C','A proteinaceous, nuclear-derived structure that embeds the microtubule spindle apparatus from pole to pole in a microtubule-independent manner during mitosis.','2013-10-27','NSRP'),(39009,1990048,'anterograde dense core granule transport','P','The directed movement of substances in dense core granules within a neuron, along the cytoskeleton, away from the neuronal cell body.','2013-10-27','NSRP'),(39010,1990049,'retrograde dense core granule transport','P','The directed movement of substances in dense core granules within a neuron, along the cytoskeleton, towards the neuronal cell body.','2013-10-27','NSRP'),(39011,1990050,'phosphatidic acid transporter activity','F','Enables the directed movement of phosphatidic acid into, out of or within a cell, or between cells. Phosphatidic acid refers to a glycophospholipids with, in general, a saturated fatty acid bonded to carbon-1, an unsaturated fatty acid bonded to carbon-2, and a phosphate group bonded to carbon-3.','2013-10-27','NSRP'),(39012,1990051,'activation of protein kinase C activity','P','Any process that initiates the activity of the inactive enzyme protein kinase C.','2013-10-27','NSRP'),(39013,1990052,'ER to chloroplast lipid transport','P','The directed movement of a lipid from the endoplasmic reticulum (ER) to the chloroplast.','2013-10-27','NSRP'),(39014,1990053,'DNA-5-methylcytosine glycosylase activity','F','Catalysis of the reaction: DNA containing 5-methylcytosine + H2O = DNA with abasic site + 5-methylcytosine. This reaction is the hydrolysis of DNA by cleavage of the N-C1\' glycosidic bond between the DNA 5-methylcytosine and the deoxyribose sugar to remove the 5-methylcytosine, leaving an abasic site.','2013-10-27','NSRP'),(39015,1990054,'response to temozolomide','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temozolomide stimulus.','2013-10-27','NSRP'),(39016,1990055,'phenylacetaldehyde synthase activity','F','Catalyzes the reaction: L-phenylalanine + O2 + H2O -> phenylacetaldehyde + ammonia + hydrogen peroxide + CO2.','2013-10-27','NSRP'),(39017,1990056,'protein kinase activity required for targeting substrate to proteasomal ubiquitin-dependent protein catabolic process','F','OBSOLETE. Catalysis of the phosphorylation of an amino acid residue in a substrate protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP, thereby targeting the substrate to the proteasomal ubiquitin mediated protein catabolic process','2013-10-27','NSRP'),(39018,1990057,'cell cycle arrest in response to DNA damage stimulus','P','OBSOLETE. The cell cycle regulatory process in which the cell cycle is halted during one of the normal phases (G1, S, G2, M) as a result of DNA damage from environmental insults or errors during metabolism.','2013-10-27','NSRP'),(39019,1990058,'fruit replum development','P','The process whose specific outcome is the progression of the fruit replum over time, from its formation to the mature structure. The fruit replum is a portion of fruit placenta tissue that divides a fruit into two or more chambers and develops from a replum.','2013-10-27','NSRP'),(39020,1990059,'fruit valve development','P','The process whose specific outcome is the progression of the fruit valve over time, from its formation to the mature structure. The fruit valve is a part of a fruit that splits apart when the fruit dehisces.','2013-10-27','NSRP'),(39021,1990060,'maltose transport complex','C','Protein complex facilitating ATP-dependent maltose transport through inner cell membrane (periplasm to cytoplasm) in Gram-negative bacteria. In E. coli the system is composed of a periplasmic maltose-binding protein (MBP), two integral membrane proteins, MalF and MalG, and two copies of the cytoplasmic ATP-binding cassette MalK.','2013-10-27','NSRP'),(39022,1990061,'bacterial degradosome','C','The degradosome is a protein complex playing a key role in mRNA degradation and RNA processing. It includes a RNA helicase, a 3\'-5\' phosphate-dependent PNPase and a RNase E bound-enolase.','2013-10-27','NSRP'),(39023,1990062,'RPAP3/R2TP/prefoldin-like complex','C','A protein complex first characterized in human and comprised of a R2TP module (R2TP complex), a prefoldin-like module (containing both prefoldin-like proteins and canonical prefoldins), WD40 repeat protein Monad/WDR92 and DNA-dependent RNA polymerase subunit RPB5. This complex might have chaperone activity.','2013-10-27','NSRP'),(39024,1990063,'Bam protein complex','C','Protein complex which is involved in assembly and insertion of beta-barrel proteins into the outer membrane. In E. coli it is composed of BamABCDE, of the outer membrane protein BamA, and four lipoproteins BamB, BamC, BamD and BamE. BamA interacts directly with BamB and the BamCDE subcomplex.','2013-10-27','NSRP'),(39025,1990064,'ground tissue pattern formation','P','The regionalization process that gives rise to the patterning of the ground tissue.','2013-10-27','NSRP'),(39026,2001020,'regulation of response to DNA damage stimulus','P','Any process that modulates the frequency, rate or extent of response to DNA damage stimulus.','2013-10-27','NSRP'),(39027,2001021,'negative regulation of response to DNA damage stimulus','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to DNA damage stimulus.','2013-10-27','NSRP'),(39028,2001022,'positive regulation of response to DNA damage stimulus','P','Any process that activates or increases the frequency, rate or extent of response to DNA damage stimulus.','2013-10-27','NSRP'),(39029,2001023,'regulation of response to drug','P','Any process that modulates the frequency, rate or extent of response to drug.','2013-10-27','NSRP'),(39030,2001024,'negative regulation of response to drug','P','Any process that stops, prevents or reduces the frequency, rate or extent of response to drug.','2013-10-27','NSRP'),(39031,2001025,'positive regulation of response to drug','P','Any process that activates or increases the frequency, rate or extent of response to drug.','2013-10-27','NSRP'),(39032,2001026,'regulation of endothelial cell chemotaxis','P','Any process that modulates the frequency, rate or extent of endothelial cell chemotaxis.','2013-10-27','NSRP'),(39033,2001027,'negative regulation of endothelial cell chemotaxis','P','Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell chemotaxis.','2013-10-27','NSRP'),(39034,2001028,'positive regulation of endothelial cell chemotaxis','P','Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis.','2013-10-27','NSRP'),(39035,2001029,'regulation of cellular glucuronidation','P','Any process that modulates the frequency, rate or extent of cellular glucuronidation.','2013-10-27','NSRP'),(39036,2001030,'negative regulation of cellular glucuronidation','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular glucuronidation.','2013-10-27','NSRP'),(39037,2001031,'positive regulation of cellular glucuronidation','P','Any process that activates or increases the frequency, rate or extent of cellular glucuronidation.','2013-10-27','NSRP'),(39038,2001032,'regulation of double-strand break repair via nonhomologous end joining','P','Any process that modulates the frequency, rate or extent of double-strand break repair via nonhomologous end joining.','2013-10-27','NSRP'),(39039,2001033,'negative regulation of double-strand break repair via nonhomologous end joining','P','Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair via nonhomologous end joining.','2013-10-27','NSRP'),(39040,2001034,'positive regulation of double-strand break repair via nonhomologous end joining','P','Any process that activates or increases the frequency, rate or extent of double-strand break repair via nonhomologous end joining.','2013-10-27','NSRP'),(39041,2001035,'regulation of tongue muscle cell differentiation','P','Any process that modulates the frequency, rate or extent of tongue muscle cell differentiation.','2013-10-27','NSRP'),(39042,2001036,'negative regulation of tongue muscle cell differentiation','P','Any process that stops, prevents or reduces the frequency, rate or extent of tongue muscle cell differentiation.','2013-10-27','NSRP'),(39043,2001037,'positive regulation of tongue muscle cell differentiation','P','Any process that activates or increases the frequency, rate or extent of tongue muscle cell differentiation.','2013-10-27','NSRP'),(39044,2001038,'regulation of cellular response to drug','P','Any process that modulates the frequency, rate or extent of cellular response to drug.','2013-10-27','NSRP'),(39045,2001039,'negative regulation of cellular response to drug','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to drug.','2013-10-27','NSRP'),(39046,2001040,'positive regulation of cellular response to drug','P','Any process that activates or increases the frequency, rate or extent of cellular response to drug.','2013-10-27','NSRP'),(39047,2001041,'regulation of cytokinetic cell separation involved in cell cycle cytokinesis','P','Any process that modulates the frequency, rate or extent of cytokinetic cell separation involved in cell cycle cytokinesis.','2013-04-22','NSRP'),(39048,2001042,'negative regulation of cytokinetic cell separation','P','Any process that stops, prevents or reduces the frequency, rate or extent of cytokinetic cell separation involved in cell cycle cytokinesis.','2013-10-27','NSRP'),(39049,2001043,'positive regulation of cytokinetic cell separation','P','Any process that activates or increases the frequency, rate or extent of cytokinetic cell separation involved in cell cycle cytokinesis.','2013-10-27','NSRP'),(39050,2001044,'regulation of integrin-mediated signaling pathway','P','Any process that modulates the frequency, rate or extent of integrin-mediated signaling pathway.','2013-10-27','NSRP'),(39051,2001045,'negative regulation of integrin-mediated signaling pathway','P','Any process that stops, prevents or reduces the frequency, rate or extent of integrin-mediated signaling pathway.','2013-10-27','NSRP'),(39052,2001046,'positive regulation of integrin-mediated signaling pathway','P','Any process that activates or increases the frequency, rate or extent of integrin-mediated signaling pathway.','2013-10-27','NSRP'),(39053,2001049,'regulation of tendon cell differentiation','P','Any process that modulates the frequency, rate or extent of tendon cell differentiation.','2013-10-27','NSRP'),(39054,2001050,'negative regulation of tendon cell differentiation','P','Any process that stops, prevents or reduces the frequency, rate or extent of tendon cell differentiation.','2013-10-27','NSRP'),(39055,2001051,'positive regulation of tendon cell differentiation','P','Any process that activates or increases the frequency, rate or extent of tendon cell differentiation.','2013-10-27','NSRP'),(39056,2001053,'regulation of mesenchymal cell apoptotic process','P','Any process that modulates the frequency, rate or extent of mesenchymal cell apoptotic process.','2013-10-27','NSRP'),(39057,2001054,'negative regulation of mesenchymal cell apoptotic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of mesenchymal cell apoptotic process.','2013-10-27','NSRP'),(39058,2001055,'positive regulation of mesenchymal cell apoptotic process','P','Any process that activates or increases the frequency, rate or extent of mesenchymal cell apoptotic process.','2013-10-27','NSRP'),(39059,2001056,'positive regulation of cysteine-type endopeptidase activity','P','Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity.','2013-10-27','NSRP'),(39060,2001057,'reactive nitrogen species metabolic process','P','The chemical reactions and pathways involving a reactive nitrogen species.','2013-10-27','NSRP'),(39061,2001058,'D-tagatose 6-phosphate metabolic process','P','The chemical reactions and pathways involving a D-tagatose 6-phosphate.','2013-10-27','NSRP'),(39062,2001059,'D-tagatose 6-phosphate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a D-tagatose 6-phosphate.','2013-10-27','NSRP'),(39063,2001060,'D-glycero-D-manno-heptose 7-phosphate metabolic process','P','The chemical reactions and pathways involving a D-glycero-D-manno-heptose 7-phosphate.','2013-10-27','NSRP'),(39064,2001061,'D-glycero-D-manno-heptose 7-phosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a D-glycero-D-manno-heptose 7-phosphate.','2013-10-27','NSRP'),(39065,2001062,'xylan binding','F','Interacting selectively and non-covalently with xylan.','2013-10-27','NSRP'),(39066,2001063,'glucomannan binding','F','Interacting selectively and non-covalently with glucomannan.','2013-10-27','NSRP'),(39067,2001064,'cellooligosaccharide binding','F','Interacting selectively and non-covalently with cellooligosaccharide.','2013-10-27','NSRP'),(39068,2001065,'mannan binding','F','Interacting selectively and non-covalently with mannan.','2013-10-27','NSRP'),(39069,2001066,'amylopectin binding','F','Interacting selectively and non-covalently with amylopectin.','2013-10-27','NSRP'),(39070,2001067,'pullulan binding','F','Interacting selectively and non-covalently with pullulan.','2013-10-27','NSRP'),(39071,2001068,'arabinoxylan binding','F','Interacting selectively and non-covalently with arabinoxylan.','2013-10-27','NSRP'),(39072,2001069,'glycogen binding','F','Interacting selectively and non-covalently with glycogen.','2013-10-27','NSRP'),(39073,2001070,'starch binding','F','Interacting selectively and non-covalently with starch.','2013-10-27','NSRP'),(39074,2001071,'maltoheptaose binding','F','Interacting selectively and non-covalently with maltoheptaose.','2013-10-27','NSRP'),(39075,2001072,'galactomannan binding','F','Interacting selectively and non-covalently with galactomannan.','2013-10-27','NSRP'),(39076,2001073,'cyclodextrin binding','F','Interacting selectively and non-covalently with cyclodextrin.','2013-10-27','NSRP'),(39077,2001074,'regulation of metanephric ureteric bud development','P','Any process that modulates the frequency, rate or extent of metanephric ureteric bud development.','2013-10-27','NSRP'),(39078,2001075,'negative regulation of metanephric ureteric bud development','P','Any process that stops, prevents or reduces the frequency, rate or extent of metanephric ureteric bud development.','2013-10-27','NSRP'),(39079,2001076,'positive regulation of metanephric ureteric bud development','P','Any process that activates or increases the frequency, rate or extent of metanephric ureteric bud development.','2013-10-27','NSRP'),(39080,2001077,'(1->3),(1->4)-beta-glucan binding','F','Interacting selectively and non-covalently with (1->3),(1->4)-beta-glucan.','2013-10-27','NSRP'),(39081,2001078,'(1->6)-beta-D-glucan binding','F','Interacting selectively and non-covalently with (1->6)-beta-D-glucan.','2013-10-27','NSRP'),(39082,2001079,'beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc binding','F','Interacting selectively and non-covalently with beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc.','2013-10-27','NSRP'),(39083,2001080,'chitosan binding','F','Interacting selectively and non-covalently with chitosan.','2013-10-27','NSRP'),(39084,2001081,'(1->4)-beta-D-galactan binding','F','Interacting selectively and non-covalently with (1->4)-beta-D-galactan.','2013-10-27','NSRP'),(39085,2001082,'inulin binding','F','Interacting selectively and non-covalently with inulin.','2013-10-27','NSRP'),(39086,2001083,'alpha-D-glucan binding','F','Interacting selectively and non-covalently with alpha-D-glucan.','2013-10-27','NSRP'),(39087,2001084,'L-arabinofuranose binding','F','Interacting selectively and non-covalently with L-arabinofuranose.','2013-10-27','NSRP'),(39088,2001085,'arabinogalactan binding','F','Interacting selectively and non-covalently with arabinogalactan.','2013-10-27','NSRP'),(39089,2001086,'laminarabiose transport','P','The directed movement of a laminarabioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39090,2001087,'sophorose transport','P','The directed movement of a sophoroseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39091,2001088,'trisaccharide transport','P','The directed movement of a trisaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39092,2001089,'maltotriose transport','P','The directed movement of a maltotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39093,2001090,'maltotriulose transport','P','The directed movement of a maltotriuloseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39094,2001091,'nigerotriose transport','P','The directed movement of a nigerotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39095,2001092,'arabinotriose transport','P','The directed movement of an arabinotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39096,2001093,'galactotriose transport','P','The directed movement of a galactotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39097,2001094,'xylotriose transport','P','The directed movement of a xylotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39098,2001095,'mannotriose transport','P','The directed movement of a mannotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39099,2001096,'cellotriose transport','P','The directed movement of a cellotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39100,2001097,'laminaritriose transport','P','The directed movement of a laminaritrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39101,2001098,'tetrasaccharide transport','P','The directed movement of a tetrasaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39102,2001099,'maltotetraose transport','P','The directed movement of a maltotetraoseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39103,2001100,'pentasaccharide transport','P','The directed movement of a pentasaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39104,2001101,'maltopentaose transport','P','The directed movement of a maltopentaoseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39105,2001102,'hexasaccharide transport','P','The directed movement of a hexasaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39106,2001103,'maltohexaose transport','P','The directed movement of a maltohexaoseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39107,2001104,'heptasaccharide transport','P','The directed movement of a heptasaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39108,2001105,'maltoheptaose transport','P','The directed movement of a maltoheptaoseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39109,2001106,'regulation of Rho guanyl-nucleotide exchange factor activity','P','Any process that modulates the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity.','2013-10-27','NSRP'),(39110,2001107,'negative regulation of Rho guanyl-nucleotide exchange factor activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity.','2013-10-27','NSRP'),(39111,2001108,'positive regulation of Rho guanyl-nucleotide exchange factor activity','P','Any process that activates or increases the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity.','2013-10-27','NSRP'),(39112,2001109,'regulation of lens epithelial cell proliferation','P','Any process that modulates the frequency, rate or extent of lens epithelial cell proliferation.','2013-10-27','NSRP'),(39113,2001110,'negative regulation of lens epithelial cell proliferation','P','Any process that stops, prevents or reduces the frequency, rate or extent of lens epithelial cell proliferation.','2013-10-27','NSRP'),(39114,2001111,'positive regulation of lens epithelial cell proliferation','P','Any process that activates or increases the frequency, rate or extent of lens epithelial cell proliferation.','2013-10-27','NSRP'),(39115,2001112,'regulation of cellular response to hepatocyte growth factor stimulus','P','Any process that modulates the frequency, rate or extent of cellular response to hepatocyte growth factor stimulus.','2013-10-27','NSRP'),(39116,2001113,'negative regulation of cellular response to hepatocyte growth factor stimulus','P','Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to hepatocyte growth factor stimulus.','2013-10-27','NSRP'),(39117,2001114,'positive regulation of cellular response to hepatocyte growth factor stimulus','P','Any process that activates or increases the frequency, rate or extent of cellular response to hepatocyte growth factor stimulus.','2013-10-27','NSRP'),(39118,2001115,'methanopterin-containing compound metabolic process','P','The chemical reactions and pathways involving a methanopterin.','2013-10-27','NSRP'),(39119,2001116,'methanopterin-containing compound biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a methanopterin.','2013-10-27','NSRP'),(39120,2001117,'tetrahydromethanopterin metabolic process','P','The chemical reactions and pathways involving a tetrahydromethanopterin.','2013-10-27','NSRP'),(39121,2001118,'tetrahydromethanopterin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a tetrahydromethanopterin.','2013-10-27','NSRP'),(39122,2001119,'methanofuran metabolic process','P','The chemical reactions and pathways involving a methanofuran.','2013-10-27','NSRP'),(39123,2001120,'methanofuran biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a methanofuran.','2013-10-27','NSRP'),(39124,2001121,'coenzyme gamma-F420-2 biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a coenzyme gamma-F420-2.','2013-10-27','NSRP'),(39125,2001122,'maltoheptaose metabolic process','P','The chemical reactions and pathways involving a maltoheptaose.','2013-10-27','NSRP'),(39126,2001123,'maltoheptaose catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a maltoheptaose.','2013-10-27','NSRP'),(39127,2001124,'regulation of translational frameshifting','P','Any process that modulates the frequency, rate or extent of translational frameshifting.','2013-10-27','NSRP'),(39128,2001125,'negative regulation of translational frameshifting','P','Any process that stops, prevents or reduces the frequency, rate or extent of translational frameshifting.','2013-10-27','NSRP'),(39129,2001126,'positive regulation of translational frameshifting','P','Any process that activates or increases the frequency, rate or extent of translational frameshifting.','2013-10-27','NSRP'),(39130,2001127,'methane biosynthetic process from formic acid','P','The chemical reactions and pathways resulting in the formation of a methane from a formic acid.','2013-10-27','NSRP'),(39131,2001128,'methane biosynthetic process from methylamine','P','The chemical reactions and pathways resulting in the formation of a methane from a methylamine.','2013-10-27','NSRP'),(39132,2001129,'methane biosynthetic process from dimethylamine','P','The chemical reactions and pathways resulting in the formation of a methane from a dimethylamine.','2013-10-27','NSRP'),(39133,2001130,'methane biosynthetic process from trimethylamine','P','The chemical reactions and pathways resulting in the formation of a methane from a trimethylamine.','2013-10-27','NSRP'),(39134,2001131,'methane biosynthetic process from dimethyl sulfide','P','The chemical reactions and pathways resulting in the formation of a methane from a dimethyl sulfide.','2013-10-27','NSRP'),(39135,2001132,'methane biosynthetic process from 3-(methylthio)propionic acid','P','The chemical reactions and pathways resulting in the formation of a methane from a 3-(methylthio)propionic acid.','2013-10-27','NSRP'),(39136,2001133,'methane biosynthetic process from methanethiol','P','The chemical reactions and pathways resulting in the formation of a methane from a methanethiol.','2013-10-27','NSRP'),(39137,2001134,'methane biosynthetic process from carbon monoxide','P','The chemical reactions and pathways resulting in the formation of a methane from a carbon monoxide.','2013-10-27','NSRP'),(39138,2001135,'regulation of endocytic recycling','P','Any process that modulates the frequency, rate or extent of endocytic recycling.','2013-10-27','NSRP'),(39139,2001136,'negative regulation of endocytic recycling','P','Any process that stops, prevents or reduces the frequency, rate or extent of endocytic recycling.','2013-10-27','NSRP'),(39140,2001137,'positive regulation of endocytic recycling','P','Any process that activates or increases the frequency, rate or extent of endocytic recycling.','2013-10-27','NSRP'),(39141,2001138,'regulation of phospholipid transport','P','Any process that modulates the frequency, rate or extent of phospholipid transport.','2013-10-27','NSRP'),(39142,2001139,'negative regulation of phospholipid transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of phospholipid transport.','2013-10-27','NSRP'),(39143,2001140,'positive regulation of phospholipid transport','P','Any process that activates or increases the frequency, rate or extent of phospholipid transport.','2013-10-27','NSRP'),(39144,2001141,'regulation of RNA biosynthetic process','P','Any process that modulates the frequency, rate or extent of RNA biosynthetic process.','2013-10-27','NSRP'),(39145,2001142,'nicotinate transport','P','The directed movement of a nicotinateacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39146,2001143,'N-methylnicotinate transport','P','The directed movement of a N-methylnicotinateacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(39147,2001144,'regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity','P','Any process that modulates the frequency, rate or extent of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity.','2013-10-27','NSRP'),(39148,2001145,'negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity','P','Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity.','2013-10-27','NSRP'),(39149,2001146,'positive regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity','P','Any process that activates or increases the frequency, rate or extent of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity.','2013-10-27','NSRP'),(39150,2001147,'camalexin binding','F','Interacting selectively and non-covalently with camalexin.','2013-10-27','NSRP'),(39151,2001148,'regulation of dipeptide transmembrane transport','P','Any process that modulates the frequency, rate or extent of dipeptide transmembrane transport.','2013-10-27','NSRP'),(39152,2001149,'negative regulation of dipeptide transmembrane transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of dipeptide transmembrane transport.','2013-10-27','NSRP'),(39153,2001150,'positive regulation of dipeptide transmembrane transport','P','Any process that activates or increases the frequency, rate or extent of dipeptide transmembrane transport.','2013-10-27','NSRP'),(39154,2001151,'regulation of renal water transport','P','Any process that modulates the frequency, rate or extent of renal water transport.','2013-10-27','NSRP'),(39155,2001152,'negative regulation of renal water transport','P','Any process that stops, prevents or reduces the frequency, rate or extent of renal water transport.','2013-10-27','NSRP'),(39156,2001153,'positive regulation of renal water transport','P','Any process that activates or increases the frequency, rate or extent of renal water transport.','2013-10-27','NSRP'),(39157,2001154,'regulation of glucose catabolic process to ethanol','P','Any process that modulates the frequency, rate or extent of glucose catabolic process to ethanol.','2013-10-27','NSRP'),(39158,2001155,'negative regulation of glucose catabolic process to ethanol','P','Any process that stops, prevents or reduces the frequency, rate or extent of glucose catabolic process to ethanol.','2013-10-27','NSRP'),(39159,2001156,'regulation of proline catabolic process to glutamate','P','Any process that modulates the frequency, rate or extent of proline catabolic process to glutamate.','2013-10-27','NSRP'),(39160,2001157,'negative regulation of proline catabolic process to glutamate','P','Any process that stops, prevents or reduces the frequency, rate or extent of proline catabolic process to glutamate.','2013-10-27','NSRP'),(39161,2001158,'positive regulation of proline catabolic process to glutamate','P','Any process that activates or increases the frequency, rate or extent of proline catabolic process to glutamate.','2013-10-27','NSRP'),(39162,2001159,'regulation of CVT pathway','P','Any process that modulates the frequency, rate or extent of CVT pathway.','2013-10-27','NSRP'),(39163,2001160,'regulation of histone H3-K79 methylation','P','Any process that modulates the frequency, rate or extent of histone H3-K79 methylation.','2013-10-27','NSRP'),(39164,2001161,'negative regulation of histone H3-K79 methylation','P','Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K79 methylation.','2013-10-27','NSRP'),(39165,2001162,'positive regulation of histone H3-K79 methylation','P','Any process that activates or increases the frequency, rate or extent of histone H3-K79 methylation.','2013-10-27','NSRP'),(39166,2001163,'regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues','P','Any process that modulates the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues.','2013-10-27','NSRP'),(39167,2001164,'negative regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues','P','Any process that stops, prevents or reduces the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues.','2013-10-27','NSRP'),(39168,2001165,'positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues','P','Any process that activates or increases the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues.','2013-10-27','NSRP'),(39169,2001166,'regulation of histone H2B ubiquitination','P','Any process that modulates the frequency, rate or extent of histone H2B ubiquitination.','2013-10-27','NSRP'),(39170,2001167,'negative regulation of histone H2B ubiquitination','P','Any process that stops, prevents or reduces the frequency, rate or extent of histone H2B ubiquitination.','2013-10-27','NSRP'),(39171,2001168,'positive regulation of histone H2B ubiquitination','P','Any process that activates or increases the frequency, rate or extent of histone H2B ubiquitination.','2013-10-27','NSRP'),(39172,2001169,'regulation of ATP biosynthetic process','P','Any process that modulates the frequency, rate or extent of ATP biosynthetic process.','2013-10-27','NSRP'),(39173,2001170,'negative regulation of ATP biosynthetic process','P','Any process that stops, prevents or reduces the frequency, rate or extent of ATP biosynthetic process.','2013-10-27','NSRP'),(39174,2001171,'positive regulation of ATP biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of ATP biosynthetic process.','2013-10-27','NSRP'),(39175,2001172,'positive regulation of glucose catabolic process to ethanol','P','Any process that activates or increases the frequency, rate or extent of glucose catabolic process to ethanol.','2013-10-27','NSRP'),(39176,2001173,'regulation of histone H2B conserved C-terminal lysine ubiquitination','P','Any process that modulates the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.','2013-10-27','NSRP'),(39177,2001174,'negative regulation of histone H2B conserved C-terminal lysine ubiquitination','P','Any process that stops, prevents or reduces the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.','2013-10-27','NSRP'),(39178,2001175,'positive regulation of histone H2B conserved C-terminal lysine ubiquitination','P','Any process that activates or increases the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.','2013-10-27','NSRP'),(39179,2001176,'regulation of mediator complex assembly','P','Any process that modulates the frequency, rate or extent of mediator complex assembly.','2013-10-27','NSRP'),(39180,2001177,'negative regulation of mediator complex assembly','P','Any process that stops, prevents or reduces the frequency, rate or extent of mediator complex assembly.','2013-10-27','NSRP'),(39181,2001178,'positive regulation of mediator complex assembly','P','Any process that activates or increases the frequency, rate or extent of mediator complex assembly.','2013-10-27','NSRP'),(39182,2001179,'regulation of interleukin-10 secretion','P','Any process that modulates the frequency, rate or extent of interleukin-10 secretion.','2013-10-27','NSRP'),